data_1r9p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1r9p _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.0 t0 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.479 ' C ' ' CG ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER 71.48 -7.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.479 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 178.29 30.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.656 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.12 94.93 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.648 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.12 126.15 7.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.01 127.13 2.27 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 ttt -133.62 98.39 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.283 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -107.49 170.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.41 160.14 26.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.91 92.98 38.3 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.152 -1.205 . . . . 0.0 109.642 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.85 -16.06 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.679 2.253 . . . . 0.0 112.052 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 -57.16 4.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.9 p -100.91 19.53 17.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.439 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.27 58.32 1.06 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 42.9 t0 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -98.29 122.43 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -108.46 115.66 30.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -110.99 113.64 26.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 9.9 tp -103.64 153.64 20.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.451 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.06 111.42 5.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -101.26 146.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -131.15 122.94 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.47 141.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.621 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -172.47 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 4.3 m-20 -62.73 45.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.648 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.4 m-20 78.5 51.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.6 -5.75 72.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.77 156.53 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -1.161 . . . . 0.0 109.385 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.43 94.57 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.73 -25.14 64.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.423 -0.798 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.19 168.47 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.89 131.15 11.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -110.87 163.13 14.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 16.2 p90 -142.1 166.6 24.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 109.379 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 101.4 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.391 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -154.1 143.39 21.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 1.2 p90 -161.82 134.7 6.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.04 -52.95 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 168.26 20.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.184 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 38.81 2.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 t -166.29 -47.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -1.161 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' C ' ' N ' ' A' ' 68' ' ' ALA . . . -48.38 -37.56 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -47.52 -19.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.613 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' ALA . . . -95.93 -40.26 9.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.403 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.644 ' HG ' ' N ' ' A' ' 70' ' ' SER . 4.7 p -50.92 -38.68 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.321 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.644 ' N ' ' HG ' ' A' ' 69' ' ' SER . 87.9 p -58.94 -38.89 80.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -63.64 -41.85 98.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 73' ' ' ILE . 1.7 tp -66.65 -73.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 72' ' ' LEU . 6.2 tt -43.26 -28.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.602 ' CG2' ' O ' ' A' ' 70' ' ' SER . 19.2 p -77.5 -41.46 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.59 2.14 38.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -110.6 -30.31 7.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.758 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 4.4 m -109.25 50.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -123.82 104.63 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.39 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 6.1 63.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.0 mmtt -98.67 175.22 6.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -1.12 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 83' ' ' GLU . 12.3 t -88.16 154.52 20.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.76 -20.16 63.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.703 ' H ' ' HG ' ' A' ' 81' ' ' SER . 49.3 tt0 -64.12 -29.95 71.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -91.56 -35.51 14.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.78 -37.86 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.36 57.57 2.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -163.27 -34.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -1.124 . . . . 0.0 109.004 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 0.8 OUTLIER -45.15 -14.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 87' ' ' ALA . 19.5 mttm 46.68 -173.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.28 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 91' ' ' SER . 24.5 p-10 -97.9 -24.14 15.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.696 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.6 -25.47 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.98 -65.36 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 109.661 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 9.5 tt -49.81 -38.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -59.75 -46.33 89.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.379 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -65.02 -28.48 69.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tm-20 -71.46 -28.99 64.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.426 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 25.8 mt -93.67 -36.96 12.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.339 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 5.7 tt0 69.72 62.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -120.1 149.3 48.87 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.942 . . . . 0.0 109.451 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.96 158.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 103' ' ' LYS . 41.4 Cg_endo -72.05 -51.11 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.766 2.311 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.47 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 41.4 t -58.04 -2.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 101' ' ' PRO . 13.7 mttp -115.6 12.18 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.24 -1.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.727 ' N ' ' HD1' ' A' ' 105' ' ' HIS . 0.3 OUTLIER -57.58 -41.62 81.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.981 . . . . 0.0 109.256 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 19.3 m -63.8 -46.82 83.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.841 . . . . 0.0 109.337 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -56.42 -46.45 80.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.343 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.6 mt -52.89 -45.32 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.305 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.5 -46.58 86.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.67 -53.39 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.93 -56.38 19.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.57 -17.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.77 -53.42 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.464 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.5 tp -57.25 -30.11 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -43.7 38.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.7 92.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.673 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.4 73.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.7 mt -63.7 -44.88 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.2 -39.77 87.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.14 -31.87 68.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.27 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -39.24 74.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.339 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -77.58 -18.49 56.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.612 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.43 70.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 tptm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.518 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.2 m-20 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.301 0.572 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -74.37 13.09 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.321 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -116.26 22.12 13.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.602 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.53 103.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.92 15.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -127.39 152.06 48.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -1.174 . . . . 0.0 109.693 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 125.5 1.56 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.7 ttp -123.79 140.44 52.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.733 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -141.37 165.1 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.43 160.69 29.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -134.84 145.44 54.69 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.303 -1.116 . . . . 0.0 109.411 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.55 -50.25 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.595 2.197 . . . . 0.0 112.05 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.84 63.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.4 m -93.73 -2.62 53.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.61 42.42 0.67 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 16.9 t0 -118.51 154.46 32.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -1.088 . . . . 0.0 109.821 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.4 t -113.48 99.63 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -82.02 102.97 11.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -91.91 138.8 31.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -134.66 126.16 28.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -128.21 133.65 48.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.7 140.89 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -118.44 140.79 49.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 73.0 t -117.17 143.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER 178.19 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.545 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-20 -62.45 45.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.663 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.1 m-20 81.09 45.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.99 -3.27 86.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 79' ' ' GLY . 40.5 mm -96.49 146.86 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -1.103 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.2 mt -56.48 94.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -0.934 . . . . 0.0 109.445 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -46.47 35.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.25 169.75 22.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.36 121.6 16.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' CD ' ' N ' ' A' ' 57' ' ' LYS . 2.9 mmtm -95.84 154.79 17.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -141.1 158.32 44.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -160.94 116.64 2.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.21 131.64 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.463 ' C ' ' OD2' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -148.12 103.76 3.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.578 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.581 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . 125.94 22.73 1.72 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -114.25 83.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.157 . . . . 0.0 109.661 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . 33.45 -101.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.633 ' C ' ' H ' ' A' ' 67' ' ' ILE . 96.1 p -136.99 19.19 3.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -1.145 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.51 4.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.8 mm -58.2 -61.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -46.57 -40.13 12.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.5 m -61.54 -32.51 72.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.567 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.6 OUTLIER -61.18 -26.31 67.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.428 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -83.21 -44.58 14.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.96 -45.42 94.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 74' ' ' THR . 17.4 tt -67.34 -55.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.567 ' OG1' ' O ' ' A' ' 70' ' ' SER . 10.5 p -53.6 -23.41 10.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.192 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.8 -21.71 21.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -92.68 -9.1 42.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.536 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.19 12.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.203 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -94.19 123.16 37.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.352 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 71.2 8.9 66.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -97.86 169.21 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -1.122 . . . . 0.0 109.554 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -83.05 162.19 21.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.57 -24.04 61.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -67.07 -31.4 71.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.77 -33.85 21.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.25 -36.78 85.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.15 36.15 3.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -147.27 -34.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -1.068 . . . . 0.0 109.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.543 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -33.42 -28.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 87' ' ' ALA . 4.4 ttmt 63.11 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.48 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 92' ' ' GLN . 7.6 p-10 -82.69 -47.74 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.601 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -43.15 -24.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.632 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.8 tp60 -70.55 -53.9 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.657 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.23 -22.12 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 109.621 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.24 -34.07 59.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 9.0 tp10 -85.37 -16.47 39.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.06 -47.4 14.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 7.6 mp -87.15 -35.68 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 8.6 tt0 70.21 73.04 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 0.0 109.785 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.64 143.72 27.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.875 . . . . 0.0 109.208 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.6 148.0 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.753 2.302 . . . . 0.0 112.45 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.2 Cg_endo -72.79 -13.64 26.83 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.799 2.333 . . . . 0.0 112.196 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.79 -0.1 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 109.54 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 101' ' ' PRO . 21.2 mttp -150.63 55.02 0.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 37.0 t -70.1 -2.79 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' CB ' ' A' ' 34' ' ' ALA . 7.5 p-80 -84.03 -26.6 28.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.312 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.69 -60.79 2.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.2 p -54.07 -54.65 36.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.26 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' C ' ' A' ' 109' ' ' LEU . 43.6 mt -44.73 -66.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 108' ' ' ILE . 4.9 mp -35.21 -50.6 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.669 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HA ' ' SD ' ' A' ' 41' ' ' MET . . . -49.9 -56.8 9.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.0 tt0 -68.56 -67.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.2 OUTLIER -34.67 -27.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -78.31 -59.11 2.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.987 . . . . 0.0 109.828 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.3 tp -48.09 -37.11 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.2 ttmt -67.76 -47.73 68.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.286 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.4 64.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.1 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.85 -55.74 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.098 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 117' ' ' ALA . 29.8 mt -42.14 -40.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.08 -54.41 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.07 -26.19 25.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 123' ' ' ALA . 21.2 t80 -76.73 -57.57 3.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.312 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -69.79 2.93 2.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 121' ' ' TYR . . . -93.8 -49.37 5.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.863 . . . . 0.0 109.647 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 26' ' ' ASN . 12.3 t0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.26 0.553 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 66.34 -4.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 24' ' ' ASP . 57.8 m-20 -107.71 -0.71 21.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.45 96.25 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.576 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.12 139.11 37.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 m -120.61 105.97 11.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -1.12 . . . . 0.0 109.49 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.79 130.04 10.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.6 ttt -132.65 117.01 17.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -1.144 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.9 159.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.98 156.05 16.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . . . -117.83 83.04 17.62 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.335 -1.097 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.54 -16.82 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.913 2.408 . . . . 0.0 112.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.01 -33.64 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.3 p -124.06 23.19 8.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.74 69.17 0.2 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 8.6 t0 -139.67 116.95 11.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.55 110.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.406 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 5.7 ttt -97.6 137.02 37.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -128.91 112.8 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.47 139.25 50.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -134.96 134.75 40.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.387 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.82 135.05 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -106.81 133.58 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -107.98 139.68 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 6.4 t0 -82.76 -88.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.3 m-20 -154.76 17.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.0 11.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.01 78.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -83.39 135.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.581 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.34 104.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.114 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.19 -24.04 37.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 109.837 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 45.6 t0 -148.21 150.62 34.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.685 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -142.04 116.61 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.343 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -97.31 152.12 19.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 15.3 p90 -147.59 166.42 27.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -170.79 117.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.23 143.71 18.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.706 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 20.1 p90 -161.92 95.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.34 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.06 -62.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.533 ' SG ' ' NZ ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -81.89 146.27 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.417 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.7 10.38 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 63' ' ' CYS . 7.4 t -136.22 -7.24 2.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -1.134 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.19 -68.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.616 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.83 -34.22 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.517 ' O ' ' OG ' ' A' ' 71' ' ' SER . . . -58.27 -57.53 12.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.2 -41.25 81.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.473 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.5 ' O ' ' CG2' ' A' ' 74' ' ' THR . 1.0 OUTLIER -61.53 -28.23 69.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 77.4 p -75.0 -49.96 18.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.72 -57.99 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 74' ' ' THR . 18.2 tt -49.15 -45.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 109.512 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 70' ' ' SER . 19.0 p -60.05 -36.25 76.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -77.98 -10.37 59.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 -30.85 12.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.596 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -96.81 38.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.671 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.06 102.85 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.16 52.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -104.77 169.39 8.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -1.111 . . . . 0.0 109.429 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -93.54 150.22 20.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.52 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.44 -26.51 3.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.63 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -69.04 -32.98 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.93 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -83.46 -34.24 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.55 54.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.27 52.05 3.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -162.43 -39.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -1.186 . . . . 0.0 109.243 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -42.76 -30.28 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.364 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 59.91 175.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -88.52 -44.33 10.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ASN . 43.4 t -38.61 -39.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 95' ' ' GLU . 16.4 tp60 -62.33 -66.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.378 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.4 mt -45.37 -31.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.229 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.36 -19.96 48.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.248 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 92' ' ' GLN . 6.2 tt0 -83.85 -20.03 33.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -97.92 -53.89 3.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -72.91 -5.56 39.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.369 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.507 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 43.26 31.95 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.619 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.95 150.79 36.95 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.334 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.18 157.95 42.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.8 2.333 . . . . 0.0 112.234 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.4 -7.14 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.893 2.395 . . . . 0.0 112.567 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.83 -14.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.533 ' NZ ' ' SG ' ' A' ' 63' ' ' CYS . 25.6 mttm -114.42 29.69 7.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.76 -9.94 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.42 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 103' ' ' LYS . 2.2 p-80 -77.35 -25.28 50.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -75.7 -41.81 52.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.138 -0.976 . . . . 0.0 109.121 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -52.97 59.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 7.1 tt -53.9 -38.73 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 108.89 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.466 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 1.6 mp -53.8 -50.04 67.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.406 ' HA ' ' SD ' ' A' ' 41' ' ' MET . . . -56.82 -54.24 48.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -48.93 -63.46 1.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.206 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.42 -27.56 10.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.0 -49.04 63.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 115' ' ' LYS . 2.4 tp -56.22 -36.31 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.985 . . . . 0.0 109.26 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -70.87 -57.04 5.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.84 7.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.37 -59.67 3.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.9 mt -46.44 -44.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.424 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.438 ' C ' ' N ' ' A' ' 121' ' ' TYR . . . -62.35 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' C ' ' OD1' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -47.89 -17.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.2 t80 -92.59 -29.28 16.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -92.1 3.37 55.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.355 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.44 -52.18 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 109.578 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.2 tttm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 -179.93 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 37.8 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.343 0.592 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.12 10.42 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.539 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -134.39 21.14 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.39 127.79 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.0 121.67 7.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -102.78 120.65 40.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.538 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.41 100.68 0.89 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ttt -96.68 133.13 41.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -1.095 . . . . 0.0 109.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.41 154.62 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.862 . . . . 0.0 109.222 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.64 143.72 17.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.14 107.18 13.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.34 -1.094 . . . . 0.0 109.083 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -76.52 15.59 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.293 1.996 . . . . 0.0 112.447 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -112.47 -102.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.765 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -121.04 6.59 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.689 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -91.7 -16.46 51.93 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 29.7 t0 50.86 -151.35 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -1.051 . . . . 0.0 109.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.523 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 6.4 t -87.35 136.62 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.7 ttt -127.34 137.41 52.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 109.589 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -124.43 123.37 40.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -119.93 126.51 51.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.958 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.56 143.64 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.515 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.88 134.16 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.476 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -102.97 136.8 42.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.9 136.05 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 38.1 t0 -59.78 -49.44 77.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.31 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.678 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.7 OUTLIER 162.83 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -34.43 9.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.11 -9.73 0.98 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -74.43 134.26 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -1.225 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.04 89.49 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.44 -54.78 39.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.578 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -144.49 152.85 41.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.898 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.708 ' H ' ' HZ1' ' A' ' 78' ' ' LYS . . . -133.58 142.44 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.741 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -114.02 143.28 45.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.053 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -119.69 165.2 14.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.86 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -171.54 81.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.512 ' HG1' ' N ' ' A' ' 61' ' ' TYR . 1.3 t -123.45 152.9 41.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.512 ' N ' ' HG1' ' A' ' 60' ' ' THR . 70.3 t80 -155.44 95.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . -179.21 -50.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 65' ' ' SER . 18.5 m -74.23 125.15 27.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.511 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -43.33 -21.72 0.17 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -120.25 7.9 10.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -1.105 . . . . 0.0 109.274 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -42.22 -43.18 3.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.518 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.518 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.2 mt -60.72 -29.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -80.58 -71.92 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.5 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.3 p -38.84 -33.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.944 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.721 ' HG ' ' H ' ' A' ' 71' ' ' SER . 12.4 p -69.19 -63.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.721 ' H ' ' HG ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -48.67 -25.76 1.95 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 109.5 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' C ' ' A' ' 73' ' ' ILE . 39.4 tp -79.15 -81.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 72' ' ' LEU . 14.5 tt -41.11 -35.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.614 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 73' ' ' ILE . 82.6 p -69.53 -39.48 77.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' LEU . 16.4 tt0 -74.51 -8.33 55.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.327 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.98 -31.88 14.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -96.42 13.14 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.708 ' HZ1' ' H ' ' A' ' 56' ' ' ALA . 4.2 mttm -89.28 93.11 9.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.54 -18.52 24.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -66.52 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.41 167.81 13.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.646 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.38 -30.19 69.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.85 . . . . 0.0 109.56 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.76 -35.05 79.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.1 -45.2 18.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.007 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.16 35.61 2.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -147.4 -38.99 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 109.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.4 pt -41.45 163.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -0.872 . . . . 0.0 109.35 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -136.72 -174.1 3.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -101.55 -5.59 24.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.221 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -64.31 -53.06 54.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 0.0 109.343 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.6 mt-30 -60.76 -62.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 mt -47.21 -25.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.45 -27.27 46.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 92' ' ' GLN . 10.2 mt-10 -87.96 -16.28 34.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.355 -0.841 . . . . 0.0 109.338 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -88.55 -43.41 11.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.67 -14.05 49.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 48.29 74.52 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.371 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.77 150.73 42.21 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 109.415 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.02 160.09 48.91 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.748 2.299 . . . . 0.0 112.193 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.0 Cg_endo -66.7 -65.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.904 2.402 . . . . 0.0 112.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.469 ' C ' ' O ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER 41.48 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 109.03 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' PRO . 20.1 mttp -138.43 10.96 2.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.527 ' C ' ' O ' ' A' ' 103' ' ' LYS . 3.7 t 34.79 53.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.765 ' CE1' ' H ' ' A' ' 37' ' ' CYS . 6.4 p-80 -98.38 -25.54 14.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.84 -70.22 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -51.32 -57.84 7.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 104' ' ' VAL . 37.1 mt -43.07 -34.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.07 81.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.71 68.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' ' 112' ' ' ASP . 56.8 tt0 -66.56 -67.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 111' ' ' GLU . 47.8 t0 -40.56 -29.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -67.1 -59.54 3.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 tp -46.21 -33.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.349 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.75 61.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.81 64.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.97 -56.8 17.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.5 -44.38 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.626 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.95 -57.54 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.89 -53.6 50.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.516 ' O ' ' C ' ' A' ' 122' ' ' LYS . 13.0 t80 -47.37 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 121' ' ' TYR . 11.2 mmtt -36.22 -44.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' TYR . 3.6 mtpt . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.913 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.654 ' C ' ' H ' ' A' ' 26' ' ' ASN . 26.3 t0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.509 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.5 OUTLIER 54.64 0.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.075 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.654 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -167.82 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.12 113.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.782 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.76 125.32 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -116.13 145.31 43.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.36 134.57 5.4 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.5 mtt -123.47 148.88 45.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.122 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.18 174.01 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.145 -0.972 . . . . 0.0 109.334 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.24 150.27 8.04 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.03 144.42 47.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.504 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 Cg_endo -71.97 -67.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.563 2.176 . . . . 0.0 111.938 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.41 -35.9 0.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.241 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' O ' ' C ' ' A' ' 38' ' ' GLY . 49.9 t -99.13 -4.97 31.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.345 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 36.68 34.66 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 37' ' ' CYS . 13.7 t0 -105.02 114.16 28.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.333 -1.098 . . . . 0.0 109.604 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 14.5 p -89.05 109.29 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ttt -99.2 152.32 20.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -147.9 126.93 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.89 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.62 128.42 37.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.034 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -118.52 136.05 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.028 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.51 144.86 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 109.643 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -111.79 141.98 44.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.81 113.65 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 17.3 t0 -47.45 -67.16 0.3 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.644 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.9 p-10 170.41 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.097 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.39 10.83 23.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.32 15.26 54.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.1 mm -102.52 148.81 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 109.592 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.478 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.3 mm -83.34 84.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.435 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' ' OD1' ' A' ' 55' ' ' ASP . 5.6 tt0 -40.89 -55.76 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' OD1' ' OE2' ' A' ' 54' ' ' GLU . 7.4 p-10 -152.34 170.99 18.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.25 126.52 18.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.474 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -99.28 135.01 41.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 2.6 p90 -109.83 162.46 14.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -171.78 102.24 0.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -164.82 139.74 5.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.444 ' CE2' HD12 ' A' ' 67' ' ' ILE . 3.3 t80 -156.02 95.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.31 -19.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.678 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -141.06 107.27 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -1.045 . . . . 0.0 109.181 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -41.08 -15.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 63' ' ' CYS . 1.8 m -82.49 -22.24 35.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -83.31 -58.7 2.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.536 ' C ' ' O ' ' A' ' 66' ' ' ALA . 42.5 mt -35.68 -59.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.9 m -49.84 -50.56 45.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.479 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 69' ' ' SER . 1.3 t -43.95 -47.57 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.587 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.569 ' O ' ' OG1' ' A' ' 74' ' ' THR . 17.3 p -70.59 -31.41 68.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -68.33 -61.82 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.1 tt -48.78 -41.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.263 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 71' ' ' SER . 23.5 p -55.84 -46.25 78.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.018 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.99 -20.23 64.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 108.916 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.21 -27.68 53.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.546 ' O ' ' C ' ' A' ' 78' ' ' LYS . 7.0 m -111.8 -111.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.499 -0.75 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.546 ' C ' ' O ' ' A' ' 77' ' ' VAL . 8.3 tttm 35.32 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.53 13.85 10.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HA ' ' HZ1' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -102.56 -166.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -1.113 . . . . 0.0 109.366 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 83' ' ' GLU . 15.5 m -108.34 135.82 49.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.959 . . . . 0.0 109.639 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' SER . 11.4 mt -45.32 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 81' ' ' SER . 5.7 tp10 -77.92 -53.12 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.173 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -32.0 69.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.07 31.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.24 47.2 3.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.61 -33.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.189 . . . . 0.0 109.425 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.5 pt -44.16 175.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -143.19 158.11 43.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -73.99 -38.25 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.19 -37.69 55.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.161 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 94' ' ' ALA . 3.5 mm100 -66.18 -68.33 0.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -45.67 -23.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.445 ' C ' ' N ' ' A' ' 96' ' ' GLU . . . -71.85 -63.45 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.825 . . . . 0.0 109.166 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -49.31 -17.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 108.941 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -80.68 -61.21 2.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 60.2 tp -76.7 -33.45 58.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER 70.0 68.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.713 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.2 pt? -103.72 146.93 33.43 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -40.24 102.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.758 2.305 . . . . 0.0 112.16 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 103' ' ' LYS . 58.8 Cg_endo -78.77 10.15 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.543 2.162 . . . . 0.0 112.41 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -11.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.238 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 101' ' ' PRO . 53.0 tttm -157.14 -34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.381 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t 60.9 60.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.286 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.44 ' HD1' ' HB3' ' A' ' 103' ' ' LYS . 13.3 p-80 -99.27 -47.66 5.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 0.0 109.527 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.6 m -61.11 -49.38 77.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.509 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.7 OUTLIER -50.66 -67.8 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' SER . 3.4 mt -44.87 -38.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 109' ' ' LEU . 4.6 mp -60.24 -39.37 86.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.67 -52.02 66.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.132 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 112' ' ' ASP . 68.2 tt0 -60.16 -60.31 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -42.76 -33.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.28 -60.45 3.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -46.99 -38.4 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -70.35 -57.77 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.99 -39.58 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.01 97.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 109.66 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.37 -39.3 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.97 72.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 -42.73 95.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -70.02 -48.66 57.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 123' ' ' ALA . 20.2 tttt -56.96 -30.15 63.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -38.93 -36.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.4 tptt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.677 ' OD1' ' N ' ' A' ' 25' ' ' SER . 57.6 t0 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.677 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 51.0 m -89.65 5.86 43.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -114.31 -2.71 13.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.19 117.56 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.843 . . . . 0.0 109.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 126.94 9.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 44' ' ' GLN . 3.0 m -112.07 151.2 29.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -1.135 . . . . 0.0 109.299 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.92 153.88 25.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.8 ttm -142.37 141.19 32.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.86 165.96 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.923 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.11 148.53 17.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -141.88 79.16 16.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.333 -1.098 . . . . 0.0 109.619 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.31 12.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.88 2.387 . . . . 0.0 112.269 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.631 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -110.54 -79.16 0.58 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.271 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 p -134.9 -36.22 0.84 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.188 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.654 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -55.02 -18.86 12.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 14.7 t0 51.69 -147.69 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 0.0 109.731 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.98 115.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.88 . . . . 0.0 109.434 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.452 ' CG ' ' N ' ' A' ' 42' ' ' GLN . 9.5 ttt -106.82 157.42 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CG ' ' A' ' 41' ' ' MET . 15.6 tt0 -143.86 130.38 20.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.686 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 1.6 tp -125.45 150.91 46.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.553 ' NE2' ' OG1' ' A' ' 29' ' ' THR . 22.1 mt-30 -142.23 144.33 33.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.539 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.17 155.95 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -130.76 122.79 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.247 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' O ' ' CG ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -115.37 140.01 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.786 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' A' ' 50' ' ' ASN . 35.0 m-20 -170.88 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.47 48.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.374 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 78.4 50.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.91 86.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.83 149.49 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -1.103 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mt -82.7 91.44 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -72.83 -38.56 67.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.333 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 47.8 t0 -124.85 158.03 34.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.828 . . . . 0.0 109.236 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -158.67 120.23 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.76 157.33 19.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -140.69 -174.03 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.751 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -169.69 81.61 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.219 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.403 ' H ' ' HG1' ' A' ' 60' ' ' THR . 0.3 OUTLIER -87.34 122.34 30.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 105.68 3.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 145.25 -44.57 0.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.445 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 15.9 m -75.0 167.36 22.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.446 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.37 -38.48 0.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -21.01 17.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -1.085 . . . . 0.0 109.498 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -88.6 0.63 56.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 66' ' ' ALA . 8.3 tp -44.36 -31.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -66.46 -47.78 72.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -43.37 -32.5 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.333 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.577 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.7 OUTLIER -58.53 -53.73 55.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 m -65.75 -32.72 74.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 75' ' ' GLU . 1.7 tp -65.1 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.856 . . . . 0.0 109.682 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 72' ' ' LEU . 16.4 tt -37.11 -41.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.963 . . . . 0.0 109.577 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 70' ' ' SER . 2.4 p -64.77 -32.38 74.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.526 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 72' ' ' LEU . 8.8 mt-10 -86.56 -7.72 58.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -109.04 -5.71 15.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 109.546 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 m -117.52 0.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -95.38 114.83 26.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 109.385 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.82 -8.36 73.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.25 168.69 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.42 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.0 m -88.79 167.59 13.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.7 mt -68.04 -26.61 65.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.565 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -66.52 -20.27 65.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.317 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -97.22 -58.02 2.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.171 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.68 62.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.246 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.44 49.23 1.06 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -168.93 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -1.128 . . . . 0.0 109.094 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 87' ' ' ALA . 5.1 pt -41.38 156.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.5 168.8 9.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.135 -0.978 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.59 -18.47 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 t -66.65 -27.61 67.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.19 -57.87 5.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.37 -38.45 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -54.79 -53.51 54.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.348 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -37.02 85.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -52.25 -41.13 62.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 tp -105.8 -29.14 10.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 94' ' ' ALA . 8.9 tm-20 64.58 58.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.347 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.751 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.2 pt? -86.46 143.43 36.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.376 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.61 142.45 1.96 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.574 2.183 . . . . 0.0 112.151 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -76.24 -3.16 13.48 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.719 2.279 . . . . 0.0 111.942 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.9 -12.21 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.615 ' NZ ' ' SG ' ' A' ' 106' ' ' CYS . 18.0 pttp -156.79 56.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.3 -11.27 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.284 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.654 ' CE1' ' H ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -54.64 -22.32 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.615 ' SG ' ' NZ ' ' A' ' 103' ' ' LYS . 59.5 m -65.03 -61.1 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.0 p -55.15 -51.67 65.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.442 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.9 mt -55.28 -26.52 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.102 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tp -68.06 -42.11 80.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 109.004 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -58.37 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.82 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 112' ' ' ASP . 7.3 tm-20 -62.33 -64.57 0.89 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.565 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 111' ' ' GLU . 62.2 t0 -39.22 -31.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.711 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -69.01 -56.73 6.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.711 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 115' ' ' LYS . 3.8 tp -52.14 -37.05 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 114' ' ' ILE . 3.1 tttp -67.98 -50.46 55.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.85 73.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.714 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -65.62 -69.7 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.698 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 117' ' ' ALA . 23.6 mt -42.7 -37.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.685 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.32 85.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 61.0 t0 -61.17 -25.19 66.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.898 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.4 t80 -78.62 -40.77 33.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -84.84 -1.78 56.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.12 24.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.275 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 27' ' ' VAL . 2.8 p30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.296 0.57 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -98.42 9.85 42.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m-80 -118.77 18.27 13.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.558 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 t -126.48 122.34 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.52 123.46 7.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 m -109.21 152.78 24.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -1.186 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.52 110.7 0.45 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 ttt -114.45 103.52 11.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.457 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.0 m -117.2 157.29 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.14 163.23 28.67 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.87 138.03 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.294 -1.121 . . . . 0.0 109.371 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.1 Cg_endo -75.57 -36.24 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -43.01 -53.31 4.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.537 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.4 2.38 20.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.65 58.3 7.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 62.3 t0 -127.75 145.39 50.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 2.6 m -115.26 114.69 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 ttt -98.93 125.3 44.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.859 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.29 119.15 38.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.023 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.1 110.92 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -118.82 108.96 15.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.042 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 pt -107.87 143.45 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.892 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.667 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 8.0 tttp -109.31 144.27 37.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.013 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.506 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 3.3 t -134.99 149.33 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.737 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.694 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 174.28 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 2.9 m-20 -62.21 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.421 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-20 79.19 48.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.85 . . . . 0.0 109.412 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.37 78.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 mm -89.24 158.85 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.8 mt -93.09 90.73 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.59 -38.56 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.708 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 2.3 p30 -147.62 162.08 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.42 119.6 10.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.712 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 6.1 p90 -137.9 163.93 30.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.734 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -158.95 111.1 2.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.207 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -156.81 132.6 9.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.133 -0.979 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.433 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 46.0 t80 -161.65 154.77 20.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 61' ' ' TYR . . . 125.08 -43.24 1.4 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 t -88.95 166.38 13.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.086 -1.243 . . . . 0.0 109.651 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.86 43.4 1.67 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -158.9 -66.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.314 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -36.27 -35.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.315 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 65' ' ' SER . 49.0 mt -54.88 -13.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.258 -0.901 . . . . 0.0 109.314 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -103.22 -53.25 2.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 109.154 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -55.56 -37.87 68.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.0 109.232 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.579 ' O ' ' OG1' ' A' ' 74' ' ' THR . 59.0 p -59.86 -39.92 86.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.214 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.573 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -62.37 -51.16 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 tp -55.74 -69.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.371 -0.831 . . . . 0.0 109.508 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.582 ' CG2' ' N ' ' A' ' 74' ' ' THR . 14.5 tt -47.53 -50.37 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.582 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 6.0 p -47.35 -38.08 12.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.53 -8.58 54.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 108.914 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.7 t90 -92.12 -11.75 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 108.977 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.04 4.22 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -79.33 104.59 10.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.92 35.38 79.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.72 -174.68 2.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 t -106.16 148.71 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.762 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.3 mt -68.77 -20.65 64.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.961 . . . . 0.0 109.244 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.93 -9.04 58.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.374 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -102.17 -43.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.18 -12.73 56.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.527 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.04 49.8 3.6 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -178.63 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -1.12 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -32.16 -31.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 109.757 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 87' ' ' ALA . 16.6 mtmt 62.42 128.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.336 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.64 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 2.5 p-10 -54.37 -46.93 73.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 90' ' ' ASN . 15.7 m -35.45 -34.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.386 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 90' ' ' ASN . 42.1 tp60 -73.44 -49.85 24.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.4 mt -50.61 -38.1 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.238 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.88 -61.32 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.64 -10.21 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.722 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -79.58 -67.73 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.1 mt -85.04 -2.21 57.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' LEU . 14.2 mt-10 44.24 75.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.73 143.05 26.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -42.27 157.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.634 2.222 . . . . 0.0 112.306 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 61.2 Cg_endo -77.29 1.38 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.167 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.85 -0.5 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.669 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -134.63 35.42 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 105' ' ' HIS . 2.4 t -84.12 -40.58 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.554 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 104' ' ' VAL . 16.0 p-80 -40.98 -33.6 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.007 . . . . 0.0 109.342 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.414 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 1.2 m -72.52 -45.93 57.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.258 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.4 t -55.87 -49.97 71.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.047 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.482 ' O ' ' C ' ' A' ' 109' ' ' LEU . 71.5 mt -50.97 -59.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.0 109.174 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.514 ' O ' ' C ' ' A' ' 110' ' ' ALA . 5.1 mp -40.54 -62.09 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.21 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -37.55 -65.68 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.842 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.459 ' CD ' ' C ' ' A' ' 111' ' ' GLU . 4.4 tp10 -42.32 -45.51 4.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -15.18 63.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.177 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -80.22 -45.16 18.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 109.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -63.7 -40.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.213 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.501 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 20.2 mttt -70.94 -34.63 71.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.32 -53.12 61.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.848 . . . . 0.0 109.519 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.34 84.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 89.0 mt -59.47 -28.75 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.988 . . . . 0.0 109.494 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.52 -46.93 12.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.74 -8.88 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.1 t80 -96.54 -43.62 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -88.38 -5.56 58.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.42 -21.09 23.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.623 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.645 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 1.9 p -75.67 -7.64 54.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.645 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -95.99 8.7 42.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.2 t -140.87 110.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.706 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.01 152.33 18.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.426 HG21 ' NE2' ' A' ' 44' ' ' GLN . 27.3 m -122.7 154.5 38.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.728 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.95 130.01 3.46 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.0 ttt -127.08 135.49 50.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -1.219 . . . . 0.0 109.947 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -154.76 146.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.0 109.208 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.9 172.26 22.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -141.79 138.77 17.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.302 -1.116 . . . . 0.0 109.198 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.62 -51.57 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.473 2.115 . . . . 0.0 112.172 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.56 -40.99 13.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 34.1 m -100.61 -0.15 38.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 39.25 47.99 2.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -130.14 148.28 51.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -1.119 . . . . 0.0 109.708 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.79 110.54 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.189 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.4 ttt -104.07 141.5 36.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.709 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -123.08 129.68 51.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 109.156 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.42 125.38 42.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.667 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.426 ' NE2' HG21 ' A' ' 29' ' ' THR . 2.2 mt-30 -121.01 161.29 21.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.0 109.117 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.31 145.42 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -119.64 123.77 44.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 109.093 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.405 ' HB ' ' HH ' ' A' ' 121' ' ' TYR . 39.2 t -113.74 134.99 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.2 m-20 -170.67 -31.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -62.94 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.398 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-20 78.88 41.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.12 74.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 53' ' ' ILE . 20.3 mm -100.61 165.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.603 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.422 ' N ' HG22 ' A' ' 52' ' ' ILE . 68.6 mt -79.02 88.47 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -54.19 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.66 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.1 t70 -146.61 163.78 34.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.11 144.94 31.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 169.46 9.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CD1' HG22 ' A' ' 74' ' ' THR . 2.6 p90 -168.28 162.93 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.6 119.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.41 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -161.01 124.86 3.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -148.4 97.61 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.27 -2.44 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.428 ' SG ' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -89.31 -177.54 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.647 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.39 -14.26 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -137.26 -3.25 1.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -1.166 . . . . 0.0 109.655 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -85.74 -44.35 12.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.2 tp -34.36 -29.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.815 . . . . 0.0 109.828 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -91.35 -41.52 10.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 109.962 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -69.17 -31.31 69.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.992 . . . . 0.0 109.746 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.401 ' O ' ' OG1' ' A' ' 74' ' ' THR . 9.4 m -57.92 -40.53 80.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.0 109.534 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 p -74.3 -41.54 61.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.9 tp -56.07 -59.06 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.632 ' CG2' ' H ' ' A' ' 74' ' ' THR . 8.7 tt -55.18 -63.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.632 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 6.0 p -43.26 -25.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' ILE . 24.2 mt-10 -91.9 -12.93 32.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.613 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.622 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.4 m0 -101.14 -13.19 18.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.711 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -111.47 34.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 109.694 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.66 ' NZ ' ' OD2' ' A' ' 55' ' ' ASP . 14.4 ttmm -120.25 89.65 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.02 -7.43 23.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -91.73 -174.67 3.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.09 154.14 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.39 -17.25 62.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.53 -40.9 76.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 109.67 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.24 -39.74 53.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.83 82.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.97 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.03 54.82 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.3 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -1.107 . . . . 0.0 109.115 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 87' ' ' ALA . 6.4 pt -42.32 -28.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.2 tttt 65.46 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -71.61 -6.7 42.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.605 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 p -73.61 -30.36 62.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.5 -39.05 91.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.19 -33.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.35 72.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.67 -46.17 14.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -49.77 -36.96 27.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.43 -27.86 12.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 63.57 74.51 0.42 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.629 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.24 159.96 30.06 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.99 160.21 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.876 2.384 . . . . 0.0 112.262 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.12 -14.33 18.82 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.818 2.346 . . . . 0.0 112.279 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.06 -1.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.612 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -146.99 36.68 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.524 ' O ' ' C ' ' A' ' 105' ' ' HIS . 41.3 t -52.45 -33.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.659 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -36.07 -58.34 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.659 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 56.8 m -32.63 -62.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.571 ' HG ' ' CD1' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -56.72 -44.04 81.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.763 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 109' ' ' LEU . 72.3 mt -58.57 -63.56 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.726 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 108' ' ' ILE . 1.1 mp -39.09 -41.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.88 -56.95 15.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.617 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 112' ' ' ASP . 3.5 tm-20 -66.39 -68.85 0.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 111' ' ' GLU . 2.4 t0 -37.52 -33.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.494 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -65.29 -52.61 53.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 115' ' ' LYS . 4.4 tp -51.99 -35.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 114' ' ' ILE . 32.4 tttt -74.44 -48.24 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.77 -54.53 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.41 -61.11 2.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.331 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . 64.2 mt -39.17 -46.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.261 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.81 65.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.598 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -57.04 -18.45 14.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.363 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.495 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 20.6 t80 -77.33 -49.76 14.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.386 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 124' ' ' LYS . 1.3 mptm? -71.88 -47.95 49.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.372 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.06 -14.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.598 ' NZ ' ' O ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.351 0.596 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.28 3.07 5.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.658 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.19 14.95 18.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.86 108.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.632 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.49 148.28 17.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.7 m -139.16 145.96 40.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.563 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 120.19 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.9 mtp -118.49 137.75 52.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -1.183 . . . . 0.0 109.586 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.65 163.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.88 143.8 12.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -127.39 131.79 24.01 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -73.56 -57.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.537 2.158 . . . . 0.0 112.477 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.49 -31.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 109.673 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 35' ' ' PRO . 38.1 m -118.39 1.41 11.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 39.25 55.56 2.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -136.39 163.29 30.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.251 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 79.4 t -127.22 129.05 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.714 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.9 ttt -112.41 119.93 39.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -109.43 119.92 40.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.09 130.4 54.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 148.04 48.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pt -122.5 146.53 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -110.4 101.77 10.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -0.828 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.48 129.71 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 6.5 t0 -64.73 -60.1 3.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' ASP . 6.0 m-20 166.44 -25.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -12.86 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.815 . . . . 0.0 109.328 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.84 20.0 5.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mm -109.88 132.63 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -1.133 . . . . 0.0 109.437 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.76 87.7 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -53.29 -42.64 66.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.89 -178.74 7.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.34 113.29 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.576 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -94.02 126.15 39.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.095 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.439 ' CD1' HG21 ' A' ' 74' ' ' THR . 37.3 p90 -114.72 170.04 8.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.849 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -170.35 97.62 0.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 109.141 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -137.38 133.9 35.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -151.24 144.55 24.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.05 -39.25 2.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -85.67 91.96 8.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 109.278 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.556 ' C ' ' HG ' ' A' ' 65' ' ' SER . . . -66.92 52.03 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.556 ' HG ' ' C ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -151.12 -22.35 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 109.316 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -97.24 -11.28 24.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ALA . 3.1 mm -40.47 -27.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -97.42 -32.36 11.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.308 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.8 t -66.5 -54.05 28.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.497 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -37.31 -51.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.53 ' O ' ' OG1' ' A' ' 74' ' ' THR . 9.2 t -62.06 -52.72 62.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 73' ' ' ILE . 43.6 tp -46.66 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.669 ' CG2' ' H ' ' A' ' 74' ' ' THR . 10.7 tt -43.69 -64.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.819 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.669 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 16.6 p -35.18 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -83.93 -32.61 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.647 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.8 m95 -82.27 -2.64 53.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.598 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 11.7 m -130.16 53.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.742 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -139.19 85.4 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.539 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.1 8.05 45.47 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -90.67 -171.36 3.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -1.149 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 154.76 18.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.94 -24.99 66.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.41 -28.44 66.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 -53.65 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.97 -25.84 22.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.128 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.73 40.87 2.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -151.01 -37.93 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -1.113 . . . . 0.0 108.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.6 pt -41.09 159.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.519 -0.738 . . . . 0.0 109.296 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.06 162.26 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.526 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.22 -25.2 64.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -66.21 -67.57 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.591 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 91' ' ' SER . 13.2 mm-40 -39.3 -60.63 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.8 mt -56.14 -28.68 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 91' ' ' SER . . . -77.42 -15.22 59.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 109.185 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.71 -18.51 21.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.66 -38.31 14.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -80.87 -0.8 40.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.553 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.527 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.3 tt0 37.12 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 109.37 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.3 pt? -63.0 149.35 90.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 102' ' ' VAL . 30.5 Cg_endo -67.17 152.82 79.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.685 2.257 . . . . 0.0 111.939 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.1 13.89 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 7.3 p -79.02 96.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 105' ' ' HIS . 7.0 mttm 67.31 58.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.212 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.3 0.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -0.818 . . . . 0.0 109.262 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.93 -53.95 45.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.637 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 87.6 m -30.96 -58.79 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.031 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -58.84 -56.22 25.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 107' ' ' SER . 44.9 mt -45.29 -51.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.63 -43.17 46.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.483 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.04 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -40.0 62.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -25.45 68.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -72.11 -62.89 1.27 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -45.31 -36.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.157 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.3 tttt -73.31 -35.8 66.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 109.512 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.88 79.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.07 89.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.9 mt -61.2 -38.01 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.66 81.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.716 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.2 -54.71 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 4.0 t80 -53.75 -32.08 50.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.762 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -81.04 -30.71 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.695 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.19 63.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.705 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.395 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.294 0.569 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 63.67 20.42 12.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.278 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.32 38.01 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.03 133.28 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.39 113.14 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -101.71 157.46 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.526 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.31 132.86 3.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.3 ttp -141.56 123.15 15.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -1.171 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.8 149.1 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 39' ' ' ASP . . . -133.06 170.17 22.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -125.61 146.47 54.91 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.354 -1.086 . . . . 0.0 109.278 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 37' ' ' CYS . 37.1 Cg_endo -69.36 -71.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.668 2.245 . . . . 0.0 112.056 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.59 -14.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.176 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 35' ' ' PRO . 1.8 t -117.11 -12.17 10.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.396 -0.815 . . . . 0.0 109.324 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 38.3 33.33 0.17 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' CYS . 39.0 t70 -101.63 148.36 25.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 109.595 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -121.29 97.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.7 ttt -86.98 119.62 27.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -109.14 101.43 10.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.422 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.74 148.48 28.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.67 132.0 25.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.253 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -111.22 141.98 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -114.25 148.44 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.264 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.65 130.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 t0 -70.77 -54.56 11.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.268 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 160.82 -22.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.357 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -94.43 11.05 32.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.8 30.36 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 mm -125.07 138.23 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.96 103.09 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.161 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -75.43 -42.5 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.806 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 86.3 m-20 -143.29 157.93 44.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.763 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.98 137.23 25.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -105.53 141.56 36.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -124.62 163.21 22.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -171.85 109.01 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -161.05 119.63 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -149.56 103.58 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.91 -20.01 0.03 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.4 t -126.74 116.45 20.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -57.17 172.71 2.39 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER 64.63 -69.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -1.173 . . . . 0.0 109.538 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -38.37 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' SER . 1.6 mt -58.65 2.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.609 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -106.67 -32.31 8.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 p -58.79 -45.62 89.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.458 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.582 ' O ' ' OG1' ' A' ' 74' ' ' THR . 35.0 p -53.73 -64.39 0.84 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' SER . 31.9 m -42.32 -45.64 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.914 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 75' ' ' GLU . 56.5 tp -65.41 -84.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 74' ' ' THR . 9.0 tt -33.68 -52.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 70' ' ' SER . 29.8 p -53.17 -44.21 67.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 72' ' ' LEU . 11.0 tm-20 -78.93 2.18 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.238 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.7 -17.97 14.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.87 . . . . 0.0 109.636 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.3 m -98.0 -28.17 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.37 128.3 35.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -20.58 28.63 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -91.51 164.53 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.287 -1.125 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -175.4 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.827 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.02 -27.24 60.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.35 -20.59 64.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.004 . . . . 0.0 109.159 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.75 -41.67 8.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.887 . . . . 0.0 109.314 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.61 8.92 15.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.62 -57.69 0.65 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.41 -4.38 29.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -1.146 . . . . 0.0 108.816 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.95 168.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.499 -0.751 . . . . 0.0 109.65 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.67 -175.15 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -94.98 -6.55 42.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.16 56.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -66.61 -59.88 3.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.857 . . . . 0.0 109.327 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mt -47.24 -41.28 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -68.04 -46.69 70.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -54.21 -25.77 24.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.49 -52.23 7.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.875 . . . . 0.0 109.566 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.8 mt -81.88 -15.87 52.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.5 mm-40 43.36 14.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.635 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.6 pt? -39.96 150.0 0.27 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -41.52 162.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.811 2.341 . . . . 0.0 112.097 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.0 Cg_endo -76.42 -49.56 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.865 2.376 . . . . 0.0 112.469 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.84 27.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' ND1' ' A' ' 105' ' ' HIS . 37.3 mttt -143.45 6.99 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.542 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 105' ' ' HIS . 10.2 p -68.92 -11.44 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.747 ' N ' ' HD1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -44.02 -57.38 3.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.542 ' H ' ' CG ' ' A' ' 105' ' ' HIS . 55.1 m -56.13 -35.1 66.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -51.25 70.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.231 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.16 -36.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -37.72 80.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.229 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.83 -51.21 65.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.326 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.24 -53.64 49.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.84 -40.99 31.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.414 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.37 13.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.31 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -46.86 -33.68 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.266 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' C ' ' A' ' 116' ' ' ALA . 10.6 ttmm -67.38 -71.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -38.43 -44.96 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.31 -54.41 36.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.8 mt -54.54 -34.68 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.544 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.98 -56.92 8.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.48 -25.18 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -80.43 -69.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.45 -24.17 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.16 16.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.292 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.596 ' OD2' ' N ' ' A' ' 26' ' ' ASN . 1.1 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.389 0.614 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 24' ' ' ASP . 92.6 p -75.83 -11.29 59.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.596 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 32.9 m120 -116.44 25.09 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -147.37 107.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.384 -0.822 . . . . 0.0 109.222 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.25 143.83 17.59 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -120.27 132.58 55.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -1.083 . . . . 0.0 109.186 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.08 123.03 4.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttt -125.15 115.91 21.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -1.085 . . . . 0.0 109.117 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.4 166.28 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.77 165.31 31.53 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -141.1 152.74 65.71 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.237 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.4 Cg_endo -77.09 -64.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.17 -45.76 2.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -94.65 -4.82 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 109.232 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.0 41.37 0.45 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' CYS . 10.0 t70 -115.47 155.63 27.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -1.122 . . . . 0.0 109.761 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.61 105.68 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.18 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.437 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -89.53 143.95 26.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.833 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.437 ' N ' ' HG2' ' A' ' 41' ' ' MET . 5.4 tt0 -129.23 110.04 11.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.125 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 44' ' ' GLN . 5.8 tt -121.97 132.34 54.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.465 ' N ' HD22 ' A' ' 43' ' ' LEU . 8.3 mp0 -124.04 177.96 5.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.86 151.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.617 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -114.64 163.6 15.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.348 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.5 107.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.545 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.71 -65.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 169.91 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.667 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -92.56 16.4 12.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.37 22.42 60.57 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.52 147.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.503 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.3 mt -82.35 112.99 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.9 -36.42 18.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.759 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.96 165.44 24.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.7 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.08 120.28 4.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -108.02 159.1 16.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.446 ' CG ' HG23 ' A' ' 74' ' ' THR . 2.8 p90 -163.34 162.16 24.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -171.44 119.47 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.342 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.0 p -116.66 102.39 9.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 0.0 109.531 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -109.54 113.49 26.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.37 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.79 -39.5 1.96 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.2 m -79.05 152.14 31.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -1.161 . . . . 0.0 109.574 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.47 38.6 2.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.66 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -1.137 . . . . 0.0 109.429 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.541 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -86.44 -36.71 18.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.541 ' C ' ' O ' ' A' ' 66' ' ' ALA . 4.9 mt -36.03 -48.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.74 -54.69 30.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 97.1 p -62.0 -49.04 77.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.362 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.553 ' O ' ' CG2' ' A' ' 74' ' ' THR . 0.2 OUTLIER -47.38 -46.59 26.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -61.59 -35.77 78.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 109.229 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.514 ' CD1' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -69.26 -68.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.9 tt -48.46 -47.57 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 70' ' ' SER . 23.1 p -49.24 -45.43 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.15 0.41 53.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.792 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -17.51 17.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.66 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.75 10.76 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -85.56 103.48 14.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.99 40.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -97.34 -171.09 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.468 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -112.74 139.72 48.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.0 mt -53.09 -28.72 26.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.259 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.02 -30.09 68.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.02 -57.66 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.272 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.35 -17.6 3.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.198 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.45 49.5 0.86 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -172.69 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -1.096 . . . . 0.0 109.324 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -50.6 178.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -137.1 -168.28 2.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.332 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.429 ' ND2' ' C ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -103.5 -30.78 10.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -51.82 -33.69 36.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' ILE . 2.0 mt-30 -69.48 -66.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 1.8 mt -44.5 -40.8 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.64 -49.63 61.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.934 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.93 -24.41 23.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.532 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 72' ' ' LEU . 3.5 tt0 -82.11 -33.19 29.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.94 -15.07 35.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 48.62 73.41 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.236 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 1.8 pt? -129.2 139.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -42.5 146.88 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.55 -20.97 22.88 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.667 2.245 . . . . 0.0 112.126 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.88 -4.68 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.444 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -135.93 16.4 3.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.568 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.525 ' O ' ' C ' ' A' ' 105' ' ' HIS . 8.4 p -60.68 -14.96 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.755 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER -33.95 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.707 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.755 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 77.0 m -31.26 -58.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.539 -0.726 . . . . 0.0 110.121 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -50.39 -64.27 0.86 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 109.62 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 5.6 mt -42.27 -42.61 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.82 -32.98 74.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -59.71 -48.29 82.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.203 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.529 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 6.3 tp10 -68.91 -51.91 34.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.371 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -53.85 -28.78 38.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.12 -60.73 2.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.455 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -48.26 -33.85 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.459 ' N ' HG21 ' A' ' 114' ' ' ILE . 7.2 tmtm? -76.41 -28.58 56.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -56.8 8.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -52.79 63.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.368 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -48.77 -38.84 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.92 66.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -77.2 -7.76 56.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.52 -38.58 6.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -71.88 -35.62 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.55 -22.26 62.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tptt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.389 179.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -72.7 10.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.756 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.6 OUTLIER -111.2 20.56 17.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.1 t -137.7 90.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.639 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.43 145.95 48.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 m -135.27 108.86 7.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -1.124 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.82 150.29 16.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 ttm -144.45 127.18 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.357 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.28 161.38 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.48 164.86 18.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.89 85.69 22.82 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.149 -1.206 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.08 -20.3 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.712 2.275 . . . . 0.0 111.94 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.42 -53.51 23.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.174 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -103.84 17.84 23.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.198 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.86 55.08 1.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 61' ' ' TYR . 40.6 t0 -126.65 146.37 50.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -1.163 . . . . 0.0 109.713 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.36 113.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 ttt -99.86 134.3 42.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.37 128.97 46.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -129.58 142.85 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.22 150.33 47.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.145 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.05 148.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.943 . . . . 0.0 109.705 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -114.74 120.93 41.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -103.96 127.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' CG ' ' N ' ' A' ' 49' ' ' ASP . 2.9 t0 -62.89 -94.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.609 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 4.8 t70 -154.22 24.43 0.48 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 14.71 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 25.24 57.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mm -108.69 130.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.582 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 53' ' ' ILE . 69.1 mt -88.45 102.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.195 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.38 -46.64 14.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.58 141.97 51.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.22 129.15 42.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -101.22 164.01 12.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 57' ' ' LYS . 30.2 p90 -156.8 162.73 39.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.574 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.22 98.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.75 138.44 32.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -157.04 123.84 5.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.319 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.05 -61.71 0.36 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 t -84.21 134.39 34.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.712 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.39 20.0 6.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -27.75 6.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.129 . . . . 0.0 109.361 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.27 7.85 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mm -77.9 -40.34 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.835 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.88 -45.25 17.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 109.656 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.542 ' O ' ' C ' ' A' ' 70' ' ' SER . 75.2 m -53.15 -49.34 66.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.562 ' OG ' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -34.35 -66.83 0.15 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.841 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.562 ' N ' ' OG ' ' A' ' 70' ' ' SER . 66.1 m -55.44 -40.44 71.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 73' ' ' ILE . 4.4 tp -60.2 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.933 . . . . 0.0 109.843 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.59 ' CG2' ' H ' ' A' ' 74' ' ' THR . 5.6 tt -36.44 -62.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.958 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.59 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 56.8 p -40.34 -39.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mm-40 -86.07 -15.39 41.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.552 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.57 -5.43 55.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 109.688 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.32 20.75 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 109.607 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -96.53 87.97 4.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.66 -3.82 7.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -89.16 167.71 12.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -1.127 . . . . 0.0 109.392 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.55 176.05 5.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.86 -21.34 66.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.575 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -70.55 -40.93 73.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -79.63 -51.01 9.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.706 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.51 63.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 109.408 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.95 26.0 25.21 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.8 18.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 109.202 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.95 171.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -136.19 140.57 43.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 108' ' ' ILE . 11.4 p30 -68.36 -23.1 64.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -56.24 -36.35 68.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -59.01 2.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mt -46.77 -40.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -73.73 -42.6 60.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 109.836 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.567 ' OE1' ' O ' ' A' ' 95' ' ' GLU . 2.6 tm-20 -57.6 -30.35 65.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.03 -39.44 29.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.003 . . . . 0.0 109.716 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -95.35 -5.04 44.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.698 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 94' ' ' ALA . 17.6 tp10 41.17 44.68 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 151.26 87.89 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.641 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.03 109.41 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.954 2.436 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 103' ' ' LYS . 65.3 Cg_endo -79.79 -79.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.699 2.266 . . . . 0.0 112.129 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.427 ' H ' ' HG2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER 53.65 -76.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 101' ' ' PRO . 9.3 mtpp -118.3 -6.21 10.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.3 t 47.38 60.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.358 -0.839 . . . . 0.0 109.56 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -91.31 -38.75 12.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 1.9 m -71.41 -67.68 0.5 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -37.43 -65.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.307 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.591 ' N ' ' OG ' ' A' ' 107' ' ' SER . 3.3 mt -44.71 -43.08 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' CYS . 0.5 OUTLIER -59.95 -37.99 81.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -57.79 -55.67 31.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -57.1 -60.82 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.293 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.65 -31.43 2.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 109.031 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -61.2 -53.24 59.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 108.98 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp -49.74 -39.93 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 108.785 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.492 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -73.01 -22.11 60.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.47 -0.769 . . . . 0.0 109.308 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -71.01 -60.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.62 -34.65 71.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.344 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.23 -43.76 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.0 91.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.89 -26.02 65.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -66.37 -65.06 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -25.37 60.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.96 80.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 mptt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.847 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.09 -4.52 29.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.702 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -124.08 20.85 9.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.11 92.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.91 22.43 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 30' ' ' GLY . 23.9 m -135.12 148.56 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.244 . . . . 0.0 109.862 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 29' ' ' THR . . . -141.48 140.43 10.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttm -133.86 113.16 11.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.49 149.69 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.93 -178.56 15.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.711 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -148.07 135.52 10.64 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.347 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.31 -38.2 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.458 2.106 . . . . 0.0 112.269 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -60.77 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLY . 20.7 m -87.88 2.44 51.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.16 46.1 3.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.665 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -116.11 148.29 40.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -1.127 . . . . 0.0 109.782 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -110.09 116.46 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.9 ttt -105.91 123.27 47.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -112.2 98.41 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -93.7 137.07 33.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.729 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -131.57 123.56 28.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.366 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 pt -105.97 156.26 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.512 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 54' ' ' GLU . 7.3 tttm -128.36 149.63 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.38 149.37 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.513 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.5 -96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.82 17.5 0.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.631 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -130.83 -25.76 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.673 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.32 9.93 3.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -100.1 133.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 0.0 109.436 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.2 mt -76.26 110.6 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.211 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -87.32 -39.0 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.576 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.37 170.3 16.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.81 120.97 2.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -96.02 161.22 14.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.322 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 4.6 p90 -150.32 170.49 18.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 4.8 tttt -172.06 97.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.6 p -110.23 104.45 13.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.425 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 100.43 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.578 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' CA ' ' OD2' ' A' ' 39' ' ' ASP . . . 148.73 -43.96 0.77 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.665 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.6 m -88.77 105.53 17.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.94 63.14 4.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.47 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.144 -1.209 . . . . 0.0 109.371 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -98.03 -15.96 19.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 68' ' ' ALA . 4.2 mt -42.15 -80.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -34.38 -56.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.674 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.473 ' HG ' ' CG2' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -45.35 -58.11 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.1 m -48.2 -37.96 17.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.882 . . . . 0.0 109.438 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.8 t -70.04 -33.53 72.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 109.411 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 75' ' ' GLU . 30.0 tp -67.31 -68.78 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -41.51 -45.73 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.226 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 71' ' ' SER . 22.6 p -58.72 -33.59 70.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.284 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.4 tt0 -83.19 -5.1 59.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -98.72 -26.59 14.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 m -94.73 -3.13 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.978 . . . . 0.0 109.796 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -81.88 107.72 14.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.46 -21.66 30.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -84.48 178.78 7.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.122 -1.222 . . . . 0.0 109.571 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.96 172.19 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.32 -28.37 62.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 -24.24 66.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 109.21 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.8 -52.66 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.03 -36.77 68.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.349 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.35 48.41 4.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.51 -37.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.162 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -37.74 161.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -130.4 170.94 13.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.27 -15.17 44.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -59.11 -39.59 82.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -71.46 -52.89 15.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.473 ' CG2' ' HG ' ' A' ' 69' ' ' SER . 35.6 mt -54.72 -41.38 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.503 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.83 -29.53 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.76 -42.06 61.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.44 -24.28 60.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.806 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.13 -36.46 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.024 -1.047 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 94' ' ' ALA . 3.5 mt-10 62.32 18.27 10.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.249 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 1.9 pt? -48.46 149.72 2.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.0 154.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.266 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 104' ' ' VAL . 45.9 Cg_endo -72.48 -74.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.824 2.349 . . . . 0.0 112.091 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER 43.01 46.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.2 OUTLIER 76.36 10.39 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER 35.92 27.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.711 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.29 -36.22 83.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.366 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 68.9 m -55.5 -65.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.572 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.8 t -53.84 -57.11 12.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.02 -32.32 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -37.51 75.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.3 88.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.033 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.25 -53.88 21.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 109.273 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -54.13 -23.78 15.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.379 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.06 -50.74 21.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 109.222 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.2 tp -51.6 -39.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 108.963 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 8.4 mttm -74.03 -49.7 23.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.389 -0.819 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -44.98 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -69.53 -59.77 2.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 108.99 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.5 mt -41.06 -38.6 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.021 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.81 -57.84 10.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.052 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -50.71 -32.67 20.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.18 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.87 -60.19 4.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.489 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.55 -44.0 97.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.45 -53.87 32.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.369 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t0 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -71.36 -1.7 13.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.49 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -105.19 18.02 23.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.354 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -152.94 97.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.515 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.93 150.96 28.34 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -127.57 150.45 49.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.42 126.49 3.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -129.4 123.49 31.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.56 165.86 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.77 165.93 27.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -137.39 132.61 17.85 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.195 -1.18 . . . . 0.0 109.527 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.33 -38.07 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.51 2.14 . . . . 0.0 111.948 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -56.87 11.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.245 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.72 -4.57 54.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.69 47.68 30.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 1.2 t0 -122.19 139.23 54.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -1.106 . . . . 0.0 109.581 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 20.5 m -92.95 123.13 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.858 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.455 ' HG3' ' N ' ' A' ' 42' ' ' GLN . 2.8 ttt -113.92 144.59 42.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 41' ' ' MET . 30.9 tt0 -149.29 120.04 7.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.22 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.39 130.85 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -123.73 155.14 38.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -0.909 . . . . 0.0 109.111 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.38 137.9 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -102.48 147.21 27.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.418 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.62 126.52 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.6 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' C ' ' OD1' ' A' ' 48' ' ' ASP . 30.2 t0 -63.29 -96.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 109.416 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -160.0 23.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.92 19.9 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 7.28 88.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.7 mm -99.84 155.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 109.447 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mt -99.08 109.83 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.05 -41.29 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.674 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 11.2 p-10 -157.62 167.59 29.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.66 129.89 41.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.342 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -95.2 125.63 39.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -114.58 157.67 22.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -166.13 99.24 0.63 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.623 ' CG2' ' HG ' ' A' ' 70' ' ' SER . 12.5 t -164.41 113.35 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.517 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 60' ' ' THR . 21.6 m-85 -137.53 102.97 4.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.97 -7.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.1 m -90.75 178.78 5.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.329 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.41 -11.8 14.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -141.43 -16.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.155 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.99 -9.64 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 68' ' ' ALA . 1.7 tt -67.69 -40.85 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.652 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' N ' ' CG2' ' A' ' 67' ' ' ILE . . . -76.55 -28.76 56.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.657 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.7 p -60.14 -58.63 7.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.623 ' HG ' ' CG2' ' A' ' 60' ' ' THR . 0.9 OUTLIER -34.8 -48.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.74 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -65.15 -46.85 79.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -63.53 -73.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.582 ' CG2' ' H ' ' A' ' 74' ' ' THR . 14.7 tt -39.22 -56.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.582 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 22.1 p -46.87 -46.1 20.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.78 -13.9 62.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.633 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.477 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 m0 -89.64 -31.38 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.01 32.15 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.689 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.94 102.14 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.59 8.67 57.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -92.28 -175.81 4.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.64 149.09 24.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.494 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.18 -19.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.144 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -51.81 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ALA . 3.7 mt-10 -68.05 -55.94 10.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.96 -44.26 9.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.96 52.8 4.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -167.2 -46.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -1.15 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -36.1 158.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.429 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -121.84 168.36 11.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.673 HD21 ' HG ' ' A' ' 107' ' ' SER . 2.1 p-10 -82.83 -20.21 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.649 ' HG ' ' N ' ' A' ' 92' ' ' GLN . 47.5 p -52.26 -40.76 62.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.649 ' N ' ' HG ' ' A' ' 91' ' ' SER . 1.7 mm-40 -67.13 -70.93 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 92' ' ' GLN . 22.0 mt -41.57 -39.7 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.42 -53.05 40.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -47.98 -47.54 32.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -38.54 82.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.7 mt -79.66 -26.55 40.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 98' ' ' GLU . 2.7 tm-20 50.91 66.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.708 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.9 pt? -112.44 145.26 32.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.54 153.18 62.95 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.47 11.19 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.878 2.386 . . . . 0.0 112.259 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.0 p -82.78 2.04 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.9 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 105' ' ' HIS . 6.2 p -72.1 -8.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.695 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -39.45 -55.75 1.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.695 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 62.0 m -31.16 -59.38 0.23 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.673 ' HG ' HD21 ' A' ' 90' ' ' ASN . 5.9 p -61.87 -55.63 27.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.984 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.44 ' N ' ' OG ' ' A' ' 107' ' ' SER . 1.6 mm -45.88 -53.85 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.51 -41.8 61.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 109.942 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.27 -65.12 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 109.671 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 11.7 tt0 -54.29 -41.85 69.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.5 -28.6 68.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.33 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -48.85 -38.05 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 1.1 mmtt -71.44 -31.46 67.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.304 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.94 67.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.63 87.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.393 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.12 -46.95 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.261 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.31 76.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -34.28 72.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.624 ' CE2' ' O ' ' A' ' 25' ' ' SER . 3.7 t80 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.953 . . . . 0.0 109.652 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -33.24 27.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.743 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 4.86 9.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.504 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 26' ' ' ASN . 37.3 t0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.3 OUTLIER 48.08 9.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.237 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 24' ' ' ASP . 61.3 m-20 -117.62 0.7 12.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.39 114.41 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.375 -0.828 . . . . 0.0 109.47 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.83 127.58 11.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.0 m -108.0 140.21 41.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -1.132 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.9 129.57 4.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 ttm -126.53 100.71 6.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -1.12 . . . . 0.0 109.35 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 32' ' ' VAL . 17.1 m -117.11 170.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.12 167.42 39.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -136.97 139.33 28.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 38' ' ' GLY . 48.5 Cg_endo -72.93 -59.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.596 2.198 . . . . 0.0 112.259 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.07 -42.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.457 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 1.2 m -98.18 -4.49 35.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 41.84 45.76 4.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.671 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 54.3 t0 -120.07 131.17 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -1.092 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 8.5 p -104.05 118.42 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.226 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.4 ttt -115.26 153.59 30.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -133.74 121.13 21.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.54 112.32 24.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.889 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -114.94 121.69 43.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.33 137.59 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -99.39 123.94 44.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.1 t -118.93 135.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 6.2 t70 -62.82 -59.99 4.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 167.08 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 0.0 109.125 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.72 -22.36 29.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.254 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.57 7.73 5.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.75 132.72 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -1.118 . . . . 0.0 109.434 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 54' ' ' GLU . 16.4 mt -84.28 84.57 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.708 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.9 OUTLIER -43.61 -53.14 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 108.863 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -143.53 -177.22 5.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.1 132.55 4.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -108.69 156.75 19.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.842 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 12.5 p90 -139.52 170.6 15.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.958 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -167.72 98.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.38 116.88 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -149.17 96.79 2.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.84 -12.09 0.08 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.671 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.8 m -96.78 168.54 10.44 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.247 -1.149 . . . . 0.0 109.358 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.38 44.14 1.43 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.49 -3.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 109.552 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -97.23 -22.86 16.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.721 ' H ' ' CD1' ' A' ' 67' ' ' ILE . 3.5 mp -36.8 -36.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -83.17 -57.62 3.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -42.33 -50.59 5.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.522 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.1 OUTLIER -36.07 -56.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' OG ' ' A' ' 70' ' ' SER . 7.0 m -64.12 -36.58 84.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 75' ' ' GLU . 8.6 tp -65.46 -79.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.54 ' C ' ' O ' ' A' ' 72' ' ' LEU . 7.8 tt -34.93 -41.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 109.74 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.522 ' OG1' ' O ' ' A' ' 70' ' ' SER . 6.6 p -68.25 -35.97 78.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.726 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 72' ' ' LEU . 3.3 mt-10 -85.57 -1.98 57.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -100.99 -23.69 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.39 50.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.88 . . . . 0.0 109.228 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -120.15 100.46 7.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.699 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.39 77.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -169.97 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -1.17 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.8 173.08 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mt -65.35 -28.03 69.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.57 -19.6 64.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.96 -31.18 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.36 40.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.625 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.69 54.66 0.84 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.9 pt -39.17 -26.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.9 ttmm 49.49 179.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' GLN . 31.5 p-10 -96.27 -55.61 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.505 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.1 m -38.27 -24.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.751 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.8 tt0 -79.29 -52.94 7.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 5.4 tt -59.48 -40.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.273 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -63.52 -46.37 86.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.269 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -37.65 79.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.065 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.88 -37.7 84.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.237 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.28 -20.36 59.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.268 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 67.67 10.26 7.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.1 152.67 92.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.476 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.0 165.74 25.26 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.861 2.374 . . . . 0.0 112.271 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.01 -41.58 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.88 2.387 . . . . 0.0 112.275 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.7 p -45.18 102.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 102' ' ' VAL . 11.0 ttmt 84.53 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 105' ' ' HIS . 13.9 p -83.8 -2.73 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.693 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -38.45 -59.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.456 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.693 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 96.5 m -33.26 -48.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 108' ' ' ILE . 71.0 m -65.14 -60.62 2.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 97.3 mt -42.8 -40.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 109.071 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -57.06 -63.56 1.17 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -36.24 -45.42 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.548 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 4.5 tp10 -64.76 -55.78 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.682 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.32 -19.62 23.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.99 -50.27 24.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.377 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -31.42 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.165 -0.959 . . . . 0.0 109.362 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -55.5 8.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.7 -52.37 11.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.724 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -59.37 -65.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 117' ' ' ALA . 6.2 mt -36.76 -33.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.086 -1.009 . . . . 0.0 109.65 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 121' ' ' TYR . . . -76.39 -64.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -0.983 . . . . 0.0 109.739 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.531 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 9.4 t0 -52.5 -2.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.602 ' H ' ' C ' ' A' ' 119' ' ' ALA . 69.4 t80 -98.19 -56.96 2.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.52 -26.97 65.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.61 71.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.522 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.524 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.354 0.597 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -96.41 9.67 40.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.524 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -125.16 0.58 7.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.88 103.08 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.712 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.56 155.92 34.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.441 ' HG1' ' CG ' ' A' ' 44' ' ' GLN . 67.7 m -136.76 126.92 26.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.247 . . . . 0.0 109.958 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.59 123.25 6.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.7 ttt -130.56 126.58 37.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.14 -1.212 . . . . 0.0 109.851 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.33 -174.34 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 109.026 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.21 144.55 8.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.21 132.58 21.67 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.358 -1.083 . . . . 0.0 109.225 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.0 Cg_endo -75.38 -53.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.547 2.165 . . . . 0.0 112.342 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.72 -47.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.7 p -114.48 11.3 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.59 62.28 0.97 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -116.26 117.4 29.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.6 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 14.1 p -87.46 119.33 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.555 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.3 ttt -111.4 122.41 47.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 109.659 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 42' ' ' GLN . 1.6 tt0 -119.44 99.04 6.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tp -101.34 127.98 47.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.583 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.562 ' OE1' ' NZ ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -115.72 125.44 52.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -114.75 118.75 34.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.09 142.23 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.559 ' OD2' ' O ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -89.02 -96.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' OD1' ' A' ' 50' ' ' ASN . 3.7 p30 -153.52 19.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.564 ' OD1' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -145.67 43.86 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . 51.63 31.94 30.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.0 mm -122.11 131.22 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 53' ' ' ILE . 36.3 mt -86.73 109.8 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.162 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -70.71 -23.57 62.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.851 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -169.91 157.73 6.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.035 . . . . 0.0 109.885 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.74 137.67 43.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.222 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 19.3 mttp -101.45 137.49 39.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.4 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 23.8 p90 -116.7 137.17 52.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.09 85.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' CD1' ' A' ' 61' ' ' TYR . 1.4 t -143.04 138.54 30.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.434 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -160.79 125.83 3.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.364 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.13 -64.71 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.46 142.55 27.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.651 ' C ' ' H ' ' A' ' 66' ' ' ALA . . . -76.5 168.35 54.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.26 -32.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -1.108 . . . . 0.0 109.528 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.651 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . -67.0 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.31 -72.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 109.425 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.3 -48.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.35 -33.72 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.377 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 67' ' ' ILE . 40.3 t -67.21 -64.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 70' ' ' SER . 7.7 p -43.41 -27.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.083 -1.011 . . . . 0.0 109.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.534 ' O ' ' C ' ' A' ' 73' ' ' ILE . 7.4 tp -78.12 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.863 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.534 ' C ' ' O ' ' A' ' 72' ' ' LEU . 8.4 tt -34.89 -41.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.667 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 74.7 p -61.61 -51.14 69.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 72' ' ' LEU . 14.3 tt0 -70.29 -5.34 27.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -88.94 -30.79 18.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.57 6.09 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -74.21 112.51 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.704 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.63 -9.13 77.2 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.18 -170.97 3.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 109.587 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER -110.34 164.41 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 mt -59.51 -24.55 63.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -59.76 -48.05 83.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.93 -36.71 75.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.519 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.55 -26.01 66.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.53 44.62 1.44 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.29 -33.85 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -35.84 -47.76 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 65.17 142.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 91' ' ' SER . 0.1 OUTLIER -66.12 -34.69 78.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.417 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 13.3 p -49.32 -41.28 38.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -58.57 -49.27 78.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.09 -35.36 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.01 -18.77 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.75 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.47 -34.76 17.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.858 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.33 -25.45 25.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.957 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -105.61 -8.8 17.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.66 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' LEU . 23.8 mp0 44.79 15.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.482 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.1 pp -41.61 148.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.539 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.7 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.816 2.344 . . . . 0.0 112.305 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 103' ' ' LYS . 60.9 Cg_endo -82.72 9.62 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.73 2.287 . . . . 0.0 112.228 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.9 m -46.4 -8.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.933 . . . . 0.0 109.338 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.654 ' N ' ' O ' ' A' ' 101' ' ' PRO . 2.7 tttm -172.55 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.863 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.5 63.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.457 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.674 ' CD2' ' H ' ' A' ' 106' ' ' CYS . 26.7 p-80 -96.86 -57.12 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.674 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -57.59 -40.59 79.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -63.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -47.4 -31.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.87 -50.68 69.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.021 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.37 -43.61 61.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.9 . . . . 0.0 108.929 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.9 -58.41 7.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.204 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 24.8 t0 -50.17 -28.91 8.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -68.67 -69.99 0.29 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.9 tp -38.37 -40.94 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.487 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.6 mmtm -72.64 -29.12 63.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.29 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.658 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.0 -48.23 71.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.73 82.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.205 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.5 mt -54.62 -44.5 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.37 85.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -57.73 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -45.86 -41.58 11.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' O ' ' C ' ' A' ' 123' ' ' ALA . 4.4 tttm -66.95 -45.55 77.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -36.98 -39.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.328 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.379 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.7 t70 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 77.7 -8.42 1.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.456 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -176.83 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.4 t -124.75 99.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.11 139.76 15.4 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -138.95 122.57 17.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.4 148.37 16.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' A' ' 42' ' ' GLN . 1.6 tpt -145.48 126.67 14.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 109.6 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 m -145.8 155.93 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.337 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.0 159.16 24.54 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 105' ' ' HIS . . . -132.35 142.4 44.81 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.294 -1.121 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.522 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.3 Cg_endo -75.31 -51.45 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.673 2.249 . . . . 0.0 112.065 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.35 -49.75 1.0 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 109.217 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.466 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 50.6 m -102.8 -8.93 20.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.36 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.77 45.68 55.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -120.31 152.31 37.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -1.133 . . . . 0.0 109.591 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.7 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.386 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 ttt -91.47 143.39 26.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' NE2' HE21 ' A' ' 44' ' ' GLN . 4.8 tt0 -132.57 126.0 31.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.223 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.41 130.76 56.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.769 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.452 HE21 ' NE2' ' A' ' 42' ' ' GLN . 30.1 mt-30 -125.8 112.82 16.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.02 141.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.646 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 1.7 mptt -113.03 137.63 51.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.34 145.04 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 10.4 p-10 -82.75 -96.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -155.81 16.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.32 4.84 2.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.77 20.31 31.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.44 HG21 HD12 ' A' ' 52' ' ' ILE . 32.7 mm -106.88 146.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -1.14 . . . . 0.0 109.353 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 54' ' ' GLU . 23.2 mm -85.87 84.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.688 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -44.87 -54.91 5.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.116 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 161.61 41.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.104 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.37 115.7 12.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 109.887 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -96.43 141.23 29.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 108.93 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 74' ' ' THR . 28.1 p90 -137.57 176.3 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.998 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 124.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -160.53 133.57 6.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 15.4 p90 -150.83 125.67 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.45 -42.64 1.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 1.1 m -79.88 142.61 35.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.552 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.81 -5.01 57.73 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.47 -2.81 13.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -91.78 -41.05 10.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.576 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' ALA . 65.6 mt -41.91 -44.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.99 -48.52 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.5 m -67.63 -66.04 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.542 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 69' ' ' SER . 17.9 m -35.7 -41.34 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.568 ' O ' ' OG1' ' A' ' 74' ' ' THR . 20.4 t -68.22 -41.38 81.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -64.64 -65.28 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 72' ' ' LEU . 13.0 tt -41.08 -46.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.938 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 71' ' ' SER . 17.2 p -55.58 -44.87 77.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.972 . . . . 0.0 109.699 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.73 -34.8 64.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.065 -1.022 . . . . 0.0 109.677 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.02 -13.56 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.94 22.38 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -98.85 117.58 33.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.67 5.61 69.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -84.71 -163.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.7 m -116.2 155.91 27.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 109.568 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.7 mt -59.55 -17.52 33.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.524 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.93 -50.44 14.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.469 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.665 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -66.21 -39.36 89.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -37.1 67.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.37 41.63 3.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -156.32 -37.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -1.154 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 87' ' ' ALA . 5.3 pt -42.06 163.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.385 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -126.88 -173.07 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -100.95 -13.85 18.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -21.81 61.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.277 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.22 -58.97 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.346 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.7 -38.74 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.52 65.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -86.13 -21.36 27.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.75 -48.11 10.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 98' ' ' GLU . 5.4 mt -90.16 -11.23 41.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.877 . . . . 0.0 109.505 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 mt-10 41.67 68.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.73 150.29 43.76 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.176 -0.953 . . . . 0.0 109.311 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -44.1 147.35 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.567 2.178 . . . . 0.0 112.032 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -69.71 -44.57 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.684 2.256 . . . . 0.0 112.157 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.502 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 1.7 p -60.0 -2.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -143.04 36.33 1.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 105' ' ' HIS . 5.2 p -84.49 -15.54 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.292 -0.88 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.633 ' C ' ' ND1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -42.43 -44.68 4.11 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 0.0 109.097 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.553 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 57.3 m -40.15 -54.58 2.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 109.836 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 108' ' ' ILE . 96.0 p -64.95 -56.02 15.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.2 mt -43.53 -40.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.125 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.476 HD13 ' HD1' ' A' ' 105' ' ' HIS . 1.2 mp -64.75 -47.84 76.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.101 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -42.18 -48.98 4.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.141 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.13 -35.03 79.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.62 -33.42 74.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.947 . . . . 0.0 109.859 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.32 -47.24 74.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 115' ' ' LYS . 1.5 tp -58.98 -39.16 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.183 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.437 ' N ' HG23 ' A' ' 114' ' ' ILE . 2.2 ttmt -70.34 -50.87 34.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.52 -32.17 66.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.0 109.384 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.93 -58.11 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.216 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -55.55 -48.2 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.95 -36.02 59.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD1' ' NZ ' ' A' ' 124' ' ' LYS . 5.3 t0 -72.59 -55.21 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.466 ' C ' ' O ' ' A' ' 120' ' ' ASP . 22.2 t80 -39.59 -56.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.62 -28.56 67.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -61.0 -46.05 92.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 120' ' ' ASP . 33.6 mmtm . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.534 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 0.3 OUTLIER -72.31 -16.3 61.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.491 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.426 ' ND2' ' CG2' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -65.11 1.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.467 ' H ' ' C ' ' A' ' 25' ' ' SER . 79.1 t -135.71 95.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.15 27.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.6 m -105.11 109.89 22.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -1.044 . . . . 0.0 109.328 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.61 91.13 0.76 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.92 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -1.22 . . . . 0.0 109.498 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.46 173.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.7 159.78 22.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -134.88 142.82 43.72 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.479 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.0 Cg_endo -74.82 -56.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.646 2.231 . . . . 0.0 112.381 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -42.52 -36.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -102.4 2.59 36.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.68 52.02 1.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' CB ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -131.11 143.56 50.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.134 . . . . 0.0 109.578 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.73 114.59 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.064 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.1 ttt -108.81 139.02 44.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.895 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -122.66 125.02 44.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.062 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tt -121.04 138.67 54.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.806 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.13 136.95 42.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.61 132.17 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -106.68 135.18 48.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.436 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -114.98 151.33 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.893 . . . . 0.0 109.527 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.46 -106.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -142.1 15.58 2.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.38 -4.24 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.545 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.74 4.73 51.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 52' ' ' ILE . 28.6 mm -94.68 136.47 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.476 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.2 115.52 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.72 -39.87 12.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -139.91 -179.25 5.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.952 . . . . 0.0 109.576 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.98 140.88 3.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.81 144.62 44.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -142.39 150.33 40.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 109.603 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' CG ' ' C ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -154.67 95.89 1.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 148.89 47.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -160.96 154.39 21.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.286 -0.884 . . . . 0.0 109.366 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.4 -53.31 0.7 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CB ' ' A' ' 39' ' ' ASP . 9.0 m -76.11 109.46 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.54 43.83 0.35 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 63' ' ' CYS . 0.3 OUTLIER -163.72 -6.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.456 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.57 -38.79 19.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 67' ' ' ILE . 7.2 mm -47.67 -49.36 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.21 -68.34 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.317 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.82 -34.33 2.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.455 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.1 t -64.75 -74.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.963 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 70' ' ' SER . 66.5 m -36.27 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.553 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' SER . 22.2 tp -76.03 -85.37 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 72' ' ' LEU . 1.1 tt -36.99 -33.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.7 p -66.99 -46.65 73.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 71' ' ' SER . 2.2 mt-10 -78.23 -7.84 57.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.31 -30.02 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.8 m -91.67 11.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -87.08 89.83 8.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.38 -14.64 15.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.54 -168.26 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -1.13 . . . . 0.0 109.565 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -119.99 -179.2 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.37 -34.07 65.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -68.89 -11.01 60.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.607 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.85 -49.58 4.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.569 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.8 -26.17 62.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.537 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.3 46.37 1.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -164.05 -38.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -1.127 . . . . 0.0 109.169 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.43 HD12 HG23 ' A' ' 88' ' ' ILE . 5.2 pt -44.9 166.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 109.466 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -132.7 -179.12 5.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.75 -19.34 24.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.365 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -62.73 -42.13 99.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.06 -60.6 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.176 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.5 mt -51.53 -42.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.895 . . . . 0.0 109.186 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.624 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -59.55 -35.14 73.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.195 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.61 -38.71 73.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.88 . . . . 0.0 109.104 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.3 -47.74 80.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.363 -0.835 . . . . 0.0 109.369 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.79 -16.63 21.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 94' ' ' ALA . 25.8 tt0 45.03 72.93 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.39 150.26 36.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -39.09 141.36 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.961 2.44 . . . . 0.0 112.31 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 103' ' ' LYS . 66.5 Cg_endo -76.89 -15.02 16.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.759 2.306 . . . . 0.0 112.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.73 25.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -170.69 34.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.438 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 105' ' ' HIS . 38.6 t -57.46 -27.48 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.676 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -34.86 -62.14 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.308 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.676 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 38.6 m -37.61 -51.46 1.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.604 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -55.28 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mt -46.65 -40.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.863 . . . . 0.0 109.35 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.408 HD12 ' ND1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -62.72 -37.83 88.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.279 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.31 -58.53 8.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.506 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 112' ' ' ASP . 3.9 tm-20 -58.76 -43.43 90.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.596 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.503 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -60.93 -29.79 69.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.88 -57.22 7.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -51.24 -35.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.506 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 114' ' ' ILE . 1.4 tttt -74.28 -48.06 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.8 -50.71 69.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.5 -53.73 50.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -58.34 -20.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.48 -47.37 19.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.193 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.99 -10.52 59.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.549 ' CE1' ' NZ ' ' A' ' 124' ' ' LYS . 1.9 t80 -91.31 -49.8 6.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.303 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -66.61 -23.62 66.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 0.0 109.203 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.534 ' O ' ' C ' ' A' ' 124' ' ' LYS . . . -68.72 -1.75 7.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.549 ' NZ ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -81.11 -3.4 51.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.39 7.2 26.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.618 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.35 114.74 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.8 138.87 14.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -125.25 114.38 18.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.561 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.12 16.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.83 124.8 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.16 -1.2 . . . . 0.0 109.665 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.56 151.08 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.148 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.05 10.28 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.56 92.65 5.08 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.29 70.87 7.32 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.755 2.303 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.53 -38.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.365 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . 6.6 t -165.48 -38.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.772 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -62.53 -49.23 75.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.5 t70 84.81 -174.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.65 99.17 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.855 . . . . 0.0 109.25 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.8 ttp -95.73 139.82 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.65 107.34 13.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.116 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.13 127.49 52.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.837 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -130.34 120.55 24.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 108.974 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.78 152.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.827 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' A' ' 54' ' ' GLU . 24.1 tttt -114.84 154.75 28.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 109.284 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 64.5 t -133.25 121.71 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD1' ' OE1' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -47.63 -53.67 14.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 162.01 -23.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.859 . . . . 0.0 109.252 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.664 ' ND2' ' H ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.8 -0.74 57.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.44 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.85 8.67 41.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 52' ' ' ILE . 5.2 mm -100.31 138.63 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.161 . . . . 0.0 109.534 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.8 mt -96.83 124.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.301 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.551 ' OE1' ' OD1' ' A' ' 48' ' ' ASP . 19.1 pt-20 -107.65 -30.08 8.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.56 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -124.87 150.36 46.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.08 155.16 42.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 109.588 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 58' ' ' PHE . 1.2 tttm -150.49 143.31 24.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' CE2' ' OG ' ' A' ' 70' ' ' SER . 4.5 p90 -138.86 -179.38 5.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -171.32 104.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 t -136.85 144.63 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.589 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.535 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 53.3 t80 -155.0 98.57 2.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 0.7 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -100.71 123.93 45.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 0.0 109.337 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -91.94 123.03 7.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER 72.61 -8.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.18 . . . . 0.0 109.536 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' CB ' ' SG ' ' A' ' 63' ' ' CYS . . . -96.44 7.69 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mt -72.99 -38.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -41.95 75.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p -56.8 -38.82 73.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 58' ' ' PHE . 17.5 t -53.47 -46.06 69.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -35.11 79.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.32 -56.27 22.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.489 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 3.8 tt -58.52 -48.58 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.76 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.47 HG22 ' CD1' ' A' ' 58' ' ' PHE . 23.3 p -60.72 -17.89 51.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 0.0 109.482 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.06 -41.75 10.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -74.22 -7.7 53.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.428 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 73' ' ' ILE . 35.0 m -115.29 36.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.343 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -133.95 78.18 1.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -0.908 . . . . 0.0 109.634 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 0.4 9.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -97.01 -165.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.09 164.65 15.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 34.3 mt -58.83 -24.8 62.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -74.67 -26.29 59.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.646 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.76 -50.21 8.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.67 63.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.269 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.02 45.61 3.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -152.45 -38.29 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -1.112 . . . . 0.0 108.688 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 87' ' ' ALA . 4.0 pt -39.35 123.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.534 -0.729 . . . . 0.0 109.119 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -99.17 162.6 12.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.612 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -57.76 -20.1 32.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 p -77.57 -33.57 53.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.78 -43.68 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 93' ' ' ILE . 10.1 mm -81.61 -33.33 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.912 . . . . 0.0 109.177 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.21 -12.5 56.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 -37.44 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.405 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -53.22 43.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.13 -23.98 19.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 51.29 68.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -96.84 146.45 31.33 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.149 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.59 147.24 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.721 2.281 . . . . 0.0 112.247 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 9.55 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.748 2.299 . . . . 0.0 112.168 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 t -92.09 -33.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -105.93 30.02 6.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 103' ' ' LYS . 20.3 t -42.55 -25.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.772 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 4.4 p-80 -52.0 -39.6 59.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.627 ' SG ' ' CE1' ' A' ' 105' ' ' HIS . 33.9 m -47.93 -60.39 2.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.308 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 109' ' ' LEU . 57.9 m -59.31 -58.81 7.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' CB ' ' A' ' 112' ' ' ASP . 63.7 mt -46.26 -22.1 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 107' ' ' SER . 0.8 OUTLIER -74.43 -57.53 3.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.5 59.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 109.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' A' ' 112' ' ' ASP . 3.3 tm-20 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 10.0 t0 -43.13 -43.33 4.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.52 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.29 -54.48 39.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -47.27 -42.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' CD ' ' OE2' ' A' ' 111' ' ' GLU . 5.6 mttp -68.36 -34.85 76.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.21 -58.55 6.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.496 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.68 -42.36 45.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.76 -48.35 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.407 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.92 -37.75 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.363 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.6 -38.41 67.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.78 -32.61 74.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -78.14 -39.77 40.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.63 -54.94 26.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.4 mttm . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.271 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -3.38 56.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -105.51 -5.89 19.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.33 116.27 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.441 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.05 144.27 17.24 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.2 m -126.7 121.93 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.06 123.77 5.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.477 ' C ' ' SD ' ' A' ' 31' ' ' MET . 2.4 ppp? -131.89 153.11 50.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.677 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -145.26 169.06 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.251 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.1 147.84 18.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -145.73 73.13 13.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -1.123 . . . . 0.0 109.34 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -58.5 71.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.85 2.366 . . . . 0.0 112.097 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -177.95 -89.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.836 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 1.5 t -118.48 -7.98 10.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.665 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -98.71 -23.87 11.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 58.45 -163.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.715 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -87.24 110.35 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 108.842 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 8.1 ttt -100.55 129.81 46.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.163 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.608 ' NE2' ' NE2' ' A' ' 44' ' ' GLN . 30.5 tt0 -120.88 108.08 13.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 tp -108.19 115.06 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.722 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.608 ' NE2' ' NE2' ' A' ' 42' ' ' GLN . 12.3 mt-30 -110.38 118.88 37.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pt -106.25 146.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.379 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -115.18 136.58 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.66 145.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.114 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -78.75 -104.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.502 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.5 t70 -141.8 9.15 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.32 12.52 2.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.301 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.04 14.61 57.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -99.87 114.35 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -1.153 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.5 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -50.29 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 49.8 t0 -127.19 170.14 12.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -162.95 115.81 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -98.92 131.69 44.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.446 ' CD2' ' OG ' ' A' ' 70' ' ' SER . 8.4 p90 -109.72 172.05 7.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.647 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -171.81 112.2 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -156.01 146.99 22.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 4.3 t80 -156.9 106.88 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.36 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.23 -25.73 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 64.4 m -83.64 131.67 34.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -1.068 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.82 9.49 60.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -152.77 -13.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -93.14 -12.69 29.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' ALA . 20.1 mt -42.15 -45.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.15 89.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -46.41 -53.41 11.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.5 ' O ' ' OG1' ' A' ' 74' ' ' THR . 6.9 t -45.17 -48.45 12.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 m -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -64.67 -76.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 72' ' ' LEU . 5.8 tt -35.51 -52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.728 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -49.54 -52.54 29.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -2.11 30.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 109.891 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -105.11 -4.5 21.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.466 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.29 5.59 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.504 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -92.76 98.38 11.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.75 11.23 23.37 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -110.74 174.29 5.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -96.71 157.46 15.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.487 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.34 -20.72 63.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -34.89 74.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.57 -32.55 36.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.96 -21.51 59.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.636 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.17 30.08 10.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -147.23 -37.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.151 -1.205 . . . . 0.0 109.507 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.545 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -34.66 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.527 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER 70.39 167.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.369 -0.832 . . . . 0.0 109.516 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.765 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -89.74 -54.83 3.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.765 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -37.84 -33.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.482 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -60.28 -53.08 61.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.56 -35.81 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.51 -39.98 81.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.84 -34.12 62.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -54.2 -45.92 72.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.336 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.19 -6.52 19.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 94' ' ' ALA . 16.8 mt-10 53.93 88.5 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -108.03 165.75 12.17 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.53 142.37 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.601 2.201 . . . . 0.0 112.053 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.92 5.75 4.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.705 2.27 . . . . 0.0 112.209 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.15 -25.7 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.643 ' O ' ' N ' ' A' ' 105' ' ' HIS . 4.2 mtpt -118.22 28.15 8.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 103' ' ' LYS . 21.3 t -38.16 -22.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.665 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 3.2 p-80 -44.47 -31.39 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.657 ' SG ' ' CE1' ' A' ' 105' ' ' HIS . 57.8 m -60.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.49 ' HG ' ' ND2' ' A' ' 90' ' ' ASN . 10.2 p -47.15 -56.87 5.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.181 -0.949 . . . . 0.0 109.095 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 6.0 mt -45.67 -36.62 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.91 -49.13 78.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.244 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -61.96 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 109.588 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 112' ' ' ASP . 30.2 tt0 -54.99 -73.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 111' ' ' GLU . 23.0 t0 -34.1 -55.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.656 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 112' ' ' ASP . . . -40.96 -70.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.418 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.1 tp -43.49 -31.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.083 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 112' ' ' ASP . 4.1 tptt -64.42 -60.17 3.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.9 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.05 -45.97 75.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.18 -45.36 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.264 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.92 64.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 109.108 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.15 -26.19 37.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 109.271 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 15.8 t80 -76.41 -54.49 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -71.42 0.41 8.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.01 -31.1 22.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 mptt . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.459 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.522 ' O ' ' O ' ' A' ' 2' ' ' ALA . 6.5 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.522 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 56.15 155.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.505 ' O ' ' C ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -46.63 -62.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -37.3 120.4 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.9 48.07 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.65 -4.16 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.659 ' CG1' ' H ' ' A' ' 8' ' ' ILE . 3.6 t -93.3 -152.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.659 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 7.4 mm 44.5 99.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.637 ' C ' ' CD2' ' A' ' 10' ' ' HIS . 2.1 m-20 -126.41 44.1 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.637 ' CD2' ' C ' ' A' ' 9' ' ' ASP . 13.7 m-70 -150.4 5.52 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.569 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.497 ' O ' ' O ' ' A' ' 10' ' ' HIS . 0.7 OUTLIER 59.71 129.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.17 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' TYR . 6.5 m-20 -109.82 145.94 33.05 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.334 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.67 145.3 46.26 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.66 2.24 . . . . 0.0 112.086 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -132.15 34.18 3.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -132.78 -173.25 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 19' ' ' SER . 8.7 m -114.42 -119.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.433 ' H ' HG22 ' A' ' 17' ' ' VAL . . . -112.98 4.08 25.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.462 ' H ' HG22 ' A' ' 17' ' ' VAL . 1.4 t -119.42 163.8 16.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -1.172 . . . . 0.0 109.626 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.45 HD11 ' NZ ' ' A' ' 46' ' ' LYS . 7.1 mt -82.09 -65.01 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 23' ' ' LYS . 4.9 m-20 -141.21 20.67 2.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.64 10.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -0.899 . . . . 0.0 109.227 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.43 3.49 9.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.0 t0 58.37 -146.61 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.296 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.479 ' C ' ' CG ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER 71.48 -7.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.479 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 178.29 30.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.656 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.12 94.93 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.648 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.12 126.15 7.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.01 127.13 2.27 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 ttt -133.62 98.39 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.283 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -107.49 170.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.41 160.14 26.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.91 92.98 38.3 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.152 -1.205 . . . . 0.0 109.642 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.85 -16.06 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.679 2.253 . . . . 0.0 112.052 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 -57.16 4.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.9 p -100.91 19.53 17.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.439 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.27 58.32 1.06 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 42.9 t0 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -98.29 122.43 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -108.46 115.66 30.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -110.99 113.64 26.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 9.9 tp -103.64 153.64 20.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.451 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.06 111.42 5.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -101.26 146.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' NZ ' HD11 ' A' ' 20' ' ' LEU . 6.8 tttm -131.15 122.94 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.47 141.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.621 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -172.47 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 4.3 m-20 -62.73 45.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.648 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.4 m-20 78.5 51.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.6 -5.75 72.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.77 156.53 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -1.161 . . . . 0.0 109.385 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.43 94.57 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.73 -25.14 64.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.423 -0.798 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.19 168.47 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.89 131.15 11.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -110.87 163.13 14.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 16.2 p90 -142.1 166.6 24.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 109.379 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 101.4 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.391 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -154.1 143.39 21.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 1.2 p90 -161.82 134.7 6.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.04 -52.95 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 168.26 20.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.184 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 38.81 2.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 t -166.29 -47.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -1.161 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' C ' ' N ' ' A' ' 68' ' ' ALA . . . -48.38 -37.56 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -47.52 -19.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.613 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' ALA . . . -95.93 -40.26 9.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.403 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.644 ' HG ' ' N ' ' A' ' 70' ' ' SER . 4.7 p -50.92 -38.68 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.321 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.644 ' N ' ' HG ' ' A' ' 69' ' ' SER . 87.9 p -58.94 -38.89 80.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -63.64 -41.85 98.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 73' ' ' ILE . 1.7 tp -66.65 -73.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 72' ' ' LEU . 6.2 tt -43.26 -28.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.602 ' CG2' ' O ' ' A' ' 70' ' ' SER . 19.2 p -77.5 -41.46 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.59 2.14 38.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -110.6 -30.31 7.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.758 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 4.4 m -109.25 50.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -123.82 104.63 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.39 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 6.1 63.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.0 mmtt -98.67 175.22 6.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -1.12 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.703 ' HG ' ' H ' ' A' ' 83' ' ' GLU . 12.3 t -88.16 154.52 20.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.4 mt -61.76 -20.16 63.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.703 ' H ' ' HG ' ' A' ' 81' ' ' SER . 49.3 tt0 -64.12 -29.95 71.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -91.56 -35.51 14.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.78 -37.86 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.36 57.57 2.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -163.27 -34.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -1.124 . . . . 0.0 109.004 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 0.8 OUTLIER -45.15 -14.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 87' ' ' ALA . 19.5 mttm 46.68 -173.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.28 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 91' ' ' SER . 24.5 p-10 -97.9 -24.14 15.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.696 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.6 -25.47 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.98 -65.36 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 109.661 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 9.5 tt -49.81 -38.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -59.75 -46.33 89.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.379 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -65.02 -28.48 69.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tm-20 -71.46 -28.99 64.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.426 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 25.8 mt -93.67 -36.96 12.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.339 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 5.7 tt0 69.72 62.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -120.1 149.3 48.87 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.942 . . . . 0.0 109.451 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.96 158.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 103' ' ' LYS . 41.4 Cg_endo -72.05 -51.11 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.766 2.311 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.47 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 41.4 t -58.04 -2.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 101' ' ' PRO . 13.7 mttp -115.6 12.18 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.24 -1.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.727 ' N ' ' HD1' ' A' ' 105' ' ' HIS . 0.3 OUTLIER -57.58 -41.62 81.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.981 . . . . 0.0 109.256 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 19.3 m -63.8 -46.82 83.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.841 . . . . 0.0 109.337 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -56.42 -46.45 80.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.343 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 19.6 mt -52.89 -45.32 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.305 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.5 -46.58 86.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -52.67 -53.39 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.93 -56.38 19.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.57 -17.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.77 -53.42 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.464 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.5 tp -57.25 -30.11 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -43.7 38.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.7 92.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.673 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.4 73.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.7 mt -63.7 -44.88 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.2 -39.77 87.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.14 -31.87 68.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.27 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -39.24 74.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.339 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -77.58 -18.49 56.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.612 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.43 70.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -101.39 19.59 17.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -84.61 -40.49 17.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.33 24.12 3.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mt -91.21 23.92 3.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -1.148 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.87 144.23 26.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 130' ' ' HIS . 7.2 m80 -148.5 118.35 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 129' ' ' HIS . 34.5 m-70 42.65 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.248 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.69 129.79 23.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -50.01 173.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.534 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.699 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 0.8 OUTLIER -163.89 163.46 23.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.674 ' CG ' ' O ' ' A' ' 133' ' ' HIS . 37.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.84 169.11 8.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 4' ' ' SER . 5.4 t80 -170.92 177.07 3.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' TYR . 6.3 t -53.5 -174.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -47.45 -46.18 26.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -170.07 -89.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.43 -47.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 pt -115.91 145.11 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.552 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' HIS . 5.5 m-20 -114.07 116.64 29.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' ASP . 7.0 t-80 57.69 111.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.14 118.51 10.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.77 136.83 58.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.955 . . . . 0.0 109.253 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.73 60.74 2.56 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.46 164.62 35.09 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.755 2.303 . . . . 0.0 112.019 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.563 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.9 ttm180 -70.21 50.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 15' ' ' ARG . 2.9 t30 53.29 161.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.56 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -102.96 -92.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.54 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.95 -110.83 0.78 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -59.05 167.1 1.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mt -117.11 -132.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -81.85 9.7 7.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.275 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 24' ' ' ASP . 12.3 tttt 62.48 -38.44 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.435 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 21' ' ' ASP . 80.9 tttt -73.8 45.4 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 26' ' ' ASN . 1.2 m-20 -131.02 139.47 49.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -74.37 13.09 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.321 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -116.26 22.12 13.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.602 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.53 103.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.92 15.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -127.39 152.06 48.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -1.174 . . . . 0.0 109.693 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 125.5 1.56 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.7 ttp -123.79 140.44 52.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.733 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -141.37 165.1 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.43 160.69 29.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -134.84 145.44 54.69 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.303 -1.116 . . . . 0.0 109.411 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.55 -50.25 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.595 2.197 . . . . 0.0 112.05 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.84 63.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.4 m -93.73 -2.62 53.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.61 42.42 0.67 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 16.9 t0 -118.51 154.46 32.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -1.088 . . . . 0.0 109.821 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.4 t -113.48 99.63 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -82.02 102.97 11.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -91.91 138.8 31.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.3 tp -134.66 126.16 28.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -128.21 133.65 48.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.7 140.89 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -118.44 140.79 49.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 73.0 t -117.17 143.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER 178.19 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.545 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-20 -62.45 45.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.663 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.1 m-20 81.09 45.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.99 -3.27 86.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 79' ' ' GLY . 40.5 mm -96.49 146.86 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -1.103 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.2 mt -56.48 94.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -0.934 . . . . 0.0 109.445 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -46.47 35.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.25 169.75 22.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.36 121.6 16.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' CD ' ' N ' ' A' ' 57' ' ' LYS . 2.9 mmtm -95.84 154.79 17.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -141.1 158.32 44.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -160.94 116.64 2.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.21 131.64 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.463 ' C ' ' OD2' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -148.12 103.76 3.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.578 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.581 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . 125.94 22.73 1.72 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -114.25 83.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.157 . . . . 0.0 109.661 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . 33.45 -101.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.633 ' C ' ' H ' ' A' ' 67' ' ' ILE . 96.1 p -136.99 19.19 3.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -1.145 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.51 4.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.633 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.8 mm -58.2 -61.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -46.57 -40.13 12.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.5 m -61.54 -32.51 72.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.567 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.6 OUTLIER -61.18 -26.31 67.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.428 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -83.21 -44.58 14.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.96 -45.42 94.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 74' ' ' THR . 17.4 tt -67.34 -55.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.567 ' OG1' ' O ' ' A' ' 70' ' ' SER . 10.5 p -53.6 -23.41 10.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.192 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.8 -21.71 21.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -92.68 -9.1 42.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.536 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.19 12.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.203 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -94.19 123.16 37.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.352 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 71.2 8.9 66.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -97.86 169.21 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -1.122 . . . . 0.0 109.554 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -83.05 162.19 21.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.57 -24.04 61.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -67.07 -31.4 71.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.77 -33.85 21.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.25 -36.78 85.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.15 36.15 3.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -147.27 -34.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -1.068 . . . . 0.0 109.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.543 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -33.42 -28.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 87' ' ' ALA . 4.4 ttmt 63.11 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.48 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 92' ' ' GLN . 7.6 p-10 -82.69 -47.74 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.601 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -43.15 -24.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.632 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.8 tp60 -70.55 -53.9 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.657 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.23 -22.12 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 109.621 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.24 -34.07 59.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 9.0 tp10 -85.37 -16.47 39.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.06 -47.4 14.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.416 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 7.6 mp -87.15 -35.68 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 8.6 tt0 70.21 73.04 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 0.0 109.785 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.64 143.72 27.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.875 . . . . 0.0 109.208 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.6 148.0 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.753 2.302 . . . . 0.0 112.45 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.2 Cg_endo -72.79 -13.64 26.83 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.799 2.333 . . . . 0.0 112.196 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.79 -0.1 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 109.54 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 101' ' ' PRO . 21.2 mttp -150.63 55.02 0.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 104' ' ' VAL . 37.0 t -70.1 -2.79 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' CB ' ' A' ' 34' ' ' ALA . 7.5 p-80 -84.03 -26.6 28.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.312 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.69 -60.79 2.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.2 p -54.07 -54.65 36.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.26 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' C ' ' A' ' 109' ' ' LEU . 43.6 mt -44.73 -66.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 108' ' ' ILE . 4.9 mp -35.21 -50.6 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.669 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.422 ' HA ' ' SD ' ' A' ' 41' ' ' MET . . . -49.9 -56.8 9.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.0 tt0 -68.56 -67.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.2 OUTLIER -34.67 -27.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -78.31 -59.11 2.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.987 . . . . 0.0 109.828 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.3 tp -48.09 -37.11 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.2 ttmt -67.76 -47.73 68.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.286 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.4 64.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.1 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.85 -55.74 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.098 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 117' ' ' ALA . 29.8 mt -42.14 -40.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.08 -54.41 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.07 -26.19 25.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 123' ' ' ALA . 21.2 t80 -76.73 -57.57 3.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.312 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -69.79 2.93 2.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 121' ' ' TYR . . . -93.8 -49.37 5.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -70.18 -3.57 17.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.863 . . . . 0.0 109.647 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -51.21 21.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -155.71 20.18 0.52 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.521 ' O ' ' C ' ' A' ' 128' ' ' GLU . 6.6 mp -133.02 2.18 3.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -1.175 . . . . 0.0 109.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.521 ' C ' ' O ' ' A' ' 127' ' ' LEU . 2.8 mm-40 36.93 -104.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.639 ' O ' ' ND1' ' A' ' 129' ' ' HIS . 6.6 p80 -85.3 141.75 29.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.137 -0.977 . . . . 0.0 109.354 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.425 ' NE2' ' HB3' ' A' ' 123' ' ' ALA . 16.4 m80 -69.5 178.01 2.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.513 ' C ' ' H ' ' A' ' 133' ' ' HIS . 21.0 m170 -80.99 105.26 12.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -71.68 13.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' A' ' 131' ' ' HIS . 14.3 m-70 -48.21 111.38 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.496 ' CD2' ' OXT' ' A' ' 134' ' ' HIS . 23.1 t-160 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.426 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HE2' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 1' ' ' MET . . . 68.63 -172.87 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 62.26 73.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.283 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 m -124.81 81.48 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.59 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.04 151.1 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.403 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -140.57 43.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -54.54 124.51 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.347 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.54 134.05 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 22.0 p-10 -116.89 84.79 2.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.4 -33.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -97.26 67.15 2.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.35 160.96 16.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.526 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -125.17 91.66 48.75 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.582 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.73 157.74 21.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.744 2.296 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -152.08 64.13 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.18 175.78 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -126.43 74.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -56.48 -167.71 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.668 ' C ' ' H ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER 74.52 168.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -1.183 . . . . 0.0 109.624 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.622 ' C ' ' H ' ' A' ' 22' ' ' LYS . 4.7 tp 63.37 -18.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.668 ' H ' ' C ' ' A' ' 19' ' ' SER . 10.0 m-20 -55.57 1.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.622 ' H ' ' C ' ' A' ' 20' ' ' LEU . 11.7 ttmt 64.32 1.88 1.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 21' ' ' ASP . 4.3 mttp -158.39 30.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.151 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 26' ' ' ASN . 12.3 t0 -91.66 26.7 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 66.34 -4.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 24' ' ' ASP . 57.8 m-20 -107.71 -0.71 21.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.45 96.25 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.576 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.12 139.11 37.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.6 m -120.61 105.97 11.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -1.12 . . . . 0.0 109.49 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.79 130.04 10.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.6 ttt -132.65 117.01 17.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -1.144 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.9 159.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.98 156.05 16.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . . . -117.83 83.04 17.62 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.335 -1.097 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.54 -16.82 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.913 2.408 . . . . 0.0 112.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.01 -33.64 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.3 p -124.06 23.19 8.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.74 69.17 0.2 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 8.6 t0 -139.67 116.95 11.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.55 110.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.406 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 5.7 ttt -97.6 137.02 37.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -128.91 112.8 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.47 139.25 50.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -134.96 134.75 40.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.387 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.82 135.05 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -106.81 133.58 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -107.98 139.68 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 6.4 t0 -82.76 -88.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.3 m-20 -154.76 17.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.0 11.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.01 78.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -83.39 135.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.581 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.34 104.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.114 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.19 -24.04 37.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 109.837 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 45.6 t0 -148.21 150.62 34.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.685 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -142.04 116.61 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.343 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -97.31 152.12 19.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 15.3 p90 -147.59 166.42 27.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -170.79 117.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.23 143.71 18.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.706 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 20.1 p90 -161.92 95.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.34 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.06 -62.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.533 ' SG ' ' NZ ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -81.89 146.27 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.417 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.7 10.38 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 63' ' ' CYS . 7.4 t -136.22 -7.24 2.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -1.134 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.19 -68.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.616 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.83 -34.22 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.517 ' O ' ' OG ' ' A' ' 71' ' ' SER . . . -58.27 -57.53 12.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.2 -41.25 81.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.473 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.5 ' O ' ' CG2' ' A' ' 74' ' ' THR . 1.0 OUTLIER -61.53 -28.23 69.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 77.4 p -75.0 -49.96 18.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.72 -57.99 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 74' ' ' THR . 18.2 tt -49.15 -45.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 109.512 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 70' ' ' SER . 19.0 p -60.05 -36.25 76.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -77.98 -10.37 59.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 -30.85 12.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.596 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.3 m -96.81 38.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.671 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.06 102.85 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.16 52.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -104.77 169.39 8.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -1.111 . . . . 0.0 109.429 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -93.54 150.22 20.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.52 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.44 -26.51 3.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.63 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -69.04 -32.98 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.93 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -83.46 -34.24 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.55 54.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.27 52.05 3.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -162.43 -39.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -1.186 . . . . 0.0 109.243 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -42.76 -30.28 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.364 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 59.91 175.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -88.52 -44.33 10.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ASN . 43.4 t -38.61 -39.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 95' ' ' GLU . 16.4 tp60 -62.33 -66.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.378 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.4 mt -45.37 -31.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.229 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.36 -19.96 48.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.248 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 92' ' ' GLN . 6.2 tt0 -83.85 -20.03 33.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -97.92 -53.89 3.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -72.91 -5.56 39.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.369 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.507 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 43.26 31.95 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.619 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.95 150.79 36.95 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.334 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.18 157.95 42.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.8 2.333 . . . . 0.0 112.234 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -76.4 -7.14 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.893 2.395 . . . . 0.0 112.567 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.83 -14.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.533 ' NZ ' ' SG ' ' A' ' 63' ' ' CYS . 25.6 mttm -114.42 29.69 7.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.76 -9.94 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.42 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 103' ' ' LYS . 2.2 p-80 -77.35 -25.28 50.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -75.7 -41.81 52.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.138 -0.976 . . . . 0.0 109.121 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -52.97 59.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 7.1 tt -53.9 -38.73 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 108.89 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' N ' ' CG2' ' A' ' 108' ' ' ILE . 1.6 mp -53.8 -50.04 67.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.406 ' HA ' ' SD ' ' A' ' 41' ' ' MET . . . -56.82 -54.24 48.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -48.93 -63.46 1.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.206 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.42 -27.56 10.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.0 -49.04 63.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 115' ' ' LYS . 2.4 tp -56.22 -36.31 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.985 . . . . 0.0 109.26 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 114' ' ' ILE . 0.7 OUTLIER -70.87 -57.04 5.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.84 7.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.37 -59.67 3.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.9 mt -46.44 -44.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.424 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.438 ' C ' ' N ' ' A' ' 121' ' ' TYR . . . -62.35 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' C ' ' OD1' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -47.89 -17.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.2 t80 -92.59 -29.28 16.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -92.1 3.37 55.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.355 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.44 -52.18 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 109.578 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -76.62 47.76 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -122.54 -26.93 4.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.485 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.16 -17.29 1.92 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.0 mt -83.89 37.0 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.28 109.56 21.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.272 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.589 ' H ' ' CD2' ' A' ' 129' ' ' HIS . 3.7 p80 -69.24 118.84 12.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.06 -2.11 13.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 t60 65.0 118.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.404 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 134' ' ' HIS . 0.3 OUTLIER -90.93 -58.01 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.537 ' C ' ' CG ' ' A' ' 134' ' ' HIS . 40.5 m80 -51.46 89.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.895 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.579 ' CD2' ' N ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.419 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 28.6 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 1' ' ' MET . . . 170.54 -62.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.467 ' O ' ' C ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -148.4 -73.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 3' ' ' TYR . 1.7 m 41.59 83.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -145.1 105.65 4.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -165.12 -27.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 t -54.19 -76.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.009 . . . . 0.0 109.469 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mt -51.61 118.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.428 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.87 142.95 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 109.335 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.473 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 1.2 p-80 -177.65 115.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -138.28 -164.33 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -106.27 142.31 36.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -141.7 162.56 45.94 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.341 -0.849 . . . . 0.0 109.321 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.8 -73.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.714 2.276 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -52.23 151.11 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -174.14 58.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.96 136.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 19' ' ' SER . . . 96.8 34.54 5.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -36.95 -93.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.387 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mt 45.48 74.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 4.3 t70 -178.02 153.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -67.65 -18.16 64.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -95.91 21.45 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.39 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' A' ' 21' ' ' ASP . 37.8 m-20 -99.18 162.98 12.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.12 10.42 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.539 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -134.39 21.14 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.39 127.79 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.0 121.67 7.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -102.78 120.65 40.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.538 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.41 100.68 0.89 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ttt -96.68 133.13 41.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -1.095 . . . . 0.0 109.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.41 154.62 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.862 . . . . 0.0 109.222 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.64 143.72 17.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.14 107.18 13.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.34 -1.094 . . . . 0.0 109.083 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -76.52 15.59 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.293 1.996 . . . . 0.0 112.447 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -112.47 -102.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.765 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -121.04 6.59 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.689 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -91.7 -16.46 51.93 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.523 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 29.7 t0 50.86 -151.35 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -1.051 . . . . 0.0 109.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 6.4 t -87.35 136.62 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.7 ttt -127.34 137.41 52.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 109.589 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -124.43 123.37 40.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -119.93 126.51 51.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.958 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.56 143.64 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.515 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.88 134.16 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.476 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -102.97 136.8 42.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.9 136.05 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 38.1 t0 -59.78 -49.44 77.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.31 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.678 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.7 OUTLIER 162.83 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -34.43 9.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.11 -9.73 0.98 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -74.43 134.26 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -1.225 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.04 89.49 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.44 -54.78 39.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.578 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -144.49 152.85 41.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.898 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.708 ' H ' ' HZ1' ' A' ' 78' ' ' LYS . . . -133.58 142.44 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.741 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -114.02 143.28 45.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.053 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -119.69 165.2 14.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.86 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -171.54 81.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.512 ' HG1' ' N ' ' A' ' 61' ' ' TYR . 1.3 t -123.45 152.9 41.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.512 ' N ' ' HG1' ' A' ' 60' ' ' THR . 70.3 t80 -155.44 95.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . -179.21 -50.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 65' ' ' SER . 18.5 m -74.23 125.15 27.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.511 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -43.33 -21.72 0.17 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -120.25 7.9 10.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -1.105 . . . . 0.0 109.274 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -42.22 -43.18 3.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.518 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.518 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.2 mt -60.72 -29.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -80.58 -71.92 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.5 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.3 p -38.84 -33.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.944 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.721 ' HG ' ' H ' ' A' ' 71' ' ' SER . 12.4 p -69.19 -63.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.721 ' H ' ' HG ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -48.67 -25.76 1.95 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 109.5 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' C ' ' A' ' 73' ' ' ILE . 39.4 tp -79.15 -81.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.462 ' C ' ' O ' ' A' ' 72' ' ' LEU . 14.5 tt -41.11 -35.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.614 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.416 ' H ' HG23 ' A' ' 73' ' ' ILE . 82.6 p -69.53 -39.48 77.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' LEU . 16.4 tt0 -74.51 -8.33 55.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.327 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.98 -31.88 14.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.9 m -96.42 13.14 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.708 ' HZ1' ' H ' ' A' ' 56' ' ' ALA . 4.2 mttm -89.28 93.11 9.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.54 -18.52 24.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -66.52 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.41 167.81 13.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.646 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.38 -30.19 69.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.85 . . . . 0.0 109.56 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.76 -35.05 79.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.1 -45.2 18.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.007 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.16 35.61 2.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -147.4 -38.99 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 109.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.4 pt -41.45 163.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -0.872 . . . . 0.0 109.35 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -136.72 -174.1 3.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -101.55 -5.59 24.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.221 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -64.31 -53.06 54.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 0.0 109.343 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.6 mt-30 -60.76 -62.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.3 mt -47.21 -25.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.45 -27.27 46.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 92' ' ' GLN . 10.2 mt-10 -87.96 -16.28 34.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.355 -0.841 . . . . 0.0 109.338 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -88.55 -43.41 11.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.67 -14.05 49.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 48.29 74.52 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.371 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.77 150.73 42.21 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 109.415 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.02 160.09 48.91 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.748 2.299 . . . . 0.0 112.193 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.0 Cg_endo -66.7 -65.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.904 2.402 . . . . 0.0 112.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.469 ' C ' ' O ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER 41.48 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 109.03 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' PRO . 20.1 mttp -138.43 10.96 2.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.527 ' C ' ' O ' ' A' ' 103' ' ' LYS . 3.7 t 34.79 53.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.765 ' CE1' ' H ' ' A' ' 37' ' ' CYS . 6.4 p-80 -98.38 -25.54 14.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.84 -70.22 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -51.32 -57.84 7.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 104' ' ' VAL . 37.1 mt -43.07 -34.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.07 81.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.71 68.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' ' 112' ' ' ASP . 56.8 tt0 -66.56 -67.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 111' ' ' GLU . 47.8 t0 -40.56 -29.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -67.1 -59.54 3.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 tp -46.21 -33.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.349 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.75 61.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.81 64.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.97 -56.8 17.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.5 -44.38 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.626 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.95 -57.54 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.89 -53.6 50.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.516 ' O ' ' C ' ' A' ' 122' ' ' LYS . 13.0 t80 -47.37 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 121' ' ' TYR . 11.2 mmtt -36.22 -44.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' TYR . 3.6 mtpt -59.46 -40.33 86.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.913 . . . . 0.0 109.424 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.448 ' CD ' ' O ' ' A' ' 125' ' ' GLN . 23.0 tm0? -131.1 74.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.54 -92.54 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -140.96 18.46 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -1.1 . . . . 0.0 109.379 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 57.93 -173.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.561 ' O ' ' ND1' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -62.53 163.62 8.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.628 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 0.4 OUTLIER -129.18 66.66 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.628 ' ND1' ' C ' ' A' ' 130' ' ' HIS . 3.1 m-70 -135.65 138.01 42.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 135.31 17.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.147 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.99 42.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.553 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.447 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.0 -32.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -47.31 37.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.611 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 4' ' ' SER . 0.3 OUTLIER -126.17 112.84 16.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.6 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.14 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 59.0 89.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.141 -0.974 . . . . 0.0 109.53 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -104.99 141.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 pt -145.04 118.73 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.624 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 3.8 p-10 -85.35 -92.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.682 ' CE1' ' O ' ' A' ' 11' ' ' TYR . 1.7 t60 -152.94 150.26 29.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' O ' ' CE1' ' A' ' 10' ' ' HIS . 2.8 m-85 -140.83 -151.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -94.2 -160.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.35 153.38 42.77 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 126.43 21.25 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.977 2.451 . . . . 0.0 112.492 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.27 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.818 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.601 ' OD1' ' N ' ' A' ' 17' ' ' VAL . 28.6 t-20 46.0 -118.22 0.76 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.601 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 60.3 t -117.79 -42.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -160.77 -117.73 0.46 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 68.0 -167.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 109.502 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HB2' ' NZ ' ' A' ' 46' ' ' LYS . 5.7 tp -135.07 77.61 1.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 23' ' ' LYS . 5.1 t70 61.0 154.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.438 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.437 ' HB3' ' NZ ' ' A' ' 22' ' ' LYS . 9.4 mtpm? -73.73 14.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.277 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 21' ' ' ASP . 38.8 mttp -48.58 -20.47 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.654 ' C ' ' H ' ' A' ' 26' ' ' ASN . 26.3 t0 42.26 -149.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.442 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.509 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.5 OUTLIER 54.64 0.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.075 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.654 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -167.82 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.12 113.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.782 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.76 125.32 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -116.13 145.31 43.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.36 134.57 5.4 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.5 mtt -123.47 148.88 45.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.122 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.18 174.01 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.145 -0.972 . . . . 0.0 109.334 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.24 150.27 8.04 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.03 144.42 47.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.504 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 Cg_endo -71.97 -67.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.563 2.176 . . . . 0.0 111.938 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.41 -35.9 0.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.241 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' O ' ' C ' ' A' ' 38' ' ' GLY . 49.9 t -99.13 -4.97 31.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.345 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 36.68 34.66 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 37' ' ' CYS . 13.7 t0 -105.02 114.16 28.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.333 -1.098 . . . . 0.0 109.604 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.48 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 14.5 p -89.05 109.29 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ttt -99.2 152.32 20.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -147.9 126.93 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.89 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.62 128.42 37.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.034 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -118.52 136.05 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.028 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pp -119.51 144.86 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 109.643 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 20' ' ' LEU . 2.4 ttmm -111.79 141.98 44.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.81 113.65 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 17.3 t0 -47.45 -67.16 0.3 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.644 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.9 p-10 170.41 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.097 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.39 10.83 23.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.32 15.26 54.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.1 mm -102.52 148.81 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 109.592 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.478 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.3 mm -83.34 84.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.435 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' ' OD1' ' A' ' 55' ' ' ASP . 5.6 tt0 -40.89 -55.76 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' OD1' ' OE2' ' A' ' 54' ' ' GLU . 7.4 p-10 -152.34 170.99 18.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.25 126.52 18.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.474 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -99.28 135.01 41.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 2.6 p90 -109.83 162.46 14.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -171.78 102.24 0.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -164.82 139.74 5.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.444 ' CE2' HD12 ' A' ' 67' ' ' ILE . 3.3 t80 -156.02 95.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.31 -19.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.678 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -141.06 107.27 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -1.045 . . . . 0.0 109.181 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -41.08 -15.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 63' ' ' CYS . 1.8 m -82.49 -22.24 35.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -83.31 -58.7 2.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.536 ' C ' ' O ' ' A' ' 66' ' ' ALA . 42.5 mt -35.68 -59.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.9 m -49.84 -50.56 45.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.479 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 69' ' ' SER . 1.3 t -43.95 -47.57 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.587 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.569 ' O ' ' OG1' ' A' ' 74' ' ' THR . 17.3 p -70.59 -31.41 68.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -68.33 -61.82 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.1 tt -48.78 -41.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.263 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 71' ' ' SER . 23.5 p -55.84 -46.25 78.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.018 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.99 -20.23 64.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 108.916 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.21 -27.68 53.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.546 ' O ' ' C ' ' A' ' 78' ' ' LYS . 7.0 m -111.8 -111.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.499 -0.75 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.546 ' C ' ' O ' ' A' ' 77' ' ' VAL . 8.3 tttm 35.32 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.53 13.85 10.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.453 ' HA ' ' HZ1' ' A' ' 80' ' ' LYS . 1.0 OUTLIER -102.56 -166.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -1.113 . . . . 0.0 109.366 -179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 83' ' ' GLU . 15.5 m -108.34 135.82 49.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.959 . . . . 0.0 109.639 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' SER . 11.4 mt -45.32 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 81' ' ' SER . 5.7 tp10 -77.92 -53.12 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.173 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -32.0 69.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.07 31.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.24 47.2 3.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.61 -33.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.189 . . . . 0.0 109.425 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.5 pt -44.16 175.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -143.19 158.11 43.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -73.99 -38.25 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.19 -37.69 55.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.161 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 94' ' ' ALA . 3.5 mm100 -66.18 -68.33 0.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -45.67 -23.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.445 ' C ' ' N ' ' A' ' 96' ' ' GLU . . . -71.85 -63.45 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.825 . . . . 0.0 109.166 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -49.31 -17.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 108.941 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -80.68 -61.21 2.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 60.2 tp -76.7 -33.45 58.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER 70.0 68.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.713 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.2 pt? -103.72 146.93 33.43 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -40.24 102.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.758 2.305 . . . . 0.0 112.16 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 103' ' ' LYS . 58.8 Cg_endo -78.77 10.15 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.543 2.162 . . . . 0.0 112.41 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -11.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.238 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 101' ' ' PRO . 53.0 tttm -157.14 -34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.381 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t 60.9 60.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.286 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.44 ' HD1' ' HB3' ' A' ' 103' ' ' LYS . 13.3 p-80 -99.27 -47.66 5.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 0.0 109.527 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.6 m -61.11 -49.38 77.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.509 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.7 OUTLIER -50.66 -67.8 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' SER . 3.4 mt -44.87 -38.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 109' ' ' LEU . 4.6 mp -60.24 -39.37 86.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.67 -52.02 66.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.132 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 112' ' ' ASP . 68.2 tt0 -60.16 -60.31 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -42.76 -33.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.28 -60.45 3.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -46.99 -38.4 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -70.35 -57.77 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.99 -39.58 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.01 97.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 109.66 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.37 -39.3 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.97 72.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 -42.73 95.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -70.02 -48.66 57.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 125' ' ' GLN . 20.2 tttt -56.96 -30.15 63.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.535 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -38.93 -36.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -73.85 26.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.461 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.535 ' H ' ' C ' ' A' ' 123' ' ' ALA . 6.5 mm-40 -138.56 26.66 2.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.57 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.628 ' O ' ' N ' ' A' ' 128' ' ' GLU . . . -178.95 -68.68 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.2 49.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.488 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -121.26 163.82 17.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 131' ' ' HIS . 63.8 t-80 -140.21 -46.39 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 66.96 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.36 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -155.67 137.63 14.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.457 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -109.06 -114.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.554 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 1.0 OUTLIER -74.5 -141.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.466 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.52 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' CG ' ' H ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 3' ' ' TYR . . . -91.71 -125.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.609 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.0 t80 79.13 131.26 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.9 t -67.77 19.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' H ' ' C ' ' A' ' 3' ' ' TYR . 2.7 tt0 -59.48 147.04 38.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -168.15 72.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 9' ' ' ASP . 3.1 t -107.27 64.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.237 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.76 44.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.63 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -141.87 -146.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.49 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.67 178.41 4.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.565 ' O ' ' O ' ' A' ' 12' ' ' GLU . 30.5 m-85 -76.39 -11.66 59.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.352 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.565 ' O ' ' O ' ' A' ' 11' ' ' TYR . 27.3 mt-10 52.59 113.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 50.75 82.22 0.25 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 179.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.736 2.29 . . . . 0.0 112.068 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 17' ' ' VAL . 22.8 ttt180 -146.99 141.02 25.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.535 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 39.4 t-20 -62.45 55.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' A' ' 15' ' ' ARG . 94.0 t -48.36 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.264 -0.897 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 169.17 159.28 14.48 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 56.19 122.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.137 -1.213 . . . . 0.0 109.357 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -108.69 -109.07 0.33 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' O ' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -117.31 118.7 32.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 21' ' ' ASP . 6.1 mtmt -35.15 -37.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.488 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -80.42 43.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.453 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.677 ' OD1' ' N ' ' A' ' 25' ' ' SER . 57.6 t0 -104.49 147.27 27.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.677 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 51.0 m -89.65 5.86 43.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -114.31 -2.71 13.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.19 117.56 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.843 . . . . 0.0 109.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 126.94 9.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 44' ' ' GLN . 3.0 m -112.07 151.2 29.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -1.135 . . . . 0.0 109.299 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.92 153.88 25.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.8 ttm -142.37 141.19 32.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.86 165.96 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.923 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.11 148.53 17.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -141.88 79.16 16.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.333 -1.098 . . . . 0.0 109.619 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.31 12.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.88 2.387 . . . . 0.0 112.269 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.631 ' H ' ' C ' ' A' ' 34' ' ' ALA . . . -110.54 -79.16 0.58 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.271 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.553 ' O ' ' C ' ' A' ' 62' ' ' GLY . 1.4 p -134.9 -36.22 0.84 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.188 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.654 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -55.02 -18.86 12.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 14.7 t0 51.69 -147.69 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 0.0 109.731 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.461 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.98 115.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.88 . . . . 0.0 109.434 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.452 ' CG ' ' N ' ' A' ' 42' ' ' GLN . 9.5 ttt -106.82 157.42 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CG ' ' A' ' 41' ' ' MET . 15.6 tt0 -143.86 130.38 20.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.686 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 1.6 tp -125.45 150.91 46.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.553 ' NE2' ' OG1' ' A' ' 29' ' ' THR . 22.1 mt-30 -142.23 144.33 33.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.539 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.17 155.95 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -130.76 122.79 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.247 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' O ' ' CG ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -115.37 140.01 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.786 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' A' ' 50' ' ' ASN . 35.0 m-20 -170.88 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.47 48.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.374 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 78.4 50.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.91 86.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.83 149.49 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -1.103 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mt -82.7 91.44 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -72.83 -38.56 67.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.333 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 47.8 t0 -124.85 158.03 34.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.828 . . . . 0.0 109.236 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -158.67 120.23 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.76 157.33 19.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -140.69 -174.03 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.751 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -169.69 81.61 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.219 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.403 ' H ' ' HG1' ' A' ' 60' ' ' THR . 0.3 OUTLIER -87.34 122.34 30.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 105.68 3.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 145.25 -44.57 0.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 15.9 m -75.0 167.36 22.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.446 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.37 -38.48 0.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -21.01 17.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -1.085 . . . . 0.0 109.498 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -88.6 0.63 56.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 66' ' ' ALA . 8.3 tp -44.36 -31.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -66.46 -47.78 72.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -43.37 -32.5 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.333 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.577 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.7 OUTLIER -58.53 -53.73 55.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 m -65.75 -32.72 74.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 75' ' ' GLU . 1.7 tp -65.1 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.856 . . . . 0.0 109.682 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.527 ' C ' ' O ' ' A' ' 72' ' ' LEU . 16.4 tt -37.11 -41.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.963 . . . . 0.0 109.577 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 70' ' ' SER . 2.4 p -64.77 -32.38 74.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.526 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 72' ' ' LEU . 8.8 mt-10 -86.56 -7.72 58.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -109.04 -5.71 15.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 109.546 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.9 m -117.52 0.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -95.38 114.83 26.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 109.385 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.82 -8.36 73.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.25 168.69 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.42 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.0 m -88.79 167.59 13.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 31.7 mt -68.04 -26.61 65.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.565 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -66.52 -20.27 65.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.317 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -97.22 -58.02 2.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.171 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.68 62.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.246 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.44 49.23 1.06 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -168.93 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -1.128 . . . . 0.0 109.094 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 87' ' ' ALA . 5.1 pt -41.38 156.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.5 168.8 9.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.135 -0.978 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.59 -18.47 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 t -66.65 -27.61 67.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.19 -57.87 5.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.37 -38.45 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -54.79 -53.51 54.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.348 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -37.02 85.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -52.25 -41.13 62.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 tp -105.8 -29.14 10.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 94' ' ' ALA . 8.9 tm-20 64.58 58.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.347 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.751 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.2 pt? -86.46 143.43 36.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.376 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.61 142.45 1.96 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.574 2.183 . . . . 0.0 112.151 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -76.24 -3.16 13.48 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.719 2.279 . . . . 0.0 111.942 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.9 -12.21 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.615 ' NZ ' ' SG ' ' A' ' 106' ' ' CYS . 18.0 pttp -156.79 56.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.3 -11.27 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.284 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.654 ' CE1' ' H ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -54.64 -22.32 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.615 ' SG ' ' NZ ' ' A' ' 103' ' ' LYS . 59.5 m -65.03 -61.1 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.0 p -55.15 -51.67 65.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.442 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.9 mt -55.28 -26.52 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.102 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tp -68.06 -42.11 80.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 109.004 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -58.37 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.82 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 112' ' ' ASP . 7.3 tm-20 -62.33 -64.57 0.89 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.565 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 111' ' ' GLU . 62.2 t0 -39.22 -31.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.711 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -69.01 -56.73 6.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.711 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.453 HG22 ' N ' ' A' ' 115' ' ' LYS . 3.8 tp -52.14 -37.05 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' N ' HG22 ' A' ' 114' ' ' ILE . 3.1 tttp -67.98 -50.46 55.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.85 73.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.714 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -65.62 -69.7 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.698 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 117' ' ' ALA . 23.6 mt -42.7 -37.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.685 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.32 85.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 61.0 t0 -61.17 -25.19 66.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.898 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.4 t80 -78.62 -40.77 33.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -84.84 -1.78 56.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.12 24.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.275 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -84.97 -25.1 27.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -54.14 -54.39 40.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 156.14 36.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.93 -16.79 29.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -1.165 . . . . 0.0 109.247 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -176.88 175.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.872 . . . . 0.0 109.368 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.645 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 0.1 OUTLIER -104.88 140.77 37.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.367 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.708 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 7.2 t-80 -124.13 -143.54 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.708 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 0.5 OUTLIER 53.0 3.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.537 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.606 ' H ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -109.77 -171.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.496 ' NE2' ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -91.81 -176.32 4.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.72 ' N ' ' ND1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.461 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.763 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 1.3 tmt? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.763 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . 164.57 66.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -47.64 125.54 8.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.63 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -104.55 98.33 8.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -37.34 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.505 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' SER . 8.0 pttp -166.14 -2.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 9' ' ' ASP . 17.0 m -89.37 55.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 mt -46.27 91.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 10' ' ' HIS . 57.0 t0 -93.74 149.21 21.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.538 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.56 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 7.0 m-70 -35.91 114.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -132.37 22.14 4.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.704 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' ASN . 1.1 mp0 -125.87 -38.56 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' C ' ' O ' ' A' ' 12' ' ' GLU . 2.5 m-80 36.63 83.06 0.21 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.83 110.36 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.944 2.429 . . . . 0.0 112.446 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.59 -81.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.251 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.29 -0.57 15.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.75 90.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.16 -179.62 49.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 21' ' ' ASP . 4.4 t -169.23 144.23 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER 64.4 -64.5 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.385 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 19' ' ' SER . 0.4 OUTLIER -41.49 146.34 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -75.66 20.61 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' H ' ' C ' ' A' ' 21' ' ' ASP . 8.9 tttm -104.74 -20.54 13.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 27' ' ' VAL . 2.8 p30 -72.3 168.27 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -98.42 9.85 42.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m-80 -118.77 18.27 13.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.558 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 t -126.48 122.34 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.52 123.46 7.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 m -109.21 152.78 24.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -1.186 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.52 110.7 0.45 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 ttt -114.45 103.52 11.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.457 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.0 m -117.2 157.29 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.14 163.23 28.67 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.87 138.03 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.294 -1.121 . . . . 0.0 109.371 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.1 Cg_endo -75.57 -36.24 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -43.01 -53.31 4.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.537 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.4 2.38 20.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.65 58.3 7.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 62.3 t0 -127.75 145.39 50.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 2.6 m -115.26 114.69 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 ttt -98.93 125.3 44.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.859 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.29 119.15 38.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.023 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.1 110.92 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.4 HE21 HD23 ' A' ' 20' ' ' LEU . 10.2 tt0 -118.82 108.96 15.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.042 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 pt -107.87 143.45 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.892 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.667 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 8.0 tttp -109.31 144.27 37.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.013 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.506 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 3.3 t -134.99 149.33 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.737 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.694 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 174.28 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 2.9 m-20 -62.21 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.421 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-20 79.19 48.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.85 . . . . 0.0 109.412 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.37 78.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.4 mm -89.24 158.85 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.392 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.8 mt -93.09 90.73 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.59 -38.56 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.708 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 2.3 p30 -147.62 162.08 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.42 119.6 10.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.712 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 6.1 p90 -137.9 163.93 30.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.734 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -158.95 111.1 2.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.207 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -156.81 132.6 9.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.133 -0.979 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.433 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 46.0 t80 -161.65 154.77 20.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 61' ' ' TYR . . . 125.08 -43.24 1.4 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 t -88.95 166.38 13.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.086 -1.243 . . . . 0.0 109.651 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.86 43.4 1.67 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -158.9 -66.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.314 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -36.27 -35.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.315 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 65' ' ' SER . 49.0 mt -54.88 -13.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.258 -0.901 . . . . 0.0 109.314 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -103.22 -53.25 2.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 109.154 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -55.56 -37.87 68.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.0 109.232 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.579 ' O ' ' OG1' ' A' ' 74' ' ' THR . 59.0 p -59.86 -39.92 86.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.214 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.573 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -62.37 -51.16 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.7 tp -55.74 -69.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.371 -0.831 . . . . 0.0 109.508 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.582 ' CG2' ' N ' ' A' ' 74' ' ' THR . 14.5 tt -47.53 -50.37 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.582 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 6.0 p -47.35 -38.08 12.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.53 -8.58 54.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 108.914 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.7 t90 -92.12 -11.75 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 108.977 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.04 4.22 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -79.33 104.59 10.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.92 35.38 79.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.72 -174.68 2.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 t -106.16 148.71 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.762 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.3 mt -68.77 -20.65 64.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.961 . . . . 0.0 109.244 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.93 -9.04 58.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.374 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -102.17 -43.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.18 -12.73 56.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.527 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.04 49.8 3.6 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -178.63 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -1.12 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -32.16 -31.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 109.757 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 87' ' ' ALA . 16.6 mtmt 62.42 128.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.336 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.64 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 2.5 p-10 -54.37 -46.93 73.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 90' ' ' ASN . 15.7 m -35.45 -34.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.386 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 90' ' ' ASN . 42.1 tp60 -73.44 -49.85 24.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.4 mt -50.61 -38.1 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.238 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.88 -61.32 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.64 -10.21 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.722 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -79.58 -67.73 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.1 mt -85.04 -2.21 57.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' LEU . 14.2 mt-10 44.24 75.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.73 143.05 26.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -42.27 157.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.634 2.222 . . . . 0.0 112.306 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 61.2 Cg_endo -77.29 1.38 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.167 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.85 -0.5 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.669 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -134.63 35.42 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 105' ' ' HIS . 2.4 t -84.12 -40.58 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.554 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 104' ' ' VAL . 16.0 p-80 -40.98 -33.6 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.007 . . . . 0.0 109.342 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.414 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 1.2 m -72.52 -45.93 57.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.258 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.4 t -55.87 -49.97 71.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.047 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.482 ' O ' ' C ' ' A' ' 109' ' ' LEU . 71.5 mt -50.97 -59.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.0 109.174 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.514 ' O ' ' C ' ' A' ' 110' ' ' ALA . 5.1 mp -40.54 -62.09 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.21 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -37.55 -65.68 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.842 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.459 ' CD ' ' C ' ' A' ' 111' ' ' GLU . 4.4 tp10 -42.32 -45.51 4.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -15.18 63.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.177 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -80.22 -45.16 18.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 109.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -63.7 -40.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.213 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.501 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 20.2 mttt -70.94 -34.63 71.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.32 -53.12 61.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.848 . . . . 0.0 109.519 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.34 84.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 89.0 mt -59.47 -28.75 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.988 . . . . 0.0 109.494 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.52 -46.93 12.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.74 -8.88 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.1 t80 -96.54 -43.62 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.53 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 41.3 tttt -88.38 -5.56 58.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.567 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.42 -21.09 23.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -95.7 46.72 1.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.623 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.28 -34.68 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.92 -10.65 52.24 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 129' ' ' HIS . 1.1 tp -115.33 46.75 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -1.212 . . . . 0.0 109.677 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -63.36 80.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.41 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 127' ' ' LEU . 1.4 t60 -87.8 64.83 8.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -88.21 -91.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.601 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -162.44 84.05 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.598 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -92.69 168.64 11.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.42 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 134' ' ' HIS . 3.8 m-70 -44.74 105.06 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.589 ' N ' ' ND1' ' A' ' 134' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.471 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.591 ' O ' ' SD ' ' A' ' 1' ' ' MET . 1.2 tmt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -139.17 52.08 1.77 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 42.05 36.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.17 169.56 21.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.793 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 12.2 mp0 -87.28 102.4 14.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -78.4 154.1 30.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 8' ' ' ILE . 7.8 p -156.36 164.9 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.424 ' N ' ' CG2' ' A' ' 7' ' ' VAL . 13.9 mt -72.98 109.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 21.6 p-10 -103.95 84.62 2.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -88.8 122.87 32.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.498 ' O ' ' C ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -82.65 3.41 29.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' TYR . 5.6 mm-40 -38.36 114.49 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.34 71.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.008 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -46.94 157.65 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.108 2.538 . . . . 0.0 112.583 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.459 ' O ' ' N ' ' A' ' 17' ' ' VAL . 20.2 mtt180 -148.1 -134.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.18 58.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.013 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -80.51 90.85 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 19' ' ' SER . . . -64.8 179.11 8.28 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 18' ' ' GLY . 70.9 m -54.52 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -1.221 . . . . 0.0 109.437 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mt -132.34 -74.55 0.51 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 23' ' ' LYS . 40.7 m-20 -112.52 24.08 12.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER 43.23 13.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.676 ' N ' ' O ' ' A' ' 21' ' ' ASP . 6.8 mttt -149.35 17.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.257 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.645 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -79.75 153.87 28.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 1.9 p -75.67 -7.64 54.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.645 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -95.99 8.7 42.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.2 t -140.87 110.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.706 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.01 152.33 18.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.426 HG21 ' NE2' ' A' ' 44' ' ' GLN . 27.3 m -122.7 154.5 38.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.728 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.95 130.01 3.46 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.0 ttt -127.08 135.49 50.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -1.219 . . . . 0.0 109.947 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.9 m -154.76 146.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.0 109.208 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.9 172.26 22.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -141.79 138.77 17.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.302 -1.116 . . . . 0.0 109.198 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.62 -51.57 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.473 2.115 . . . . 0.0 112.172 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.56 -40.99 13.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 34.1 m -100.61 -0.15 38.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 39.25 47.99 2.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -130.14 148.28 51.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -1.119 . . . . 0.0 109.708 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.79 110.54 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.189 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.4 ttt -104.07 141.5 36.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.709 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -123.08 129.68 51.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 109.156 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.42 125.38 42.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.667 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.426 ' NE2' HG21 ' A' ' 29' ' ' THR . 2.2 mt-30 -121.01 161.29 21.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.0 109.117 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.31 145.42 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -119.64 123.77 44.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 109.093 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.405 ' HB ' ' HH ' ' A' ' 121' ' ' TYR . 39.2 t -113.74 134.99 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.2 m-20 -170.67 -31.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -62.94 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.398 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.622 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-20 78.88 41.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.12 74.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 53' ' ' ILE . 20.3 mm -100.61 165.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.603 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.422 ' N ' HG22 ' A' ' 52' ' ' ILE . 68.6 mt -79.02 88.47 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -54.19 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.66 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.1 t70 -146.61 163.78 34.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.11 144.94 31.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 169.46 9.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CD1' HG22 ' A' ' 74' ' ' THR . 2.6 p90 -168.28 162.93 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.6 119.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.41 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -161.01 124.86 3.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -148.4 97.61 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.27 -2.44 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.428 ' SG ' ' HB1' ' A' ' 66' ' ' ALA . 0.5 OUTLIER -89.31 -177.54 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.647 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.39 -14.26 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -137.26 -3.25 1.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -1.166 . . . . 0.0 109.655 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -85.74 -44.35 12.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.2 tp -34.36 -29.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.815 . . . . 0.0 109.828 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -91.35 -41.52 10.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 109.962 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.442 ' N ' ' O ' ' A' ' 66' ' ' ALA . 0.4 OUTLIER -69.17 -31.31 69.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.992 . . . . 0.0 109.746 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.401 ' O ' ' OG1' ' A' ' 74' ' ' THR . 9.4 m -57.92 -40.53 80.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.0 109.534 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 p -74.3 -41.54 61.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.9 tp -56.07 -59.06 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.632 ' CG2' ' H ' ' A' ' 74' ' ' THR . 8.7 tt -55.18 -63.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.632 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 6.0 p -43.26 -25.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' ILE . 24.2 mt-10 -91.9 -12.93 32.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.613 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.622 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.4 m0 -101.14 -13.19 18.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.711 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -111.47 34.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 109.694 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.66 ' NZ ' ' OD2' ' A' ' 55' ' ' ASP . 14.4 ttmm -120.25 89.65 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.02 -7.43 23.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -91.73 -174.67 3.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.09 154.14 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.39 -17.25 62.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.53 -40.9 76.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 109.67 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.24 -39.74 53.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.83 82.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.97 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.03 54.82 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.3 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -1.107 . . . . 0.0 109.115 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 87' ' ' ALA . 6.4 pt -42.32 -28.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.2 tttt 65.46 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -71.61 -6.7 42.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.605 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 p -73.61 -30.36 62.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.5 -39.05 91.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.19 -33.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.35 72.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.67 -46.17 14.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -49.77 -36.96 27.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.43 -27.86 12.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 63.57 74.51 0.42 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.629 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.24 159.96 30.06 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.99 160.21 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.876 2.384 . . . . 0.0 112.262 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.12 -14.33 18.82 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.818 2.346 . . . . 0.0 112.279 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.06 -1.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.612 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -146.99 36.68 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.524 ' O ' ' C ' ' A' ' 105' ' ' HIS . 41.3 t -52.45 -33.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.659 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -36.07 -58.34 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.659 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 56.8 m -32.63 -62.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.571 ' HG ' ' CD1' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -56.72 -44.04 81.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.763 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 109' ' ' LEU . 72.3 mt -58.57 -63.56 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.726 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 108' ' ' ILE . 1.1 mp -39.09 -41.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.88 -56.95 15.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.617 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 112' ' ' ASP . 3.5 tm-20 -66.39 -68.85 0.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 111' ' ' GLU . 2.4 t0 -37.52 -33.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.494 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -65.29 -52.61 53.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.457 HG22 ' N ' ' A' ' 115' ' ' LYS . 4.4 tp -51.99 -35.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' N ' HG22 ' A' ' 114' ' ' ILE . 32.4 tttt -74.44 -48.24 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.77 -54.53 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.41 -61.11 2.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.331 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . 64.2 mt -39.17 -46.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.261 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.81 65.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.598 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -57.04 -18.45 14.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.363 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.495 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 20.6 t80 -77.33 -49.76 14.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.386 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 124' ' ' LYS . 1.3 mptm? -71.88 -47.95 49.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.372 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.06 -14.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.598 ' NZ ' ' O ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -100.23 -10.19 21.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -109.67 -17.26 13.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.88 -71.05 0.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 128' ' ' GLU . 6.4 tp -45.99 -39.6 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 129' ' ' HIS . 0.5 OUTLIER 58.07 125.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.586 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 35.7 m-70 -86.79 -151.12 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.51 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 12.2 t-160 -97.74 67.53 2.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.509 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -97.63 36.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.458 ' O ' ' CG ' ' A' ' 133' ' ' HIS . 18.3 t-80 -85.05 111.27 19.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 132' ' ' HIS . 90.3 m-70 -156.93 -98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.51 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.536 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.57 76.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -80.18 -78.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.439 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 3' ' ' TYR . 6.4 t 36.6 44.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -82.65 -95.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -120.89 23.22 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.301 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t 47.83 78.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.2 pt -45.6 139.91 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.22 153.04 4.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.662 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -67.19 -99.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.531 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.518 ' H ' ' CG ' ' A' ' 10' ' ' HIS . 0.7 OUTLIER -67.76 -173.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -3.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.524 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.453 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 10.6 m120 -128.15 55.2 15.73 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.523 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 37.9 Cg_endo -69.95 117.83 5.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.818 2.345 . . . . 0.0 112.041 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.679 ' O ' ' N ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -126.58 -42.0 1.83 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -62.07 57.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.679 ' N ' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -137.03 154.39 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.607 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . 113.67 62.46 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 2.8 p 83.17 110.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -1.139 . . . . 0.0 109.472 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.5 -65.98 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 109.472 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 22' ' ' LYS . 8.4 t70 -145.09 174.0 11.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 6.0 mttp -88.84 5.06 45.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.937 . . . . 0.0 109.414 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -117.99 30.55 7.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.38 132.82 54.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.28 3.07 5.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.658 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.19 14.95 18.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.86 108.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.632 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.49 148.28 17.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.7 m -139.16 145.96 40.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.563 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 120.19 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.9 mtp -118.49 137.75 52.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -1.183 . . . . 0.0 109.586 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.65 163.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.88 143.8 12.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -127.39 131.79 24.01 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -73.56 -57.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.537 2.158 . . . . 0.0 112.477 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.49 -31.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 109.673 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 35' ' ' PRO . 38.1 m -118.39 1.41 11.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 39.25 55.56 2.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -136.39 163.29 30.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.251 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 79.4 t -127.22 129.05 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.714 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.9 ttt -112.41 119.93 39.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -109.43 119.92 40.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.09 130.4 54.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 148.04 48.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 pt -122.5 146.53 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -110.4 101.77 10.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -0.828 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.48 129.71 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 6.5 t0 -64.73 -60.1 3.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' ASP . 6.0 m-20 166.44 -25.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -12.86 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.815 . . . . 0.0 109.328 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.84 20.0 5.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mm -109.88 132.63 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -1.133 . . . . 0.0 109.437 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.76 87.7 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -53.29 -42.64 66.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.89 -178.74 7.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.34 113.29 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.576 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -94.02 126.15 39.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.095 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.439 ' CD1' HG21 ' A' ' 74' ' ' THR . 37.3 p90 -114.72 170.04 8.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.849 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -170.35 97.62 0.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 109.141 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -137.38 133.9 35.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -151.24 144.55 24.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.05 -39.25 2.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -85.67 91.96 8.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 109.278 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.556 ' C ' ' HG ' ' A' ' 65' ' ' SER . . . -66.92 52.03 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.556 ' HG ' ' C ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER -151.12 -22.35 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 109.316 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -97.24 -11.28 24.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ALA . 3.1 mm -40.47 -27.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -97.42 -32.36 11.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.308 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.8 t -66.5 -54.05 28.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.497 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.7 OUTLIER -37.31 -51.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.53 ' O ' ' OG1' ' A' ' 74' ' ' THR . 9.2 t -62.06 -52.72 62.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 73' ' ' ILE . 43.6 tp -46.66 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.669 ' CG2' ' H ' ' A' ' 74' ' ' THR . 10.7 tt -43.69 -64.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.819 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.669 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 16.6 p -35.18 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -83.93 -32.61 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.647 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.8 m95 -82.27 -2.64 53.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.598 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 77' ' ' VAL . 11.7 m -130.16 53.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.742 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -139.19 85.4 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.539 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.1 8.05 45.47 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -90.67 -171.36 3.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -1.149 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 154.76 18.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.94 -24.99 66.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.41 -28.44 66.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 -53.65 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.97 -25.84 22.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.128 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.73 40.87 2.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -151.01 -37.93 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -1.113 . . . . 0.0 108.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.6 pt -41.09 159.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.519 -0.738 . . . . 0.0 109.296 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.06 162.26 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.526 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.22 -25.2 64.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -66.21 -67.57 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.591 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 91' ' ' SER . 13.2 mm-40 -39.3 -60.63 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.8 mt -56.14 -28.68 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 91' ' ' SER . . . -77.42 -15.22 59.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 109.185 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.71 -18.51 21.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.66 -38.31 14.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -80.87 -0.8 40.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.553 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.527 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.3 tt0 37.12 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 109.37 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.3 pt? -63.0 149.35 90.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 102' ' ' VAL . 30.5 Cg_endo -67.17 152.82 79.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.685 2.257 . . . . 0.0 111.939 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.1 13.89 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 102' ' ' VAL . 7.3 p -79.02 96.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 105' ' ' HIS . 7.0 mttm 67.31 58.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.212 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.3 0.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -0.818 . . . . 0.0 109.262 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.93 -53.95 45.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.637 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 87.6 m -30.96 -58.79 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.031 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -58.84 -56.22 25.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 107' ' ' SER . 44.9 mt -45.29 -51.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.63 -43.17 46.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.483 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.04 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -40.0 62.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -25.45 68.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -72.11 -62.89 1.27 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -45.31 -36.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.157 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.3 tttt -73.31 -35.8 66.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 109.512 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.88 79.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.54 -38.07 89.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.9 mt -61.2 -38.01 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.66 81.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.716 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.2 -54.71 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 4.0 t80 -53.75 -32.08 50.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.762 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -81.04 -30.71 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.695 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.19 63.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.705 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -94.14 35.94 1.15 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.395 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.9 44.79 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.479 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . -85.69 -95.85 0.77 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.21 11.87 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.693 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.612 ' H ' ' C ' ' A' ' 126' ' ' GLY . 1.9 mt-10 56.01 176.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.566 ' ND1' ' C ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -154.58 37.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -139.68 -33.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.619 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' HIS . 1.4 t60 48.8 28.25 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.273 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -45.49 -18.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' HIS . 3.3 m-70 -71.13 -168.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.469 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.7 mpp? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.23 140.61 49.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 109.43 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.57 -128.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -121.55 -25.29 5.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -51.5 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 tttm 62.85 158.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 0.0 109.591 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.422 ' CG1' ' H ' ' A' ' 8' ' ' ILE . 10.9 t -135.74 -122.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.422 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 17.8 mt -150.28 51.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.639 ' C ' ' CD2' ' A' ' 10' ' ' HIS . 17.4 t0 -133.61 105.29 6.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.639 ' CD2' ' C ' ' A' ' 9' ' ' ASP . 14.9 m-70 -154.23 -157.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.378 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.44 39.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.2 -0.937 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 49.0 mt-10 -102.24 -80.9 0.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 2.7 t30 170.23 86.03 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -46.55 133.83 16.56 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.751 2.301 . . . . 0.0 112.043 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.722 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -139.9 129.18 23.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.99 123.25 18.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.45 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -123.6 138.38 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.513 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.76 -87.41 1.99 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p 58.35 166.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.155 . . . . 0.0 109.46 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp 59.0 36.85 24.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.665 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 52.7 t0 -54.13 -23.03 12.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.0 tttp 78.15 -9.48 1.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.601 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -140.08 14.1 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.938 . . . . 0.0 109.647 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.11 -159.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 63.67 20.42 12.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.278 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.32 38.01 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.03 133.28 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.39 113.14 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -101.71 157.46 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.526 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.31 132.86 3.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.3 ttp -141.56 123.15 15.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -1.171 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.8 149.1 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 39' ' ' ASP . . . -133.06 170.17 22.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -125.61 146.47 54.91 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.354 -1.086 . . . . 0.0 109.278 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 37' ' ' CYS . 37.1 Cg_endo -69.36 -71.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.668 2.245 . . . . 0.0 112.056 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.59 -14.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.176 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 35' ' ' PRO . 1.8 t -117.11 -12.17 10.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.396 -0.815 . . . . 0.0 109.324 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 38.3 33.33 0.17 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' CYS . 39.0 t70 -101.63 148.36 25.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 109.595 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -121.29 97.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.7 ttt -86.98 119.62 27.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -109.14 101.43 10.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.422 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.74 148.48 28.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.67 132.0 25.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.253 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -111.22 141.98 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -114.25 148.44 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.264 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.65 130.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 t0 -70.77 -54.56 11.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.268 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 160.82 -22.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.357 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -94.43 11.05 32.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.8 30.36 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 mm -125.07 138.23 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.96 103.09 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.161 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -75.43 -42.5 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.806 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 86.3 m-20 -143.29 157.93 44.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.763 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.98 137.23 25.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -105.53 141.56 36.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -124.62 163.21 22.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -171.85 109.01 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -161.05 119.63 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -149.56 103.58 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.91 -20.01 0.03 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.4 t -126.74 116.45 20.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -57.17 172.71 2.39 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER 64.63 -69.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -1.173 . . . . 0.0 109.538 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.609 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -38.37 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' SER . 1.6 mt -58.65 2.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.609 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -106.67 -32.31 8.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 p -58.79 -45.62 89.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.458 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.582 ' O ' ' OG1' ' A' ' 74' ' ' THR . 35.0 p -53.73 -64.39 0.84 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' SER . 31.9 m -42.32 -45.64 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.914 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 75' ' ' GLU . 56.5 tp -65.41 -84.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.561 ' CG2' ' N ' ' A' ' 74' ' ' THR . 9.0 tt -33.68 -52.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 70' ' ' SER . 29.8 p -53.17 -44.21 67.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 72' ' ' LEU . 11.0 tm-20 -78.93 2.18 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.238 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.7 -17.97 14.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.87 . . . . 0.0 109.636 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.3 m -98.0 -28.17 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.37 128.3 35.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -20.58 28.63 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -91.51 164.53 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.287 -1.125 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -175.4 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.827 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.02 -27.24 60.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.35 -20.59 64.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.004 . . . . 0.0 109.159 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.75 -41.67 8.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.887 . . . . 0.0 109.314 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.61 8.92 15.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.62 -57.69 0.65 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.41 -4.38 29.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -1.146 . . . . 0.0 108.816 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.95 168.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.499 -0.751 . . . . 0.0 109.65 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.67 -175.15 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -94.98 -6.55 42.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.16 56.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -66.61 -59.88 3.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.857 . . . . 0.0 109.327 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.8 mt -47.24 -41.28 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -68.04 -46.69 70.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -54.21 -25.77 24.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.49 -52.23 7.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.875 . . . . 0.0 109.566 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.8 mt -81.88 -15.87 52.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.615 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.5 mm-40 43.36 14.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.635 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.6 pt? -39.96 150.0 0.27 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -41.52 162.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.811 2.341 . . . . 0.0 112.097 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.543 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.0 Cg_endo -76.42 -49.56 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.865 2.376 . . . . 0.0 112.469 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.84 27.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' ND1' ' A' ' 105' ' ' HIS . 37.3 mttt -143.45 6.99 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.542 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 105' ' ' HIS . 10.2 p -68.92 -11.44 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.747 ' N ' ' HD1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -44.02 -57.38 3.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.542 ' H ' ' CG ' ' A' ' 105' ' ' HIS . 55.1 m -56.13 -35.1 66.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -51.25 70.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.231 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.16 -36.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.85 -37.72 80.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.229 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.83 -51.21 65.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.326 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.24 -53.64 49.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -48.84 -40.99 31.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.414 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.37 13.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.31 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 tp -46.86 -33.68 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.266 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' C ' ' A' ' 116' ' ' ALA . 10.6 ttmm -67.38 -71.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -38.43 -44.96 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.31 -54.41 36.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.8 mt -54.54 -34.68 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.544 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.98 -56.92 8.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.48 -25.18 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -80.43 -69.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.45 -24.17 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.16 16.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.292 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.23 -24.93 3.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.28 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.623 ' C ' ' H ' ' A' ' 127' ' ' LEU . 31.1 tt0 -170.21 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.341 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 127' ' ' LEU . . . -66.4 19.15 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.623 ' H ' ' C ' ' A' ' 125' ' ' GLN . 1.1 mp 68.57 23.79 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 28.3 tp10 -142.25 -107.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.621 ' O ' ' ND1' ' A' ' 130' ' ' HIS . 1.5 t-160 82.36 87.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.343 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.621 ' ND1' ' O ' ' A' ' 129' ' ' HIS . 1.3 m80 -161.63 10.68 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.129 -0.982 . . . . 0.0 109.797 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.6 t60 58.63 35.36 24.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 133' ' ' HIS . 15.0 t-80 -117.27 124.24 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -78.73 140.51 38.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.507 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.551 ' OXT' ' CG ' ' A' ' 134' ' ' HIS . 86.4 t60 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.531 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' ALA . 42.9 mmm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 44.45 32.17 0.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 4' ' ' SER . 66.5 t80 -156.8 143.62 18.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -56.32 163.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.563 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -127.03 160.55 30.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.271 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -177.09 136.92 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 p -171.63 -21.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 109.31 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.2 mt -45.46 131.01 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.841 . . . . 0.0 109.565 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.21 98.33 11.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.188 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 10' ' ' HIS . 32.7 t-80 -80.69 -17.59 50.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.565 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -72.17 -131.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -92.84 143.14 26.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' C ' HD21 ' A' ' 13' ' ' ASN . 0.2 OUTLIER -133.68 71.17 75.27 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 15' ' ' ARG . 46.9 Cg_endo -73.09 97.78 0.95 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.179 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.541 ' C ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -35.77 144.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -133.38 119.61 19.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 16' ' ' ASN . 1.0 OUTLIER -42.36 -62.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.44 4.55 73.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.92 135.5 52.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -1.087 . . . . 0.0 109.511 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -123.74 -57.24 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.123 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 23' ' ' LYS . 18.7 m-20 -128.55 8.42 5.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.142 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 49.4 13.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.2 tttm -148.69 13.28 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.596 ' OD2' ' N ' ' A' ' 26' ' ' ASN . 1.1 t70 -61.89 170.55 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 24' ' ' ASP . 92.6 p -75.83 -11.29 59.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.596 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 32.9 m120 -116.44 25.09 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -147.37 107.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.384 -0.822 . . . . 0.0 109.222 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.25 143.83 17.59 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -120.27 132.58 55.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -1.083 . . . . 0.0 109.186 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.08 123.03 4.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttt -125.15 115.91 21.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -1.085 . . . . 0.0 109.117 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.4 166.28 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.77 165.31 31.53 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -141.1 152.74 65.71 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.237 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.4 Cg_endo -77.09 -64.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.17 -45.76 2.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -94.65 -4.82 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 109.232 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.0 41.37 0.45 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' CYS . 10.0 t70 -115.47 155.63 27.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -1.122 . . . . 0.0 109.761 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.61 105.68 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.18 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.437 ' HG2' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -89.53 143.95 26.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.833 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.437 ' N ' ' HG2' ' A' ' 41' ' ' MET . 5.4 tt0 -129.23 110.04 11.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.125 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 44' ' ' GLN . 5.8 tt -121.97 132.34 54.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.465 ' N ' HD22 ' A' ' 43' ' ' LEU . 8.3 mp0 -124.04 177.96 5.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.86 151.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.617 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -114.64 163.6 15.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.348 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.5 107.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.545 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.71 -65.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 169.91 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.667 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -92.56 16.4 12.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.37 22.42 60.57 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.52 147.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.503 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.3 mt -82.35 112.99 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.9 -36.42 18.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.759 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.96 165.44 24.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.7 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.08 120.28 4.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -108.02 159.1 16.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.446 ' CG ' HG23 ' A' ' 74' ' ' THR . 2.8 p90 -163.34 162.16 24.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -171.44 119.47 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.342 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.0 p -116.66 102.39 9.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 0.0 109.531 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -109.54 113.49 26.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.37 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.79 -39.5 1.96 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.2 m -79.05 152.14 31.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -1.161 . . . . 0.0 109.574 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.47 38.6 2.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.66 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -1.137 . . . . 0.0 109.429 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -86.44 -36.71 18.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.541 ' C ' ' O ' ' A' ' 66' ' ' ALA . 4.9 mt -36.03 -48.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.74 -54.69 30.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 97.1 p -62.0 -49.04 77.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.362 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.553 ' O ' ' CG2' ' A' ' 74' ' ' THR . 0.2 OUTLIER -47.38 -46.59 26.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -61.59 -35.77 78.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 109.229 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' CD1' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -69.26 -68.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.9 tt -48.46 -47.57 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 70' ' ' SER . 23.1 p -49.24 -45.43 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.15 0.41 53.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.792 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -17.51 17.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.66 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.8 m -111.75 10.76 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -85.56 103.48 14.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.99 40.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -97.34 -171.09 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.468 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -112.74 139.72 48.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.0 mt -53.09 -28.72 26.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.259 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.02 -30.09 68.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.02 -57.66 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.272 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.35 -17.6 3.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.198 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.45 49.5 0.86 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -172.69 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -1.096 . . . . 0.0 109.324 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -50.6 178.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -137.1 -168.28 2.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.332 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.429 ' ND2' ' C ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -103.5 -30.78 10.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -51.82 -33.69 36.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' ILE . 2.0 mt-30 -69.48 -66.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 1.8 mt -44.5 -40.8 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.64 -49.63 61.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.934 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.93 -24.41 23.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.532 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 72' ' ' LEU . 3.5 tt0 -82.11 -33.19 29.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.94 -15.07 35.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 48.62 73.41 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.236 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 1.8 pt? -129.2 139.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -42.5 146.88 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.55 -20.97 22.88 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.667 2.245 . . . . 0.0 112.126 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.88 -4.68 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.444 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -135.93 16.4 3.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.568 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.525 ' O ' ' C ' ' A' ' 105' ' ' HIS . 8.4 p -60.68 -14.96 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.755 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER -33.95 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.707 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.755 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 77.0 m -31.26 -58.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.539 -0.726 . . . . 0.0 110.121 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -50.39 -64.27 0.86 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 109.62 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 5.6 mt -42.27 -42.61 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.82 -32.98 74.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -59.71 -48.29 82.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.203 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.529 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 6.3 tp10 -68.91 -51.91 34.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.371 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -53.85 -28.78 38.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.12 -60.73 2.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.455 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -48.26 -33.85 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.459 ' N ' HG21 ' A' ' 114' ' ' ILE . 7.2 tmtm? -76.41 -28.58 56.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -56.8 8.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -52.79 63.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.368 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -48.77 -38.84 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.92 66.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -77.2 -7.76 56.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.52 -38.58 6.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -71.88 -35.62 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.55 -22.26 62.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -84.08 42.12 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.389 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -106.52 -54.06 2.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.49 -96.02 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.1 mp -114.13 23.77 12.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 129' ' ' HIS . 22.9 mt-10 56.16 -124.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 128' ' ' GLU . 0.1 OUTLIER -179.43 149.91 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -145.78 -75.97 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.325 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -129.77 -162.0 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.379 -0.826 . . . . 0.0 109.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -141.52 175.86 9.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 1.0 OUTLIER -90.66 -112.31 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 mtm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.07 169.96 16.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.6 -26.66 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.07 156.23 16.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.95 -31.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -46.35 126.25 7.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.878 . . . . 0.0 109.58 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -69.99 -162.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 mt -111.49 -87.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.625 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 10' ' ' HIS . 19.6 p-10 -112.97 89.22 3.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.543 ' O ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -52.59 -166.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.243 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 1.4 p90 -100.57 10.23 41.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -54.34 -92.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.242 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -158.7 68.05 3.41 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.24 141.19 97.56 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.926 2.417 . . . . 0.0 112.178 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.724 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -111.6 118.47 35.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -100.23 124.91 46.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.87 163.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.418 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 19' ' ' SER . . . -69.56 -72.37 0.87 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 58.45 129.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -1.08 . . . . 0.0 109.618 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tp 55.69 30.57 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 12.3 t70 -102.64 -5.55 23.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.9 tttp 72.03 -5.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 21' ' ' ASP . 13.9 mttp -118.28 18.16 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.744 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -102.59 138.74 39.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.457 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -72.7 10.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.756 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.6 OUTLIER -111.2 20.56 17.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.1 t -137.7 90.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.639 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.43 145.95 48.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 m -135.27 108.86 7.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -1.124 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.82 150.29 16.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 ttm -144.45 127.18 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.357 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.28 161.38 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.48 164.86 18.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.89 85.69 22.82 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.149 -1.206 . . . . 0.0 109.854 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.08 -20.3 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.712 2.275 . . . . 0.0 111.94 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.42 -53.51 23.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.174 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -103.84 17.84 23.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.198 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.86 55.08 1.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 61' ' ' TYR . 40.6 t0 -126.65 146.37 50.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -1.163 . . . . 0.0 109.713 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.36 113.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 ttt -99.86 134.3 42.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.37 128.97 46.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -129.58 142.85 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.22 150.33 47.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.145 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.05 148.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.943 . . . . 0.0 109.705 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -114.74 120.93 41.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -103.96 127.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' CG ' ' N ' ' A' ' 49' ' ' ASP . 2.9 t0 -62.89 -94.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.609 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 4.8 t70 -154.22 24.43 0.48 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 14.71 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 25.24 57.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mm -108.69 130.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.582 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.42 HG21 HD11 ' A' ' 53' ' ' ILE . 69.1 mt -88.45 102.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.195 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.38 -46.64 14.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.58 141.97 51.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.22 129.15 42.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HG3' ' H ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -101.22 164.01 12.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.437 ' H ' ' HG3' ' A' ' 57' ' ' LYS . 30.2 p90 -156.8 162.73 39.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.574 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.22 98.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.75 138.44 32.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -157.04 123.84 5.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.319 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.05 -61.71 0.36 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 t -84.21 134.39 34.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.712 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.39 20.0 6.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -27.75 6.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.129 . . . . 0.0 109.361 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.27 7.85 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mm -77.9 -40.34 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.835 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.88 -45.25 17.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 109.656 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.542 ' O ' ' C ' ' A' ' 70' ' ' SER . 75.2 m -53.15 -49.34 66.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.562 ' OG ' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -34.35 -66.83 0.15 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.841 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.562 ' N ' ' OG ' ' A' ' 70' ' ' SER . 66.1 m -55.44 -40.44 71.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 73' ' ' ILE . 4.4 tp -60.2 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.933 . . . . 0.0 109.843 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.59 ' CG2' ' H ' ' A' ' 74' ' ' THR . 5.6 tt -36.44 -62.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.958 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.59 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 56.8 p -40.34 -39.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mm-40 -86.07 -15.39 41.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.552 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.57 -5.43 55.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 109.688 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.32 20.75 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 109.607 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -96.53 87.97 4.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.66 -3.82 7.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -89.16 167.71 12.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -1.127 . . . . 0.0 109.392 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.55 176.05 5.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.86 -21.34 66.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.575 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -70.55 -40.93 73.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -79.63 -51.01 9.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.706 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.51 63.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 109.408 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.95 26.0 25.21 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.8 18.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 109.202 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -79.95 171.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -136.19 140.57 43.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 108' ' ' ILE . 11.4 p30 -68.36 -23.1 64.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -56.24 -36.35 68.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -59.01 2.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mt -46.77 -40.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.594 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -73.73 -42.6 60.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 109.836 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.567 ' OE1' ' O ' ' A' ' 95' ' ' GLU . 2.6 tm-20 -57.6 -30.35 65.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.03 -39.44 29.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.003 . . . . 0.0 109.716 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -95.35 -5.04 44.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.698 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 94' ' ' ALA . 17.6 tp10 41.17 44.68 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 151.26 87.89 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.641 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.03 109.41 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.954 2.436 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 103' ' ' LYS . 65.3 Cg_endo -79.79 -79.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.699 2.266 . . . . 0.0 112.129 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.427 ' H ' ' HG2' ' A' ' 101' ' ' PRO . 0.4 OUTLIER 53.65 -76.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 101' ' ' PRO . 9.3 mtpp -118.3 -6.21 10.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.3 t 47.38 60.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.358 -0.839 . . . . 0.0 109.56 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -91.31 -38.75 12.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 1.9 m -71.41 -67.68 0.5 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -37.43 -65.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.307 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.591 ' N ' ' OG ' ' A' ' 107' ' ' SER . 3.3 mt -44.71 -43.08 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' CYS . 0.5 OUTLIER -59.95 -37.99 81.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -57.79 -55.67 31.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -57.1 -60.82 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.293 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.65 -31.43 2.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 109.031 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -61.2 -53.24 59.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 108.98 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp -49.74 -39.93 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 108.785 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.492 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -73.01 -22.11 60.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.47 -0.769 . . . . 0.0 109.308 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -71.01 -60.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.62 -34.65 71.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.344 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.23 -43.76 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.0 91.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.89 -26.02 65.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -66.37 -65.06 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -25.37 60.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -57.38 -47.96 80.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -75.11 15.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.463 ' H ' ' C ' ' A' ' 123' ' ' ALA . 13.8 tt0 -117.2 2.84 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.36 -1.13 63.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.37 38.63 29.9 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 0.0 109.345 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -116.17 119.13 34.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -123.47 152.59 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.359 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.607 ' O ' ' ND1' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -144.77 -42.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' HIS . 0.7 OUTLIER -43.32 113.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 109.466 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.561 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 56.2 t-80 -100.94 -0.12 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.53 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 134' ' ' HIS . 16.7 t-80 -90.21 -47.73 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.47 ' O ' ' ND1' ' A' ' 133' ' ' HIS . 3.2 t-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.392 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.3 0.571 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.06 -150.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.45 148.07 29.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -99.27 162.47 13.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.33 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.91 3.45 12.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -122.48 -172.11 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' ILE . 1.3 m -124.39 -165.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.535 ' C ' ' O ' ' A' ' 7' ' ' VAL . 12.7 tt -37.62 157.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.177 -0.952 . . . . 0.0 109.234 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 10' ' ' HIS . 11.8 p30 -133.17 -138.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.608 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -98.85 172.28 7.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.549 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -77.83 12.68 1.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 56.65 -171.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.49 65.68 72.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 109.422 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -45.96 -61.19 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.916 2.411 . . . . 0.0 112.287 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' ASN . 1.1 tpm_? -84.78 110.93 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' ARG . 1.2 m-20 -43.37 142.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -56.94 157.43 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -74.98 0.56 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.55 138.69 45.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.478 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.2 mp -92.86 -109.17 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 109.713 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -81.28 4.66 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.784 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.3 tttp 74.61 -13.62 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 109.416 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.26 39.54 3.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.627 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -83.71 163.98 19.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.09 -4.52 29.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.702 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -124.08 20.85 9.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.11 92.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.91 22.43 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 30' ' ' GLY . 23.9 m -135.12 148.56 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.244 . . . . 0.0 109.862 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 29' ' ' THR . . . -141.48 140.43 10.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttm -133.86 113.16 11.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.49 149.69 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.93 -178.56 15.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.711 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -148.07 135.52 10.64 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.347 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.31 -38.2 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.458 2.106 . . . . 0.0 112.269 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -60.77 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLY . 20.7 m -87.88 2.44 51.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.16 46.1 3.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.665 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -116.11 148.29 40.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -1.127 . . . . 0.0 109.782 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -110.09 116.46 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.9 ttt -105.91 123.27 47.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -112.2 98.41 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tp -93.7 137.07 33.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.729 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -131.57 123.56 28.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.366 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 pt -105.97 156.26 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.512 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 54' ' ' GLU . 7.3 tttm -128.36 149.63 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.38 149.37 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.513 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.5 -96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.82 17.5 0.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.631 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -130.83 -25.76 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.673 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.32 9.93 3.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -100.1 133.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 0.0 109.436 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.2 mt -76.26 110.6 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.211 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -87.32 -39.0 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.576 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.37 170.3 16.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.81 120.97 2.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -96.02 161.22 14.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.322 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 4.6 p90 -150.32 170.49 18.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 4.8 tttt -172.06 97.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.6 p -110.23 104.45 13.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.425 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 100.43 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.578 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' CA ' ' OD2' ' A' ' 39' ' ' ASP . . . 148.73 -43.96 0.77 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.665 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.6 m -88.77 105.53 17.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.94 63.14 4.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.47 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.144 -1.209 . . . . 0.0 109.371 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -98.03 -15.96 19.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 68' ' ' ALA . 4.2 mt -42.15 -80.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -34.38 -56.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.674 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.473 ' HG ' ' CG2' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -45.35 -58.11 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.1 m -48.2 -37.96 17.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.882 . . . . 0.0 109.438 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.8 t -70.04 -33.53 72.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 109.411 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 75' ' ' GLU . 30.0 tp -67.31 -68.78 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -41.51 -45.73 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.226 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 71' ' ' SER . 22.6 p -58.72 -33.59 70.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.284 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.4 tt0 -83.19 -5.1 59.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -98.72 -26.59 14.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 m -94.73 -3.13 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.978 . . . . 0.0 109.796 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -81.88 107.72 14.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.46 -21.66 30.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -84.48 178.78 7.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.122 -1.222 . . . . 0.0 109.571 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.96 172.19 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.32 -28.37 62.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 -24.24 66.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 109.21 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.8 -52.66 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.03 -36.77 68.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.349 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.35 48.41 4.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.51 -37.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.162 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -37.74 161.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -130.4 170.94 13.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.27 -15.17 44.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -59.11 -39.59 82.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -71.46 -52.89 15.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.473 ' CG2' ' HG ' ' A' ' 69' ' ' SER . 35.6 mt -54.72 -41.38 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.503 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.83 -29.53 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.76 -42.06 61.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.44 -24.28 60.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.806 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.13 -36.46 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.024 -1.047 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 94' ' ' ALA . 3.5 mt-10 62.32 18.27 10.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.249 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 1.9 pt? -48.46 149.72 2.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.0 154.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.266 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 104' ' ' VAL . 45.9 Cg_endo -72.48 -74.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.824 2.349 . . . . 0.0 112.091 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER 43.01 46.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.2 OUTLIER 76.36 10.39 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER 35.92 27.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.711 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.29 -36.22 83.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.366 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 68.9 m -55.5 -65.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.572 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.8 t -53.84 -57.11 12.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.02 -32.32 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.01 -37.51 75.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.3 88.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.033 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.25 -53.88 21.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 109.273 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -54.13 -23.78 15.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.379 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.06 -50.74 21.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 109.222 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.2 tp -51.6 -39.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 108.963 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 8.4 mttm -74.03 -49.7 23.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.389 -0.819 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -44.98 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -69.53 -59.77 2.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 108.99 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.5 mt -41.06 -38.6 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.021 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.81 -57.84 10.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.052 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -50.71 -32.67 20.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.18 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.87 -60.19 4.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.489 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.55 -44.0 97.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.45 -53.87 32.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -29.98 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.369 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.447 ' C ' ' H ' ' A' ' 127' ' ' LEU . 6.6 tt0 -91.97 -102.71 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.644 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . 78.4 -25.3 2.39 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 125' ' ' GLN . 4.5 mm? -66.43 20.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.548 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.644 ' H ' ' C ' ' A' ' 126' ' ' GLY . 5.2 mt-10 -74.86 -78.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -111.44 145.62 38.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -177.64 4.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.707 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.64 36.67 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -85.31 -4.99 59.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.239 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -51.12 152.36 2.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 109.434 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 133' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.482 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.238 0.542 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 3' ' ' TYR . . . -81.85 158.14 24.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.435 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 4.0 m-85 68.76 -176.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.506 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.625 ' O ' ' N ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -133.95 166.04 23.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.284 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 64.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.6 ttmm -93.19 60.63 3.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 6' ' ' LYS . 51.7 t -39.76 137.26 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.609 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.8 mp -87.97 -116.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.648 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' H ' ' CG2' ' A' ' 8' ' ' ILE . 49.7 t0 -148.28 -88.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -108.91 -40.52 5.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 174.89 -65.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 179.9 0.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' N ' HD21 ' A' ' 13' ' ' ASN . 1.3 m-80 58.12 83.56 0.22 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.28 -134.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.821 2.347 . . . . 0.0 112.038 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -95.86 137.04 35.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' ARG . 1.4 m120 -59.86 -146.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.407 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.55 146.27 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 0.0 109.476 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.92 -61.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m -86.55 164.57 16.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -1.177 . . . . 0.0 109.587 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.39 -88.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -138.64 129.94 27.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 21' ' ' ASP . 9.6 mttt -40.53 -38.78 0.91 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 109.433 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.48 48.05 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -125.63 135.3 52.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -71.36 -1.7 13.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.49 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -105.19 18.02 23.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.354 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -152.94 97.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.515 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.93 150.96 28.34 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -127.57 150.45 49.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.42 126.49 3.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -129.4 123.49 31.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.56 165.86 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.77 165.93 27.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -137.39 132.61 17.85 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.195 -1.18 . . . . 0.0 109.527 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.33 -38.07 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.51 2.14 . . . . 0.0 111.948 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -56.87 11.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.245 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.72 -4.57 54.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.69 47.68 30.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 1.2 t0 -122.19 139.23 54.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -1.106 . . . . 0.0 109.581 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 20.5 m -92.95 123.13 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.858 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.455 ' HG3' ' N ' ' A' ' 42' ' ' GLN . 2.8 ttt -113.92 144.59 42.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' N ' ' HG3' ' A' ' 41' ' ' MET . 30.9 tt0 -149.29 120.04 7.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.22 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.39 130.85 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -123.73 155.14 38.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -0.909 . . . . 0.0 109.111 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.38 137.9 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -102.48 147.21 27.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.418 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.62 126.52 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.6 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' C ' ' OD1' ' A' ' 48' ' ' ASP . 30.2 t0 -63.29 -96.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 109.416 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -160.0 23.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.92 19.9 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 7.28 88.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.7 mm -99.84 155.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 109.447 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mt -99.08 109.83 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.05 -41.29 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.674 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 11.2 p-10 -157.62 167.59 29.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.66 129.89 41.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.342 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -95.2 125.63 39.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -114.58 157.67 22.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -166.13 99.24 0.63 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.623 ' CG2' ' HG ' ' A' ' 70' ' ' SER . 12.5 t -164.41 113.35 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.517 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 60' ' ' THR . 21.6 m-85 -137.53 102.97 4.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.97 -7.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.1 m -90.75 178.78 5.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.329 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.41 -11.8 14.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -141.43 -16.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.155 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.99 -9.64 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 68' ' ' ALA . 1.7 tt -67.69 -40.85 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.652 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' N ' ' CG2' ' A' ' 67' ' ' ILE . . . -76.55 -28.76 56.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.657 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.7 p -60.14 -58.63 7.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.623 ' HG ' ' CG2' ' A' ' 60' ' ' THR . 0.9 OUTLIER -34.8 -48.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.74 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -65.15 -46.85 79.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -63.53 -73.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.582 ' CG2' ' H ' ' A' ' 74' ' ' THR . 14.7 tt -39.22 -56.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.582 ' H ' ' CG2' ' A' ' 73' ' ' ILE . 22.1 p -46.87 -46.1 20.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.78 -13.9 62.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.633 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.477 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 m0 -89.64 -31.38 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.01 32.15 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.689 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.94 102.14 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.59 8.67 57.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -92.28 -175.81 4.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.64 149.09 24.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.494 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.18 -19.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.144 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -51.81 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ALA . 3.7 mt-10 -68.05 -55.94 10.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.96 -44.26 9.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.96 52.8 4.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -167.2 -46.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -1.15 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -36.1 158.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.429 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -121.84 168.36 11.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.673 HD21 ' HG ' ' A' ' 107' ' ' SER . 2.1 p-10 -82.83 -20.21 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.649 ' HG ' ' N ' ' A' ' 92' ' ' GLN . 47.5 p -52.26 -40.76 62.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.649 ' N ' ' HG ' ' A' ' 91' ' ' SER . 1.7 mm-40 -67.13 -70.93 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 92' ' ' GLN . 22.0 mt -41.57 -39.7 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.42 -53.05 40.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -47.98 -47.54 32.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -38.54 82.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.7 mt -79.66 -26.55 40.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 98' ' ' GLU . 2.7 tm-20 50.91 66.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.708 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.679 ' H ' ' CD2' ' A' ' 99' ' ' LEU . 1.9 pt? -112.44 145.26 32.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.54 153.18 62.95 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.47 11.19 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.878 2.386 . . . . 0.0 112.259 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.0 p -82.78 2.04 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.9 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 105' ' ' HIS . 6.2 p -72.1 -8.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.695 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -39.45 -55.75 1.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.695 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 62.0 m -31.16 -59.38 0.23 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.673 ' HG ' HD21 ' A' ' 90' ' ' ASN . 5.9 p -61.87 -55.63 27.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.984 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.44 ' N ' ' OG ' ' A' ' 107' ' ' SER . 1.6 mm -45.88 -53.85 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.51 -41.8 61.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 109.942 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.27 -65.12 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 109.671 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 11.7 tt0 -54.29 -41.85 69.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.5 -28.6 68.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.33 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -48.85 -38.05 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 1.1 mmtt -71.44 -31.46 67.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.304 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.94 67.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.63 87.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.393 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.12 -46.95 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.261 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.31 76.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -34.28 72.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.624 ' CE2' ' O ' ' A' ' 25' ' ' SER . 3.7 t80 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.953 . . . . 0.0 109.652 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -33.24 27.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.743 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 4.86 9.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.504 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -112.67 10.34 19.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -82.18 -68.69 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.398 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . 133.41 18.52 1.02 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.58 -10.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.006 -1.29 . . . . 0.0 109.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 6.1 tt0 -49.09 -52.97 22.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.536 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.524 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.3 t-80 77.4 131.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 51.23 58.07 5.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.263 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.777 ' H ' ' CD2' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -83.23 133.96 34.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.444 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -109.68 -49.15 3.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.642 ' ND1' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -175.69 113.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.577 ' ND1' ' C ' ' A' ' 133' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.385 0.612 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 -4.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.498 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 5' ' ' GLU . 50.4 m -142.15 151.73 42.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.502 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 4' ' ' SER . 4.4 mm-40 -58.01 -132.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.447 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.0 99.36 10.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.3 m -51.97 154.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 109.259 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.688 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -80.12 177.79 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.31 109.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.549 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -122.84 45.15 2.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.09 148.85 24.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -169.84 123.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER 179.71 65.22 0.13 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.66 92.48 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.929 2.419 . . . . 0.0 112.401 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER 62.8 142.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.613 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.572 ' O ' ' O ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER 51.22 166.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.02 -3.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.373 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.89 -86.88 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -66.95 176.88 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -1.124 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.4 mt -137.0 -68.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 109.515 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.594 ' C ' ' H ' ' A' ' 23' ' ' LYS . 21.1 m-20 -123.92 20.26 9.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.506 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.4 tttt 56.31 -0.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.645 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.7 tttm -167.06 51.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 26' ' ' ASN . 37.3 t0 -95.1 27.3 3.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.412 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.3 OUTLIER 48.08 9.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.237 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.601 ' H ' ' C ' ' A' ' 24' ' ' ASP . 61.3 m-20 -117.62 0.7 12.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.39 114.41 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.375 -0.828 . . . . 0.0 109.47 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.83 127.58 11.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.0 m -108.0 140.21 41.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -1.132 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.9 129.57 4.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 ttm -126.53 100.71 6.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -1.12 . . . . 0.0 109.35 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' H ' HG23 ' A' ' 32' ' ' VAL . 17.1 m -117.11 170.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.12 167.42 39.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -136.97 139.33 28.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 38' ' ' GLY . 48.5 Cg_endo -72.93 -59.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.596 2.198 . . . . 0.0 112.259 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.07 -42.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.457 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 1.2 m -98.18 -4.49 35.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 41.84 45.76 4.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.671 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 54.3 t0 -120.07 131.17 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -1.092 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 8.5 p -104.05 118.42 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.226 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.4 ttt -115.26 153.59 30.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -133.74 121.13 21.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.54 112.32 24.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.889 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -114.94 121.69 43.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.33 137.59 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -99.39 123.94 44.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.1 t -118.93 135.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 6.2 t70 -62.82 -59.99 4.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 167.08 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 0.0 109.125 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.72 -22.36 29.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.254 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.57 7.73 5.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.75 132.72 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -1.118 . . . . 0.0 109.434 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 54' ' ' GLU . 16.4 mt -84.28 84.57 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.708 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.9 OUTLIER -43.61 -53.14 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 108.863 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -143.53 -177.22 5.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.1 132.55 4.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -108.69 156.75 19.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.842 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 12.5 p90 -139.52 170.6 15.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.958 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -167.72 98.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.38 116.88 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -149.17 96.79 2.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.84 -12.09 0.08 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.671 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.8 m -96.78 168.54 10.44 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.247 -1.149 . . . . 0.0 109.358 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.38 44.14 1.43 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.49 -3.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 109.552 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -97.23 -22.86 16.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.721 ' H ' ' CD1' ' A' ' 67' ' ' ILE . 3.5 mp -36.8 -36.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -83.17 -57.62 3.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -42.33 -50.59 5.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.522 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.1 OUTLIER -36.07 -56.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' OG ' ' A' ' 70' ' ' SER . 7.0 m -64.12 -36.58 84.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 75' ' ' GLU . 8.6 tp -65.46 -79.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.54 ' C ' ' O ' ' A' ' 72' ' ' LEU . 7.8 tt -34.93 -41.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 109.74 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.522 ' OG1' ' O ' ' A' ' 70' ' ' SER . 6.6 p -68.25 -35.97 78.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.726 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 72' ' ' LEU . 3.3 mt-10 -85.57 -1.98 57.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -100.99 -23.69 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.8 m -115.39 50.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.88 . . . . 0.0 109.228 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -120.15 100.46 7.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.699 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.39 77.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -169.97 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -1.17 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.8 173.08 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mt -65.35 -28.03 69.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.57 -19.6 64.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.96 -31.18 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.36 40.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.625 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.69 54.66 0.84 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.9 pt -39.17 -26.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.9 ttmm 49.49 179.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' GLN . 31.5 p-10 -96.27 -55.61 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.505 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.1 m -38.27 -24.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.751 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.8 tt0 -79.29 -52.94 7.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 5.4 tt -59.48 -40.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.273 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -63.52 -46.37 86.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.269 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -37.65 79.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.065 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.88 -37.7 84.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.237 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.28 -20.36 59.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.268 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 67.67 10.26 7.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.1 152.67 92.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.476 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.0 165.74 25.26 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.861 2.374 . . . . 0.0 112.271 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.01 -41.58 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.88 2.387 . . . . 0.0 112.275 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.7 p -45.18 102.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 102' ' ' VAL . 11.0 ttmt 84.53 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.504 ' O ' ' C ' ' A' ' 105' ' ' HIS . 13.9 p -83.8 -2.73 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.693 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -38.45 -59.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.456 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.693 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 96.5 m -33.26 -48.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 108' ' ' ILE . 71.0 m -65.14 -60.62 2.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 97.3 mt -42.8 -40.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 109.071 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.529 ' O ' ' C ' ' A' ' 110' ' ' ALA . 0.9 OUTLIER -57.06 -63.56 1.17 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -36.24 -45.42 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.548 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 4.5 tp10 -64.76 -55.78 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.682 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.32 -19.62 23.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.99 -50.27 24.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.377 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -31.42 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.165 -0.959 . . . . 0.0 109.362 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -55.5 8.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.7 -52.37 11.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.724 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -59.37 -65.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 117' ' ' ALA . 6.2 mt -36.76 -33.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.086 -1.009 . . . . 0.0 109.65 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 121' ' ' TYR . . . -76.39 -64.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -0.983 . . . . 0.0 109.739 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.531 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 9.4 t0 -52.5 -2.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.602 ' H ' ' C ' ' A' ' 119' ' ' ALA . 69.4 t80 -98.19 -56.96 2.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.52 -26.97 65.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.61 71.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.522 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.4 -40.16 74.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -103.44 28.99 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.529 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . -108.74 -102.85 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.441 ' H ' HD12 ' A' ' 127' ' ' LEU . 3.0 mp -69.33 40.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 109.648 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 126' ' ' GLY . 32.4 mt-10 -147.41 74.07 1.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 30.9 m170 -86.59 14.88 6.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.651 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 129' ' ' HIS . 12.0 m-70 -165.29 -94.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.521 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 77.0 t60 -162.18 -119.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.521 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 5.1 t60 -66.2 89.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.239 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -127.11 128.19 45.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.433 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -113.08 74.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.526 ' C ' ' O ' ' A' ' 2' ' ' ALA . 71.2 m-85 36.83 -120.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.508 ' C ' ' OE1' ' A' ' 5' ' ' GLU . 48.1 t -110.63 -92.97 0.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -109.83 146.83 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -174.51 73.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 0.0 109.408 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -84.84 111.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.76 140.46 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.08 113.81 25.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.36 127.55 36.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.3 -92.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.657 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.56 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.084 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.23 163.51 24.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.767 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.35 108.77 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.894 2.396 . . . . 0.0 112.622 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.703 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -136.16 19.53 3.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.045 179.395 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 16' ' ' ASN . 2.6 t30 -109.03 6.11 24.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.193 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 18' ' ' GLY . 3.7 t -71.29 -36.47 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -50.39 -95.22 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -71.11 171.29 11.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -1.203 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mp -103.0 -86.7 0.43 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -149.54 163.85 36.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 0.0 109.667 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -76.47 -17.13 59.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.224 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -105.21 27.57 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.852 . . . . 0.0 109.246 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.524 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -88.82 165.19 14.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.0 109.534 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -96.41 9.67 40.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.524 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -125.16 0.58 7.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.88 103.08 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.712 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.56 155.92 34.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.441 ' HG1' ' CG ' ' A' ' 44' ' ' GLN . 67.7 m -136.76 126.92 26.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.247 . . . . 0.0 109.958 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.59 123.25 6.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.7 ttt -130.56 126.58 37.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.14 -1.212 . . . . 0.0 109.851 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.33 -174.34 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 109.026 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.21 144.55 8.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.21 132.58 21.67 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.358 -1.083 . . . . 0.0 109.225 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.0 Cg_endo -75.38 -53.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.547 2.165 . . . . 0.0 112.342 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.72 -47.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.7 p -114.48 11.3 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.59 62.28 0.97 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -116.26 117.4 29.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.6 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 40' ' ' VAL . 14.1 p -87.46 119.33 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.555 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.3 ttt -111.4 122.41 47.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 109.659 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 42' ' ' GLN . 1.6 tt0 -119.44 99.04 6.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tp -101.34 127.98 47.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.583 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.562 ' OE1' ' NZ ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -115.72 125.44 52.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -114.75 118.75 34.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.09 142.23 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.559 ' OD2' ' O ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -89.02 -96.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' OD1' ' A' ' 50' ' ' ASN . 3.7 p30 -153.52 19.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.564 ' OD1' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -145.67 43.86 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . 51.63 31.94 30.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.0 mm -122.11 131.22 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 53' ' ' ILE . 36.3 mt -86.73 109.8 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.162 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -70.71 -23.57 62.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.851 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -169.91 157.73 6.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.035 . . . . 0.0 109.885 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.74 137.67 43.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.222 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 19.3 mttp -101.45 137.49 39.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.4 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 23.8 p90 -116.7 137.17 52.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.09 85.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' CD1' ' A' ' 61' ' ' TYR . 1.4 t -143.04 138.54 30.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.434 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -160.79 125.83 3.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.364 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.13 -64.71 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.46 142.55 27.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.651 ' C ' ' H ' ' A' ' 66' ' ' ALA . . . -76.5 168.35 54.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.26 -32.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -1.108 . . . . 0.0 109.528 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.651 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . -67.0 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.31 -72.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 109.425 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.3 -48.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.35 -33.72 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.377 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 67' ' ' ILE . 40.3 t -67.21 -64.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 70' ' ' SER . 7.7 p -43.41 -27.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.083 -1.011 . . . . 0.0 109.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.534 ' O ' ' C ' ' A' ' 73' ' ' ILE . 7.4 tp -78.12 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.863 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.534 ' C ' ' O ' ' A' ' 72' ' ' LEU . 8.4 tt -34.89 -41.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.667 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 73' ' ' ILE . 74.7 p -61.61 -51.14 69.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 72' ' ' LEU . 14.3 tt0 -70.29 -5.34 27.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -88.94 -30.79 18.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.57 6.09 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -74.21 112.51 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.704 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.63 -9.13 77.2 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.18 -170.97 3.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 109.587 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 51' ' ' GLY . 0.4 OUTLIER -110.34 164.41 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.9 mt -59.51 -24.55 63.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -59.76 -48.05 83.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.93 -36.71 75.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.519 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.55 -26.01 66.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.53 44.62 1.44 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.29 -33.85 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -35.84 -47.76 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 65.17 142.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 91' ' ' SER . 0.1 OUTLIER -66.12 -34.69 78.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.417 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 13.3 p -49.32 -41.28 38.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -58.57 -49.27 78.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.09 -35.36 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.01 -18.77 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.75 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.47 -34.76 17.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.858 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.33 -25.45 25.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.957 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -105.61 -8.8 17.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.66 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' LEU . 23.8 mp0 44.79 15.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.482 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.1 pp -41.61 148.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.539 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.7 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.816 2.344 . . . . 0.0 112.305 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 103' ' ' LYS . 60.9 Cg_endo -82.72 9.62 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.73 2.287 . . . . 0.0 112.228 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.9 m -46.4 -8.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.933 . . . . 0.0 109.338 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.654 ' N ' ' O ' ' A' ' 101' ' ' PRO . 2.7 tttm -172.55 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.863 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.5 63.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.457 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.674 ' CD2' ' H ' ' A' ' 106' ' ' CYS . 26.7 p-80 -96.86 -57.12 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.674 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -57.59 -40.59 79.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -63.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -47.4 -31.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.87 -50.68 69.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.021 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.37 -43.61 61.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.9 . . . . 0.0 108.929 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.9 -58.41 7.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.204 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 24.8 t0 -50.17 -28.91 8.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.658 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -68.67 -69.99 0.29 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.9 tp -38.37 -40.94 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.487 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.6 mmtm -72.64 -29.12 63.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.29 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.658 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.0 -48.23 71.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.16 -46.73 82.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.205 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.5 mt -54.62 -44.5 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.37 85.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -57.73 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -45.86 -41.58 11.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' O ' ' C ' ' A' ' 123' ' ' ALA . 4.4 tttm -66.95 -45.55 77.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -36.98 -39.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.328 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -42.3 14.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.379 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -100.77 37.06 1.79 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -145.54 -66.05 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.519 ' O ' ' C ' ' A' ' 128' ' ' GLU . 2.9 mm? -59.57 -37.59 78.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 127' ' ' LEU . 55.6 mt-10 37.7 -129.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.426 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -118.2 109.25 16.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -169.86 142.76 2.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.431 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -138.03 -59.52 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.53 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -154.04 157.58 39.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.53 ' C ' ' O ' ' A' ' 132' ' ' HIS . 22.9 m80 -35.34 128.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 109.67 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.453 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.602 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.57 -24.1 11.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.38 -2.38 6.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -65.32 -18.53 65.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.312 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.22 -34.91 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -83.1 -67.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -62.16 135.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.908 . . . . 0.0 109.517 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.535 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -55.95 130.75 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.438 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -82.29 21.23 0.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.902 . . . . 0.0 109.634 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.669 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -54.06 174.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 9' ' ' ASP . 65.3 m-85 -150.5 -175.27 5.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 0.0 109.61 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.646 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 50.4 mp0 -98.88 -2.1 38.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -169.66 63.79 0.49 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.15 128.89 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.01 2.473 . . . . 0.0 112.409 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -114.84 -28.48 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.785 ' H ' HD21 ' A' ' 16' ' ' ASN . 0.0 OUTLIER -84.18 -145.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 t 59.83 -102.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.36 83.53 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -157.88 166.28 33.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -1.165 . . . . 0.0 109.488 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -105.28 -74.17 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.568 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -90.98 -16.77 27.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.38 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.0 tttm 71.21 -22.73 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -0.865 . . . . 0.0 109.451 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' H ' ' C ' ' A' ' 21' ' ' ASP . 14.2 tttt -66.5 -14.81 62.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.7 t70 69.58 -147.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 77.7 -8.42 1.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -176.83 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.4 t -124.75 99.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.11 139.76 15.4 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -138.95 122.57 17.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.4 148.37 16.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' A' ' 42' ' ' GLN . 1.6 tpt -145.48 126.67 14.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 109.6 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 m -145.8 155.93 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.337 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.0 159.16 24.54 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 105' ' ' HIS . . . -132.35 142.4 44.81 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.294 -1.121 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.522 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.3 Cg_endo -75.31 -51.45 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.673 2.249 . . . . 0.0 112.065 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.35 -49.75 1.0 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 109.217 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.425 ' HB3' ' SG ' ' A' ' 63' ' ' CYS . 50.6 m -102.8 -8.93 20.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.36 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.77 45.68 55.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -120.31 152.31 37.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -1.133 . . . . 0.0 109.591 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.7 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.386 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 ttt -91.47 143.39 26.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' NE2' HE21 ' A' ' 44' ' ' GLN . 4.8 tt0 -132.57 126.0 31.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.223 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.41 130.76 56.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.769 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.452 HE21 ' NE2' ' A' ' 42' ' ' GLN . 30.1 mt-30 -125.8 112.82 16.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.02 141.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.646 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 1.7 mptt -113.03 137.63 51.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.34 145.04 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 10.4 p-10 -82.75 -96.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -155.81 16.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.32 4.84 2.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.77 20.31 31.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.44 HG21 HD12 ' A' ' 52' ' ' ILE . 32.7 mm -106.88 146.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -1.14 . . . . 0.0 109.353 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.415 ' O ' ' C ' ' A' ' 54' ' ' GLU . 23.2 mm -85.87 84.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.688 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -44.87 -54.91 5.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.116 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 161.61 41.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.104 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.37 115.7 12.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 109.887 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -96.43 141.23 29.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 108.93 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 74' ' ' THR . 28.1 p90 -137.57 176.3 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.998 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 124.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -160.53 133.57 6.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 15.4 p90 -150.83 125.67 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.45 -42.64 1.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 1.1 m -79.88 142.61 35.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.552 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.81 -5.01 57.73 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.47 -2.81 13.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -91.78 -41.05 10.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.576 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' ALA . 65.6 mt -41.91 -44.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.99 -48.52 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.5 m -67.63 -66.04 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.542 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 69' ' ' SER . 17.9 m -35.7 -41.34 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.568 ' O ' ' OG1' ' A' ' 74' ' ' THR . 20.4 t -68.22 -41.38 81.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -64.64 -65.28 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 72' ' ' LEU . 13.0 tt -41.08 -46.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.938 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.568 ' OG1' ' O ' ' A' ' 71' ' ' SER . 17.2 p -55.58 -44.87 77.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.972 . . . . 0.0 109.699 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.73 -34.8 64.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.065 -1.022 . . . . 0.0 109.677 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.02 -13.56 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.94 22.38 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -98.85 117.58 33.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.67 5.61 69.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -84.71 -163.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.7 m -116.2 155.91 27.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 109.568 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.7 mt -59.55 -17.52 33.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.524 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.93 -50.44 14.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.469 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.665 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -66.21 -39.36 89.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -37.1 67.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.37 41.63 3.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -156.32 -37.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -1.154 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 87' ' ' ALA . 5.3 pt -42.06 163.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.385 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -126.88 -173.07 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -100.95 -13.85 18.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -21.81 61.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.277 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.22 -58.97 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.346 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.7 -38.74 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.52 65.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -86.13 -21.36 27.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.75 -48.11 10.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 98' ' ' GLU . 5.4 mt -90.16 -11.23 41.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.877 . . . . 0.0 109.505 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 mt-10 41.67 68.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.73 150.29 43.76 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.176 -0.953 . . . . 0.0 109.311 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -44.1 147.35 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.567 2.178 . . . . 0.0 112.032 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -69.71 -44.57 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.684 2.256 . . . . 0.0 112.157 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.502 ' O ' ' CG2' ' A' ' 102' ' ' VAL . 1.7 p -60.0 -2.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -143.04 36.33 1.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 105' ' ' HIS . 5.2 p -84.49 -15.54 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.292 -0.88 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.633 ' C ' ' ND1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -42.43 -44.68 4.11 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 0.0 109.097 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.553 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 57.3 m -40.15 -54.58 2.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 109.836 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 108' ' ' ILE . 96.0 p -64.95 -56.02 15.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.2 mt -43.53 -40.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.125 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.476 HD13 ' HD1' ' A' ' 105' ' ' HIS . 1.2 mp -64.75 -47.84 76.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.101 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -42.18 -48.98 4.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.141 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.13 -35.03 79.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.62 -33.42 74.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.947 . . . . 0.0 109.859 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.32 -47.24 74.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 115' ' ' LYS . 1.5 tp -58.98 -39.16 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.183 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' N ' HG23 ' A' ' 114' ' ' ILE . 2.2 ttmt -70.34 -50.87 34.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.52 -32.17 66.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.0 109.384 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.93 -58.11 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.216 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -55.55 -48.2 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.95 -36.02 59.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD1' ' NZ ' ' A' ' 124' ' ' LYS . 5.3 t0 -72.59 -55.21 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.466 ' C ' ' O ' ' A' ' 120' ' ' ASP . 22.2 t80 -39.59 -56.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.62 -28.56 67.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -61.0 -46.05 92.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 120' ' ' ASP . 33.6 mmtm -67.26 -20.71 65.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.49 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.52 61.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.82 1.16 2.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.27 35.57 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -1.14 . . . . 0.0 109.279 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -56.42 20.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.573 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -150.01 83.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -75.53 127.26 32.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.68 99.03 8.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.515 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.449 ' ND1' ' HB2' ' A' ' 133' ' ' HIS . 7.3 p80 -72.83 -169.14 0.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.487 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.449 ' HB2' ' ND1' ' A' ' 132' ' ' HIS . 1.2 t-80 64.44 -136.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.485 179.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.309 0.576 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.55 95.07 2.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.25 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.3 p -111.52 168.99 9.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -150.62 164.73 35.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -115.45 144.12 44.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.637 ' CG1' ' H ' ' A' ' 8' ' ' ILE . 3.3 t 60.59 -149.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.637 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 24.3 mm 57.09 68.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.552 ' O ' ' O ' ' A' ' 10' ' ' HIS . 1.3 m-20 41.68 -158.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.517 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.554 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.7 OUTLIER 52.4 109.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.381 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -81.27 97.11 7.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 46.34 -148.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.494 ' OD1' ' NH1' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -143.33 78.65 14.68 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.866 . . . . 0.0 109.408 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.71 48.38 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.763 2.309 . . . . 0.0 112.359 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.733 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -55.94 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.359 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -125.46 -103.83 0.35 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 17' ' ' VAL . 9.0 p -176.76 95.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.943 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 59.03 153.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER 54.2 160.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp 66.91 6.14 4.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 21' ' ' ASP . 38.8 p30 -131.27 167.72 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.33 11.31 3.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -85.67 -14.56 45.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.51 148.52 33.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.534 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 0.3 OUTLIER -72.31 -16.3 61.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.491 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' ND2' ' CG2' ' A' ' 27' ' ' VAL . 0.7 OUTLIER -65.11 1.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.467 ' H ' ' C ' ' A' ' 25' ' ' SER . 79.1 t -135.71 95.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.15 27.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.6 m -105.11 109.89 22.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -1.044 . . . . 0.0 109.328 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.61 91.13 0.76 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.92 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -1.22 . . . . 0.0 109.498 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.46 173.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.7 159.78 22.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.471 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -134.88 142.82 43.72 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.479 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.0 Cg_endo -74.82 -56.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.646 2.231 . . . . 0.0 112.381 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -42.52 -36.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -102.4 2.59 36.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.68 52.02 1.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' CB ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -131.11 143.56 50.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.134 . . . . 0.0 109.578 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.73 114.59 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.064 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.1 ttt -108.81 139.02 44.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.895 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -122.66 125.02 44.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.062 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tt -121.04 138.67 54.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.806 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.13 136.95 42.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.61 132.17 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -106.68 135.18 48.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.436 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -114.98 151.33 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.893 . . . . 0.0 109.527 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.46 -106.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -142.1 15.58 2.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.38 -4.24 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.545 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.74 4.73 51.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 52' ' ' ILE . 28.6 mm -94.68 136.47 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.476 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.2 115.52 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.72 -39.87 12.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -139.91 -179.25 5.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.952 . . . . 0.0 109.576 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.98 140.88 3.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.81 144.62 44.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.623 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -142.39 150.33 40.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 109.603 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' CG ' ' C ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -154.67 95.89 1.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 148.89 47.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -160.96 154.39 21.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.286 -0.884 . . . . 0.0 109.366 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.4 -53.31 0.7 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CB ' ' A' ' 39' ' ' ASP . 9.0 m -76.11 109.46 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.54 43.83 0.35 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 63' ' ' CYS . 0.3 OUTLIER -163.72 -6.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.456 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.57 -38.79 19.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 67' ' ' ILE . 7.2 mm -47.67 -49.36 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.21 -68.34 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.317 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.82 -34.33 2.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.455 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.1 t -64.75 -74.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.963 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 70' ' ' SER . 66.5 m -36.27 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.553 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' SER . 22.2 tp -76.03 -85.37 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 72' ' ' LEU . 1.1 tt -36.99 -33.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.486 ' N ' ' O ' ' A' ' 72' ' ' LEU . 9.7 p -66.99 -46.65 73.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 71' ' ' SER . 2.2 mt-10 -78.23 -7.84 57.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.31 -30.02 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.8 m -91.67 11.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -87.08 89.83 8.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.38 -14.64 15.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.54 -168.26 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -1.13 . . . . 0.0 109.565 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -119.99 -179.2 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.37 -34.07 65.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -68.89 -11.01 60.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.607 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.85 -49.58 4.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.569 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.8 -26.17 62.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.537 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.3 46.37 1.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -164.05 -38.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -1.127 . . . . 0.0 109.169 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.43 HD12 HG23 ' A' ' 88' ' ' ILE . 5.2 pt -44.9 166.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 109.466 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -132.7 -179.12 5.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.75 -19.34 24.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.365 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -62.73 -42.13 99.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.06 -60.6 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.176 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.5 mt -51.53 -42.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.895 . . . . 0.0 109.186 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.624 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -59.55 -35.14 73.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.195 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.61 -38.71 73.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.88 . . . . 0.0 109.104 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.3 -47.74 80.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.363 -0.835 . . . . 0.0 109.369 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.79 -16.63 21.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 94' ' ' ALA . 25.8 tt0 45.03 72.93 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.39 150.26 36.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -39.09 141.36 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.961 2.44 . . . . 0.0 112.31 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 103' ' ' LYS . 66.5 Cg_endo -76.89 -15.02 16.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.759 2.306 . . . . 0.0 112.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.73 25.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -170.69 34.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.438 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 105' ' ' HIS . 38.6 t -57.46 -27.48 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.676 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -34.86 -62.14 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.308 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.676 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 38.6 m -37.61 -51.46 1.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.604 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -55.28 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mt -46.65 -40.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.863 . . . . 0.0 109.35 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.408 HD12 ' ND1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -62.72 -37.83 88.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.279 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.31 -58.53 8.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.506 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 112' ' ' ASP . 3.9 tm-20 -58.76 -43.43 90.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.596 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.503 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -60.93 -29.79 69.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.88 -57.22 7.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -51.24 -35.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.506 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' N ' HG22 ' A' ' 114' ' ' ILE . 1.4 tttt -74.28 -48.06 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.8 -50.71 69.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.5 -53.73 50.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -58.34 -20.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.48 -47.37 19.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.193 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.99 -10.52 59.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.549 ' CE1' ' NZ ' ' A' ' 124' ' ' LYS . 1.9 t80 -91.31 -49.8 6.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.303 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -66.61 -23.62 66.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 0.0 109.203 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 125' ' ' GLN . . . -68.72 -1.75 7.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.549 ' NZ ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -35.75 -30.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 123' ' ' ALA . 20.2 tt0 -97.92 -53.37 3.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.05 34.51 0.47 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.46 -9.23 57.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 109.399 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 54.42 -169.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -159.17 140.8 13.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.523 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 25.6 t60 -132.24 -127.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 109.371 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.523 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 33.4 t-80 -123.48 -49.32 1.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 109.409 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.497 ' CD2' ' O ' ' A' ' 132' ' ' HIS . 24.1 p-80 -106.36 74.33 1.02 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -111.08 43.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.449 -179.851 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.582 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 1' ' ' MET . . . 79.78 170.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.355 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.4 t80 54.88 85.48 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.413 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -168.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.529 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -96.78 -69.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -89.66 -179.41 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 8' ' ' ILE . 35.2 t -95.66 160.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.56 ' O ' ' CG2' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -148.02 83.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.655 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.41 127.47 32.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.856 . . . . 0.0 109.765 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.488 ' CD2' ' H ' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -116.84 162.6 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.297 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -113.5 142.11 46.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.156 -0.965 . . . . 0.0 109.732 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -175.63 139.42 0.42 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.224 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.59 160.5 0.1 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.314 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.96 -171.73 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.338 . . . . 0.0 112.283 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -148.23 121.89 9.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.331 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.78 ' ND2' ' HZ1' ' A' ' 46' ' ' LYS . 15.8 m-20 -106.99 163.29 13.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 109.602 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' SER . 16.9 t -105.62 114.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 17' ' ' VAL . . . 45.52 -95.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.03 -179.68 7.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.512 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.521 ' N ' ' OG ' ' A' ' 19' ' ' SER . 4.4 mm? -93.2 -165.58 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.92 122.93 11.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.5 -39.05 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.724 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -86.03 51.83 2.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 143.53 32.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.337 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -81.11 -3.4 51.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.39 7.2 26.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.618 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.35 114.74 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.8 138.87 14.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -125.25 114.38 18.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.561 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.12 16.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.83 124.8 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.16 -1.2 . . . . 0.0 109.665 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.56 151.08 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.148 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.05 10.28 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.56 92.65 5.08 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.29 70.87 7.32 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.755 2.303 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.53 -38.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.365 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . 6.6 t -165.48 -38.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.772 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -62.53 -49.23 75.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.5 t70 84.81 -174.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.65 99.17 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.855 . . . . 0.0 109.25 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.8 ttp -95.73 139.82 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.65 107.34 13.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.116 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.13 127.49 52.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.837 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -130.34 120.55 24.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 108.974 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.78 152.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.827 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.78 ' HZ1' ' ND2' ' A' ' 16' ' ' ASN . 24.1 tttt -114.84 154.75 28.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 109.284 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 64.5 t -133.25 121.71 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD1' ' OE1' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -47.63 -53.67 14.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 162.01 -23.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.859 . . . . 0.0 109.252 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.664 ' ND2' ' H ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.8 -0.74 57.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.44 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.85 8.67 41.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 52' ' ' ILE . 5.2 mm -100.31 138.63 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.161 . . . . 0.0 109.534 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.8 mt -96.83 124.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.301 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.551 ' OE1' ' OD1' ' A' ' 48' ' ' ASP . 19.1 pt-20 -107.65 -30.08 8.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.56 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -124.87 150.36 46.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.08 155.16 42.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 109.588 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 58' ' ' PHE . 1.2 tttm -150.49 143.31 24.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' CE2' ' OG ' ' A' ' 70' ' ' SER . 4.5 p90 -138.86 -179.38 5.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -171.32 104.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 t -136.85 144.63 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.589 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.535 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 53.3 t80 -155.0 98.57 2.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 0.7 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -100.71 123.93 45.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 0.0 109.337 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -91.94 123.03 7.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER 72.61 -8.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.18 . . . . 0.0 109.536 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' CB ' ' SG ' ' A' ' 63' ' ' CYS . . . -96.44 7.69 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mt -72.99 -38.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -41.95 75.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p -56.8 -38.82 73.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 58' ' ' PHE . 17.5 t -53.47 -46.06 69.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -35.11 79.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.32 -56.27 22.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.489 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 3.8 tt -58.52 -48.58 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.76 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.47 HG22 ' CD1' ' A' ' 58' ' ' PHE . 23.3 p -60.72 -17.89 51.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 0.0 109.482 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.06 -41.75 10.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -74.22 -7.7 53.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.428 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 73' ' ' ILE . 35.0 m -115.29 36.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.343 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -133.95 78.18 1.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -0.908 . . . . 0.0 109.634 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 0.4 9.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -97.01 -165.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.09 164.65 15.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 34.3 mt -58.83 -24.8 62.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -74.67 -26.29 59.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.646 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.76 -50.21 8.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.67 63.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.269 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.02 45.61 3.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -152.45 -38.29 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -1.112 . . . . 0.0 108.688 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 87' ' ' ALA . 4.0 pt -39.35 123.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.534 -0.729 . . . . 0.0 109.119 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -99.17 162.6 12.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.612 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -57.76 -20.1 32.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 p -77.57 -33.57 53.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.78 -43.68 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 93' ' ' ILE . 10.1 mm -81.61 -33.33 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.912 . . . . 0.0 109.177 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.21 -12.5 56.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 -37.44 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.405 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -53.22 43.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.13 -23.98 19.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 51.29 68.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -96.84 146.45 31.33 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.149 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.59 147.24 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.721 2.281 . . . . 0.0 112.247 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 9.55 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.748 2.299 . . . . 0.0 112.168 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 t -92.09 -33.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -105.93 30.02 6.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 103' ' ' LYS . 20.3 t -42.55 -25.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.772 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 4.4 p-80 -52.0 -39.6 59.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 33.9 m -47.93 -60.39 2.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.308 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 109' ' ' LEU . 57.9 m -59.31 -58.81 7.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' CB ' ' A' ' 112' ' ' ASP . 63.7 mt -46.26 -22.1 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 107' ' ' SER . 0.8 OUTLIER -74.43 -57.53 3.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.5 59.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 109.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' A' ' 112' ' ' ASP . 3.3 tm-20 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 10.0 t0 -43.13 -43.33 4.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.52 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.29 -54.48 39.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -47.27 -42.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' CD ' ' OE2' ' A' ' 111' ' ' GLU . 5.6 mttp -68.36 -34.85 76.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.21 -58.55 6.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.496 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.68 -42.36 45.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.76 -48.35 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.407 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.92 -37.75 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.363 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.6 -38.41 67.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.78 -32.61 74.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -78.14 -39.77 40.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -52.63 -54.94 26.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 109.533 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.22 0.07 2.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.271 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 123' ' ' ALA . 2.0 tt0 -151.78 63.33 0.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.632 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -173.93 -44.61 0.05 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 126' ' ' GLY . 6.3 tp -41.71 -47.83 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.683 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 129' ' ' HIS . 1.4 tt0 -69.69 166.14 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.46 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 1.7 m80 -92.32 -146.75 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.407 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -101.84 -166.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -135.28 115.73 13.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.532 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 133' ' ' HIS . 43.4 m-70 -132.29 85.16 2.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 132' ' ' HIS . 14.0 p80 -45.86 126.22 6.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.5 m80 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.446 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.78 129.5 34.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.656 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.4 93.05 4.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.82 120.34 40.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.558 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.81 117.3 1.8 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.363 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -79.95 90.89 5.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 7' ' ' VAL . 12.3 p -142.87 39.42 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.863 . . . . 0.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.41 -104.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.549 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 19.3 t0 65.13 -153.96 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 9' ' ' ASP . 4.6 m-70 -142.16 -16.89 0.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 10' ' ' HIS . 0.2 OUTLIER 56.89 113.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 109.429 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -90.59 120.95 32.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.531 ' ND2' ' N ' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -176.31 52.96 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.393 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 34.4 Cg_endo -67.75 16.62 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.764 2.31 . . . . 0.0 112.091 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.718 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -54.51 129.83 37.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.518 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 18' ' ' GLY . 6.7 p-10 -146.8 -6.27 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 18' ' ' GLY . 2.6 m -51.58 -3.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 16' ' ' ASN . . . -57.35 -128.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -161.9 -66.28 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -1.113 . . . . 0.0 109.452 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 19' ' ' SER . 13.5 tp 50.98 108.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.567 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 23' ' ' LYS . 34.9 t70 -163.79 -3.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 64.66 -8.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.558 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -102.2 19.72 18.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.16 160.63 19.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -3.38 56.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -105.51 -5.89 19.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.33 116.27 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.441 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.05 144.27 17.24 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.2 m -126.7 121.93 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.06 123.77 5.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.477 ' C ' ' SD ' ' A' ' 31' ' ' MET . 2.4 ppp? -131.89 153.11 50.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.677 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -145.26 169.06 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.251 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.1 147.84 18.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -145.73 73.13 13.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -1.123 . . . . 0.0 109.34 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -58.5 71.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.85 2.366 . . . . 0.0 112.097 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -177.95 -89.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.836 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 1.5 t -118.48 -7.98 10.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.665 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -98.71 -23.87 11.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 58.45 -163.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.715 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -87.24 110.35 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 108.842 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 8.1 ttt -100.55 129.81 46.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.163 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.608 ' NE2' ' NE2' ' A' ' 44' ' ' GLN . 30.5 tt0 -120.88 108.08 13.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 tp -108.19 115.06 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.722 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.608 ' NE2' ' NE2' ' A' ' 42' ' ' GLN . 12.3 mt-30 -110.38 118.88 37.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.2 pt -106.25 146.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.379 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -115.18 136.58 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.66 145.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.114 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -78.75 -104.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.502 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.5 t70 -141.8 9.15 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.32 12.52 2.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.301 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.04 14.61 57.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -99.87 114.35 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -1.153 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.5 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -50.29 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 49.8 t0 -127.19 170.14 12.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.521 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -162.95 115.81 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -98.92 131.69 44.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.446 ' CD2' ' OG ' ' A' ' 70' ' ' SER . 8.4 p90 -109.72 172.05 7.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.647 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -171.81 112.2 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -156.01 146.99 22.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 4.3 t80 -156.9 106.88 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.36 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.23 -25.73 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 64.4 m -83.64 131.67 34.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -1.068 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.82 9.49 60.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -152.77 -13.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -93.14 -12.69 29.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' ALA . 20.1 mt -42.15 -45.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.15 89.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -46.41 -53.41 11.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.5 ' O ' ' OG1' ' A' ' 74' ' ' THR . 6.9 t -45.17 -48.45 12.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 m -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -64.67 -76.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 72' ' ' LEU . 5.8 tt -35.51 -52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.728 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER -49.54 -52.54 29.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -2.11 30.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 109.891 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -105.11 -4.5 21.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.466 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.29 5.59 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.504 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -92.76 98.38 11.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.75 11.23 23.37 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -110.74 174.29 5.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -96.71 157.46 15.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.487 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.34 -20.72 63.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -34.89 74.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.57 -32.55 36.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.96 -21.51 59.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.636 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.17 30.08 10.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -147.23 -37.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.151 -1.205 . . . . 0.0 109.507 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.545 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -34.66 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.527 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER 70.39 167.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.369 -0.832 . . . . 0.0 109.516 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.765 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -89.74 -54.83 3.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.765 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -37.84 -33.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.482 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -60.28 -53.08 61.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.56 -35.81 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.51 -39.98 81.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.84 -34.12 62.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -54.2 -45.92 72.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.336 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.19 -6.52 19.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 94' ' ' ALA . 16.8 mt-10 53.93 88.5 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -108.03 165.75 12.17 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.53 142.37 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.601 2.201 . . . . 0.0 112.053 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.92 5.75 4.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.705 2.27 . . . . 0.0 112.209 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.15 -25.7 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.643 ' O ' ' N ' ' A' ' 105' ' ' HIS . 4.2 mtpt -118.22 28.15 8.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 103' ' ' LYS . 21.3 t -38.16 -22.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.665 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 3.2 p-80 -44.47 -31.39 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.8 m -60.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.49 ' HG ' ' ND2' ' A' ' 90' ' ' ASN . 10.2 p -47.15 -56.87 5.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.181 -0.949 . . . . 0.0 109.095 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 6.0 mt -45.67 -36.62 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.91 -49.13 78.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.244 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -61.96 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 109.588 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 112' ' ' ASP . 30.2 tt0 -54.99 -73.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 111' ' ' GLU . 23.0 t0 -34.1 -55.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.656 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 112' ' ' ASP . . . -40.96 -70.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.418 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.443 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.1 tp -43.49 -31.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.083 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 112' ' ' ASP . 4.1 tptt -64.42 -60.17 3.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.9 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.05 -45.97 75.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.18 -45.36 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.264 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.92 64.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 109.108 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.15 -26.19 37.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 109.271 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 15.8 t80 -76.41 -54.49 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -71.42 0.41 8.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.01 -31.1 22.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -96.62 35.75 1.47 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.459 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -121.94 -31.46 3.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -47.65 -84.93 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.429 ' C ' ' H ' ' A' ' 129' ' ' HIS . 25.0 mt -135.8 14.26 3.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -1.196 . . . . 0.0 109.462 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 53.53 11.85 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.429 ' H ' ' C ' ' A' ' 127' ' ' LEU . 31.5 m80 -148.05 158.72 44.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.87 -23.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.095 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.634 ' C ' ' H ' ' A' ' 133' ' ' HIS . 56.0 m80 -65.88 95.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.23 8.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.634 ' H ' ' C ' ' A' ' 131' ' ' HIS . 25.7 t-80 -114.15 -8.76 12.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.495 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.0 t0 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.479 ' C ' ' CG ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER 71.48 -7.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.479 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 178.29 30.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.656 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.12 94.93 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.648 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.12 126.15 7.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.01 127.13 2.27 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 ttt -133.62 98.39 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.283 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -107.49 170.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.41 160.14 26.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . . . -128.91 92.98 38.3 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.152 -1.205 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.85 -16.06 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.679 2.253 . . . . 0.0 112.052 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 -57.16 4.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.9 p -100.91 19.53 17.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.439 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.27 58.32 1.06 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 42.9 t0 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -98.29 122.43 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -108.46 115.66 30.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -110.99 113.64 26.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 9.9 tp -103.64 153.64 20.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.06 111.42 5.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -101.26 146.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -131.15 122.94 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.47 141.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.621 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.687 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -172.47 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 4.3 m-20 -62.73 45.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.4 m-20 78.5 51.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.6 -5.75 72.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.77 156.53 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -1.161 . . . . 0.0 109.385 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.43 94.57 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.73 -25.14 64.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.423 -0.798 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.19 168.47 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.89 131.15 11.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -110.87 163.13 14.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.737 ' CD1' HG21 ' A' ' 74' ' ' THR . 16.2 p90 -142.1 166.6 24.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 109.379 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 101.4 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.391 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -154.1 143.39 21.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 1.2 p90 -161.82 134.7 6.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.04 -52.95 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 168.26 20.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.184 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 38.81 2.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 t -166.29 -47.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -1.161 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.479 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . . . -48.38 -37.56 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -47.52 -19.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.613 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' ALA . . . -95.93 -40.26 9.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.403 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.783 ' O ' HG22 ' A' ' 73' ' ' ILE . 4.7 p -50.92 -38.68 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.321 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.707 ' O ' HG23 ' A' ' 74' ' ' THR . 87.9 p -58.94 -38.89 80.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -63.64 -41.85 98.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 73' ' ' ILE . 1.7 tp -66.65 -73.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.813 ' O ' HG22 ' A' ' 77' ' ' VAL . 6.2 tt -43.26 -28.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.737 HG21 ' CD1' ' A' ' 58' ' ' PHE . 19.2 p -77.5 -41.46 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.59 2.14 38.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -110.6 -30.31 7.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.758 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 73' ' ' ILE . 4.4 m -109.25 50.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -123.82 104.63 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.39 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 6.1 63.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.0 mmtt -98.67 175.22 6.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -1.12 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 t -88.16 154.52 20.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 118' ' ' ILE . 66.4 mt -61.76 -20.16 63.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -64.12 -29.95 71.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -91.56 -35.51 14.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.78 -37.86 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.36 57.57 2.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -163.27 -34.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -1.124 . . . . 0.0 109.004 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 0.8 OUTLIER -45.15 -14.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 87' ' ' ALA . 19.5 mttm 46.68 -173.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.28 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 91' ' ' SER . 24.5 p-10 -97.9 -24.14 15.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.696 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.6 -25.47 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.98 -65.36 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 109.661 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 9.5 tt -49.81 -38.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -59.75 -46.33 89.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.379 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -65.02 -28.48 69.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tm-20 -71.46 -28.99 64.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.426 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 25.8 mt -93.67 -36.96 12.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.339 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 5.7 tt0 69.72 62.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.435 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -120.1 149.3 48.87 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.942 . . . . 0.0 109.451 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.96 158.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 103' ' ' LYS . 41.4 Cg_endo -72.05 -51.11 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.766 2.311 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 102' ' ' VAL . 41.4 t -58.04 -2.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 101' ' ' PRO . 13.7 mttp -115.6 12.18 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.24 -1.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.6 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 0.3 OUTLIER -57.58 -41.62 81.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.981 . . . . 0.0 109.256 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 19.3 m -63.8 -46.82 83.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.841 . . . . 0.0 109.337 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -56.42 -46.45 80.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.343 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 105' ' ' HIS . 19.6 mt -52.89 -45.32 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.305 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 6.0 mp -58.5 -46.58 86.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -52.67 -53.39 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.93 -56.38 19.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.57 -17.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -79.77 -53.42 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.464 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.5 tp -57.25 -30.11 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -43.7 38.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.7 92.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.673 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.4 73.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.556 HG12 HD22 ' A' ' 82' ' ' LEU . 63.7 mt -63.7 -44.88 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.2 -39.77 87.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.14 -31.87 68.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.27 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -39.24 74.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.339 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -77.58 -18.49 56.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.612 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.43 70.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 tptm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.518 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' ND2' ' A' ' 26' ' ' ASN . 1.2 m-20 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.301 0.572 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -74.37 13.09 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.321 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -116.26 22.12 13.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.602 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.53 103.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.92 15.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -127.39 152.06 48.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -1.174 . . . . 0.0 109.693 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 125.5 1.56 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.7 ttp -123.79 140.44 52.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.733 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -141.37 165.1 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.43 160.69 29.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.84 145.44 54.69 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.303 -1.116 . . . . 0.0 109.411 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.55 -50.25 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.595 2.197 . . . . 0.0 112.05 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.84 63.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.664 ' HB2' ' CE1' ' A' ' 105' ' ' HIS . 1.4 m -93.73 -2.62 53.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.61 42.42 0.67 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 16.9 t0 -118.51 154.46 32.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -1.088 . . . . 0.0 109.821 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.4 t -113.48 99.63 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.767 ' CE ' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -82.02 102.97 11.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -91.91 138.8 31.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.767 HD13 ' CE ' ' A' ' 41' ' ' MET . 7.3 tp -134.66 126.16 28.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -128.21 133.65 48.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -121.7 140.89 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -118.44 140.79 49.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 73.0 t -117.17 143.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER 178.19 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.545 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-20 -62.45 45.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.663 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.1 m-20 81.09 45.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.99 -3.27 86.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 79' ' ' GLY . 40.5 mm -96.49 146.86 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -1.103 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.2 mt -56.48 94.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -0.934 . . . . 0.0 109.445 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -46.47 35.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.25 169.75 22.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.36 121.6 16.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' CD ' ' N ' ' A' ' 57' ' ' LYS . 2.9 mmtm -95.84 154.79 17.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD1' HG21 ' A' ' 74' ' ' THR . 27.4 p90 -141.1 158.32 44.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -160.94 116.64 2.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.21 131.64 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.463 ' C ' ' OD2' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -148.12 103.76 3.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.578 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.581 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . 125.94 22.73 1.72 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -114.25 83.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.157 . . . . 0.0 109.661 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . 33.45 -101.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 67' ' ' ILE . 96.1 p -136.99 19.19 3.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -1.145 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.51 4.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.8 mm -58.2 -61.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 67' ' ' ILE . . . -46.57 -40.13 12.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 73' ' ' ILE . 10.5 m -61.54 -32.51 72.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -61.18 -26.31 67.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.428 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -83.21 -44.58 14.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.96 -45.42 94.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.723 HG23 ' N ' ' A' ' 74' ' ' THR . 17.4 tt -67.34 -55.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.723 ' N ' HG23 ' A' ' 73' ' ' ILE . 10.5 p -53.6 -23.41 10.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.192 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.8 -21.71 21.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -92.68 -9.1 42.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.536 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 73' ' ' ILE . 32.7 m -121.19 12.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.203 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -94.19 123.16 37.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.352 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 71.2 8.9 66.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -97.86 169.21 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -1.122 . . . . 0.0 109.554 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -83.05 162.19 21.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.57 -24.04 61.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -67.07 -31.4 71.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.77 -33.85 21.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -65.25 -36.78 85.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.15 36.15 3.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -147.27 -34.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -1.068 . . . . 0.0 109.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.543 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -33.42 -28.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 87' ' ' ALA . 4.4 ttmt 63.11 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.48 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 92' ' ' GLN . 7.6 p-10 -82.69 -47.74 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.601 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -43.15 -24.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.632 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.8 tp60 -70.55 -53.9 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.657 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.23 -22.12 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 109.621 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.24 -34.07 59.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 9.0 tp10 -85.37 -16.47 39.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.06 -47.4 14.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.462 HD22 ' OG ' ' A' ' 69' ' ' SER . 7.6 mp -87.15 -35.68 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 8.6 tt0 70.21 73.04 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 0.0 109.785 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -106.64 143.72 27.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.875 . . . . 0.0 109.208 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.6 148.0 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.753 2.302 . . . . 0.0 112.45 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.2 Cg_endo -72.79 -13.64 26.83 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.799 2.333 . . . . 0.0 112.196 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.79 -0.1 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 109.54 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 101' ' ' PRO . 21.2 mttp -150.63 55.02 0.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.587 ' O ' HG12 ' A' ' 104' ' ' VAL . 37.0 t -70.1 -2.79 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.664 ' CE1' ' HB2' ' A' ' 37' ' ' CYS . 6.7 p80 -84.03 -26.6 28.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.312 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.69 -60.79 2.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.2 p -54.07 -54.65 36.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.26 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' C ' ' A' ' 109' ' ' LEU . 43.6 mt -44.73 -66.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 108' ' ' ILE . 4.9 mp -35.21 -50.6 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.669 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HA ' ' SD ' ' A' ' 41' ' ' MET . . . -49.9 -56.8 9.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.0 tt0 -68.56 -67.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.2 OUTLIER -34.67 -27.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -78.31 -59.11 2.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.987 . . . . 0.0 109.828 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.562 HG12 ' HB1' ' A' ' 85' ' ' ALA . 3.3 tp -48.09 -37.11 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.2 ttmt -67.76 -47.73 68.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.286 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.4 64.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.1 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.85 -55.74 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.098 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 117' ' ' ALA . 29.8 mt -42.14 -40.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.08 -54.41 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.07 -26.19 25.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -76.73 -57.57 3.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.312 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -69.79 2.93 2.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.8 -49.37 5.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.863 . . . . 0.0 109.647 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' A' ' 24' ' ' ASP . 12.3 t0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.26 0.553 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 66.34 -4.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 24' ' ' ASP . 57.8 m-20 -107.71 -0.71 21.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.45 96.25 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.576 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.12 139.11 37.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.433 HG23 HE21 ' A' ' 44' ' ' GLN . 6.6 m -120.61 105.97 11.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -1.12 . . . . 0.0 109.49 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.79 130.04 10.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.6 ttt -132.65 117.01 17.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -1.144 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.9 159.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.98 156.05 16.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . . . -117.83 83.04 17.62 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.335 -1.097 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.54 -16.82 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.913 2.408 . . . . 0.0 112.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.01 -33.64 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.3 p -124.06 23.19 8.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.74 69.17 0.2 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 8.6 t0 -139.67 116.95 11.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.55 110.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 5.7 ttt -97.6 137.02 37.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -128.91 112.8 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.47 139.25 50.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.433 HE21 HG23 ' A' ' 29' ' ' THR . 2.6 mt-30 -134.96 134.75 40.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.82 135.05 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -106.81 133.58 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -107.98 139.68 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 6.4 t0 -82.76 -88.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.3 m-20 -154.76 17.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.0 11.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.01 78.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -83.39 135.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.581 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.34 104.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.114 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.19 -24.04 37.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 109.837 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 45.6 t0 -148.21 150.62 34.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.685 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -142.04 116.61 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.343 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -97.31 152.12 19.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CG ' HG21 ' A' ' 74' ' ' THR . 15.3 p90 -147.59 166.42 27.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -170.79 117.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.407 HG21 ' HB3' ' A' ' 70' ' ' SER . 0.8 OUTLIER -157.23 143.71 18.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.706 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 20.1 p90 -161.92 95.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.34 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.06 -62.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -81.89 146.27 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.417 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.7 10.38 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 7.4 t -136.22 -7.24 2.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -1.134 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.19 -68.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.616 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.83 -34.22 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 65' ' ' SER . . . -58.27 -57.53 12.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -68.2 -41.25 81.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.473 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -61.53 -28.23 69.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 77.4 p -75.0 -49.96 18.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.72 -57.99 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 74' ' ' THR . 18.2 tt -49.15 -45.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 109.512 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 70' ' ' SER . 19.0 p -60.05 -36.25 76.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -77.98 -10.37 59.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 -30.85 12.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.596 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 77' ' ' VAL . 15.3 m -96.81 38.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.671 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.06 102.85 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.16 52.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -104.77 169.39 8.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -1.111 . . . . 0.0 109.429 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -93.54 150.22 20.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.52 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 82' ' ' LEU . 27.9 mt -49.44 -26.51 3.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.63 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -69.04 -32.98 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.93 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -83.46 -34.24 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.55 54.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.27 52.05 3.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -162.43 -39.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -1.186 . . . . 0.0 109.243 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -42.76 -30.28 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.364 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 59.91 175.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -88.52 -44.33 10.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ASN . 43.4 t -38.61 -39.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 95' ' ' GLU . 5.9 tp-100 -62.33 -66.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.378 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.4 mt -45.37 -31.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.229 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.36 -19.96 48.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.248 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 92' ' ' GLN . 6.2 tt0 -83.85 -20.03 33.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -97.92 -53.89 3.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -72.91 -5.56 39.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.369 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.507 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 43.26 31.95 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.619 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.95 150.79 36.95 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.334 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.18 157.95 42.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.8 2.333 . . . . 0.0 112.234 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.649 ' O ' HG23 ' A' ' 104' ' ' VAL . 60.9 Cg_endo -76.4 -7.14 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.893 2.395 . . . . 0.0 112.567 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.83 -14.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 105' ' ' HIS . 25.6 mttm -114.42 29.69 7.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 101' ' ' PRO . 21.8 t -66.76 -9.94 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.646 ' O ' HD13 ' A' ' 109' ' ' LEU . 2.2 p-80 -77.35 -25.28 50.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -75.7 -41.81 52.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.138 -0.976 . . . . 0.0 109.121 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -52.97 59.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 7.1 tt -53.9 -38.73 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 108.89 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.646 HD13 ' O ' ' A' ' 105' ' ' HIS . 1.6 mp -53.8 -50.04 67.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -56.82 -54.24 48.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 114' ' ' ILE . 16.2 tt0 -48.93 -63.46 1.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.206 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.42 -27.56 10.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -68.0 -49.04 63.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 111' ' ' GLU . 2.4 tp -56.22 -36.31 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.985 . . . . 0.0 109.26 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -70.87 -57.04 5.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.84 7.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.37 -59.67 3.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.9 mt -46.44 -44.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.424 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.438 ' C ' ' N ' ' A' ' 121' ' ' TYR . . . -62.35 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' C ' ' OD1' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -47.89 -17.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.2 t80 -92.59 -29.28 16.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -92.1 3.37 55.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.355 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.44 -52.18 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 109.578 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.2 tttm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 -179.93 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 37.8 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.343 0.592 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.12 10.42 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.539 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -134.39 21.14 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.39 127.79 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.0 121.67 7.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -102.78 120.65 40.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.538 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.41 100.68 0.89 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ttt -96.68 133.13 41.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -1.095 . . . . 0.0 109.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.41 154.62 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.862 . . . . 0.0 109.222 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.64 143.72 17.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.14 107.18 13.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.34 -1.094 . . . . 0.0 109.083 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -76.52 15.59 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.293 1.996 . . . . 0.0 112.447 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.658 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -112.47 -102.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.832 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -121.04 6.59 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.689 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -91.7 -16.46 51.93 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 29.7 t0 50.86 -151.35 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -1.051 . . . . 0.0 109.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 6.4 t -87.35 136.62 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.7 ttt -127.34 137.41 52.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 109.589 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -124.43 123.37 40.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -119.93 126.51 51.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.958 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.56 143.64 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.515 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.5 pp -132.88 134.16 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -102.97 136.8 42.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.9 136.05 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 38.1 t0 -59.78 -49.44 77.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.31 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.678 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.7 OUTLIER 162.83 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -34.43 9.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.11 -9.73 0.98 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -74.43 134.26 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -1.225 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.04 89.49 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.44 -54.78 39.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.578 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -144.49 152.85 41.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.898 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.594 ' H ' ' HZ3' ' A' ' 78' ' ' LYS . . . -133.58 142.44 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.741 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -114.02 143.28 45.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.053 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.524 ' HB3' HG21 ' A' ' 74' ' ' THR . 4.4 p90 -119.69 165.2 14.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.86 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -171.54 81.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -123.45 152.9 41.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -155.44 95.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . -179.21 -50.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 18.5 m -74.23 125.15 27.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.511 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -43.33 -21.72 0.17 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -120.25 7.9 10.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -1.105 . . . . 0.0 109.274 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 63' ' ' CYS . . . -42.22 -43.18 3.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.518 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.518 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.2 mt -60.72 -29.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -80.58 -71.92 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.733 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.3 p -38.84 -33.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.944 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 74' ' ' THR . 12.4 p -69.19 -63.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 0.8 OUTLIER -48.67 -25.76 1.95 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 109.5 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' C ' ' A' ' 73' ' ' ILE . 39.4 tp -79.15 -81.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 69' ' ' SER . 14.5 tt -41.11 -35.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.614 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 70' ' ' SER . 82.6 p -69.53 -39.48 77.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' LEU . 16.4 tt0 -74.51 -8.33 55.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.327 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.98 -31.88 14.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 114' ' ' ILE . 4.9 m -96.42 13.14 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HZ3' ' H ' ' A' ' 56' ' ' ALA . 4.2 mttm -89.28 93.11 9.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.54 -18.52 24.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -66.52 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.41 167.81 13.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.646 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.38 -30.19 69.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.85 . . . . 0.0 109.56 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.76 -35.05 79.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.1 -45.2 18.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.007 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.16 35.61 2.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -147.4 -38.99 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 109.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.509 HD11 HG12 ' A' ' 114' ' ' ILE . 1.4 pt -41.45 163.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -0.872 . . . . 0.0 109.35 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -136.72 -174.1 3.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -101.55 -5.59 24.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.221 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -64.31 -53.06 54.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 0.0 109.343 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.6 mt-30 -60.76 -62.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 93' ' ' ILE . 37.3 mt -47.21 -25.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.45 -27.27 46.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 92' ' ' GLN . 10.2 mt-10 -87.96 -16.28 34.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.355 -0.841 . . . . 0.0 109.338 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -88.55 -43.41 11.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.67 -14.05 49.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 48.29 74.52 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.371 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -110.77 150.73 42.21 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 109.415 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.02 160.09 48.91 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.748 2.299 . . . . 0.0 112.193 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.0 Cg_endo -66.7 -65.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.904 2.402 . . . . 0.0 112.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG23 ' C ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER 41.48 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 109.03 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' PRO . 20.1 mttp -138.43 10.96 2.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.683 ' O ' HD12 ' A' ' 108' ' ' ILE . 3.7 t 34.79 53.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.832 ' CE1' ' H ' ' A' ' 37' ' ' CYS . 6.4 p-80 -98.38 -25.54 14.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.84 -70.22 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -51.32 -57.84 7.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 104' ' ' VAL . 37.1 mt -43.07 -34.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.07 81.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.71 68.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' ' 112' ' ' ASP . 56.8 tt0 -66.56 -67.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 111' ' ' GLU . 47.8 t0 -40.56 -29.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -67.1 -59.54 3.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.509 HG12 HD11 ' A' ' 88' ' ' ILE . 1.9 tp -46.21 -33.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.75 61.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.81 64.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.97 -56.8 17.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.5 -44.38 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.626 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.95 -57.54 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 2.4 m-20 -53.89 -53.6 50.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.516 ' O ' ' C ' ' A' ' 122' ' ' LYS . 13.0 t80 -47.37 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 121' ' ' TYR . 11.2 mmtt -36.22 -44.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 120' ' ' ASP . . . -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.569 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' TYR . 3.6 mtpt . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.913 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 26' ' ' ASN . 26.3 t0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.509 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.5 OUTLIER 54.64 0.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.075 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -167.82 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.12 113.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.782 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.76 125.32 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -116.13 145.31 43.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.36 134.57 5.4 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.5 mtt -123.47 148.88 45.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.122 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.18 174.01 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.145 -0.972 . . . . 0.0 109.334 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.24 150.27 8.04 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.03 144.42 47.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.504 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 Cg_endo -71.97 -67.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.563 2.176 . . . . 0.0 111.938 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.41 -35.9 0.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.241 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' O ' ' C ' ' A' ' 38' ' ' GLY . 49.9 t -99.13 -4.97 31.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.345 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 36.68 34.66 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 37' ' ' CYS . 13.7 t0 -105.02 114.16 28.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.333 -1.098 . . . . 0.0 109.604 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 40' ' ' VAL . 14.5 p -89.05 109.29 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ttt -99.2 152.32 20.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -147.9 126.93 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.89 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.62 128.42 37.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.034 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -118.52 136.05 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.028 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.4 pp -119.51 144.86 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -111.79 141.98 44.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.81 113.65 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 17.3 t0 -47.45 -67.16 0.3 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.644 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.9 p-10 170.41 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.097 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.39 10.83 23.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.32 15.26 54.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.1 mm -102.52 148.81 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 109.592 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.478 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.3 mm -83.34 84.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.435 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' ' OD1' ' A' ' 55' ' ' ASP . 5.6 tt0 -40.89 -55.76 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' OD1' ' OE2' ' A' ' 54' ' ' GLU . 7.4 p-10 -152.34 170.99 18.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.25 126.52 18.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.474 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -99.28 135.01 41.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 2.6 p90 -109.83 162.46 14.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -171.78 102.24 0.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -164.82 139.74 5.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.651 ' CE2' HD11 ' A' ' 67' ' ' ILE . 3.3 t80 -156.02 95.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.31 -19.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.678 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -141.06 107.27 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -1.045 . . . . 0.0 109.181 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -41.08 -15.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 63' ' ' CYS . 1.8 m -82.49 -22.24 35.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -83.31 -58.7 2.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.651 HD11 ' CE2' ' A' ' 61' ' ' TYR . 42.5 mt -35.68 -59.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.9 m -49.84 -50.56 45.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.479 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 74' ' ' THR . 1.3 t -43.95 -47.57 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.587 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.569 ' O ' ' OG1' ' A' ' 74' ' ' THR . 17.3 p -70.59 -31.41 68.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -68.33 -61.82 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 77' ' ' VAL . 6.1 tt -48.78 -41.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 70' ' ' SER . 23.5 p -55.84 -46.25 78.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.018 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.99 -20.23 64.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 108.916 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.21 -27.68 53.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 73' ' ' ILE . 7.0 m -111.8 -111.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.499 -0.75 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' H ' HG23 ' A' ' 77' ' ' VAL . 8.3 tttm 35.32 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.53 13.85 10.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.56 -166.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -1.113 . . . . 0.0 109.366 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 83' ' ' GLU . 15.5 m -108.34 135.82 49.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.959 . . . . 0.0 109.639 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' SER . 11.4 mt -45.32 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 81' ' ' SER . 5.7 tp10 -77.92 -53.12 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.173 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -32.0 69.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.07 31.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.24 47.2 3.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.61 -33.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.189 . . . . 0.0 109.425 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.5 pt -44.16 175.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -143.19 158.11 43.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -73.99 -38.25 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -52.19 -37.69 55.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.161 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 94' ' ' ALA . 3.5 mm100 -66.18 -68.33 0.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -45.67 -23.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 91' ' ' SER . . . -71.85 -63.45 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.825 . . . . 0.0 109.166 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -49.31 -17.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 108.941 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -80.68 -61.21 2.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 60.2 tp -76.7 -33.45 58.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER 70.0 68.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.035 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.2 pt? -103.72 146.93 33.43 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -40.24 102.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.758 2.305 . . . . 0.0 112.16 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 103' ' ' LYS . 58.8 Cg_endo -78.77 10.15 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.543 2.162 . . . . 0.0 112.41 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -11.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.238 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 101' ' ' PRO . 53.0 tttm -157.14 -34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.381 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t 60.9 60.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.286 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.624 ' O ' HD13 ' A' ' 109' ' ' LEU . 13.3 p-80 -99.27 -47.66 5.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 0.0 109.527 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.403 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.6 m -61.11 -49.38 77.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.509 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.547 ' OG ' HD11 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -50.66 -67.8 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' SER . 3.4 mt -44.87 -38.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.6 mp -60.24 -39.37 86.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -61.67 -52.02 66.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.132 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 112' ' ' ASP . 68.2 tt0 -60.16 -60.31 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -42.76 -33.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -64.28 -60.45 3.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -46.99 -38.4 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' HA ' HD12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -70.35 -57.77 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.99 -39.58 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.01 97.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 109.66 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 115' ' ' LYS . 44.2 mt -64.37 -39.3 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.97 72.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 -42.73 95.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -70.02 -48.66 57.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 123' ' ' ALA . 20.2 tttt -56.96 -30.15 63.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -38.93 -36.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.4 tptt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.677 ' OD1' ' N ' ' A' ' 25' ' ' SER . 57.6 t0 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.677 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 51.0 m -89.65 5.86 43.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -114.31 -2.71 13.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.19 117.56 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.843 . . . . 0.0 109.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 126.94 9.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -112.07 151.2 29.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -1.135 . . . . 0.0 109.299 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.92 153.88 25.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.8 ttm -142.37 141.19 32.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.86 165.96 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.923 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.11 148.53 17.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -141.88 79.16 16.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.333 -1.098 . . . . 0.0 109.619 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.31 12.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.88 2.387 . . . . 0.0 112.269 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.635 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -110.54 -79.16 0.58 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.271 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 1.4 p -134.9 -36.22 0.84 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.188 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.688 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -55.02 -18.86 12.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.535 ' N ' ' HB3' ' A' ' 34' ' ' ALA . 14.7 t0 51.69 -147.69 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 0.0 109.731 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.424 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.98 115.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.88 . . . . 0.0 109.434 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.452 ' CG ' ' N ' ' A' ' 42' ' ' GLN . 9.5 ttt -106.82 157.42 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CG ' ' A' ' 41' ' ' MET . 15.6 tt0 -143.86 130.38 20.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.686 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 1.6 tp -125.45 150.91 46.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.463 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 14.3 mt-30 -142.23 144.33 33.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.539 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.17 155.95 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -130.76 122.79 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.247 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.629 HG11 HD11 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -115.37 140.01 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.786 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' A' ' 50' ' ' ASN . 35.0 m-20 -170.88 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.47 48.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.374 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 78.4 50.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.91 86.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.83 149.49 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -1.103 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mt -82.7 91.44 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -72.83 -38.56 67.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.333 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 47.8 t0 -124.85 158.03 34.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.828 . . . . 0.0 109.236 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -158.67 120.23 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.76 157.33 19.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -140.69 -174.03 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.751 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -169.69 81.61 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.219 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.34 122.34 30.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 105.68 3.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 145.25 -44.57 0.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.466 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 15.9 m -75.0 167.36 22.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.446 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.37 -38.48 0.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -21.01 17.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -1.085 . . . . 0.0 109.498 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -88.6 0.63 56.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 66' ' ' ALA . 8.3 tp -44.36 -31.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -66.46 -47.78 72.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.599 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -43.37 -32.5 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.333 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.7 OUTLIER -58.53 -53.73 55.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 m -65.75 -32.72 74.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 75' ' ' GLU . 1.7 tp -65.1 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.856 . . . . 0.0 109.682 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.733 ' O ' HG22 ' A' ' 77' ' ' VAL . 16.4 tt -37.11 -41.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.963 . . . . 0.0 109.577 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 73' ' ' ILE . 2.4 p -64.77 -32.38 74.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.526 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 72' ' ' LEU . 8.8 mt-10 -86.56 -7.72 58.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -109.04 -5.71 15.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 109.546 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 73' ' ' ILE . 24.9 m -117.52 0.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -95.38 114.83 26.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 109.385 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.82 -8.36 73.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.25 168.69 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.42 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.0 m -88.79 167.59 13.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 HG11 ' A' ' 47' ' ' VAL . 31.7 mt -68.04 -26.61 65.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.565 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -66.52 -20.27 65.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.317 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -97.22 -58.02 2.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.171 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.68 62.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.246 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 118' ' ' ILE . . . -101.44 49.23 1.06 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -168.93 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -1.128 . . . . 0.0 109.094 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 87' ' ' ALA . 5.1 pt -41.38 156.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.5 168.8 9.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.135 -0.978 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.59 -18.47 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 t -66.65 -27.61 67.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.19 -57.87 5.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.533 HG21 ' OG ' ' A' ' 69' ' ' SER . 5.1 mt -62.37 -38.45 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -54.79 -53.51 54.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.348 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -37.02 85.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -52.25 -41.13 62.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 tp -105.8 -29.14 10.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 94' ' ' ALA . 8.9 tm-20 64.58 58.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.347 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.068 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.2 pt? -86.46 143.43 36.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.376 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.61 142.45 1.96 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.574 2.183 . . . . 0.0 112.151 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -76.24 -3.16 13.48 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.719 2.279 . . . . 0.0 111.942 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 102' ' ' VAL . 3.0 t -59.9 -12.21 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HD2' ' SG ' ' A' ' 106' ' ' CYS . 18.0 pttp -156.79 56.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 104' ' ' VAL . 86.0 t -57.3 -11.27 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.284 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.688 ' CE1' ' H ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -54.64 -22.32 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.42 ' SG ' ' HD2' ' A' ' 103' ' ' LYS . 59.5 m -65.03 -61.1 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.0 p -55.15 -51.67 65.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.442 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.9 mt -55.28 -26.52 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.102 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 109' ' ' LEU . 1.9 tp -68.06 -42.11 80.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 109.004 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -58.37 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.82 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 112' ' ' ASP . 7.3 tm-20 -62.33 -64.57 0.89 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.565 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 111' ' ' GLU . 62.2 t0 -39.22 -31.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.711 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -69.01 -56.73 6.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.711 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.8 tp -52.14 -37.05 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 3.1 tttp -67.98 -50.46 55.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.85 73.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.714 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -65.62 -69.7 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.698 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.471 HD13 ' HA3' ' A' ' 86' ' ' GLY . 23.6 mt -42.7 -37.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.685 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.32 85.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 61.0 t0 -61.17 -25.19 66.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.898 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.4 t80 -78.62 -40.77 33.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -84.84 -1.78 56.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.12 24.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.275 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 27' ' ' VAL . 2.8 p30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.296 0.57 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -98.42 9.85 42.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m-80 -118.77 18.27 13.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.558 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 t -126.48 122.34 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.52 123.46 7.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 m -109.21 152.78 24.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -1.186 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.52 110.7 0.45 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 ttt -114.45 103.52 11.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.457 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.0 m -117.2 157.29 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.14 163.23 28.67 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.87 138.03 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.294 -1.121 . . . . 0.0 109.371 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.1 Cg_endo -75.57 -36.24 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -43.01 -53.31 4.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.537 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.4 2.38 20.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.65 58.3 7.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 62.3 t0 -127.75 145.39 50.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 2.6 m -115.26 114.69 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 ttt -98.93 125.3 44.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.859 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.29 119.15 38.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.023 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.1 110.92 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -118.82 108.96 15.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.042 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 pt -107.87 143.45 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.892 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.667 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 8.0 tttp -109.31 144.27 37.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.013 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.506 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 3.3 t -134.99 149.33 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.737 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.694 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 174.28 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 2.9 m-20 -62.21 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.421 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-20 79.19 48.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.85 . . . . 0.0 109.412 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.37 78.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 53' ' ' ILE . 5.4 mm -89.24 158.85 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.392 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 52' ' ' ILE . 46.8 mt -93.09 90.73 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.59 -38.56 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.708 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 2.3 p30 -147.62 162.08 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.42 119.6 10.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.712 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' HG21 ' A' ' 74' ' ' THR . 6.1 p90 -137.9 163.93 30.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.734 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -158.95 111.1 2.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.207 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -156.81 132.6 9.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.133 -0.979 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.433 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 46.0 t80 -161.65 154.77 20.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 61' ' ' TYR . . . 125.08 -43.24 1.4 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 t -88.95 166.38 13.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.086 -1.243 . . . . 0.0 109.651 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.86 43.4 1.67 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -158.9 -66.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.314 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -36.27 -35.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.315 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 65' ' ' SER . 49.0 mt -54.88 -13.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.258 -0.901 . . . . 0.0 109.314 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -103.22 -53.25 2.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 109.154 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -55.56 -37.87 68.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.0 109.232 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 74' ' ' THR . 59.0 p -59.86 -39.92 86.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.214 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.573 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -62.37 -51.16 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 73' ' ' ILE . 10.7 tp -55.74 -69.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.371 -0.831 . . . . 0.0 109.508 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 74' ' ' THR . 14.5 tt -47.53 -50.37 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.674 ' N ' HG23 ' A' ' 73' ' ' ILE . 6.0 p -47.35 -38.08 12.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.53 -8.58 54.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 108.914 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.7 t90 -92.12 -11.75 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 108.977 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.04 4.22 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -79.33 104.59 10.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.92 35.38 79.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.72 -174.68 2.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 t -106.16 148.71 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.762 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.4 HD22 HG12 ' A' ' 118' ' ' ILE . 27.3 mt -68.77 -20.65 64.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.961 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.93 -9.04 58.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.374 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -102.17 -43.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.18 -12.73 56.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.527 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.04 49.8 3.6 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -178.63 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -1.12 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -32.16 -31.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 109.757 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 87' ' ' ALA . 16.6 mtmt 62.42 128.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.336 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.64 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 2.5 p-10 -54.37 -46.93 73.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 90' ' ' ASN . 15.7 m -35.45 -34.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.386 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 90' ' ' ASN . 42.1 tp60 -73.44 -49.85 24.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.4 mt -50.61 -38.1 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.238 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.88 -61.32 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.64 -10.21 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.722 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -79.58 -67.73 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.1 mt -85.04 -2.21 57.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' LEU . 14.2 mt-10 44.24 75.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.73 143.05 26.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -42.27 157.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.634 2.222 . . . . 0.0 112.306 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 61.2 Cg_endo -77.29 1.38 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.167 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.85 -0.5 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.669 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -134.63 35.42 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -84.12 -40.58 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.554 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 104' ' ' VAL . 16.0 p-80 -40.98 -33.6 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.007 . . . . 0.0 109.342 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.414 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 1.2 m -72.52 -45.93 57.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.258 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.4 t -55.87 -49.97 71.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.047 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.482 ' O ' ' C ' ' A' ' 109' ' ' LEU . 71.5 mt -50.97 -59.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.0 109.174 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.514 ' O ' ' C ' ' A' ' 110' ' ' ALA . 5.1 mp -40.54 -62.09 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.21 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -37.55 -65.68 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.842 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.459 ' CD ' ' C ' ' A' ' 111' ' ' GLU . 4.4 tp10 -42.32 -45.51 4.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -15.18 63.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.177 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -80.22 -45.16 18.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 109.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -63.7 -40.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.213 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.501 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 20.2 mttt -70.94 -34.63 71.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.32 -53.12 61.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.848 . . . . 0.0 109.519 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.34 84.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 115' ' ' LYS . 89.0 mt -59.47 -28.75 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.988 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.52 -46.93 12.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.74 -8.88 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.1 t80 -96.54 -43.62 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -88.38 -5.56 58.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.42 -21.09 23.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.623 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.645 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 1.9 p -75.67 -7.64 54.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.645 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -95.99 8.7 42.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 46' ' ' LYS . 61.2 t -140.87 110.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.706 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.01 152.33 18.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.759 HG23 ' NE2' ' A' ' 44' ' ' GLN . 27.3 m -122.7 154.5 38.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.728 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.95 130.01 3.46 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 9.0 ttt -127.08 135.49 50.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -1.219 . . . . 0.0 109.947 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 31' ' ' MET . 10.9 m -154.76 146.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.0 109.208 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.9 172.26 22.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -141.79 138.77 17.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.302 -1.116 . . . . 0.0 109.198 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.62 -51.57 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.473 2.115 . . . . 0.0 112.172 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.56 -40.99 13.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 34.1 m -100.61 -0.15 38.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 39.25 47.99 2.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -130.14 148.28 51.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -1.119 . . . . 0.0 109.708 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.79 110.54 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.189 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 109' ' ' LEU . 9.4 ttt -104.07 141.5 36.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.709 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -123.08 129.68 51.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 109.156 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.42 125.38 42.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.667 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.759 ' NE2' HG23 ' A' ' 29' ' ' THR . 2.2 mt-30 -121.01 161.29 21.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.0 109.117 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.31 145.42 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HG3' HG22 ' A' ' 27' ' ' VAL . 13.2 tttt -119.64 123.77 44.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 109.093 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.74 134.99 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.2 m-20 -170.67 -31.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -62.94 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.398 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-20 78.88 41.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.12 74.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 53' ' ' ILE . 20.3 mm -100.61 165.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.603 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.567 ' N ' HG22 ' A' ' 52' ' ' ILE . 68.6 mt -79.02 88.47 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -54.19 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.66 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.1 t70 -146.61 163.78 34.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.11 144.94 31.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 169.46 9.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.755 ' CG ' HG21 ' A' ' 74' ' ' THR . 2.6 p90 -168.28 162.93 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.6 119.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.41 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 60' ' ' THR . 5.5 t -161.01 124.86 3.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -148.4 97.61 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.27 -2.44 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.31 -177.54 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.647 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.39 -14.26 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -137.26 -3.25 1.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -1.166 . . . . 0.0 109.655 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -85.74 -44.35 12.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.2 tp -34.36 -29.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.815 . . . . 0.0 109.828 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -91.35 -41.52 10.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 109.962 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.646 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -69.17 -31.31 69.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.992 . . . . 0.0 109.746 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' HG21 ' A' ' 60' ' ' THR . 9.4 m -57.92 -40.53 80.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.0 109.534 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 p -74.3 -41.54 61.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.9 tp -56.07 -59.06 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.908 HG23 ' H ' ' A' ' 74' ' ' THR . 8.7 tt -55.18 -63.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.908 ' H ' HG23 ' A' ' 73' ' ' ILE . 6.0 p -43.26 -25.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' ILE . 24.2 mt-10 -91.9 -12.93 32.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.613 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.619 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.4 m0 -101.14 -13.19 18.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.711 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.521 ' O ' HG21 ' A' ' 53' ' ' ILE . 35.3 m -111.47 34.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 109.694 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.66 ' NZ ' ' OD2' ' A' ' 55' ' ' ASP . 14.4 ttmm -120.25 89.65 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.02 -7.43 23.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -91.73 -174.67 3.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.09 154.14 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.39 -17.25 62.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.53 -40.9 76.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 109.67 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.24 -39.74 53.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.83 82.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.97 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.03 54.82 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.3 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -1.107 . . . . 0.0 109.115 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 87' ' ' ALA . 6.4 pt -42.32 -28.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.2 tttt 65.46 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -71.61 -6.7 42.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.605 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 p -73.61 -30.36 62.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.5 -39.05 91.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.19 -33.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.35 72.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.67 -46.17 14.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -49.77 -36.96 27.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.43 -27.86 12.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.461 ' C ' HD23 ' A' ' 99' ' ' LEU . 8.9 tt0 63.57 74.51 0.42 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.839 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.24 159.96 30.06 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.99 160.21 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.876 2.384 . . . . 0.0 112.262 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.12 -14.33 18.82 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.818 2.346 . . . . 0.0 112.279 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.06 -1.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.612 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -146.99 36.68 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.524 ' O ' ' C ' ' A' ' 105' ' ' HIS . 41.3 t -52.45 -33.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.729 ' ND1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -36.07 -58.34 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.659 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 56.8 m -32.63 -62.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.72 -44.04 81.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 109' ' ' LEU . 72.3 mt -58.57 -63.56 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.726 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.729 HD13 ' ND1' ' A' ' 105' ' ' HIS . 1.1 mp -39.09 -41.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.88 -56.95 15.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.617 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 112' ' ' ASP . 3.5 tm-20 -66.39 -68.85 0.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 111' ' ' GLU . 2.4 t0 -37.52 -33.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.494 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 109' ' ' LEU . . . -65.29 -52.61 53.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 111' ' ' GLU . 4.4 tp -51.99 -35.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 32.4 tttt -74.44 -48.24 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.77 -54.53 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.41 -61.11 2.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.331 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . 64.2 mt -39.17 -46.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.261 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.81 65.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -57.04 -18.45 14.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.363 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.495 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 20.6 t80 -77.33 -49.76 14.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.386 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 124' ' ' LYS . 1.3 mptm? -71.88 -47.95 49.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.372 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.06 -14.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.351 0.596 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.28 3.07 5.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.658 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.19 14.95 18.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.86 108.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.632 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.49 148.28 17.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.7 m -139.16 145.96 40.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.563 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 120.19 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.9 mtp -118.49 137.75 52.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -1.183 . . . . 0.0 109.586 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.65 163.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.88 143.8 12.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -127.39 131.79 24.01 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -73.56 -57.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.537 2.158 . . . . 0.0 112.477 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.49 -31.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 109.673 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 35' ' ' PRO . 38.1 m -118.39 1.41 11.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 39.25 55.56 2.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -136.39 163.29 30.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.251 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 79.4 t -127.22 129.05 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.714 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.9 ttt -112.41 119.93 39.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -109.43 119.92 40.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.09 130.4 54.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 148.04 48.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.489 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.0 pt -122.5 146.53 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -110.4 101.77 10.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -0.828 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG21 ' CD2' ' A' ' 121' ' ' TYR . 21.7 t -80.48 129.71 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.641 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 6.5 t0 -64.73 -60.1 3.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' ASP . 6.0 m-20 166.44 -25.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -12.86 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.815 . . . . 0.0 109.328 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.84 20.0 5.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mm -109.88 132.63 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -1.133 . . . . 0.0 109.437 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.76 87.7 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -53.29 -42.64 66.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.89 -178.74 7.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.34 113.29 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.576 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -94.02 126.15 39.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.095 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.681 ' CD1' HG21 ' A' ' 74' ' ' THR . 37.3 p90 -114.72 170.04 8.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.849 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -170.35 97.62 0.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 109.141 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -137.38 133.9 35.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -151.24 144.55 24.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.05 -39.25 2.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -85.67 91.96 8.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 109.278 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.92 52.03 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -151.12 -22.35 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 109.316 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -97.24 -11.28 24.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ALA . 3.1 mm -40.47 -27.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -97.42 -32.36 11.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.308 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.8 t -66.5 -54.05 28.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 74' ' ' THR . 0.7 OUTLIER -37.31 -51.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.517 ' O ' ' OG1' ' A' ' 74' ' ' THR . 9.2 t -62.06 -52.72 62.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 73' ' ' ILE . 43.6 tp -46.66 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.922 HG23 ' H ' ' A' ' 74' ' ' THR . 10.7 tt -43.69 -64.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.819 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.922 ' H ' HG23 ' A' ' 73' ' ' ILE . 16.6 p -35.18 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -83.93 -32.61 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.647 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.8 m95 -82.27 -2.64 53.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.598 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 77' ' ' VAL . 11.7 m -130.16 53.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.742 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -139.19 85.4 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.539 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.1 8.05 45.47 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -90.67 -171.36 3.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -1.149 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 154.76 18.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.94 -24.99 66.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.41 -28.44 66.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 -53.65 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.97 -25.84 22.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.128 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.73 40.87 2.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -151.01 -37.93 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -1.113 . . . . 0.0 108.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.6 pt -41.09 159.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.519 -0.738 . . . . 0.0 109.296 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.06 162.26 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.526 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -69.22 -25.2 64.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -66.21 -67.57 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.591 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 91' ' ' SER . 13.2 mm-40 -39.3 -60.63 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.8 mt -56.14 -28.68 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 91' ' ' SER . . . -77.42 -15.22 59.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 109.185 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.71 -18.51 21.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.66 -38.31 14.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -80.87 -0.8 40.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.553 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.527 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.3 tt0 37.12 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 109.37 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.7 ' N ' HD23 ' A' ' 99' ' ' LEU . 1.3 pt? -63.0 149.35 90.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.405 ' HG2' HG12 ' A' ' 102' ' ' VAL . 30.5 Cg_endo -67.17 152.82 79.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.685 2.257 . . . . 0.0 111.939 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.1 13.89 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.3 p -79.02 96.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 105' ' ' HIS . 7.0 mttm 67.31 58.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.212 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.3 0.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -0.818 . . . . 0.0 109.262 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.93 -53.95 45.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.637 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 87.6 m -30.96 -58.79 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.031 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -58.84 -56.22 25.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 107' ' ' SER . 44.9 mt -45.29 -51.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -49.63 -43.17 46.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.483 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.04 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -52.78 -40.0 62.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -25.45 68.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -72.11 -62.89 1.27 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -45.31 -36.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.157 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.3 tttt -73.31 -35.8 66.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 109.512 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.88 79.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.489 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -64.54 -38.07 89.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.9 mt -61.2 -38.01 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.66 81.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.716 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.2 -54.71 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.669 ' CD2' HG21 ' A' ' 47' ' ' VAL . 4.0 t80 -53.75 -32.08 50.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.762 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -81.04 -30.71 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.695 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.19 63.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.705 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.395 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.294 0.569 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 63.67 20.42 12.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.278 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.32 38.01 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.03 133.28 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.39 113.14 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -101.71 157.46 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.526 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.31 132.86 3.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.3 ttp -141.56 123.15 15.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -1.171 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.8 149.1 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 39' ' ' ASP . . . -133.06 170.17 22.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -125.61 146.47 54.91 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.354 -1.086 . . . . 0.0 109.278 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 37' ' ' CYS . 37.1 Cg_endo -69.36 -71.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.668 2.245 . . . . 0.0 112.056 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.59 -14.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.176 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 35' ' ' PRO . 1.8 t -117.11 -12.17 10.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.396 -0.815 . . . . 0.0 109.324 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 38.3 33.33 0.17 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' CYS . 39.0 t70 -101.63 148.36 25.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 109.595 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -121.29 97.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.7 ttt -86.98 119.62 27.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -109.14 101.43 10.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.422 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.74 148.48 28.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.67 132.0 25.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.253 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.738 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.5 pt -111.22 141.98 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -114.25 148.44 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.264 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.65 130.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 t0 -70.77 -54.56 11.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.268 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 160.82 -22.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.357 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -94.43 11.05 32.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.8 30.36 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 mm -125.07 138.23 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.96 103.09 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.161 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -75.43 -42.5 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.806 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 86.3 m-20 -143.29 157.93 44.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.763 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.98 137.23 25.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -105.53 141.56 36.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -124.62 163.21 22.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -171.85 109.01 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -161.05 119.63 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -149.56 103.58 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.91 -20.01 0.03 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.4 t -126.74 116.45 20.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -57.17 172.71 2.39 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER 64.63 -69.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -1.173 . . . . 0.0 109.538 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -38.37 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' SER . 1.6 mt -58.65 2.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -106.67 -32.31 8.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 73' ' ' ILE . 17.9 p -58.79 -45.62 89.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.458 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' SER . 35.0 p -53.73 -64.39 0.84 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' SER . 31.9 m -42.32 -45.64 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.914 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 75' ' ' GLU . 56.5 tp -65.41 -84.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.704 HG23 ' N ' ' A' ' 74' ' ' THR . 9.0 tt -33.68 -52.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.704 ' N ' HG23 ' A' ' 73' ' ' ILE . 29.8 p -53.17 -44.21 67.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 72' ' ' LEU . 11.0 tm-20 -78.93 2.18 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.238 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.7 -17.97 14.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.87 . . . . 0.0 109.636 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 114' ' ' ILE . 14.3 m -98.0 -28.17 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.37 128.3 35.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -20.58 28.63 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -91.51 164.53 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.287 -1.125 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -175.4 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.827 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.02 -27.24 60.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.35 -20.59 64.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.004 . . . . 0.0 109.159 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.75 -41.67 8.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.887 . . . . 0.0 109.314 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.61 8.92 15.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.62 -57.69 0.65 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.41 -4.38 29.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -1.146 . . . . 0.0 108.816 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.95 168.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.499 -0.751 . . . . 0.0 109.65 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.423 ' O ' HD12 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -153.67 -175.15 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -94.98 -6.55 42.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.16 56.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -66.61 -59.88 3.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.857 . . . . 0.0 109.327 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 89' ' ' LYS . 3.8 mt -47.24 -41.28 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -68.04 -46.69 70.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -54.21 -25.77 24.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.49 -52.23 7.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.875 . . . . 0.0 109.566 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.8 mt -81.88 -15.87 52.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.5 mm-40 43.36 14.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.843 ' N ' HD23 ' A' ' 99' ' ' LEU . 1.6 pt? -39.96 150.0 0.27 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -41.52 162.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.811 2.341 . . . . 0.0 112.097 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.0 Cg_endo -76.42 -49.56 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.865 2.376 . . . . 0.0 112.469 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.84 27.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' ND1' ' A' ' 105' ' ' HIS . 37.3 mttt -143.45 6.99 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.542 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 105' ' ' HIS . 10.2 p -68.92 -11.44 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.614 ' ND1' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -44.02 -57.38 3.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 105' ' ' HIS . 55.1 m -56.13 -35.1 66.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -51.25 70.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.231 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.549 HG22 ' OD2' ' A' ' 112' ' ' ASP . 61.0 mt -59.16 -36.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.629 ' CD1' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -59.85 -37.72 80.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.229 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -63.83 -51.21 65.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.326 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.24 -53.64 49.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' HG22 ' A' ' 108' ' ' ILE . 2.6 m-20 -48.84 -40.99 31.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.414 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.37 13.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.31 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 77' ' ' VAL . 1.4 tp -46.86 -33.68 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.266 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' C ' ' A' ' 116' ' ' ALA . 10.6 ttmm -67.38 -71.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -38.43 -44.96 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.738 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -53.31 -54.41 36.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.8 mt -54.54 -34.68 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.544 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.98 -56.92 8.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.48 -25.18 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -80.43 -69.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.45 -24.17 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.16 16.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.292 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.596 ' OD2' ' N ' ' A' ' 26' ' ' ASN . 1.1 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.389 0.614 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 24' ' ' ASP . 92.6 p -75.83 -11.29 59.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.596 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 32.9 m120 -116.44 25.09 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -147.37 107.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.384 -0.822 . . . . 0.0 109.222 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.25 143.83 17.59 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -120.27 132.58 55.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -1.083 . . . . 0.0 109.186 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.08 123.03 4.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttt -125.15 115.91 21.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -1.085 . . . . 0.0 109.117 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.4 166.28 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.77 165.31 31.53 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.1 152.74 65.71 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.237 . . . . 0.0 109.67 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.4 Cg_endo -77.09 -64.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.17 -45.76 2.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.656 ' HB2' ' CE1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -94.65 -4.82 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 109.232 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.0 41.37 0.45 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' CYS . 10.0 t70 -115.47 155.63 27.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -1.122 . . . . 0.0 109.761 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.61 105.68 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.18 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.471 ' HG3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -89.53 143.95 26.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.833 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 41' ' ' MET . 5.4 tt0 -129.23 110.04 11.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.125 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 44' ' ' GLN . 5.8 tt -121.97 132.34 54.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.492 ' N ' HD23 ' A' ' 43' ' ' LEU . 8.3 mp0 -124.04 177.96 5.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 44' ' ' GLN . 6.6 pt -154.86 151.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.617 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -114.64 163.6 15.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.348 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 4.9 t -132.5 107.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.545 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.71 -65.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 169.91 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.667 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -92.56 16.4 12.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.37 22.42 60.57 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.52 147.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.503 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.3 mt -82.35 112.99 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.9 -36.42 18.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.759 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.96 165.44 24.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.7 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.08 120.28 4.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -108.02 159.1 16.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD2' HG21 ' A' ' 74' ' ' THR . 2.8 p90 -163.34 162.16 24.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -171.44 119.47 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.342 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 41' ' ' MET . 17.0 p -116.66 102.39 9.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 0.0 109.531 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -109.54 113.49 26.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.37 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.79 -39.5 1.96 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.2 m -79.05 152.14 31.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -1.161 . . . . 0.0 109.574 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.47 38.6 2.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -167.66 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -1.137 . . . . 0.0 109.429 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.541 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -86.44 -36.71 18.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.541 ' C ' ' O ' ' A' ' 66' ' ' ALA . 4.9 mt -36.03 -48.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.74 -54.69 30.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 73' ' ' ILE . 97.1 p -62.0 -49.04 77.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.362 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -47.38 -46.59 26.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -61.59 -35.77 78.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 109.229 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.514 ' CD1' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -69.26 -68.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 69' ' ' SER . 5.9 tt -48.46 -47.57 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 70' ' ' SER . 23.1 p -49.24 -45.43 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.15 0.41 53.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.792 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -17.51 17.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.66 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 114' ' ' ILE . 17.8 m -111.75 10.76 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -85.56 103.48 14.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.99 40.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -97.34 -171.09 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.468 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -112.74 139.72 48.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.0 mt -53.09 -28.72 26.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.259 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.02 -30.09 68.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.02 -57.66 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.272 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.35 -17.6 3.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.198 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.45 49.5 0.86 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -172.69 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -1.096 . . . . 0.0 109.324 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -50.6 178.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -137.1 -168.28 2.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.332 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -103.5 -30.78 10.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -51.82 -33.69 36.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' ILE . 5.5 mt-30 -69.48 -66.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 1.8 mt -44.5 -40.8 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.64 -49.63 61.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.934 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.93 -24.41 23.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.532 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 72' ' ' LEU . 3.5 tt0 -82.11 -33.19 29.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.94 -15.07 35.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 48.62 73.41 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.236 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.027 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -129.2 139.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -42.5 146.88 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.55 -20.97 22.88 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.667 2.245 . . . . 0.0 112.126 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.88 -4.68 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.444 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -135.93 16.4 3.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.568 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.525 ' O ' ' C ' ' A' ' 105' ' ' HIS . 8.4 p -60.68 -14.96 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.755 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER -33.95 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.707 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.755 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 77.0 m -31.26 -58.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.539 -0.726 . . . . 0.0 110.121 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -50.39 -64.27 0.86 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 109.62 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 5.6 mt -42.27 -42.61 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.82 -32.98 74.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -59.71 -48.29 82.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.203 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.529 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 6.3 tp10 -68.91 -51.91 34.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.371 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -53.85 -28.78 38.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.12 -60.73 2.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.455 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -48.26 -33.85 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -76.41 -28.58 56.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -56.8 8.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -52.79 63.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.368 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -48.77 -38.84 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.92 66.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -77.2 -7.76 56.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.52 -38.58 6.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -71.88 -35.62 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.55 -22.26 62.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tptt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.389 179.975 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -72.7 10.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 24' ' ' ASP . 1.8 m120 -111.2 20.56 17.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 27' ' ' VAL . 45.1 t -137.7 90.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.639 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.43 145.95 48.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 m -135.27 108.86 7.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -1.124 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 117' ' ' ALA . . . -105.82 150.29 16.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 ttm -144.45 127.18 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.357 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.28 161.38 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.48 164.86 18.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB2' HD22 ' A' ' 109' ' ' LEU . . . -136.89 85.69 22.82 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.149 -1.206 . . . . 0.0 109.854 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.08 -20.3 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.712 2.275 . . . . 0.0 111.94 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.42 -53.51 23.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.174 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -103.84 17.84 23.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.198 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.86 55.08 1.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 61' ' ' TYR . 40.6 t0 -126.65 146.37 50.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -1.163 . . . . 0.0 109.713 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.36 113.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 ttt -99.86 134.3 42.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.37 128.97 46.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -129.58 142.85 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.22 150.33 47.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.145 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.05 148.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.943 . . . . 0.0 109.705 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -114.74 120.93 41.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -103.96 127.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' CG ' ' N ' ' A' ' 49' ' ' ASP . 2.9 t0 -62.89 -94.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.609 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 4.8 t70 -154.22 24.43 0.48 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 14.71 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 25.24 57.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mm -108.69 130.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.582 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -88.45 102.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.195 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.38 -46.64 14.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.58 141.97 51.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.22 129.15 42.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -101.22 164.01 12.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD1' HG21 ' A' ' 74' ' ' THR . 30.2 p90 -156.8 162.73 39.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.574 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.22 98.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.75 138.44 32.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -157.04 123.84 5.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.319 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.05 -61.71 0.36 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 t -84.21 134.39 34.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.712 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.39 20.0 6.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -27.75 6.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.129 . . . . 0.0 109.361 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.27 7.85 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mm -77.9 -40.34 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.835 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.88 -45.25 17.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 109.656 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' ILE . 75.2 m -53.15 -49.34 66.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.562 ' OG ' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -34.35 -66.83 0.15 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.841 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.562 ' N ' ' OG ' ' A' ' 70' ' ' SER . 66.1 m -55.44 -40.44 71.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 73' ' ' ILE . 4.4 tp -60.2 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.933 . . . . 0.0 109.843 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.836 HG23 ' H ' ' A' ' 74' ' ' THR . 5.6 tt -36.44 -62.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.958 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.836 ' H ' HG23 ' A' ' 73' ' ' ILE . 56.8 p -40.34 -39.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mm-40 -86.07 -15.39 41.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.552 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.57 -5.43 55.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 109.688 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.32 20.75 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 109.607 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -96.53 87.97 4.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.66 -3.82 7.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -89.16 167.71 12.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -1.127 . . . . 0.0 109.392 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.55 176.05 5.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.86 -21.34 66.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.575 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -70.55 -40.93 73.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -79.63 -51.01 9.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.706 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.51 63.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 109.408 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.95 26.0 25.21 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.8 18.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 109.202 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.467 HD11 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -79.95 171.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.414 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -136.19 140.57 43.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 108' ' ' ILE . 11.4 p30 -68.36 -23.1 64.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -56.24 -36.35 68.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -73.54 -59.01 2.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 109.735 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mt -46.77 -40.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -73.73 -42.6 60.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 109.836 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.567 ' OE1' ' O ' ' A' ' 95' ' ' GLU . 2.6 tm-20 -57.6 -30.35 65.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.03 -39.44 29.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.003 . . . . 0.0 109.716 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -95.35 -5.04 44.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.698 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 94' ' ' ALA . 17.6 tp10 41.17 44.68 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 151.26 87.89 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.641 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.03 109.41 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.954 2.436 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 103' ' ' LYS . 65.3 Cg_endo -79.79 -79.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.699 2.266 . . . . 0.0 112.129 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.518 HG23 ' C ' ' A' ' 101' ' ' PRO . 0.4 OUTLIER 53.65 -76.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 101' ' ' PRO . 9.3 mtpp -118.3 -6.21 10.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 108' ' ' ILE . 17.3 t 47.38 60.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.358 -0.839 . . . . 0.0 109.56 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.502 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 12.3 p80 -91.31 -38.75 12.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 1.9 m -71.41 -67.68 0.5 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -37.43 -65.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.307 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.591 ' N ' ' OG ' ' A' ' 107' ' ' SER . 3.3 mt -44.71 -43.08 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.82 HD22 ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -59.95 -37.99 81.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -57.79 -55.67 31.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 114' ' ' ILE . 2.8 tm-20 -57.1 -60.82 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.65 -31.43 2.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 109.031 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -61.2 -53.24 59.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 108.98 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp -49.74 -39.93 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 108.785 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.492 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -73.01 -22.11 60.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.47 -0.769 . . . . 0.0 109.308 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -71.01 -60.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.408 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . -58.62 -34.65 71.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.344 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.23 -43.76 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.0 91.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.89 -26.02 65.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -66.37 -65.06 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -25.37 60.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.96 80.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 mptt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.847 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.09 -4.52 29.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.702 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -124.08 20.85 9.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.11 92.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.91 22.43 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -135.12 148.56 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.244 . . . . 0.0 109.862 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.48 140.43 10.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttm -133.86 113.16 11.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.49 149.69 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.93 -178.56 15.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.711 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -148.07 135.52 10.64 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.347 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.31 -38.2 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.458 2.106 . . . . 0.0 112.269 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -60.77 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLY . 20.7 m -87.88 2.44 51.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.16 46.1 3.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.665 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -116.11 148.29 40.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -1.127 . . . . 0.0 109.782 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -110.09 116.46 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.444 ' CE ' HD13 ' A' ' 43' ' ' LEU . 12.9 ttt -105.91 123.27 47.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -112.2 98.41 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.444 HD13 ' CE ' ' A' ' 41' ' ' MET . 8.7 tp -93.7 137.07 33.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.729 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -131.57 123.56 28.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.366 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.467 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.9 pt -105.97 156.26 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.512 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' A' ' 54' ' ' GLU . 7.3 tttm -128.36 149.63 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.38 149.37 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.513 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.5 -96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.82 17.5 0.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -130.83 -25.76 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.673 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.32 9.93 3.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -100.1 133.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 0.0 109.436 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.2 mt -76.26 110.6 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.211 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -87.32 -39.0 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.576 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.37 170.3 16.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.81 120.97 2.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -96.02 161.22 14.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.322 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 4.6 p90 -150.32 170.49 18.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 4.8 tttt -172.06 97.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.735 HG21 ' OG ' ' A' ' 70' ' ' SER . 70.6 p -110.23 104.45 13.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.425 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 100.43 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.578 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' CA ' ' OD2' ' A' ' 39' ' ' ASP . . . 148.73 -43.96 0.77 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.665 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.6 m -88.77 105.53 17.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.94 63.14 4.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.47 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.144 -1.209 . . . . 0.0 109.371 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . . . -98.03 -15.96 19.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 68' ' ' ALA . 4.2 mt -42.15 -80.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -34.38 -56.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.674 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -45.35 -58.11 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.735 ' OG ' HG21 ' A' ' 60' ' ' THR . 46.1 m -48.2 -37.96 17.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.882 . . . . 0.0 109.438 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.8 t -70.04 -33.53 72.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 109.411 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 75' ' ' GLU . 30.0 tp -67.31 -68.78 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -41.51 -45.73 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.226 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' SER . 22.6 p -58.72 -33.59 70.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.284 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.4 tt0 -83.19 -5.1 59.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.434 ' HE1' HD11 ' A' ' 72' ' ' LEU . 17.7 m0 -98.72 -26.59 14.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG11 HD11 ' A' ' 114' ' ' ILE . 8.2 m -94.73 -3.13 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.978 . . . . 0.0 109.796 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -81.88 107.72 14.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.46 -21.66 30.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -84.48 178.78 7.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.122 -1.222 . . . . 0.0 109.571 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.96 172.19 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.32 -28.37 62.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 -24.24 66.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 109.21 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.8 -52.66 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.03 -36.77 68.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.349 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.35 48.41 4.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.51 -37.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.162 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -37.74 161.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -130.4 170.94 13.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.529 ' OD1' HD13 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -85.27 -15.17 44.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -59.11 -39.59 82.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -71.46 -52.89 15.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.6 mt -54.72 -41.38 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.83 -29.53 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.76 -42.06 61.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.44 -24.28 60.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.806 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.13 -36.46 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.024 -1.047 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 94' ' ' ALA . 3.5 mt-10 62.32 18.27 10.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.249 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.716 ' N ' HD23 ' A' ' 99' ' ' LEU . 1.9 pt? -48.46 149.72 2.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.0 154.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.266 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 104' ' ' VAL . 45.9 Cg_endo -72.48 -74.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.824 2.349 . . . . 0.0 112.091 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER 43.01 46.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.2 OUTLIER 76.36 10.39 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER 35.92 27.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.711 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.29 -36.22 83.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.366 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 68.9 m -55.5 -65.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.572 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.8 t -53.84 -57.11 12.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.529 HD13 ' OD1' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -47.02 -32.32 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.577 HD13 ' HD1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -70.01 -37.51 75.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.3 88.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.033 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.25 -53.88 21.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 109.273 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -54.13 -23.78 15.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.379 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.06 -50.74 21.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 109.222 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.702 HD11 HG11 ' A' ' 77' ' ' VAL . 1.2 tp -51.6 -39.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 108.963 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 8.4 mttm -74.03 -49.7 23.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.389 -0.819 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -44.98 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -69.53 -59.77 2.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 108.99 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.5 mt -41.06 -38.6 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.021 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.81 -57.84 10.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.052 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -50.71 -32.67 20.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.18 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.87 -60.19 4.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.489 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.55 -44.0 97.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.45 -53.87 32.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.369 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t0 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -71.36 -1.7 13.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.49 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.416 ' C ' HG23 ' A' ' 27' ' ' VAL . 49.2 m-20 -105.19 18.02 23.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.354 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 26' ' ' ASN . 73.6 t -152.94 97.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.515 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.93 150.96 28.34 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -127.57 150.45 49.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.42 126.49 3.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -129.4 123.49 31.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.56 165.86 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.77 165.93 27.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -137.39 132.61 17.85 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.195 -1.18 . . . . 0.0 109.527 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.33 -38.07 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.51 2.14 . . . . 0.0 111.948 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -56.87 11.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.245 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.72 -4.57 54.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.69 47.68 30.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 1.2 t0 -122.19 139.23 54.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -1.106 . . . . 0.0 109.581 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 20.5 m -92.95 123.13 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.858 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 42' ' ' GLN . 2.8 ttt -113.92 144.59 42.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' N ' ' HG3' ' A' ' 41' ' ' MET . 22.1 tt0 -149.29 120.04 7.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.22 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.39 130.85 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -123.73 155.14 38.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -0.909 . . . . 0.0 109.111 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.38 137.9 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -102.48 147.21 27.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.418 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.62 126.52 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.6 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' C ' ' OD1' ' A' ' 48' ' ' ASP . 30.2 t0 -63.29 -96.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 109.416 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -160.0 23.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.92 19.9 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 7.28 88.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.7 mm -99.84 155.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 109.447 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mt -99.08 109.83 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.05 -41.29 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.674 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 11.2 p-10 -157.62 167.59 29.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.66 129.89 41.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.342 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -95.2 125.63 39.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -114.58 157.67 22.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -166.13 99.24 0.63 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 60' ' ' THR . 12.5 t -164.41 113.35 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.517 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 60' ' ' THR . 21.6 m-85 -137.53 102.97 4.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.97 -7.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 66' ' ' ALA . 1.1 m -90.75 178.78 5.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.329 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.41 -11.8 14.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -141.43 -16.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.155 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . . . -79.99 -9.64 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 68' ' ' ALA . 1.7 tt -67.69 -40.85 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.652 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.512 ' N ' HG23 ' A' ' 67' ' ' ILE . . . -76.55 -28.76 56.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.657 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.7 p -60.14 -58.63 7.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' THR . 0.9 OUTLIER -34.8 -48.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.74 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -65.15 -46.85 79.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -63.53 -73.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.755 HG23 ' N ' ' A' ' 74' ' ' THR . 14.7 tt -39.22 -56.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.755 ' N ' HG23 ' A' ' 73' ' ' ILE . 22.1 p -46.87 -46.1 20.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.78 -13.9 62.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.633 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.41 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 m0 -89.64 -31.38 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.01 32.15 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.689 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.94 102.14 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.59 8.67 57.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -92.28 -175.81 4.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.64 149.09 24.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.494 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.18 -19.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.144 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -51.81 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ALA . 3.7 mt-10 -68.05 -55.94 10.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.96 -44.26 9.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.96 52.8 4.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -167.2 -46.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -1.15 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -36.1 158.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.429 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -121.84 168.36 11.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 7.5 p30 -82.83 -20.21 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.5 p -52.26 -40.76 62.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' ILE . 1.7 mm-40 -67.13 -70.93 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 92' ' ' GLN . 22.0 mt -41.57 -39.7 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.42 -53.05 40.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -47.98 -47.54 32.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -38.54 82.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.7 mt -79.66 -26.55 40.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 98' ' ' GLU . 2.7 tm-20 50.91 66.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.708 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 1.047 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.9 pt? -112.44 145.26 32.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.54 153.18 62.95 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.47 11.19 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.878 2.386 . . . . 0.0 112.259 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.569 HG13 ' HG2' ' A' ' 103' ' ' LYS . 8.0 p -82.78 2.04 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.569 ' HG2' HG13 ' A' ' 102' ' ' VAL . 0.6 OUTLIER 179.9 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 105' ' ' HIS . 6.2 p -72.1 -8.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.695 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -39.45 -55.75 1.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.695 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 62.0 m -31.16 -59.38 0.23 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.44 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 5.9 p -61.87 -55.63 27.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.984 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.44 ' N ' ' OG ' ' A' ' 107' ' ' SER . 1.6 mm -45.88 -53.85 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.51 -41.8 61.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 109.942 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.27 -65.12 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 109.671 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 11.7 tt0 -54.29 -41.85 69.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.5 -28.6 68.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.33 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -48.85 -38.05 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 1.1 mmtt -71.44 -31.46 67.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.304 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.94 67.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.63 87.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.393 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.12 -46.95 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.261 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.31 76.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -34.28 72.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.624 ' CE2' ' O ' ' A' ' 25' ' ' SER . 3.7 t80 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.953 . . . . 0.0 109.652 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -33.24 27.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.743 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 4.86 9.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.504 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 26' ' ' ASN . 37.3 t0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.3 OUTLIER 48.08 9.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.237 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 24' ' ' ASP . 61.3 m-20 -117.62 0.7 12.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.39 114.41 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.375 -0.828 . . . . 0.0 109.47 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.83 127.58 11.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.0 m -108.0 140.21 41.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -1.132 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.9 129.57 4.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 ttm -126.53 100.71 6.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -1.12 . . . . 0.0 109.35 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.1 m -117.11 170.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.12 167.42 39.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -136.97 139.33 28.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 38' ' ' GLY . 48.5 Cg_endo -72.93 -59.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.596 2.198 . . . . 0.0 112.259 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.07 -42.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 1.2 m -98.18 -4.49 35.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 41.84 45.76 4.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.671 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 54.3 t0 -120.07 131.17 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -1.092 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 40' ' ' VAL . 8.5 p -104.05 118.42 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.226 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.4 ttt -115.26 153.59 30.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -133.74 121.13 21.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -108.54 112.32 24.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.889 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -114.94 121.69 43.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.33 137.59 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -99.39 123.94 44.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.1 t -118.93 135.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 6.2 t70 -62.82 -59.99 4.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 167.08 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 0.0 109.125 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.72 -22.36 29.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.254 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.57 7.73 5.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.75 132.72 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -1.118 . . . . 0.0 109.434 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 54' ' ' GLU . 16.4 mt -84.28 84.57 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.708 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.9 OUTLIER -43.61 -53.14 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 108.863 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -143.53 -177.22 5.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.1 132.55 4.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -108.69 156.75 19.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.842 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.728 ' CD1' HG21 ' A' ' 74' ' ' THR . 12.5 p90 -139.52 170.6 15.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.958 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -167.72 98.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.38 116.88 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -149.17 96.79 2.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.84 -12.09 0.08 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.671 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.8 m -96.78 168.54 10.44 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.247 -1.149 . . . . 0.0 109.358 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.38 44.14 1.43 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.49 -3.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 109.552 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -97.23 -22.86 16.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.077 ' H ' HD12 ' A' ' 67' ' ' ILE . 3.5 mp -36.8 -36.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -83.17 -57.62 3.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -42.33 -50.59 5.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -36.07 -56.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' OG ' ' A' ' 70' ' ' SER . 7.0 m -64.12 -36.58 84.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 75' ' ' GLU . 8.6 tp -65.46 -79.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 77' ' ' VAL . 7.8 tt -34.93 -41.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 109.74 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.728 HG21 ' CD1' ' A' ' 58' ' ' PHE . 6.6 p -68.25 -35.97 78.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.726 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 72' ' ' LEU . 3.3 mt-10 -85.57 -1.98 57.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -100.99 -23.69 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 73' ' ' ILE . 33.8 m -115.39 50.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.88 . . . . 0.0 109.228 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -120.15 100.46 7.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.699 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.39 77.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -169.97 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -1.17 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.8 173.08 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mt -65.35 -28.03 69.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.57 -19.6 64.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.96 -31.18 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.36 40.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.625 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.69 54.66 0.84 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.9 pt -39.17 -26.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.9 ttmm 49.49 179.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' GLN . 31.5 p-10 -96.27 -55.61 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.1 m -38.27 -24.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.751 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 90' ' ' ASN . 27.5 tt0 -79.29 -52.94 7.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 5.4 tt -59.48 -40.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.273 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -63.52 -46.37 86.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.269 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -37.65 79.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.065 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.88 -37.7 84.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.237 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.28 -20.36 59.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.268 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 67.67 10.26 7.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.1 152.67 92.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.476 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.0 165.74 25.26 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.861 2.374 . . . . 0.0 112.271 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.01 -41.58 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.88 2.387 . . . . 0.0 112.275 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.7 p -45.18 102.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 102' ' ' VAL . 11.0 ttmt 84.53 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 107' ' ' SER . 13.9 p -83.8 -2.73 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.693 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -38.45 -59.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.456 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.693 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 96.5 m -33.26 -48.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.518 ' HB2' HG22 ' A' ' 104' ' ' VAL . 71.0 m -65.14 -60.62 2.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 97.3 mt -42.8 -40.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 109.071 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.535 HD22 ' HE1' ' A' ' 105' ' ' HIS . 0.9 OUTLIER -57.06 -63.56 1.17 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -36.24 -45.42 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.548 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 4.5 tp10 -64.76 -55.78 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.682 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.32 -19.62 23.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 43' ' ' LEU . . . -72.99 -50.27 24.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -31.42 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.165 -0.959 . . . . 0.0 109.362 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -55.5 8.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.7 -52.37 11.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.724 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -59.37 -65.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 117' ' ' ALA . 6.2 mt -36.76 -33.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.086 -1.009 . . . . 0.0 109.65 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 121' ' ' TYR . . . -76.39 -64.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -0.983 . . . . 0.0 109.739 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.531 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 9.4 t0 -52.5 -2.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.562 ' H ' ' C ' ' A' ' 119' ' ' ALA . 69.4 t80 -98.19 -56.96 2.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.52 -26.97 65.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.61 71.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.522 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.354 0.597 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -96.41 9.67 40.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.16 0.58 7.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.88 103.08 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.712 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.56 155.92 34.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 44' ' ' GLN . 67.7 m -136.76 126.92 26.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.247 . . . . 0.0 109.958 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 117' ' ' ALA . . . -109.59 123.25 6.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.7 ttt -130.56 126.58 37.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.14 -1.212 . . . . 0.0 109.851 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.33 -174.34 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 109.026 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.21 144.55 8.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -111.21 132.58 21.67 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.358 -1.083 . . . . 0.0 109.225 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.0 Cg_endo -75.38 -53.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.547 2.165 . . . . 0.0 112.342 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.72 -47.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.7 p -114.48 11.3 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.59 62.28 0.97 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -116.26 117.4 29.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.6 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 40' ' ' VAL . 14.1 p -87.46 119.33 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.555 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.3 ttt -111.4 122.41 47.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 109.659 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -119.44 99.04 6.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 74' ' ' THR . 7.5 tp -101.34 127.98 47.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.583 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -115.72 125.44 52.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -114.75 118.75 34.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.09 142.23 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.559 ' OD2' ' O ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -89.02 -96.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.714 ' OD1' ' ND2' ' A' ' 50' ' ' ASN . 3.7 p30 -153.52 19.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.714 ' ND2' ' OD1' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -145.67 43.86 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.63 31.94 30.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.0 mm -122.11 131.22 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.73 109.8 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.162 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -70.71 -23.57 62.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.851 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -169.91 157.73 6.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.035 . . . . 0.0 109.885 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.74 137.67 43.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.222 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 19.3 mttp -101.45 137.49 39.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.735 ' HB3' HG21 ' A' ' 74' ' ' THR . 23.8 p90 -116.7 137.17 52.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.09 85.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' CD1' ' A' ' 61' ' ' TYR . 1.4 t -143.04 138.54 30.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.434 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -160.79 125.83 3.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.364 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.13 -64.71 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.46 142.55 27.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' A' ' 66' ' ' ALA . . . -76.5 168.35 54.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.26 -32.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -1.108 . . . . 0.0 109.528 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . -67.0 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.31 -72.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 109.425 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.3 -48.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.35 -33.72 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.377 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 67' ' ' ILE . 40.3 t -67.21 -64.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 70' ' ' SER . 7.7 p -43.41 -27.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.083 -1.011 . . . . 0.0 109.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.534 ' O ' ' C ' ' A' ' 73' ' ' ILE . 7.4 tp -78.12 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.863 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.534 ' C ' ' O ' ' A' ' 72' ' ' LEU . 8.4 tt -34.89 -41.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.667 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.735 HG21 ' HB3' ' A' ' 58' ' ' PHE . 74.7 p -61.61 -51.14 69.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 72' ' ' LEU . 14.3 tt0 -70.29 -5.34 27.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -88.94 -30.79 18.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.57 6.09 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -74.21 112.51 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.704 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.63 -9.13 77.2 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.18 -170.97 3.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 109.587 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.34 164.41 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.422 HD22 HG12 ' A' ' 118' ' ' ILE . 27.9 mt -59.51 -24.55 63.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -59.76 -48.05 83.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.93 -36.71 75.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.519 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.55 -26.01 66.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.53 44.62 1.44 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.29 -33.85 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -35.84 -47.76 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 65.17 142.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -66.12 -34.69 78.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.3 p -49.32 -41.28 38.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -58.57 -49.27 78.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.09 -35.36 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.01 -18.77 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.75 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.47 -34.76 17.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.858 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.33 -25.45 25.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.957 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -105.61 -8.8 17.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.66 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' LEU . 23.8 mp0 44.79 15.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.482 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.1 pp -41.61 148.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.539 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.7 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.816 2.344 . . . . 0.0 112.305 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 103' ' ' LYS . 60.9 Cg_endo -82.72 9.62 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.73 2.287 . . . . 0.0 112.228 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.9 m -46.4 -8.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.933 . . . . 0.0 109.338 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.654 ' N ' ' O ' ' A' ' 101' ' ' PRO . 2.7 tttm -172.55 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.863 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.5 63.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.457 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.511 ' CD2' ' H ' ' A' ' 105' ' ' HIS . 15.5 p80 -96.86 -57.12 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.505 ' H ' ' CG ' ' A' ' 105' ' ' HIS . 2.2 m -57.59 -40.59 79.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -63.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -47.4 -31.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -62.87 -50.68 69.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.021 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.37 -43.61 61.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.9 . . . . 0.0 108.929 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.9 -58.41 7.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.204 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 24.8 t0 -50.17 -28.91 8.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.645 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -68.67 -69.99 0.29 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.9 tp -38.37 -40.94 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.487 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.6 mmtm -72.64 -29.12 63.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.29 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.645 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.0 -48.23 71.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' HB2' ' N ' ' A' ' 30' ' ' GLY . . . -64.16 -46.73 82.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.205 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.422 HG12 HD22 ' A' ' 82' ' ' LEU . 67.5 mt -54.62 -44.5 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.37 85.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -57.73 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -45.86 -41.58 11.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' O ' ' C ' ' A' ' 123' ' ' ALA . 4.4 tttm -66.95 -45.55 77.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -36.98 -39.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.328 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.379 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.7 t70 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 77.7 -8.42 1.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.456 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -176.83 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.4 t -124.75 99.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.11 139.76 15.4 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -138.95 122.57 17.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.4 148.37 16.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 tpt -145.48 126.67 14.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 109.6 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 m -145.8 155.93 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.337 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.0 159.16 24.54 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -132.35 142.4 44.81 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.294 -1.121 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.522 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.3 Cg_endo -75.31 -51.45 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.673 2.249 . . . . 0.0 112.065 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.35 -49.75 1.0 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 109.217 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 50.6 m -102.8 -8.93 20.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.36 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.77 45.68 55.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -120.31 152.31 37.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -1.133 . . . . 0.0 109.591 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.7 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.386 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 ttt -91.47 143.39 26.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -132.57 126.0 31.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.223 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.41 130.76 56.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.769 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -125.8 112.82 16.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.066 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.525 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -107.02 141.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.646 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 1.7 mptt -113.03 137.63 51.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.34 145.04 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 10.4 p-10 -82.75 -96.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.578 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -155.81 16.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.32 4.84 2.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.77 20.31 31.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.7 mm -106.88 146.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -1.14 . . . . 0.0 109.353 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' O ' HG22 ' A' ' 53' ' ' ILE . 23.2 mm -85.87 84.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.688 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -44.87 -54.91 5.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.116 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 161.61 41.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.104 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.37 115.7 12.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 109.887 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -96.43 141.23 29.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 108.93 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CD1' HG21 ' A' ' 74' ' ' THR . 28.1 p90 -137.57 176.3 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.998 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 124.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -160.53 133.57 6.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 15.4 p90 -150.83 125.67 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.45 -42.64 1.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 1.1 m -79.88 142.61 35.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.552 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.81 -5.01 57.73 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.47 -2.81 13.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -91.78 -41.05 10.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.576 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' ALA . 65.6 mt -41.91 -44.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.99 -48.52 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.5 m -67.63 -66.04 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.542 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 69' ' ' SER . 17.9 m -35.7 -41.34 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 20.4 t -68.22 -41.38 81.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -64.64 -65.28 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.573 ' O ' HG22 ' A' ' 77' ' ' VAL . 13.0 tt -41.08 -46.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.938 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.677 HG21 ' CD1' ' A' ' 58' ' ' PHE . 17.2 p -55.58 -44.87 77.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.972 . . . . 0.0 109.699 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.73 -34.8 64.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.065 -1.022 . . . . 0.0 109.677 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.02 -13.56 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 73' ' ' ILE . 6.0 m -121.94 22.38 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -98.85 117.58 33.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.67 5.61 69.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -84.71 -163.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.7 m -116.2 155.91 27.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 109.568 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 82' ' ' LEU . 46.7 mt -59.55 -17.52 33.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.524 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.93 -50.44 14.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.469 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.665 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -66.21 -39.36 89.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -37.1 67.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.37 41.63 3.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -156.32 -37.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -1.154 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 84' ' ' GLU . 5.3 pt -42.06 163.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.385 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -126.88 -173.07 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -100.95 -13.85 18.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -21.81 61.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.277 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.22 -58.97 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.346 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.7 -38.74 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.52 65.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -86.13 -21.36 27.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.75 -48.11 10.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 98' ' ' GLU . 5.4 mt -90.16 -11.23 41.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.877 . . . . 0.0 109.505 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 mt-10 41.67 68.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.662 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.73 150.29 43.76 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.176 -0.953 . . . . 0.0 109.311 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -44.1 147.35 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.567 2.178 . . . . 0.0 112.032 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -69.71 -44.57 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.684 2.256 . . . . 0.0 112.157 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 102' ' ' VAL . 1.7 p -60.0 -2.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -143.04 36.33 1.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 105' ' ' HIS . 5.2 p -84.49 -15.54 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.292 -0.88 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.633 ' C ' ' ND1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -42.43 -44.68 4.11 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 0.0 109.097 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.553 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 57.3 m -40.15 -54.58 2.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 109.836 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 108' ' ' ILE . 96.0 p -64.95 -56.02 15.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.2 mt -43.53 -40.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.125 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.514 HD13 ' HD1' ' A' ' 105' ' ' HIS . 1.2 mp -64.75 -47.84 76.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.101 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -42.18 -48.98 4.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.141 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.13 -35.03 79.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.62 -33.42 74.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.947 . . . . 0.0 109.859 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.32 -47.24 74.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.5 tp -58.98 -39.16 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.183 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.427 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.2 ttmt -70.34 -50.87 34.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.52 -32.17 66.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.0 109.384 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -64.93 -58.11 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.216 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -55.55 -48.2 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.95 -36.02 59.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD1' ' NZ ' ' A' ' 124' ' ' LYS . 5.3 t0 -72.59 -55.21 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.466 ' C ' ' O ' ' A' ' 120' ' ' ASP . 22.2 t80 -39.59 -56.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.62 -28.56 67.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -61.0 -46.05 92.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 120' ' ' ASP . 33.6 mmtm . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.534 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 0.3 OUTLIER -72.31 -16.3 61.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.491 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.822 ' ND2' HG23 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -65.11 1.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.822 HG23 ' ND2' ' A' ' 26' ' ' ASN . 79.1 t -135.71 95.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.15 27.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.6 m -105.11 109.89 22.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -1.044 . . . . 0.0 109.328 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.61 91.13 0.76 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -93.92 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -1.22 . . . . 0.0 109.498 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -158.46 173.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' CA ' HD21 ' A' ' 109' ' ' LEU . . . 176.7 159.78 22.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.82 43.72 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.0 Cg_endo -74.82 -56.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.646 2.231 . . . . 0.0 112.381 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -42.52 -36.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -102.4 2.59 36.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.68 52.02 1.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' CB ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -131.11 143.56 50.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.134 . . . . 0.0 109.578 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.73 114.59 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.064 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.1 ttt -108.81 139.02 44.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.895 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -122.66 125.02 44.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.062 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tt -121.04 138.67 54.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.806 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.13 136.95 42.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.61 132.17 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HG3' HD22 ' A' ' 26' ' ' ASN . 16.6 tttp -106.68 135.18 48.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.436 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -114.98 151.33 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.893 . . . . 0.0 109.527 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.46 -106.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -142.1 15.58 2.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.38 -4.24 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.545 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.74 4.73 51.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 mm -94.68 136.47 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.2 115.52 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.72 -39.87 12.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -139.91 -179.25 5.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.952 . . . . 0.0 109.576 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.98 140.88 3.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.81 144.62 44.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.806 ' CG ' HG21 ' A' ' 74' ' ' THR . 0.4 OUTLIER -142.39 150.33 40.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 109.603 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' CG ' ' C ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -154.67 95.89 1.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 148.89 47.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -160.96 154.39 21.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.286 -0.884 . . . . 0.0 109.366 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.4 -53.31 0.7 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CB ' ' A' ' 39' ' ' ASP . 9.0 m -76.11 109.46 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.54 43.83 0.35 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' CYS . 0.3 OUTLIER -163.72 -6.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.456 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.41 ' H ' ' H ' ' A' ' 65' ' ' SER . . . -84.57 -38.79 19.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 67' ' ' ILE . 7.2 mm -47.67 -49.36 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.21 -68.34 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.317 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.82 -34.33 2.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.455 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.1 t -64.75 -74.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.963 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 70' ' ' SER . 66.5 m -36.27 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.553 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' SER . 22.2 tp -76.03 -85.37 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 77' ' ' VAL . 1.1 tt -36.99 -33.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.806 HG21 ' CG ' ' A' ' 58' ' ' PHE . 9.7 p -66.99 -46.65 73.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 71' ' ' SER . 2.2 mt-10 -78.23 -7.84 57.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.31 -30.02 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 73' ' ' ILE . 4.8 m -91.67 11.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -87.08 89.83 8.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.38 -14.64 15.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.54 -168.26 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -1.13 . . . . 0.0 109.565 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -119.99 -179.2 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.37 -34.07 65.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -68.89 -11.01 60.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.607 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.85 -49.58 4.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.569 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.8 -26.17 62.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.537 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.3 46.37 1.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -164.05 -38.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -1.127 . . . . 0.0 109.169 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' ALA . 5.2 pt -44.9 166.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 109.466 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -132.7 -179.12 5.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.75 -19.34 24.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.365 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -62.73 -42.13 99.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.06 -60.6 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.176 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.5 mt -51.53 -42.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.895 . . . . 0.0 109.186 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -59.55 -35.14 73.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.195 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.61 -38.71 73.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.88 . . . . 0.0 109.104 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.3 -47.74 80.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.363 -0.835 . . . . 0.0 109.369 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.79 -16.63 21.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.619 ' N ' ' O ' ' A' ' 94' ' ' ALA . 25.8 tt0 45.03 72.93 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.39 150.26 36.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -39.09 141.36 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.961 2.44 . . . . 0.0 112.31 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 103' ' ' LYS . 66.5 Cg_endo -76.89 -15.02 16.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.759 2.306 . . . . 0.0 112.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.73 25.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HZ3' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -170.69 34.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.438 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 105' ' ' HIS . 38.6 t -57.46 -27.48 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.676 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -34.86 -62.14 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.308 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.676 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 38.6 m -37.61 -51.46 1.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.604 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -55.28 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mt -46.65 -40.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.863 . . . . 0.0 109.35 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 ' ND1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -62.72 -37.83 88.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.279 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.31 -58.53 8.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.506 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 112' ' ' ASP . 3.9 tm-20 -58.76 -43.43 90.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.596 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.503 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -60.93 -29.79 69.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.88 -57.22 7.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -51.24 -35.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.506 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -74.28 -48.06 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -55.8 -50.71 69.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.5 -53.73 50.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -58.34 -20.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -77.48 -47.37 19.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.193 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.99 -10.52 59.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.549 ' CE1' ' NZ ' ' A' ' 124' ' ' LYS . 1.9 t80 -91.31 -49.8 6.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.303 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -66.61 -23.62 66.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 0.0 109.203 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.534 ' O ' ' C ' ' A' ' 124' ' ' LYS . . . -68.72 -1.75 7.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.549 ' NZ ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -81.11 -3.4 51.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.39 7.2 26.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.618 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.35 114.74 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.8 138.87 14.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -125.25 114.38 18.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.561 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.12 16.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.83 124.8 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.16 -1.2 . . . . 0.0 109.665 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.56 151.08 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.148 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.05 10.28 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' N ' ' A' ' 39' ' ' ASP . . . -146.56 92.65 5.08 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.29 70.87 7.32 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.755 2.303 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.53 -38.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.365 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . 6.6 t -165.48 -38.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.772 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -62.53 -49.23 75.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.5 t70 84.81 -174.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.65 99.17 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.855 . . . . 0.0 109.25 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.8 ttp -95.73 139.82 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -119.65 107.34 13.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.116 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.13 127.49 52.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.837 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -130.34 120.55 24.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 108.974 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.78 152.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.827 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 47' ' ' VAL . 24.1 tttt -114.84 154.75 28.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 109.284 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 64.5 t -133.25 121.71 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD1' ' OE1' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -47.63 -53.67 14.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 162.01 -23.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.859 . . . . 0.0 109.252 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -0.74 57.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.44 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.85 8.67 41.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.31 138.63 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.161 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.8 mt -96.83 124.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.301 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.551 ' OE1' ' OD1' ' A' ' 48' ' ' ASP . 19.1 pt-20 -107.65 -30.08 8.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.56 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -124.87 150.36 46.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.08 155.16 42.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 109.588 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 58' ' ' PHE . 1.2 tttm -150.49 143.31 24.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.691 ' CD1' HG21 ' A' ' 74' ' ' THR . 4.5 p90 -138.86 -179.38 5.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -171.32 104.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 t -136.85 144.63 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.589 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.535 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 53.3 t80 -155.0 98.57 2.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 0.7 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -100.71 123.93 45.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 0.0 109.337 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -91.94 123.03 7.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER 72.61 -8.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.18 . . . . 0.0 109.536 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HB3' ' SG ' ' A' ' 63' ' ' CYS . . . -96.44 7.69 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mt -72.99 -38.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -41.95 75.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p -56.8 -38.82 73.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 58' ' ' PHE . 17.5 t -53.47 -46.06 69.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -35.11 79.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.32 -56.27 22.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.949 ' O ' HG22 ' A' ' 77' ' ' VAL . 3.8 tt -58.52 -48.58 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.76 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.691 HG21 ' CD1' ' A' ' 58' ' ' PHE . 23.3 p -60.72 -17.89 51.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 0.0 109.482 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.06 -41.75 10.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -74.22 -7.7 53.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.428 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 73' ' ' ILE . 35.0 m -115.29 36.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.343 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -133.95 78.18 1.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -0.908 . . . . 0.0 109.634 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 0.4 9.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -97.01 -165.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.09 164.65 15.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 82' ' ' LEU . 34.3 mt -58.83 -24.8 62.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -74.67 -26.29 59.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.646 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.76 -50.21 8.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.67 63.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.269 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.02 45.61 3.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -152.45 -38.29 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -1.112 . . . . 0.0 108.688 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 87' ' ' ALA . 4.0 pt -39.35 123.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.534 -0.729 . . . . 0.0 109.119 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -99.17 162.6 12.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.612 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -57.76 -20.1 32.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 1.4 p -77.57 -33.57 53.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.78 -43.68 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 mm -81.61 -33.33 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.912 . . . . 0.0 109.177 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -66.21 -12.5 56.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 -37.44 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.405 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -53.22 43.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.13 -23.98 19.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 51.29 68.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -96.84 146.45 31.33 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.149 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.59 147.24 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.721 2.281 . . . . 0.0 112.247 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 9.55 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.748 2.299 . . . . 0.0 112.168 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 t -92.09 -33.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -105.93 30.02 6.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 103' ' ' LYS . 20.3 t -42.55 -25.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.772 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 4.4 p-80 -52.0 -39.6 59.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.627 ' SG ' ' CE1' ' A' ' 105' ' ' HIS . 33.9 m -47.93 -60.39 2.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.308 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 109' ' ' LEU . 57.9 m -59.31 -58.81 7.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' CB ' ' A' ' 112' ' ' ASP . 63.7 mt -46.26 -22.1 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 107' ' ' SER . 0.8 OUTLIER -74.43 -57.53 3.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.5 59.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 109.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' A' ' 112' ' ' ASP . 3.3 tm-20 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 10.0 t0 -43.13 -43.33 4.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.52 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.29 -54.48 39.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -47.27 -42.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' CD ' ' OE2' ' A' ' 111' ' ' GLU . 5.6 mttp -68.36 -34.85 76.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.21 -58.55 6.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.496 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.68 -42.36 45.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 122' ' ' LYS . 65.0 mt -63.76 -48.35 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.92 -37.75 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.363 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.6 -38.41 67.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.78 -32.61 74.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 118' ' ' ILE . 7.1 mtpt -78.14 -39.77 40.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.63 -54.94 26.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.4 mttm . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.271 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -3.38 56.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -105.51 -5.89 19.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.33 116.27 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.441 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.05 144.27 17.24 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.2 m -126.7 121.93 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.06 123.77 5.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.477 ' C ' ' SD ' ' A' ' 31' ' ' MET . 2.4 ppp? -131.89 153.11 50.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.677 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -145.26 169.06 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.251 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.1 147.84 18.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -145.73 73.13 13.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -1.123 . . . . 0.0 109.34 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -58.5 71.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.85 2.366 . . . . 0.0 112.097 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -177.95 -89.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.836 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 1.5 t -118.48 -7.98 10.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.665 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -98.71 -23.87 11.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 58.45 -163.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.715 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.0 p -87.24 110.35 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 108.842 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.401 ' CE ' HD13 ' A' ' 43' ' ' LEU . 8.1 ttt -100.55 129.81 46.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.163 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -120.88 108.08 13.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.401 HD13 ' CE ' ' A' ' 41' ' ' MET . 4.5 tp -108.19 115.06 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.722 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.487 HE21 ' HB3' ' A' ' 44' ' ' GLN . 2.2 mt-30 -110.38 118.88 37.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.2 pt -106.25 146.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -115.18 136.58 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.66 145.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.114 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -78.75 -104.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.502 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.5 t70 -141.8 9.15 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.32 12.52 2.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.301 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.04 14.61 57.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -99.87 114.35 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -1.153 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.5 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -50.29 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 49.8 t0 -127.19 170.14 12.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -162.95 115.81 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -98.92 131.69 44.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CD2' ' OG ' ' A' ' 70' ' ' SER . 8.4 p90 -109.72 172.05 7.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.647 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -171.81 112.2 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -156.01 146.99 22.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 4.3 t80 -156.9 106.88 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.36 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.23 -25.73 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 66' ' ' ALA . 64.4 m -83.64 131.67 34.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -1.068 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.82 9.49 60.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -152.77 -13.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 63' ' ' CYS . . . -93.14 -12.69 29.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' ALA . 20.1 mt -42.15 -45.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.15 89.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -46.41 -53.41 11.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.436 ' OG ' ' CD2' ' A' ' 58' ' ' PHE . 6.9 t -45.17 -48.45 12.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 m -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -64.67 -76.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.832 ' O ' HG22 ' A' ' 77' ' ' VAL . 5.8 tt -35.51 -52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.728 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.605 ' H ' HG23 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -49.54 -52.54 29.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -2.11 30.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 109.891 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -105.11 -4.5 21.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.466 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.832 HG22 ' O ' ' A' ' 73' ' ' ILE . 11.7 m -124.29 5.59 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.504 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -92.76 98.38 11.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.75 11.23 23.37 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -110.74 174.29 5.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -96.71 157.46 15.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.487 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.34 -20.72 63.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -34.89 74.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.57 -32.55 36.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.513 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -73.96 -21.51 59.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.636 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.17 30.08 10.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -147.23 -37.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.151 -1.205 . . . . 0.0 109.507 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.545 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -34.66 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.527 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER 70.39 167.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.369 -0.832 . . . . 0.0 109.516 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 91' ' ' SER . 8.6 p30 -89.74 -54.83 3.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.615 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -37.84 -33.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.482 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -60.28 -53.08 61.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.56 -35.81 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.51 -39.98 81.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.84 -34.12 62.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -54.2 -45.92 72.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.336 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.19 -6.52 19.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 94' ' ' ALA . 16.8 mt-10 53.93 88.5 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -108.03 165.75 12.17 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.53 142.37 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.601 2.201 . . . . 0.0 112.053 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.92 5.75 4.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.705 2.27 . . . . 0.0 112.209 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.15 -25.7 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.643 ' O ' ' N ' ' A' ' 105' ' ' HIS . 4.2 mtpt -118.22 28.15 8.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 103' ' ' LYS . 21.3 t -38.16 -22.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.665 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 3.2 p-80 -44.47 -31.39 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.657 ' SG ' ' CE1' ' A' ' 105' ' ' HIS . 57.8 m -60.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 10.2 p -47.15 -56.87 5.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.181 -0.949 . . . . 0.0 109.095 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 6.0 mt -45.67 -36.62 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.91 -49.13 78.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.244 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -61.96 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 109.588 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 112' ' ' ASP . 30.2 tt0 -54.99 -73.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 111' ' ' GLU . 23.0 t0 -34.1 -55.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.656 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 112' ' ' ASP . . . -40.96 -70.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.418 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.513 HG12 ' HB1' ' A' ' 85' ' ' ALA . 1.1 tp -43.49 -31.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.083 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 112' ' ' ASP . 4.1 tptt -64.42 -60.17 3.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.9 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.411 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -67.05 -45.97 75.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 109.409 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.18 -45.36 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.264 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.92 64.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 109.108 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.15 -26.19 37.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 109.271 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 15.8 t80 -76.41 -54.49 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -71.42 0.41 8.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.01 -31.1 22.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 mptt . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.459 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.522 ' O ' ' O ' ' A' ' 2' ' ' ALA . 6.5 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.522 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 56.15 155.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.505 ' O ' ' C ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -46.63 -62.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -37.3 120.4 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.9 48.07 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.65 -4.16 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.979 HG12 ' H ' ' A' ' 8' ' ' ILE . 3.6 t -93.3 -152.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.979 ' H ' HG12 ' A' ' 7' ' ' VAL . 7.4 mm 44.5 99.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.442 ' C ' ' ND1' ' A' ' 10' ' ' HIS . 2.1 m-20 -126.41 44.1 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 11' ' ' TYR . 13.4 m80 -150.4 5.52 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.569 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.497 ' O ' ' O ' ' A' ' 10' ' ' HIS . 0.7 OUTLIER 59.71 129.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.17 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' TYR . 6.5 m-20 -109.82 145.94 33.05 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.334 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.67 145.3 46.26 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.66 2.24 . . . . 0.0 112.086 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -132.15 34.18 3.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -132.78 -173.25 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.621 HG23 ' H ' ' A' ' 19' ' ' SER . 8.7 m -114.42 -119.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -112.98 4.08 25.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.621 ' H ' HG23 ' A' ' 17' ' ' VAL . 1.4 t -119.42 163.8 16.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -1.172 . . . . 0.0 109.626 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.625 HD12 ' NZ ' ' A' ' 46' ' ' LYS . 7.1 mt -82.09 -65.01 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 23' ' ' LYS . 4.9 m-20 -141.21 20.67 2.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.64 10.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -0.899 . . . . 0.0 109.227 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.43 3.49 9.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.0 t0 58.37 -146.61 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.296 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.479 ' C ' ' CG ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER 71.48 -7.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.479 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 178.29 30.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.656 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.12 94.93 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.648 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.12 126.15 7.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.01 127.13 2.27 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 ttt -133.62 98.39 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.283 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -107.49 170.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.41 160.14 26.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . . . -128.91 92.98 38.3 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.152 -1.205 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.85 -16.06 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.679 2.253 . . . . 0.0 112.052 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 -57.16 4.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.9 p -100.91 19.53 17.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.439 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.27 58.32 1.06 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 42.9 t0 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -98.29 122.43 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -108.46 115.66 30.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -110.99 113.64 26.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 9.9 tp -103.64 153.64 20.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.06 111.42 5.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -101.26 146.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' NZ ' HD12 ' A' ' 20' ' ' LEU . 6.8 tttm -131.15 122.94 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.47 141.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.621 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.687 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -172.47 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 4.3 m-20 -62.73 45.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.4 m-20 78.5 51.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.6 -5.75 72.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.77 156.53 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -1.161 . . . . 0.0 109.385 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.43 94.57 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.73 -25.14 64.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.423 -0.798 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.19 168.47 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.89 131.15 11.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -110.87 163.13 14.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.737 ' CD1' HG21 ' A' ' 74' ' ' THR . 16.2 p90 -142.1 166.6 24.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 109.379 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 101.4 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.391 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -154.1 143.39 21.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 1.2 p90 -161.82 134.7 6.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.04 -52.95 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 168.26 20.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.184 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 38.81 2.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 t -166.29 -47.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -1.161 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.479 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . . . -48.38 -37.56 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -47.52 -19.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.613 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' ALA . . . -95.93 -40.26 9.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.403 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.783 ' O ' HG22 ' A' ' 73' ' ' ILE . 4.7 p -50.92 -38.68 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.321 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.707 ' O ' HG23 ' A' ' 74' ' ' THR . 87.9 p -58.94 -38.89 80.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -63.64 -41.85 98.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 73' ' ' ILE . 1.7 tp -66.65 -73.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.813 ' O ' HG22 ' A' ' 77' ' ' VAL . 6.2 tt -43.26 -28.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.737 HG21 ' CD1' ' A' ' 58' ' ' PHE . 19.2 p -77.5 -41.46 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.59 2.14 38.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -110.6 -30.31 7.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.758 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 73' ' ' ILE . 4.4 m -109.25 50.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -123.82 104.63 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.39 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 6.1 63.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.0 mmtt -98.67 175.22 6.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -1.12 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 t -88.16 154.52 20.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 118' ' ' ILE . 66.4 mt -61.76 -20.16 63.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -64.12 -29.95 71.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -91.56 -35.51 14.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.78 -37.86 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.36 57.57 2.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -163.27 -34.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -1.124 . . . . 0.0 109.004 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 0.8 OUTLIER -45.15 -14.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 87' ' ' ALA . 19.5 mttm 46.68 -173.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.28 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 91' ' ' SER . 24.5 p-10 -97.9 -24.14 15.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.696 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.6 -25.47 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.98 -65.36 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 109.661 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 9.5 tt -49.81 -38.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -59.75 -46.33 89.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.379 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -65.02 -28.48 69.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tm-20 -71.46 -28.99 64.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.426 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 25.8 mt -93.67 -36.96 12.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.339 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 5.7 tt0 69.72 62.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.435 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -120.1 149.3 48.87 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.942 . . . . 0.0 109.451 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.96 158.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 103' ' ' LYS . 41.4 Cg_endo -72.05 -51.11 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.766 2.311 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 102' ' ' VAL . 41.4 t -58.04 -2.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 101' ' ' PRO . 13.7 mttp -115.6 12.18 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.24 -1.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.6 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 0.3 OUTLIER -57.58 -41.62 81.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.981 . . . . 0.0 109.256 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 19.3 m -63.8 -46.82 83.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.841 . . . . 0.0 109.337 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -56.42 -46.45 80.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.343 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 105' ' ' HIS . 19.6 mt -52.89 -45.32 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.305 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 6.0 mp -58.5 -46.58 86.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -52.67 -53.39 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.93 -56.38 19.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.57 -17.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -79.77 -53.42 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.464 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.5 tp -57.25 -30.11 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -43.7 38.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.7 92.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.673 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.4 73.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.556 HG12 HD22 ' A' ' 82' ' ' LEU . 63.7 mt -63.7 -44.88 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.2 -39.77 87.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.14 -31.87 68.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.27 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -39.24 74.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.339 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -77.58 -18.49 56.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.612 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.43 70.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -101.39 19.59 17.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -84.61 -40.49 17.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.33 24.12 3.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mt -91.21 23.92 3.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -1.148 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.87 144.23 26.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 130' ' ' HIS . 7.2 m80 -148.5 118.35 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 129' ' ' HIS . 34.5 m-70 42.65 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.248 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.69 129.79 23.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -50.01 173.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.534 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.699 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 0.8 OUTLIER -163.89 163.46 23.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.674 ' CG ' ' O ' ' A' ' 133' ' ' HIS . 37.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.84 169.11 8.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 4' ' ' SER . 5.4 t80 -170.92 177.07 3.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' TYR . 6.3 t -53.5 -174.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -47.45 -46.18 26.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -170.07 -89.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.43 -47.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 pt -115.91 145.11 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.552 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' HIS . 5.5 m-20 -114.07 116.64 29.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' ASP . 7.0 t-80 57.69 111.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.14 118.51 10.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.77 136.83 58.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.955 . . . . 0.0 109.253 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -155.73 60.74 2.56 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 16' ' ' ASN . 43.3 Cg_endo -72.46 164.62 35.09 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.755 2.303 . . . . 0.0 112.019 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.563 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.9 ttm180 -70.21 50.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 15' ' ' ARG . 9.3 t-20 53.29 161.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.56 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -102.96 -92.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.54 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.95 -110.83 0.78 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -59.05 167.1 1.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD11 ' CE ' ' A' ' 46' ' ' LYS . 6.6 mt -117.11 -132.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -81.85 9.7 7.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.275 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.3 tttt 62.48 -38.44 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.435 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 21' ' ' ASP . 80.9 tttt -73.8 45.4 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' ND2' ' A' ' 26' ' ' ASN . 1.2 m-20 -131.02 139.47 49.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -74.37 13.09 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.321 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -116.26 22.12 13.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.602 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.53 103.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.92 15.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -127.39 152.06 48.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -1.174 . . . . 0.0 109.693 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 125.5 1.56 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.7 ttp -123.79 140.44 52.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.733 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -141.37 165.1 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.43 160.69 29.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -134.84 145.44 54.69 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.303 -1.116 . . . . 0.0 109.411 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.55 -50.25 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.595 2.197 . . . . 0.0 112.05 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.84 63.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.4 m -93.73 -2.62 53.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.61 42.42 0.67 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 16.9 t0 -118.51 154.46 32.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -1.088 . . . . 0.0 109.821 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.4 t -113.48 99.63 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.767 ' CE ' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -82.02 102.97 11.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -91.91 138.8 31.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.767 HD13 ' CE ' ' A' ' 41' ' ' MET . 7.3 tp -134.66 126.16 28.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -128.21 133.65 48.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -121.7 140.89 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.4 ' CE ' HD11 ' A' ' 20' ' ' LEU . 19.7 tttt -118.44 140.79 49.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 73.0 t -117.17 143.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER 178.19 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.545 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-20 -62.45 45.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.663 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.1 m-20 81.09 45.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.99 -3.27 86.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 79' ' ' GLY . 40.5 mm -96.49 146.86 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -1.103 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.2 mt -56.48 94.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -0.934 . . . . 0.0 109.445 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -46.47 35.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.25 169.75 22.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.36 121.6 16.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' CD ' ' N ' ' A' ' 57' ' ' LYS . 2.9 mmtm -95.84 154.79 17.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD1' HG21 ' A' ' 74' ' ' THR . 27.4 p90 -141.1 158.32 44.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -160.94 116.64 2.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.21 131.64 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.463 ' C ' ' OD2' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -148.12 103.76 3.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.578 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.581 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . 125.94 22.73 1.72 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -114.25 83.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.157 . . . . 0.0 109.661 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . 33.45 -101.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 67' ' ' ILE . 96.1 p -136.99 19.19 3.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -1.145 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.51 4.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.8 mm -58.2 -61.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 67' ' ' ILE . . . -46.57 -40.13 12.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 73' ' ' ILE . 10.5 m -61.54 -32.51 72.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -61.18 -26.31 67.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.428 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -83.21 -44.58 14.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.96 -45.42 94.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.723 HG23 ' N ' ' A' ' 74' ' ' THR . 17.4 tt -67.34 -55.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.723 ' N ' HG23 ' A' ' 73' ' ' ILE . 10.5 p -53.6 -23.41 10.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.192 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.8 -21.71 21.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -92.68 -9.1 42.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.536 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 73' ' ' ILE . 32.7 m -121.19 12.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.203 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -94.19 123.16 37.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.352 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 71.2 8.9 66.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -97.86 169.21 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -1.122 . . . . 0.0 109.554 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -83.05 162.19 21.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.57 -24.04 61.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -67.07 -31.4 71.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.77 -33.85 21.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -65.25 -36.78 85.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.15 36.15 3.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -147.27 -34.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -1.068 . . . . 0.0 109.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.543 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -33.42 -28.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 87' ' ' ALA . 4.4 ttmt 63.11 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.48 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 92' ' ' GLN . 7.6 p-10 -82.69 -47.74 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.601 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -43.15 -24.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.632 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.8 tp60 -70.55 -53.9 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.657 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.23 -22.12 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 109.621 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.24 -34.07 59.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 9.0 tp10 -85.37 -16.47 39.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.06 -47.4 14.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.462 HD22 ' OG ' ' A' ' 69' ' ' SER . 7.6 mp -87.15 -35.68 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 8.6 tt0 70.21 73.04 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 0.0 109.785 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -106.64 143.72 27.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.875 . . . . 0.0 109.208 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.6 148.0 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.753 2.302 . . . . 0.0 112.45 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.2 Cg_endo -72.79 -13.64 26.83 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.799 2.333 . . . . 0.0 112.196 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.79 -0.1 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 109.54 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 101' ' ' PRO . 21.2 mttp -150.63 55.02 0.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.587 ' O ' HG12 ' A' ' 104' ' ' VAL . 37.0 t -70.1 -2.79 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' CB ' ' A' ' 34' ' ' ALA . 7.5 p-80 -84.03 -26.6 28.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.312 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.69 -60.79 2.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.2 p -54.07 -54.65 36.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.26 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' C ' ' A' ' 109' ' ' LEU . 43.6 mt -44.73 -66.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 108' ' ' ILE . 4.9 mp -35.21 -50.6 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.669 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HA ' ' SD ' ' A' ' 41' ' ' MET . . . -49.9 -56.8 9.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.0 tt0 -68.56 -67.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.2 OUTLIER -34.67 -27.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -78.31 -59.11 2.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.987 . . . . 0.0 109.828 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.562 HG12 ' HB1' ' A' ' 85' ' ' ALA . 3.3 tp -48.09 -37.11 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.2 ttmt -67.76 -47.73 68.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.286 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.4 64.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.1 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.85 -55.74 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.098 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 117' ' ' ALA . 29.8 mt -42.14 -40.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.08 -54.41 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.07 -26.19 25.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -76.73 -57.57 3.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.312 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -69.79 2.93 2.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' A' ' 130' ' ' HIS . . . -93.8 -49.37 5.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -70.18 -3.57 17.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.863 . . . . 0.0 109.647 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -51.21 21.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.865 ' C ' HD12 ' A' ' 127' ' ' LEU . . . -155.71 20.18 0.52 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.865 HD12 ' C ' ' A' ' 126' ' ' GLY . 6.6 mp -133.02 2.18 3.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -1.175 . . . . 0.0 109.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.521 ' C ' ' O ' ' A' ' 127' ' ' LEU . 2.8 mm-40 36.93 -104.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.639 ' O ' ' ND1' ' A' ' 129' ' ' HIS . 6.6 p80 -85.3 141.75 29.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.137 -0.977 . . . . 0.0 109.354 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.512 ' NE2' ' HB2' ' A' ' 123' ' ' ALA . 16.4 m80 -69.5 178.01 2.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.476 ' C ' ' H ' ' A' ' 133' ' ' HIS . 21.0 m170 -80.99 105.26 12.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -71.68 13.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.476 ' H ' ' C ' ' A' ' 131' ' ' HIS . 14.3 m-70 -48.21 111.38 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.426 179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.555 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 68.63 -172.87 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 62.26 73.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.283 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 m -124.81 81.48 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.59 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.04 151.1 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.403 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -140.57 43.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 7' ' ' VAL . 2.7 t -54.54 124.51 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.54 134.05 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 22.0 p-10 -116.89 84.79 2.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.4 -33.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -97.26 67.15 2.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.35 160.96 16.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.526 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -125.17 91.66 48.75 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.582 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.73 157.74 21.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.744 2.296 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -152.08 64.13 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.18 175.78 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -126.43 74.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -56.48 -167.71 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER 74.52 168.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -1.183 . . . . 0.0 109.624 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.617 ' C ' ' H ' ' A' ' 22' ' ' LYS . 4.7 tp 63.37 -18.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' H ' ' C ' ' A' ' 19' ' ' SER . 10.0 m-20 -55.57 1.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.617 ' H ' ' C ' ' A' ' 20' ' ' LEU . 11.7 ttmt 64.32 1.88 1.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -158.39 30.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.151 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' A' ' 24' ' ' ASP . 12.3 t0 -91.66 26.7 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 66.34 -4.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 24' ' ' ASP . 57.8 m-20 -107.71 -0.71 21.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.45 96.25 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.576 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.12 139.11 37.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.433 HG23 HE21 ' A' ' 44' ' ' GLN . 6.6 m -120.61 105.97 11.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -1.12 . . . . 0.0 109.49 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.79 130.04 10.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.6 ttt -132.65 117.01 17.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -1.144 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.9 159.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.98 156.05 16.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . . . -117.83 83.04 17.62 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.335 -1.097 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.54 -16.82 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.913 2.408 . . . . 0.0 112.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.01 -33.64 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.3 p -124.06 23.19 8.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.74 69.17 0.2 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 8.6 t0 -139.67 116.95 11.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.55 110.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 5.7 ttt -97.6 137.02 37.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -128.91 112.8 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.47 139.25 50.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.433 HE21 HG23 ' A' ' 29' ' ' THR . 2.6 mt-30 -134.96 134.75 40.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.82 135.05 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -106.81 133.58 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -107.98 139.68 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 6.4 t0 -82.76 -88.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.3 m-20 -154.76 17.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.0 11.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.01 78.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -83.39 135.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.581 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.34 104.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.114 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.19 -24.04 37.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 109.837 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 45.6 t0 -148.21 150.62 34.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.685 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -142.04 116.61 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.343 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -97.31 152.12 19.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CG ' HG21 ' A' ' 74' ' ' THR . 15.3 p90 -147.59 166.42 27.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -170.79 117.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.407 HG21 ' HB3' ' A' ' 70' ' ' SER . 0.8 OUTLIER -157.23 143.71 18.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.706 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 20.1 p90 -161.92 95.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.34 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.06 -62.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -81.89 146.27 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.417 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.7 10.38 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 7.4 t -136.22 -7.24 2.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -1.134 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.19 -68.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.616 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.83 -34.22 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 65' ' ' SER . . . -58.27 -57.53 12.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -68.2 -41.25 81.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.473 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -61.53 -28.23 69.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 77.4 p -75.0 -49.96 18.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.72 -57.99 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 74' ' ' THR . 18.2 tt -49.15 -45.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 109.512 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 70' ' ' SER . 19.0 p -60.05 -36.25 76.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -77.98 -10.37 59.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 -30.85 12.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.596 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 77' ' ' VAL . 15.3 m -96.81 38.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.671 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.06 102.85 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.16 52.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -104.77 169.39 8.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -1.111 . . . . 0.0 109.429 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -93.54 150.22 20.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.52 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 82' ' ' LEU . 27.9 mt -49.44 -26.51 3.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.63 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -69.04 -32.98 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.93 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -83.46 -34.24 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.55 54.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.27 52.05 3.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -162.43 -39.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -1.186 . . . . 0.0 109.243 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -42.76 -30.28 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.364 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 59.91 175.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -88.52 -44.33 10.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ASN . 43.4 t -38.61 -39.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 95' ' ' GLU . 5.9 tp-100 -62.33 -66.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.378 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.4 mt -45.37 -31.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.229 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.36 -19.96 48.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.248 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 92' ' ' GLN . 6.2 tt0 -83.85 -20.03 33.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -97.92 -53.89 3.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -72.91 -5.56 39.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.369 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.507 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 43.26 31.95 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.619 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.95 150.79 36.95 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.334 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.18 157.95 42.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.8 2.333 . . . . 0.0 112.234 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.649 ' O ' HG23 ' A' ' 104' ' ' VAL . 60.9 Cg_endo -76.4 -7.14 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.893 2.395 . . . . 0.0 112.567 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.83 -14.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 105' ' ' HIS . 25.6 mttm -114.42 29.69 7.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 101' ' ' PRO . 21.8 t -66.76 -9.94 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.646 ' O ' HD13 ' A' ' 109' ' ' LEU . 2.2 p-80 -77.35 -25.28 50.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -75.7 -41.81 52.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.138 -0.976 . . . . 0.0 109.121 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -52.97 59.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 7.1 tt -53.9 -38.73 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 108.89 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.646 HD13 ' O ' ' A' ' 105' ' ' HIS . 1.6 mp -53.8 -50.04 67.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -56.82 -54.24 48.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 114' ' ' ILE . 16.2 tt0 -48.93 -63.46 1.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.206 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.42 -27.56 10.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -68.0 -49.04 63.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 111' ' ' GLU . 2.4 tp -56.22 -36.31 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.985 . . . . 0.0 109.26 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -70.87 -57.04 5.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.84 7.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.37 -59.67 3.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.9 mt -46.44 -44.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.424 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.438 ' C ' ' N ' ' A' ' 121' ' ' TYR . . . -62.35 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' C ' ' OD1' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -47.89 -17.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.2 t80 -92.59 -29.28 16.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -92.1 3.37 55.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.355 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.44 -52.18 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 109.578 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -76.62 47.76 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -122.54 -26.93 4.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.485 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.16 -17.29 1.92 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.0 mt -83.89 37.0 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.28 109.56 21.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.272 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -69.24 118.84 12.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.06 -2.11 13.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 t60 65.0 118.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.404 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 134' ' ' HIS . 0.3 OUTLIER -90.93 -58.01 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.537 ' C ' ' CG ' ' A' ' 134' ' ' HIS . 40.5 m80 -51.46 89.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.895 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.537 ' CG ' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.419 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 28.6 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 170.54 -62.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.467 ' O ' ' C ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -148.4 -73.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 3' ' ' TYR . 1.7 m 41.59 83.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -145.1 105.65 4.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -165.12 -27.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 7' ' ' VAL . 12.0 t -54.19 -76.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.009 . . . . 0.0 109.469 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mt -51.61 118.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.428 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.87 142.95 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 109.335 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.473 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 1.2 p-80 -177.65 115.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -138.28 -164.33 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -106.27 142.31 36.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -141.7 162.56 45.94 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.341 -0.849 . . . . 0.0 109.321 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.8 -73.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.714 2.276 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -52.23 151.11 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -174.14 58.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -54.96 136.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 19' ' ' SER . . . 96.8 34.54 5.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -36.95 -93.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.387 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mt 45.48 74.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 4.3 t70 -178.02 153.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -67.65 -18.16 64.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -95.91 21.45 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.39 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' A' ' 21' ' ' ASP . 37.8 m-20 -99.18 162.98 12.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.12 10.42 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.539 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -134.39 21.14 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.39 127.79 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.0 121.67 7.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -102.78 120.65 40.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.538 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.41 100.68 0.89 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ttt -96.68 133.13 41.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -1.095 . . . . 0.0 109.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.41 154.62 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.862 . . . . 0.0 109.222 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.64 143.72 17.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.14 107.18 13.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.34 -1.094 . . . . 0.0 109.083 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -76.52 15.59 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.293 1.996 . . . . 0.0 112.447 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.658 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -112.47 -102.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.832 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -121.04 6.59 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.689 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -91.7 -16.46 51.93 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 29.7 t0 50.86 -151.35 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -1.051 . . . . 0.0 109.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 6.4 t -87.35 136.62 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.7 ttt -127.34 137.41 52.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 109.589 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -124.43 123.37 40.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -119.93 126.51 51.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.958 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.56 143.64 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.515 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.5 pp -132.88 134.16 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -102.97 136.8 42.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.9 136.05 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 38.1 t0 -59.78 -49.44 77.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.31 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.678 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.7 OUTLIER 162.83 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -34.43 9.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.11 -9.73 0.98 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -74.43 134.26 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -1.225 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.04 89.49 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.44 -54.78 39.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.578 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -144.49 152.85 41.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.898 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.594 ' H ' ' HZ3' ' A' ' 78' ' ' LYS . . . -133.58 142.44 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.741 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -114.02 143.28 45.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.053 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.524 ' HB3' HG21 ' A' ' 74' ' ' THR . 4.4 p90 -119.69 165.2 14.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.86 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -171.54 81.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -123.45 152.9 41.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -155.44 95.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . -179.21 -50.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 18.5 m -74.23 125.15 27.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.511 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -43.33 -21.72 0.17 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -120.25 7.9 10.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -1.105 . . . . 0.0 109.274 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 63' ' ' CYS . . . -42.22 -43.18 3.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.518 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.518 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.2 mt -60.72 -29.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -80.58 -71.92 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.733 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.3 p -38.84 -33.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.944 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 74' ' ' THR . 12.4 p -69.19 -63.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 0.8 OUTLIER -48.67 -25.76 1.95 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 109.5 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' C ' ' A' ' 73' ' ' ILE . 39.4 tp -79.15 -81.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 69' ' ' SER . 14.5 tt -41.11 -35.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.614 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 70' ' ' SER . 82.6 p -69.53 -39.48 77.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' LEU . 16.4 tt0 -74.51 -8.33 55.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.327 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.98 -31.88 14.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 114' ' ' ILE . 4.9 m -96.42 13.14 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HZ3' ' H ' ' A' ' 56' ' ' ALA . 4.2 mttm -89.28 93.11 9.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.54 -18.52 24.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -66.52 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.41 167.81 13.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.646 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.38 -30.19 69.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.85 . . . . 0.0 109.56 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.76 -35.05 79.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.1 -45.2 18.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.007 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.16 35.61 2.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -147.4 -38.99 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 109.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.509 HD11 HG12 ' A' ' 114' ' ' ILE . 1.4 pt -41.45 163.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -0.872 . . . . 0.0 109.35 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -136.72 -174.1 3.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -101.55 -5.59 24.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.221 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -64.31 -53.06 54.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 0.0 109.343 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.6 mt-30 -60.76 -62.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 93' ' ' ILE . 37.3 mt -47.21 -25.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.45 -27.27 46.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 92' ' ' GLN . 10.2 mt-10 -87.96 -16.28 34.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.355 -0.841 . . . . 0.0 109.338 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -88.55 -43.41 11.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.67 -14.05 49.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 48.29 74.52 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.371 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -110.77 150.73 42.21 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 109.415 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.02 160.09 48.91 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.748 2.299 . . . . 0.0 112.193 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.0 Cg_endo -66.7 -65.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.904 2.402 . . . . 0.0 112.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG23 ' C ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER 41.48 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 109.03 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' PRO . 20.1 mttp -138.43 10.96 2.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.683 ' O ' HD12 ' A' ' 108' ' ' ILE . 3.7 t 34.79 53.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.832 ' CE1' ' H ' ' A' ' 37' ' ' CYS . 6.4 p-80 -98.38 -25.54 14.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.84 -70.22 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -51.32 -57.84 7.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 104' ' ' VAL . 37.1 mt -43.07 -34.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.07 81.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.71 68.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' ' 112' ' ' ASP . 56.8 tt0 -66.56 -67.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 111' ' ' GLU . 47.8 t0 -40.56 -29.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -67.1 -59.54 3.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.509 HG12 HD11 ' A' ' 88' ' ' ILE . 1.9 tp -46.21 -33.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.75 61.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.81 64.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.97 -56.8 17.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.5 -44.38 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.626 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.95 -57.54 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 2.4 m-20 -53.89 -53.6 50.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.516 ' O ' ' C ' ' A' ' 122' ' ' LYS . 13.0 t80 -47.37 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 121' ' ' TYR . 11.2 mmtt -36.22 -44.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 120' ' ' ASP . . . -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.569 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' TYR . 3.6 mtpt -59.46 -40.33 86.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.913 . . . . 0.0 109.424 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.448 ' CD ' ' O ' ' A' ' 125' ' ' GLN . 23.0 tm0? -131.1 74.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.54 -92.54 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.914 ' H ' HD12 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -140.96 18.46 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -1.1 . . . . 0.0 109.379 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 57.93 -173.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.632 ' HD1' ' C ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -62.53 163.62 8.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.628 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 0.4 OUTLIER -129.18 66.66 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.628 ' ND1' ' C ' ' A' ' 130' ' ' HIS . 3.1 m-70 -135.65 138.01 42.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 135.31 17.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.147 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.99 42.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.553 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.447 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.0 -32.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -47.31 37.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.611 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 4' ' ' SER . 0.3 OUTLIER -126.17 112.84 16.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.6 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.14 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 59.0 89.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.141 -0.974 . . . . 0.0 109.53 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -104.99 141.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 pt -145.04 118.73 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 3.8 p-10 -85.35 -92.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.682 ' CE1' ' O ' ' A' ' 11' ' ' TYR . 1.7 t60 -152.94 150.26 29.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' O ' ' CE1' ' A' ' 10' ' ' HIS . 2.8 m-85 -140.83 -151.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -94.2 -160.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.35 153.38 42.77 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 126.43 21.25 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.977 2.451 . . . . 0.0 112.492 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.27 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.818 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.716 ' OD1' HG23 ' A' ' 17' ' ' VAL . 28.6 t-20 46.0 -118.22 0.76 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG23 ' OD1' ' A' ' 16' ' ' ASN . 60.3 t -117.79 -42.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -160.77 -117.73 0.46 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 68.0 -167.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 109.502 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.475 HD22 ' HZ2' ' A' ' 46' ' ' LYS . 5.7 tp -135.07 77.61 1.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 23' ' ' LYS . 5.1 t70 61.0 154.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.438 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.45 ' HB3' ' NZ ' ' A' ' 22' ' ' LYS . 9.4 mtpm? -73.73 14.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.277 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 21' ' ' ASP . 38.8 mttp -48.58 -20.47 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 26' ' ' ASN . 26.3 t0 42.26 -149.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.442 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.509 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.5 OUTLIER 54.64 0.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.075 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -167.82 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.12 113.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.782 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.76 125.32 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -116.13 145.31 43.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.36 134.57 5.4 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.5 mtt -123.47 148.88 45.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.122 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.18 174.01 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.145 -0.972 . . . . 0.0 109.334 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.24 150.27 8.04 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.03 144.42 47.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.504 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 Cg_endo -71.97 -67.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.563 2.176 . . . . 0.0 111.938 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.41 -35.9 0.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.241 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' O ' ' C ' ' A' ' 38' ' ' GLY . 49.9 t -99.13 -4.97 31.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.345 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 36.68 34.66 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 37' ' ' CYS . 13.7 t0 -105.02 114.16 28.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.333 -1.098 . . . . 0.0 109.604 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 40' ' ' VAL . 14.5 p -89.05 109.29 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ttt -99.2 152.32 20.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -147.9 126.93 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.89 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.62 128.42 37.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.034 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -118.52 136.05 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.028 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.4 pp -119.51 144.86 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HZ2' HD22 ' A' ' 20' ' ' LEU . 2.4 ttmm -111.79 141.98 44.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.81 113.65 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 17.3 t0 -47.45 -67.16 0.3 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.644 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.9 p-10 170.41 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.097 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.39 10.83 23.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.32 15.26 54.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.1 mm -102.52 148.81 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 109.592 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.478 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.3 mm -83.34 84.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.435 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' ' OD1' ' A' ' 55' ' ' ASP . 5.6 tt0 -40.89 -55.76 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' OD1' ' OE2' ' A' ' 54' ' ' GLU . 7.4 p-10 -152.34 170.99 18.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.25 126.52 18.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.474 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -99.28 135.01 41.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 2.6 p90 -109.83 162.46 14.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -171.78 102.24 0.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -164.82 139.74 5.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.651 ' CE2' HD11 ' A' ' 67' ' ' ILE . 3.3 t80 -156.02 95.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.31 -19.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.678 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -141.06 107.27 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -1.045 . . . . 0.0 109.181 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -41.08 -15.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 63' ' ' CYS . 1.8 m -82.49 -22.24 35.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -83.31 -58.7 2.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.651 HD11 ' CE2' ' A' ' 61' ' ' TYR . 42.5 mt -35.68 -59.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.9 m -49.84 -50.56 45.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.479 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 74' ' ' THR . 1.3 t -43.95 -47.57 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.587 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.569 ' O ' ' OG1' ' A' ' 74' ' ' THR . 17.3 p -70.59 -31.41 68.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -68.33 -61.82 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 77' ' ' VAL . 6.1 tt -48.78 -41.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 70' ' ' SER . 23.5 p -55.84 -46.25 78.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.018 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.99 -20.23 64.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 108.916 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.21 -27.68 53.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 73' ' ' ILE . 7.0 m -111.8 -111.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.499 -0.75 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' H ' HG23 ' A' ' 77' ' ' VAL . 8.3 tttm 35.32 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.53 13.85 10.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.56 -166.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -1.113 . . . . 0.0 109.366 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 83' ' ' GLU . 15.5 m -108.34 135.82 49.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.959 . . . . 0.0 109.639 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' SER . 11.4 mt -45.32 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 81' ' ' SER . 5.7 tp10 -77.92 -53.12 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.173 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -32.0 69.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.07 31.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.24 47.2 3.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.61 -33.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.189 . . . . 0.0 109.425 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.5 pt -44.16 175.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -143.19 158.11 43.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -73.99 -38.25 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -52.19 -37.69 55.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.161 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 94' ' ' ALA . 3.5 mm100 -66.18 -68.33 0.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -45.67 -23.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 91' ' ' SER . . . -71.85 -63.45 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.825 . . . . 0.0 109.166 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -49.31 -17.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 108.941 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -80.68 -61.21 2.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 60.2 tp -76.7 -33.45 58.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER 70.0 68.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.035 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.2 pt? -103.72 146.93 33.43 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -40.24 102.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.758 2.305 . . . . 0.0 112.16 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 103' ' ' LYS . 58.8 Cg_endo -78.77 10.15 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.543 2.162 . . . . 0.0 112.41 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -11.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.238 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 101' ' ' PRO . 53.0 tttm -157.14 -34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.381 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t 60.9 60.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.286 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.624 ' O ' HD13 ' A' ' 109' ' ' LEU . 13.3 p-80 -99.27 -47.66 5.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 0.0 109.527 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.403 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.6 m -61.11 -49.38 77.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.509 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.547 ' OG ' HD11 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -50.66 -67.8 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' SER . 3.4 mt -44.87 -38.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.6 mp -60.24 -39.37 86.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -61.67 -52.02 66.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.132 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 112' ' ' ASP . 68.2 tt0 -60.16 -60.31 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -42.76 -33.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -64.28 -60.45 3.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -46.99 -38.4 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' HA ' HD12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -70.35 -57.77 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.99 -39.58 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.01 97.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 109.66 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 115' ' ' LYS . 44.2 mt -64.37 -39.3 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.97 72.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 -42.73 95.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -70.02 -48.66 57.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 125' ' ' GLN . 20.2 tttt -56.96 -30.15 63.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -38.93 -36.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -73.85 26.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.461 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 122' ' ' LYS . 6.5 mm-40 -138.56 26.66 2.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.57 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 128' ' ' GLU . . . -178.95 -68.68 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.2 49.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.488 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.645 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -121.26 163.82 17.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' A' ' 131' ' ' HIS . 63.8 t-80 -140.21 -46.39 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 66.96 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.36 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -155.67 137.63 14.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.457 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -109.06 -114.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.554 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 1.0 OUTLIER -74.5 -141.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.466 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.52 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 3' ' ' TYR . . . -91.71 -125.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 2.0 t80 79.13 131.26 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.9 t -67.77 19.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 3' ' ' TYR . 2.7 tt0 -59.48 147.04 38.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -168.15 72.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 9' ' ' ASP . 3.1 t -107.27 64.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.237 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.76 44.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.63 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -141.87 -146.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.49 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.67 178.41 4.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.565 ' O ' ' O ' ' A' ' 12' ' ' GLU . 30.5 m-85 -76.39 -11.66 59.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.352 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.565 ' O ' ' O ' ' A' ' 11' ' ' TYR . 27.3 mt-10 52.59 113.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 50.75 82.22 0.25 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 179.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.736 2.29 . . . . 0.0 112.068 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 17' ' ' VAL . 22.8 ttt180 -146.99 141.02 25.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.535 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 39.4 t-20 -62.45 55.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' A' ' 15' ' ' ARG . 94.0 t -48.36 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.264 -0.897 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 169.17 159.28 14.48 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 56.19 122.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.137 -1.213 . . . . 0.0 109.357 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -108.69 -109.07 0.33 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' O ' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -117.31 118.7 32.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 21' ' ' ASP . 6.1 mtmt -35.15 -37.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.488 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -80.42 43.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.453 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.677 ' OD1' ' N ' ' A' ' 25' ' ' SER . 57.6 t0 -104.49 147.27 27.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.677 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 51.0 m -89.65 5.86 43.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -114.31 -2.71 13.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.19 117.56 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.843 . . . . 0.0 109.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 126.94 9.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -112.07 151.2 29.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -1.135 . . . . 0.0 109.299 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.92 153.88 25.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.8 ttm -142.37 141.19 32.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.86 165.96 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.923 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.11 148.53 17.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -141.88 79.16 16.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.333 -1.098 . . . . 0.0 109.619 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.31 12.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.88 2.387 . . . . 0.0 112.269 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.635 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -110.54 -79.16 0.58 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.271 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 1.4 p -134.9 -36.22 0.84 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.188 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.688 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -55.02 -18.86 12.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.535 ' N ' ' HB3' ' A' ' 34' ' ' ALA . 14.7 t0 51.69 -147.69 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 0.0 109.731 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.424 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.98 115.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.88 . . . . 0.0 109.434 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.452 ' CG ' ' N ' ' A' ' 42' ' ' GLN . 9.5 ttt -106.82 157.42 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CG ' ' A' ' 41' ' ' MET . 15.6 tt0 -143.86 130.38 20.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.686 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 1.6 tp -125.45 150.91 46.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 14.3 mt-30 -142.23 144.33 33.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.539 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.17 155.95 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -130.76 122.79 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.247 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.629 HG11 HD11 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -115.37 140.01 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.786 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' A' ' 50' ' ' ASN . 35.0 m-20 -170.88 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.47 48.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.374 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 78.4 50.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.91 86.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.83 149.49 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -1.103 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mt -82.7 91.44 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -72.83 -38.56 67.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.333 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 47.8 t0 -124.85 158.03 34.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.828 . . . . 0.0 109.236 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -158.67 120.23 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.76 157.33 19.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -140.69 -174.03 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.751 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -169.69 81.61 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.219 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.34 122.34 30.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 105.68 3.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 145.25 -44.57 0.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.466 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 15.9 m -75.0 167.36 22.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.446 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.37 -38.48 0.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -21.01 17.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -1.085 . . . . 0.0 109.498 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -88.6 0.63 56.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 66' ' ' ALA . 8.3 tp -44.36 -31.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -66.46 -47.78 72.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.599 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -43.37 -32.5 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.333 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.7 OUTLIER -58.53 -53.73 55.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 m -65.75 -32.72 74.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 75' ' ' GLU . 1.7 tp -65.1 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.856 . . . . 0.0 109.682 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.733 ' O ' HG22 ' A' ' 77' ' ' VAL . 16.4 tt -37.11 -41.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.963 . . . . 0.0 109.577 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 73' ' ' ILE . 2.4 p -64.77 -32.38 74.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.526 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 72' ' ' LEU . 8.8 mt-10 -86.56 -7.72 58.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -109.04 -5.71 15.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 109.546 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 73' ' ' ILE . 24.9 m -117.52 0.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -95.38 114.83 26.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 109.385 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.82 -8.36 73.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.25 168.69 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.42 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.0 m -88.79 167.59 13.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 HG11 ' A' ' 47' ' ' VAL . 31.7 mt -68.04 -26.61 65.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.565 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -66.52 -20.27 65.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.317 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -97.22 -58.02 2.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.171 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.68 62.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.246 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 118' ' ' ILE . . . -101.44 49.23 1.06 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -168.93 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -1.128 . . . . 0.0 109.094 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 87' ' ' ALA . 5.1 pt -41.38 156.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.5 168.8 9.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.135 -0.978 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.59 -18.47 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 t -66.65 -27.61 67.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.19 -57.87 5.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.533 HG21 ' OG ' ' A' ' 69' ' ' SER . 5.1 mt -62.37 -38.45 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -54.79 -53.51 54.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.348 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -37.02 85.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -52.25 -41.13 62.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 tp -105.8 -29.14 10.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 94' ' ' ALA . 8.9 tm-20 64.58 58.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.347 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.068 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.2 pt? -86.46 143.43 36.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.376 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.61 142.45 1.96 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.574 2.183 . . . . 0.0 112.151 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -76.24 -3.16 13.48 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.719 2.279 . . . . 0.0 111.942 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 102' ' ' VAL . 3.0 t -59.9 -12.21 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' NZ ' ' SG ' ' A' ' 106' ' ' CYS . 18.0 pttp -156.79 56.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 104' ' ' VAL . 86.0 t -57.3 -11.27 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.284 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.688 ' CE1' ' H ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -54.64 -22.32 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.499 ' SG ' ' NZ ' ' A' ' 103' ' ' LYS . 59.5 m -65.03 -61.1 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.0 p -55.15 -51.67 65.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.442 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.9 mt -55.28 -26.52 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.102 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 109' ' ' LEU . 1.9 tp -68.06 -42.11 80.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 109.004 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -58.37 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.82 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 112' ' ' ASP . 7.3 tm-20 -62.33 -64.57 0.89 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.565 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 111' ' ' GLU . 62.2 t0 -39.22 -31.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.711 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -69.01 -56.73 6.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.711 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.8 tp -52.14 -37.05 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 3.1 tttp -67.98 -50.46 55.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.85 73.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.714 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -65.62 -69.7 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.698 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.471 HD13 ' HA3' ' A' ' 86' ' ' GLY . 23.6 mt -42.7 -37.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.685 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.32 85.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 61.0 t0 -61.17 -25.19 66.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.898 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.4 t80 -78.62 -40.77 33.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -84.84 -1.78 56.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.12 24.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.275 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -84.97 -25.1 27.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -54.14 -54.39 40.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 156.14 36.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.93 -16.79 29.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -1.165 . . . . 0.0 109.247 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -176.88 175.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.872 . . . . 0.0 109.368 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.645 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 0.1 OUTLIER -104.88 140.77 37.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.367 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.658 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 7.2 t-80 -124.13 -143.54 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.658 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 0.5 OUTLIER 53.0 3.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.537 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.572 ' H ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -109.77 -171.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.496 ' NE2' ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -91.81 -176.32 4.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.72 ' N ' ' ND1' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.461 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.763 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 1.3 tmt? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.763 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . 164.57 66.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -47.64 125.54 8.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.63 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -104.55 98.33 8.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -37.34 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.505 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' SER . 8.0 pttp -166.14 -2.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 7' ' ' VAL . 17.0 m -89.37 55.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 mt -46.27 91.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 10' ' ' HIS . 57.0 t0 -93.74 149.21 21.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.538 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.56 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 7.0 m-70 -35.91 114.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -132.37 22.14 4.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.704 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' ASN . 1.1 mp0 -125.87 -38.56 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' C ' ' O ' ' A' ' 12' ' ' GLU . 6.9 m120 36.63 83.06 0.21 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.83 110.36 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.944 2.429 . . . . 0.0 112.446 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.59 -81.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.251 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.29 -0.57 15.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.75 90.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.16 -179.62 49.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 21' ' ' ASP . 4.4 t -169.23 144.23 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER 64.4 -64.5 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.385 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 19' ' ' SER . 0.4 OUTLIER -41.49 146.34 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -75.66 20.61 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 21' ' ' ASP . 8.9 tttm -104.74 -20.54 13.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 27' ' ' VAL . 2.8 p30 -72.3 168.27 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -98.42 9.85 42.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m-80 -118.77 18.27 13.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.558 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 t -126.48 122.34 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.52 123.46 7.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 m -109.21 152.78 24.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -1.186 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.52 110.7 0.45 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 ttt -114.45 103.52 11.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.457 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.0 m -117.2 157.29 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.14 163.23 28.67 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.87 138.03 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.294 -1.121 . . . . 0.0 109.371 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.1 Cg_endo -75.57 -36.24 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -43.01 -53.31 4.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.537 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.4 2.38 20.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.65 58.3 7.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 62.3 t0 -127.75 145.39 50.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 2.6 m -115.26 114.69 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 ttt -98.93 125.3 44.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.859 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.29 119.15 38.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.023 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.1 110.92 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -118.82 108.96 15.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.042 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 pt -107.87 143.45 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.892 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.667 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 8.0 tttp -109.31 144.27 37.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.013 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.506 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 3.3 t -134.99 149.33 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.737 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.694 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 174.28 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 2.9 m-20 -62.21 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.421 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-20 79.19 48.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.85 . . . . 0.0 109.412 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.37 78.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 53' ' ' ILE . 5.4 mm -89.24 158.85 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.392 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 52' ' ' ILE . 46.8 mt -93.09 90.73 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.59 -38.56 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.708 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 2.3 p30 -147.62 162.08 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.42 119.6 10.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.712 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' HG21 ' A' ' 74' ' ' THR . 6.1 p90 -137.9 163.93 30.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.734 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -158.95 111.1 2.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.207 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -156.81 132.6 9.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.133 -0.979 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.433 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 46.0 t80 -161.65 154.77 20.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 61' ' ' TYR . . . 125.08 -43.24 1.4 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 t -88.95 166.38 13.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.086 -1.243 . . . . 0.0 109.651 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.86 43.4 1.67 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -158.9 -66.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.314 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -36.27 -35.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.315 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 65' ' ' SER . 49.0 mt -54.88 -13.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.258 -0.901 . . . . 0.0 109.314 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -103.22 -53.25 2.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 109.154 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -55.56 -37.87 68.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.0 109.232 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 74' ' ' THR . 59.0 p -59.86 -39.92 86.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.214 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.573 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -62.37 -51.16 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 73' ' ' ILE . 10.7 tp -55.74 -69.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.371 -0.831 . . . . 0.0 109.508 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 74' ' ' THR . 14.5 tt -47.53 -50.37 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.674 ' N ' HG23 ' A' ' 73' ' ' ILE . 6.0 p -47.35 -38.08 12.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.53 -8.58 54.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 108.914 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.7 t90 -92.12 -11.75 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 108.977 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.04 4.22 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -79.33 104.59 10.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.92 35.38 79.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.72 -174.68 2.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 t -106.16 148.71 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.762 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.4 HD22 HG12 ' A' ' 118' ' ' ILE . 27.3 mt -68.77 -20.65 64.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.961 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.93 -9.04 58.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.374 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -102.17 -43.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.18 -12.73 56.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.527 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.04 49.8 3.6 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -178.63 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -1.12 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -32.16 -31.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 109.757 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 87' ' ' ALA . 16.6 mtmt 62.42 128.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.336 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.64 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 2.5 p-10 -54.37 -46.93 73.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 90' ' ' ASN . 15.7 m -35.45 -34.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.386 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 90' ' ' ASN . 42.1 tp60 -73.44 -49.85 24.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.4 mt -50.61 -38.1 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.238 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.88 -61.32 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.64 -10.21 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.722 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -79.58 -67.73 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.1 mt -85.04 -2.21 57.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' LEU . 14.2 mt-10 44.24 75.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.73 143.05 26.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -42.27 157.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.634 2.222 . . . . 0.0 112.306 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 61.2 Cg_endo -77.29 1.38 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.167 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.85 -0.5 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.669 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -134.63 35.42 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -84.12 -40.58 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.554 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 104' ' ' VAL . 16.0 p-80 -40.98 -33.6 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.007 . . . . 0.0 109.342 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.414 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 1.2 m -72.52 -45.93 57.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.258 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.4 t -55.87 -49.97 71.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.047 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.482 ' O ' ' C ' ' A' ' 109' ' ' LEU . 71.5 mt -50.97 -59.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.0 109.174 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.514 ' O ' ' C ' ' A' ' 110' ' ' ALA . 5.1 mp -40.54 -62.09 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.21 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -37.55 -65.68 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.842 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.459 ' CD ' ' C ' ' A' ' 111' ' ' GLU . 4.4 tp10 -42.32 -45.51 4.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -15.18 63.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.177 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -80.22 -45.16 18.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 109.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -63.7 -40.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.213 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.501 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 20.2 mttt -70.94 -34.63 71.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.32 -53.12 61.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.848 . . . . 0.0 109.519 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.34 84.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 115' ' ' LYS . 89.0 mt -59.47 -28.75 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.988 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.52 -46.93 12.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.74 -8.88 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.1 t80 -96.54 -43.62 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.53 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 41.3 tttt -88.38 -5.56 58.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.567 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HA ' ' CG ' ' A' ' 128' ' ' GLU . . . -89.42 -21.09 23.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -95.7 46.72 1.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.623 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -130.28 -34.68 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.92 -10.65 52.24 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 129' ' ' HIS . 1.1 tp -115.33 46.75 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -1.212 . . . . 0.0 109.677 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -63.36 80.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.41 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 127' ' ' LEU . 1.4 t60 -87.8 64.83 8.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -88.21 -91.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.601 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -162.44 84.05 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.598 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -92.69 168.64 11.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.42 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 134' ' ' HIS . 3.8 m-70 -44.74 105.06 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.589 ' N ' ' ND1' ' A' ' 134' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.471 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.591 ' O ' ' SD ' ' A' ' 1' ' ' MET . 1.2 tmt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -139.17 52.08 1.77 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 42.05 36.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.17 169.56 21.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.793 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 12.2 mp0 -87.28 102.4 14.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -78.4 154.1 30.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 8' ' ' ILE . 7.8 p -156.36 164.9 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.584 ' N ' HG22 ' A' ' 7' ' ' VAL . 13.9 mt -72.98 109.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 21.6 p-10 -103.95 84.62 2.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -88.8 122.87 32.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.498 ' O ' ' C ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -82.65 3.41 29.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' TYR . 5.6 mm-40 -38.36 114.49 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.34 71.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.008 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -46.94 157.65 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.108 2.538 . . . . 0.0 112.583 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.559 ' O ' HG22 ' A' ' 17' ' ' VAL . 20.2 mtt180 -148.1 -134.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.18 58.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.013 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -80.51 90.85 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 19' ' ' SER . . . -64.8 179.11 8.28 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 18' ' ' GLY . 70.9 m -54.52 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -1.221 . . . . 0.0 109.437 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mt -132.34 -74.55 0.51 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 23' ' ' LYS . 40.7 m-20 -112.52 24.08 12.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER 43.23 13.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.676 ' N ' ' O ' ' A' ' 21' ' ' ASP . 6.8 mttt -149.35 17.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.257 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.645 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -79.75 153.87 28.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 1.9 p -75.67 -7.64 54.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.645 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -95.99 8.7 42.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 46' ' ' LYS . 61.2 t -140.87 110.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.706 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.01 152.33 18.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.759 HG23 ' NE2' ' A' ' 44' ' ' GLN . 27.3 m -122.7 154.5 38.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.728 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.95 130.01 3.46 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 9.0 ttt -127.08 135.49 50.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -1.219 . . . . 0.0 109.947 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 31' ' ' MET . 10.9 m -154.76 146.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.0 109.208 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.9 172.26 22.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -141.79 138.77 17.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.302 -1.116 . . . . 0.0 109.198 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.62 -51.57 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.473 2.115 . . . . 0.0 112.172 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.56 -40.99 13.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 34.1 m -100.61 -0.15 38.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 39.25 47.99 2.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -130.14 148.28 51.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -1.119 . . . . 0.0 109.708 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.79 110.54 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.189 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 109' ' ' LEU . 9.4 ttt -104.07 141.5 36.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.709 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -123.08 129.68 51.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 109.156 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.42 125.38 42.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.667 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.759 ' NE2' HG23 ' A' ' 29' ' ' THR . 2.2 mt-30 -121.01 161.29 21.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.0 109.117 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.31 145.42 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HG3' HG22 ' A' ' 27' ' ' VAL . 13.2 tttt -119.64 123.77 44.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 109.093 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.74 134.99 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.2 m-20 -170.67 -31.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -62.94 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.398 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-20 78.88 41.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.12 74.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 53' ' ' ILE . 20.3 mm -100.61 165.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.603 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.567 ' N ' HG22 ' A' ' 52' ' ' ILE . 68.6 mt -79.02 88.47 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -54.19 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.66 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.1 t70 -146.61 163.78 34.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.11 144.94 31.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 169.46 9.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.755 ' CG ' HG21 ' A' ' 74' ' ' THR . 2.6 p90 -168.28 162.93 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.6 119.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.41 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 60' ' ' THR . 5.5 t -161.01 124.86 3.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -148.4 97.61 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.27 -2.44 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.31 -177.54 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.647 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.39 -14.26 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -137.26 -3.25 1.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -1.166 . . . . 0.0 109.655 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -85.74 -44.35 12.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.2 tp -34.36 -29.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.815 . . . . 0.0 109.828 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -91.35 -41.52 10.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 109.962 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.646 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -69.17 -31.31 69.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.992 . . . . 0.0 109.746 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' HG21 ' A' ' 60' ' ' THR . 9.4 m -57.92 -40.53 80.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.0 109.534 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 p -74.3 -41.54 61.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.9 tp -56.07 -59.06 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.908 HG23 ' H ' ' A' ' 74' ' ' THR . 8.7 tt -55.18 -63.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.908 ' H ' HG23 ' A' ' 73' ' ' ILE . 6.0 p -43.26 -25.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' ILE . 24.2 mt-10 -91.9 -12.93 32.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.613 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.619 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.4 m0 -101.14 -13.19 18.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.711 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.521 ' O ' HG21 ' A' ' 53' ' ' ILE . 35.3 m -111.47 34.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 109.694 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.66 ' NZ ' ' OD2' ' A' ' 55' ' ' ASP . 14.4 ttmm -120.25 89.65 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.02 -7.43 23.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -91.73 -174.67 3.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.09 154.14 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.39 -17.25 62.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.53 -40.9 76.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 109.67 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.24 -39.74 53.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.83 82.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.97 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.03 54.82 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.3 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -1.107 . . . . 0.0 109.115 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 87' ' ' ALA . 6.4 pt -42.32 -28.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.2 tttt 65.46 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -71.61 -6.7 42.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.605 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 p -73.61 -30.36 62.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.5 -39.05 91.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.19 -33.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.35 72.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.67 -46.17 14.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -49.77 -36.96 27.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.43 -27.86 12.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.461 ' C ' HD23 ' A' ' 99' ' ' LEU . 8.9 tt0 63.57 74.51 0.42 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.839 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.24 159.96 30.06 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.99 160.21 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.876 2.384 . . . . 0.0 112.262 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.12 -14.33 18.82 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.818 2.346 . . . . 0.0 112.279 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.06 -1.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.612 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -146.99 36.68 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.524 ' O ' ' C ' ' A' ' 105' ' ' HIS . 41.3 t -52.45 -33.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.729 ' ND1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -36.07 -58.34 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.659 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 56.8 m -32.63 -62.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.72 -44.04 81.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 109' ' ' LEU . 72.3 mt -58.57 -63.56 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.726 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.729 HD13 ' ND1' ' A' ' 105' ' ' HIS . 1.1 mp -39.09 -41.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.88 -56.95 15.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.617 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 112' ' ' ASP . 3.5 tm-20 -66.39 -68.85 0.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 111' ' ' GLU . 2.4 t0 -37.52 -33.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.494 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 109' ' ' LEU . . . -65.29 -52.61 53.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 111' ' ' GLU . 4.4 tp -51.99 -35.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 32.4 tttt -74.44 -48.24 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.77 -54.53 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.41 -61.11 2.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.331 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . 64.2 mt -39.17 -46.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.261 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.81 65.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -57.04 -18.45 14.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.363 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.495 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 20.6 t80 -77.33 -49.76 14.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.386 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 124' ' ' LYS . 1.3 mptm? -71.88 -47.95 49.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.372 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.06 -14.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -100.23 -10.19 21.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -109.67 -17.26 13.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.88 -71.05 0.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 128' ' ' GLU . 6.4 tp -45.99 -39.6 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 129' ' ' HIS . 0.5 OUTLIER 58.07 125.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.586 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 35.7 m-70 -86.79 -151.12 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.51 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 1.7 t60 -97.74 67.53 2.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.509 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -97.63 36.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.458 ' O ' ' CG ' ' A' ' 133' ' ' HIS . 18.3 t-80 -85.05 111.27 19.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 132' ' ' HIS . 62.8 m80 -156.93 -98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.51 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.536 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.57 76.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.606 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -80.18 -78.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.439 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 3' ' ' TYR . 6.4 t 36.6 44.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -82.65 -95.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -120.89 23.22 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.301 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t 47.83 78.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.2 pt -45.6 139.91 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.22 153.04 4.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.662 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -67.19 -99.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.531 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' H ' ' CG ' ' A' ' 10' ' ' HIS . 0.7 OUTLIER -67.76 -173.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -3.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.524 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.453 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 10.6 m120 -128.15 55.2 15.73 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.523 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 37.9 Cg_endo -69.95 117.83 5.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.818 2.345 . . . . 0.0 112.041 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.679 ' O ' ' N ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -126.58 -42.0 1.83 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -62.07 57.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.679 ' N ' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -137.03 154.39 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.607 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . 113.67 62.46 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 2.8 p 83.17 110.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -1.139 . . . . 0.0 109.472 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -79.5 -65.98 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 109.472 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 22' ' ' LYS . 8.4 t70 -145.09 174.0 11.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 6.0 mttp -88.84 5.06 45.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.937 . . . . 0.0 109.414 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -117.99 30.55 7.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.38 132.82 54.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.28 3.07 5.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.658 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.19 14.95 18.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.86 108.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.632 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.49 148.28 17.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.7 m -139.16 145.96 40.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.563 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 120.19 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.9 mtp -118.49 137.75 52.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -1.183 . . . . 0.0 109.586 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.65 163.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.88 143.8 12.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -127.39 131.79 24.01 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -73.56 -57.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.537 2.158 . . . . 0.0 112.477 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.49 -31.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 109.673 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 35' ' ' PRO . 38.1 m -118.39 1.41 11.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 39.25 55.56 2.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -136.39 163.29 30.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.251 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 79.4 t -127.22 129.05 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.714 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.9 ttt -112.41 119.93 39.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -109.43 119.92 40.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.09 130.4 54.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 148.04 48.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.489 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.0 pt -122.5 146.53 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -110.4 101.77 10.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -0.828 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG21 ' CD2' ' A' ' 121' ' ' TYR . 21.7 t -80.48 129.71 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.641 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 6.5 t0 -64.73 -60.1 3.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' ASP . 6.0 m-20 166.44 -25.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -12.86 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.815 . . . . 0.0 109.328 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.84 20.0 5.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mm -109.88 132.63 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -1.133 . . . . 0.0 109.437 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.76 87.7 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -53.29 -42.64 66.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.89 -178.74 7.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.34 113.29 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.576 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -94.02 126.15 39.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.095 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.681 ' CD1' HG21 ' A' ' 74' ' ' THR . 37.3 p90 -114.72 170.04 8.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.849 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -170.35 97.62 0.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 109.141 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -137.38 133.9 35.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -151.24 144.55 24.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.05 -39.25 2.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -85.67 91.96 8.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 109.278 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.92 52.03 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -151.12 -22.35 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 109.316 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -97.24 -11.28 24.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ALA . 3.1 mm -40.47 -27.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -97.42 -32.36 11.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.308 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.8 t -66.5 -54.05 28.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 74' ' ' THR . 0.7 OUTLIER -37.31 -51.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.517 ' O ' ' OG1' ' A' ' 74' ' ' THR . 9.2 t -62.06 -52.72 62.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 73' ' ' ILE . 43.6 tp -46.66 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.922 HG23 ' H ' ' A' ' 74' ' ' THR . 10.7 tt -43.69 -64.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.819 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.922 ' H ' HG23 ' A' ' 73' ' ' ILE . 16.6 p -35.18 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -83.93 -32.61 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.647 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.8 m95 -82.27 -2.64 53.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.598 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.672 ' O ' HG23 ' A' ' 77' ' ' VAL . 11.7 m -130.16 53.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.742 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -139.19 85.4 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.539 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.1 8.05 45.47 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -90.67 -171.36 3.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -1.149 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 154.76 18.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.94 -24.99 66.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.41 -28.44 66.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 -53.65 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.97 -25.84 22.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.128 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.73 40.87 2.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -151.01 -37.93 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -1.113 . . . . 0.0 108.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.6 pt -41.09 159.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.519 -0.738 . . . . 0.0 109.296 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.06 162.26 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.526 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -69.22 -25.2 64.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -66.21 -67.57 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.591 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 91' ' ' SER . 13.2 mm-40 -39.3 -60.63 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.8 mt -56.14 -28.68 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 91' ' ' SER . . . -77.42 -15.22 59.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 109.185 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.71 -18.51 21.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.66 -38.31 14.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -80.87 -0.8 40.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.553 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.527 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.3 tt0 37.12 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 109.37 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.7 ' N ' HD23 ' A' ' 99' ' ' LEU . 1.3 pt? -63.0 149.35 90.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.405 ' HG2' HG12 ' A' ' 102' ' ' VAL . 30.5 Cg_endo -67.17 152.82 79.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.685 2.257 . . . . 0.0 111.939 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.1 13.89 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.3 p -79.02 96.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 105' ' ' HIS . 7.0 mttm 67.31 58.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.212 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.3 0.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -0.818 . . . . 0.0 109.262 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.93 -53.95 45.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.637 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 87.6 m -30.96 -58.79 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.031 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -58.84 -56.22 25.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 107' ' ' SER . 44.9 mt -45.29 -51.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -49.63 -43.17 46.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.483 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.04 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -52.78 -40.0 62.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -25.45 68.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -72.11 -62.89 1.27 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -45.31 -36.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.157 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.3 tttt -73.31 -35.8 66.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 109.512 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.88 79.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.489 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -64.54 -38.07 89.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.9 mt -61.2 -38.01 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.66 81.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.716 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.2 -54.71 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.669 ' CD2' HG21 ' A' ' 47' ' ' VAL . 4.0 t80 -53.75 -32.08 50.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.762 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -81.04 -30.71 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.695 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.19 63.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.705 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -94.14 35.94 1.15 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.395 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.9 44.79 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.479 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . -85.69 -95.85 0.77 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.21 11.87 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.693 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.566 ' H ' ' C ' ' A' ' 126' ' ' GLY . 1.9 mt-10 56.01 176.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.566 ' ND1' ' C ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -154.58 37.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -139.68 -33.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.619 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' HIS . 1.4 t60 48.8 28.25 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.273 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -45.49 -18.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' HIS . 3.3 m-70 -71.13 -168.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.469 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.7 mpp? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.23 140.61 49.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 109.43 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.57 -128.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -121.55 -25.29 5.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -51.5 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 tttm 62.85 158.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 0.0 109.591 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 8' ' ' ILE . 10.9 t -135.74 -122.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.479 ' N ' HG12 ' A' ' 7' ' ' VAL . 17.8 mt -150.28 51.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.464 ' C ' ' CG ' ' A' ' 10' ' ' HIS . 17.4 t0 -133.61 105.29 6.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.464 ' CG ' ' C ' ' A' ' 9' ' ' ASP . 12.3 m80 -154.23 -157.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.378 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.44 39.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.2 -0.937 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 49.0 mt-10 -102.24 -80.9 0.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 2.7 t30 170.23 86.03 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -46.55 133.83 16.56 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.751 2.301 . . . . 0.0 112.043 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.734 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -139.9 129.18 23.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.99 123.25 18.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.45 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -123.6 138.38 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.513 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.76 -87.41 1.99 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p 58.35 166.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.155 . . . . 0.0 109.46 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp 59.0 36.85 24.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.665 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 52.7 t0 -54.13 -23.03 12.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.0 tttp 78.15 -9.48 1.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.601 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -140.08 14.1 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.938 . . . . 0.0 109.647 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.11 -159.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 63.67 20.42 12.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.278 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.32 38.01 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.03 133.28 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.39 113.14 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -101.71 157.46 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.526 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.31 132.86 3.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.3 ttp -141.56 123.15 15.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -1.171 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.8 149.1 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 39' ' ' ASP . . . -133.06 170.17 22.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -125.61 146.47 54.91 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.354 -1.086 . . . . 0.0 109.278 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 37' ' ' CYS . 37.1 Cg_endo -69.36 -71.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.668 2.245 . . . . 0.0 112.056 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.59 -14.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.176 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 35' ' ' PRO . 1.8 t -117.11 -12.17 10.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.396 -0.815 . . . . 0.0 109.324 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 38.3 33.33 0.17 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' CYS . 39.0 t70 -101.63 148.36 25.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 109.595 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -121.29 97.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.7 ttt -86.98 119.62 27.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -109.14 101.43 10.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.422 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.74 148.48 28.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.67 132.0 25.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.253 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.738 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.5 pt -111.22 141.98 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -114.25 148.44 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.264 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.65 130.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 t0 -70.77 -54.56 11.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.268 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 160.82 -22.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.357 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -94.43 11.05 32.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.8 30.36 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 mm -125.07 138.23 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.96 103.09 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.161 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -75.43 -42.5 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.806 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 86.3 m-20 -143.29 157.93 44.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.763 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.98 137.23 25.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -105.53 141.56 36.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -124.62 163.21 22.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -171.85 109.01 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -161.05 119.63 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -149.56 103.58 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.91 -20.01 0.03 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.4 t -126.74 116.45 20.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -57.17 172.71 2.39 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER 64.63 -69.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -1.173 . . . . 0.0 109.538 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -38.37 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' SER . 1.6 mt -58.65 2.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -106.67 -32.31 8.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 73' ' ' ILE . 17.9 p -58.79 -45.62 89.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.458 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' SER . 35.0 p -53.73 -64.39 0.84 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' SER . 31.9 m -42.32 -45.64 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.914 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 75' ' ' GLU . 56.5 tp -65.41 -84.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.704 HG23 ' N ' ' A' ' 74' ' ' THR . 9.0 tt -33.68 -52.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.704 ' N ' HG23 ' A' ' 73' ' ' ILE . 29.8 p -53.17 -44.21 67.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 72' ' ' LEU . 11.0 tm-20 -78.93 2.18 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.238 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.7 -17.97 14.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.87 . . . . 0.0 109.636 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 114' ' ' ILE . 14.3 m -98.0 -28.17 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.37 128.3 35.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -20.58 28.63 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -91.51 164.53 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.287 -1.125 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -175.4 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.827 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.02 -27.24 60.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.35 -20.59 64.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.004 . . . . 0.0 109.159 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.75 -41.67 8.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.887 . . . . 0.0 109.314 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.61 8.92 15.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.62 -57.69 0.65 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.41 -4.38 29.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -1.146 . . . . 0.0 108.816 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.95 168.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.499 -0.751 . . . . 0.0 109.65 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.423 ' O ' HD12 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -153.67 -175.15 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -94.98 -6.55 42.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.16 56.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -66.61 -59.88 3.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.857 . . . . 0.0 109.327 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 89' ' ' LYS . 3.8 mt -47.24 -41.28 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -68.04 -46.69 70.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -54.21 -25.77 24.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.49 -52.23 7.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.875 . . . . 0.0 109.566 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.8 mt -81.88 -15.87 52.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.5 mm-40 43.36 14.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.843 ' N ' HD23 ' A' ' 99' ' ' LEU . 1.6 pt? -39.96 150.0 0.27 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -41.52 162.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.811 2.341 . . . . 0.0 112.097 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.0 Cg_endo -76.42 -49.56 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.865 2.376 . . . . 0.0 112.469 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.84 27.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' ND1' ' A' ' 105' ' ' HIS . 37.3 mttt -143.45 6.99 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.542 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 105' ' ' HIS . 10.2 p -68.92 -11.44 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.614 ' ND1' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -44.02 -57.38 3.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 105' ' ' HIS . 55.1 m -56.13 -35.1 66.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -51.25 70.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.231 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.549 HG22 ' OD2' ' A' ' 112' ' ' ASP . 61.0 mt -59.16 -36.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.629 ' CD1' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -59.85 -37.72 80.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.229 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -63.83 -51.21 65.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.326 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.24 -53.64 49.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' HG22 ' A' ' 108' ' ' ILE . 2.6 m-20 -48.84 -40.99 31.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.414 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.37 13.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.31 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 77' ' ' VAL . 1.4 tp -46.86 -33.68 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.266 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' C ' ' A' ' 116' ' ' ALA . 10.6 ttmm -67.38 -71.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -38.43 -44.96 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.738 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -53.31 -54.41 36.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.8 mt -54.54 -34.68 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.544 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.98 -56.92 8.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.48 -25.18 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -80.43 -69.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.45 -24.17 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.16 16.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.292 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.23 -24.93 3.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.28 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.584 ' C ' ' H ' ' A' ' 127' ' ' LEU . 8.5 tt0 -170.21 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.341 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 127' ' ' LEU . . . -66.4 19.15 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.584 ' H ' ' C ' ' A' ' 125' ' ' GLN . 1.1 mp 68.57 23.79 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 28.3 tp10 -142.25 -107.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.621 ' O ' ' ND1' ' A' ' 130' ' ' HIS . 1.5 t-160 82.36 87.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.343 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.621 ' ND1' ' O ' ' A' ' 129' ' ' HIS . 1.3 m80 -161.63 10.68 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.129 -0.982 . . . . 0.0 109.797 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.6 t60 58.63 35.36 24.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 133' ' ' HIS . 15.0 t-80 -117.27 124.24 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -78.73 140.51 38.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.507 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.551 ' OXT' ' CG ' ' A' ' 134' ' ' HIS . 86.4 t60 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.531 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' ALA . 42.9 mmm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 44.45 32.17 0.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 4' ' ' SER . 66.5 t80 -156.8 143.62 18.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -56.32 163.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.563 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -127.03 160.55 30.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.271 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -177.09 136.92 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 p -171.63 -21.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 109.31 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.2 mt -45.46 131.01 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.841 . . . . 0.0 109.565 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.21 98.33 11.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.188 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 10' ' ' HIS . 32.7 t-80 -80.69 -17.59 50.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.565 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -72.17 -131.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -92.84 143.14 26.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -133.68 71.17 75.27 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 15' ' ' ARG . 46.9 Cg_endo -73.09 97.78 0.95 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.179 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.541 ' C ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -35.77 144.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -133.38 119.61 19.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 16' ' ' ASN . 1.0 OUTLIER -42.36 -62.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.44 4.55 73.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.92 135.5 52.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -1.087 . . . . 0.0 109.511 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -123.74 -57.24 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.123 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 23' ' ' LYS . 18.7 m-20 -128.55 8.42 5.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.142 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 49.4 13.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 21' ' ' ASP . 11.2 tttm -148.69 13.28 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.596 ' OD2' ' N ' ' A' ' 26' ' ' ASN . 1.1 t70 -61.89 170.55 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 24' ' ' ASP . 92.6 p -75.83 -11.29 59.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.596 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 32.9 m120 -116.44 25.09 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -147.37 107.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.384 -0.822 . . . . 0.0 109.222 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.25 143.83 17.59 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -120.27 132.58 55.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -1.083 . . . . 0.0 109.186 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.08 123.03 4.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttt -125.15 115.91 21.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -1.085 . . . . 0.0 109.117 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.4 166.28 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.77 165.31 31.53 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.1 152.74 65.71 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.237 . . . . 0.0 109.67 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.4 Cg_endo -77.09 -64.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.17 -45.76 2.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.656 ' HB2' ' CE1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -94.65 -4.82 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 109.232 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.0 41.37 0.45 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' CYS . 10.0 t70 -115.47 155.63 27.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -1.122 . . . . 0.0 109.761 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.61 105.68 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.18 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.471 ' HG3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -89.53 143.95 26.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.833 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 41' ' ' MET . 5.4 tt0 -129.23 110.04 11.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.125 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 44' ' ' GLN . 5.8 tt -121.97 132.34 54.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.492 ' N ' HD23 ' A' ' 43' ' ' LEU . 8.3 mp0 -124.04 177.96 5.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 44' ' ' GLN . 6.6 pt -154.86 151.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.617 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -114.64 163.6 15.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.348 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 4.9 t -132.5 107.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.545 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.71 -65.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 169.91 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.667 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -92.56 16.4 12.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.37 22.42 60.57 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.52 147.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.503 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.3 mt -82.35 112.99 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.9 -36.42 18.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.759 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.96 165.44 24.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.7 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.08 120.28 4.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -108.02 159.1 16.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD2' HG21 ' A' ' 74' ' ' THR . 2.8 p90 -163.34 162.16 24.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -171.44 119.47 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.342 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 41' ' ' MET . 17.0 p -116.66 102.39 9.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 0.0 109.531 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -109.54 113.49 26.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.37 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.79 -39.5 1.96 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.2 m -79.05 152.14 31.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -1.161 . . . . 0.0 109.574 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.47 38.6 2.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -167.66 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -1.137 . . . . 0.0 109.429 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -86.44 -36.71 18.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.541 ' C ' ' O ' ' A' ' 66' ' ' ALA . 4.9 mt -36.03 -48.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.74 -54.69 30.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 73' ' ' ILE . 97.1 p -62.0 -49.04 77.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.362 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -47.38 -46.59 26.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -61.59 -35.77 78.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 109.229 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' CD1' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -69.26 -68.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 69' ' ' SER . 5.9 tt -48.46 -47.57 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 70' ' ' SER . 23.1 p -49.24 -45.43 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.15 0.41 53.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.792 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -17.51 17.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.66 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 114' ' ' ILE . 17.8 m -111.75 10.76 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -85.56 103.48 14.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.99 40.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -97.34 -171.09 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.468 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -112.74 139.72 48.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.0 mt -53.09 -28.72 26.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.259 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.02 -30.09 68.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.02 -57.66 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.272 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.35 -17.6 3.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.198 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.45 49.5 0.86 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -172.69 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -1.096 . . . . 0.0 109.324 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -50.6 178.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -137.1 -168.28 2.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.332 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -103.5 -30.78 10.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -51.82 -33.69 36.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' ILE . 5.5 mt-30 -69.48 -66.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 1.8 mt -44.5 -40.8 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.64 -49.63 61.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.934 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.93 -24.41 23.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.532 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 72' ' ' LEU . 3.5 tt0 -82.11 -33.19 29.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.94 -15.07 35.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 48.62 73.41 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.236 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.027 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -129.2 139.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -42.5 146.88 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.55 -20.97 22.88 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.667 2.245 . . . . 0.0 112.126 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.88 -4.68 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.444 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -135.93 16.4 3.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.568 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.525 ' O ' ' C ' ' A' ' 105' ' ' HIS . 8.4 p -60.68 -14.96 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.755 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER -33.95 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.707 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.755 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 77.0 m -31.26 -58.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.539 -0.726 . . . . 0.0 110.121 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -50.39 -64.27 0.86 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 109.62 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 5.6 mt -42.27 -42.61 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.82 -32.98 74.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -59.71 -48.29 82.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.203 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.529 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 6.3 tp10 -68.91 -51.91 34.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.371 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -53.85 -28.78 38.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.12 -60.73 2.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.455 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -48.26 -33.85 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -76.41 -28.58 56.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -56.8 8.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -52.79 63.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.368 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -48.77 -38.84 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.92 66.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -77.2 -7.76 56.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.52 -38.58 6.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -71.88 -35.62 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.55 -22.26 62.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -84.08 42.12 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.389 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -106.52 -54.06 2.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.49 -96.02 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 127' ' ' LEU . 1.1 mp -114.13 23.77 12.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 129' ' ' HIS . 22.9 mt-10 56.16 -124.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 128' ' ' GLU . 0.1 OUTLIER -179.43 149.91 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -145.78 -75.97 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.325 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -129.77 -162.0 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.379 -0.826 . . . . 0.0 109.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -141.52 175.86 9.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 133' ' ' HIS . 1.0 OUTLIER -90.66 -112.31 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 mtm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.07 169.96 16.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.6 -26.66 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.07 156.23 16.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.95 -31.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -46.35 126.25 7.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.878 . . . . 0.0 109.58 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -69.99 -162.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 mt -111.49 -87.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.625 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 10' ' ' HIS . 19.6 p-10 -112.97 89.22 3.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.543 ' O ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -52.59 -166.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.243 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 1.4 p90 -100.57 10.23 41.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -54.34 -92.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.242 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -158.7 68.05 3.41 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.24 141.19 97.56 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.926 2.417 . . . . 0.0 112.178 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.733 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -111.6 118.47 35.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -100.23 124.91 46.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.87 163.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.418 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 19' ' ' SER . . . -69.56 -72.37 0.87 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 58.45 129.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -1.08 . . . . 0.0 109.618 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tp 55.69 30.57 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 12.3 t70 -102.64 -5.55 23.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.9 tttp 72.03 -5.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -118.28 18.16 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.744 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -102.59 138.74 39.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.457 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -72.7 10.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 24' ' ' ASP . 1.8 m120 -111.2 20.56 17.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 27' ' ' VAL . 45.1 t -137.7 90.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.639 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.43 145.95 48.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 m -135.27 108.86 7.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -1.124 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 117' ' ' ALA . . . -105.82 150.29 16.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 ttm -144.45 127.18 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.357 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.28 161.38 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.48 164.86 18.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB2' HD22 ' A' ' 109' ' ' LEU . . . -136.89 85.69 22.82 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.149 -1.206 . . . . 0.0 109.854 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.08 -20.3 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.712 2.275 . . . . 0.0 111.94 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.42 -53.51 23.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.174 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -103.84 17.84 23.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.198 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.86 55.08 1.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 61' ' ' TYR . 40.6 t0 -126.65 146.37 50.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -1.163 . . . . 0.0 109.713 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.36 113.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 ttt -99.86 134.3 42.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.37 128.97 46.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -129.58 142.85 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.22 150.33 47.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.145 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.05 148.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.943 . . . . 0.0 109.705 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -114.74 120.93 41.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -103.96 127.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' CG ' ' N ' ' A' ' 49' ' ' ASP . 2.9 t0 -62.89 -94.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.609 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 4.8 t70 -154.22 24.43 0.48 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 14.71 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 25.24 57.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mm -108.69 130.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.582 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -88.45 102.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.195 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.38 -46.64 14.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.58 141.97 51.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.22 129.15 42.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -101.22 164.01 12.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD1' HG21 ' A' ' 74' ' ' THR . 30.2 p90 -156.8 162.73 39.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.574 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.22 98.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.75 138.44 32.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -157.04 123.84 5.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.319 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.05 -61.71 0.36 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 t -84.21 134.39 34.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.712 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.39 20.0 6.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -27.75 6.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.129 . . . . 0.0 109.361 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.27 7.85 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mm -77.9 -40.34 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.835 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.88 -45.25 17.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 109.656 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' ILE . 75.2 m -53.15 -49.34 66.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.562 ' OG ' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -34.35 -66.83 0.15 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.841 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.562 ' N ' ' OG ' ' A' ' 70' ' ' SER . 66.1 m -55.44 -40.44 71.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 73' ' ' ILE . 4.4 tp -60.2 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.933 . . . . 0.0 109.843 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.836 HG23 ' H ' ' A' ' 74' ' ' THR . 5.6 tt -36.44 -62.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.958 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.836 ' H ' HG23 ' A' ' 73' ' ' ILE . 56.8 p -40.34 -39.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mm-40 -86.07 -15.39 41.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.552 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.57 -5.43 55.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 109.688 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.32 20.75 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 109.607 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -96.53 87.97 4.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.66 -3.82 7.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -89.16 167.71 12.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -1.127 . . . . 0.0 109.392 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.55 176.05 5.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.86 -21.34 66.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.575 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -70.55 -40.93 73.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -79.63 -51.01 9.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.706 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.51 63.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 109.408 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.95 26.0 25.21 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.8 18.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 109.202 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.467 HD11 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -79.95 171.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.414 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -136.19 140.57 43.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 108' ' ' ILE . 11.4 p30 -68.36 -23.1 64.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -56.24 -36.35 68.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -73.54 -59.01 2.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 109.735 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mt -46.77 -40.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -73.73 -42.6 60.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 109.836 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.567 ' OE1' ' O ' ' A' ' 95' ' ' GLU . 2.6 tm-20 -57.6 -30.35 65.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.03 -39.44 29.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.003 . . . . 0.0 109.716 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -95.35 -5.04 44.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.698 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 94' ' ' ALA . 17.6 tp10 41.17 44.68 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 151.26 87.89 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.641 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.03 109.41 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.954 2.436 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 103' ' ' LYS . 65.3 Cg_endo -79.79 -79.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.699 2.266 . . . . 0.0 112.129 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.518 HG23 ' C ' ' A' ' 101' ' ' PRO . 0.4 OUTLIER 53.65 -76.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 101' ' ' PRO . 9.3 mtpp -118.3 -6.21 10.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 108' ' ' ILE . 17.3 t 47.38 60.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.358 -0.839 . . . . 0.0 109.56 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -91.31 -38.75 12.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 1.9 m -71.41 -67.68 0.5 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -37.43 -65.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.307 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.591 ' N ' ' OG ' ' A' ' 107' ' ' SER . 3.3 mt -44.71 -43.08 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.82 HD22 ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -59.95 -37.99 81.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -57.79 -55.67 31.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 114' ' ' ILE . 2.8 tm-20 -57.1 -60.82 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.65 -31.43 2.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 109.031 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -61.2 -53.24 59.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 108.98 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp -49.74 -39.93 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 108.785 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.492 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -73.01 -22.11 60.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.47 -0.769 . . . . 0.0 109.308 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -71.01 -60.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.408 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . -58.62 -34.65 71.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.344 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.23 -43.76 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.0 91.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.89 -26.02 65.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -66.37 -65.06 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -25.37 60.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -57.38 -47.96 80.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -75.11 15.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 123' ' ' ALA . 13.8 tt0 -117.2 2.84 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.36 -1.13 63.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.37 38.63 29.9 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 0.0 109.345 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -116.17 119.13 34.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -123.47 152.59 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.359 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.715 ' HD1' ' C ' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -144.77 -42.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' HIS . 0.7 OUTLIER -43.32 113.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 109.466 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.561 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 56.2 t-80 -100.94 -0.12 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.53 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.412 ' ND1' ' O ' ' A' ' 134' ' ' HIS . 16.7 t-80 -90.21 -47.73 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.412 ' O ' ' ND1' ' A' ' 133' ' ' HIS . 3.2 t-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.392 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.3 0.571 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.06 -150.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.45 148.07 29.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -99.27 162.47 13.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.33 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.91 3.45 12.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -122.48 -172.11 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' ILE . 1.3 m -124.39 -165.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.535 ' C ' ' O ' ' A' ' 7' ' ' VAL . 12.7 tt -37.62 157.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.177 -0.952 . . . . 0.0 109.234 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 10' ' ' HIS . 11.8 p30 -133.17 -138.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.608 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -98.85 172.28 7.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.549 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -77.83 12.68 1.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 56.65 -171.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -133.49 65.68 72.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 109.422 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -45.96 -61.19 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.916 2.411 . . . . 0.0 112.287 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' ASN . 1.1 tpm_? -84.78 110.93 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' ARG . 1.2 m-20 -43.37 142.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -56.94 157.43 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -74.98 0.56 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.55 138.69 45.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 20' ' ' LEU . 5.2 mp -92.86 -109.17 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 109.713 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -81.28 4.66 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.784 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.3 tttp 74.61 -13.62 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 109.416 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.26 39.54 3.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.627 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -83.71 163.98 19.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.09 -4.52 29.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.702 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -124.08 20.85 9.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.11 92.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.91 22.43 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -135.12 148.56 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.244 . . . . 0.0 109.862 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.48 140.43 10.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttm -133.86 113.16 11.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.49 149.69 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.93 -178.56 15.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.711 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -148.07 135.52 10.64 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.347 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.31 -38.2 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.458 2.106 . . . . 0.0 112.269 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -60.77 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLY . 20.7 m -87.88 2.44 51.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.16 46.1 3.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.665 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -116.11 148.29 40.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -1.127 . . . . 0.0 109.782 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -110.09 116.46 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.444 ' CE ' HD13 ' A' ' 43' ' ' LEU . 12.9 ttt -105.91 123.27 47.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -112.2 98.41 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.444 HD13 ' CE ' ' A' ' 41' ' ' MET . 8.7 tp -93.7 137.07 33.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.729 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -131.57 123.56 28.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.366 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.467 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.9 pt -105.97 156.26 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.512 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' A' ' 54' ' ' GLU . 7.3 tttm -128.36 149.63 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.38 149.37 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.513 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.5 -96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.82 17.5 0.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -130.83 -25.76 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.673 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.32 9.93 3.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -100.1 133.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 0.0 109.436 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.2 mt -76.26 110.6 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.211 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -87.32 -39.0 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.576 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.37 170.3 16.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.81 120.97 2.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -96.02 161.22 14.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.322 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' C ' ' CD1' ' A' ' 58' ' ' PHE . 4.6 p90 -150.32 170.49 18.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 4.8 tttt -172.06 97.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.735 HG21 ' OG ' ' A' ' 70' ' ' SER . 70.6 p -110.23 104.45 13.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.425 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 100.43 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.578 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' CA ' ' OD2' ' A' ' 39' ' ' ASP . . . 148.73 -43.96 0.77 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.665 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.6 m -88.77 105.53 17.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.94 63.14 4.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.47 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.144 -1.209 . . . . 0.0 109.371 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . . . -98.03 -15.96 19.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 68' ' ' ALA . 4.2 mt -42.15 -80.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -34.38 -56.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.674 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -45.35 -58.11 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.735 ' OG ' HG21 ' A' ' 60' ' ' THR . 46.1 m -48.2 -37.96 17.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.882 . . . . 0.0 109.438 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.8 t -70.04 -33.53 72.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 109.411 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 75' ' ' GLU . 30.0 tp -67.31 -68.78 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -41.51 -45.73 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.226 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' SER . 22.6 p -58.72 -33.59 70.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.284 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.4 tt0 -83.19 -5.1 59.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.434 ' HE1' HD11 ' A' ' 72' ' ' LEU . 17.7 m0 -98.72 -26.59 14.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG11 HD11 ' A' ' 114' ' ' ILE . 8.2 m -94.73 -3.13 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.978 . . . . 0.0 109.796 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -81.88 107.72 14.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.46 -21.66 30.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -84.48 178.78 7.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.122 -1.222 . . . . 0.0 109.571 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.96 172.19 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.32 -28.37 62.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 -24.24 66.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 109.21 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.8 -52.66 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.03 -36.77 68.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.349 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.35 48.41 4.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.51 -37.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.162 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -37.74 161.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -130.4 170.94 13.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.529 ' OD1' HD13 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -85.27 -15.17 44.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -59.11 -39.59 82.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -71.46 -52.89 15.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.6 mt -54.72 -41.38 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.83 -29.53 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.76 -42.06 61.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.44 -24.28 60.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.806 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.13 -36.46 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.024 -1.047 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 94' ' ' ALA . 3.5 mt-10 62.32 18.27 10.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.249 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.716 ' N ' HD23 ' A' ' 99' ' ' LEU . 1.9 pt? -48.46 149.72 2.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.0 154.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.266 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 104' ' ' VAL . 45.9 Cg_endo -72.48 -74.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.824 2.349 . . . . 0.0 112.091 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER 43.01 46.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.2 OUTLIER 76.36 10.39 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER 35.92 27.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.711 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.29 -36.22 83.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.366 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 68.9 m -55.5 -65.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.572 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.8 t -53.84 -57.11 12.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.529 HD13 ' OD1' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -47.02 -32.32 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.577 HD13 ' HD1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -70.01 -37.51 75.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.3 88.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.033 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.25 -53.88 21.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 109.273 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -54.13 -23.78 15.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.379 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.06 -50.74 21.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 109.222 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.702 HD11 HG11 ' A' ' 77' ' ' VAL . 1.2 tp -51.6 -39.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 108.963 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 8.4 mttm -74.03 -49.7 23.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.389 -0.819 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -44.98 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -69.53 -59.77 2.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 108.99 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.5 mt -41.06 -38.6 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.021 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.81 -57.84 10.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.052 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -50.71 -32.67 20.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.18 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.87 -60.19 4.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.489 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.55 -44.0 97.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.45 -53.87 32.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -29.98 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.369 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 126' ' ' GLY . 6.6 tt0 -91.97 -102.71 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . 78.4 -25.3 2.39 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 127' ' ' LEU . 4.5 mm? -66.43 20.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.548 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.607 ' H ' ' C ' ' A' ' 126' ' ' GLY . 5.2 mt-10 -74.86 -78.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -111.44 145.62 38.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -177.64 4.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.707 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.64 36.67 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -85.31 -4.99 59.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.239 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -51.12 152.36 2.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 109.434 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 133' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.482 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.238 0.542 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 3' ' ' TYR . . . -81.85 158.14 24.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.435 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 4.0 m-85 68.76 -176.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.506 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.625 ' O ' ' N ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -133.95 166.04 23.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.284 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 64.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.6 ttmm -93.19 60.63 3.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 6' ' ' LYS . 51.7 t -39.76 137.26 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.885 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.8 mp -87.97 -116.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.648 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.697 ' N ' HG22 ' A' ' 8' ' ' ILE . 49.7 t0 -148.28 -88.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -108.91 -40.52 5.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 174.89 -65.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 179.9 0.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m120 58.12 83.56 0.22 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.28 -134.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.821 2.347 . . . . 0.0 112.038 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -95.86 137.04 35.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' ARG . 2.3 m-20 -59.86 -146.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.407 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.55 146.27 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 0.0 109.476 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.92 -61.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m -86.55 164.57 16.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -1.177 . . . . 0.0 109.587 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.39 -88.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -138.64 129.94 27.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 21' ' ' ASP . 9.6 mttt -40.53 -38.78 0.91 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 109.433 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.48 48.05 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -125.63 135.3 52.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -71.36 -1.7 13.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.49 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.416 ' C ' HG23 ' A' ' 27' ' ' VAL . 49.2 m-20 -105.19 18.02 23.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.354 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 26' ' ' ASN . 73.6 t -152.94 97.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.515 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.93 150.96 28.34 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -127.57 150.45 49.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.42 126.49 3.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -129.4 123.49 31.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.56 165.86 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.77 165.93 27.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -137.39 132.61 17.85 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.195 -1.18 . . . . 0.0 109.527 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.33 -38.07 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.51 2.14 . . . . 0.0 111.948 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -56.87 11.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.245 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.72 -4.57 54.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.69 47.68 30.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 1.2 t0 -122.19 139.23 54.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -1.106 . . . . 0.0 109.581 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 20.5 m -92.95 123.13 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.858 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 42' ' ' GLN . 2.8 ttt -113.92 144.59 42.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' N ' ' HG3' ' A' ' 41' ' ' MET . 22.1 tt0 -149.29 120.04 7.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.22 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.39 130.85 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -123.73 155.14 38.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -0.909 . . . . 0.0 109.111 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.38 137.9 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -102.48 147.21 27.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.418 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.62 126.52 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.6 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' C ' ' OD1' ' A' ' 48' ' ' ASP . 30.2 t0 -63.29 -96.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 109.416 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -160.0 23.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.92 19.9 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 7.28 88.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.7 mm -99.84 155.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 109.447 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mt -99.08 109.83 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.05 -41.29 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.674 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 11.2 p-10 -157.62 167.59 29.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.66 129.89 41.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.342 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -95.2 125.63 39.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.696 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -114.58 157.67 22.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -166.13 99.24 0.63 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 60' ' ' THR . 12.5 t -164.41 113.35 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.517 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 60' ' ' THR . 21.6 m-85 -137.53 102.97 4.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.97 -7.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 66' ' ' ALA . 1.1 m -90.75 178.78 5.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.329 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.41 -11.8 14.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -141.43 -16.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.155 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . . . -79.99 -9.64 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 68' ' ' ALA . 1.7 tt -67.69 -40.85 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.652 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.512 ' N ' HG23 ' A' ' 67' ' ' ILE . . . -76.55 -28.76 56.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.657 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.7 p -60.14 -58.63 7.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' THR . 0.9 OUTLIER -34.8 -48.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.74 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -65.15 -46.85 79.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -63.53 -73.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.755 HG23 ' N ' ' A' ' 74' ' ' THR . 14.7 tt -39.22 -56.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.755 ' N ' HG23 ' A' ' 73' ' ' ILE . 22.1 p -46.87 -46.1 20.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.78 -13.9 62.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.633 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.41 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 m0 -89.64 -31.38 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.01 32.15 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.689 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.94 102.14 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.59 8.67 57.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -92.28 -175.81 4.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.64 149.09 24.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.494 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.18 -19.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.144 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -51.81 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ALA . 3.7 mt-10 -68.05 -55.94 10.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.96 -44.26 9.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.96 52.8 4.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -167.2 -46.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -1.15 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -36.1 158.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.429 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -121.84 168.36 11.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 7.5 p30 -82.83 -20.21 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.5 p -52.26 -40.76 62.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' ILE . 1.7 mm-40 -67.13 -70.93 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 92' ' ' GLN . 22.0 mt -41.57 -39.7 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.42 -53.05 40.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -47.98 -47.54 32.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -38.54 82.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.7 mt -79.66 -26.55 40.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 98' ' ' GLU . 2.7 tm-20 50.91 66.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.708 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 1.047 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.9 pt? -112.44 145.26 32.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.54 153.18 62.95 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.47 11.19 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.878 2.386 . . . . 0.0 112.259 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.569 HG13 ' HG2' ' A' ' 103' ' ' LYS . 8.0 p -82.78 2.04 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.569 ' HG2' HG13 ' A' ' 102' ' ' VAL . 0.6 OUTLIER 179.9 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 105' ' ' HIS . 6.2 p -72.1 -8.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.695 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -39.45 -55.75 1.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.695 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 62.0 m -31.16 -59.38 0.23 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.44 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 5.9 p -61.87 -55.63 27.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.984 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.44 ' N ' ' OG ' ' A' ' 107' ' ' SER . 1.6 mm -45.88 -53.85 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.51 -41.8 61.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 109.942 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.27 -65.12 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 109.671 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 11.7 tt0 -54.29 -41.85 69.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.5 -28.6 68.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.33 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -48.85 -38.05 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 1.1 mmtt -71.44 -31.46 67.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.304 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.94 67.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.63 87.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.393 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.12 -46.95 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.261 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.31 76.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -34.28 72.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.624 ' CE2' ' O ' ' A' ' 25' ' ' SER . 3.7 t80 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.953 . . . . 0.0 109.652 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -33.24 27.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.743 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 4.86 9.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.504 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -112.67 10.34 19.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -82.18 -68.69 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.398 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.404 ' C ' ' N ' ' A' ' 128' ' ' GLU . . . 133.41 18.52 1.02 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.58 -10.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.006 -1.29 . . . . 0.0 109.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 6.1 tt0 -49.09 -52.97 22.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.536 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.524 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.3 t-80 77.4 131.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 51.23 58.07 5.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.263 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.23 133.96 34.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.444 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -109.68 -49.15 3.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.642 ' ND1' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -175.69 113.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.577 ' ND1' ' C ' ' A' ' 133' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.385 0.612 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 -4.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.498 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 5' ' ' GLU . 50.4 m -142.15 151.73 42.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.502 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 4' ' ' SER . 4.4 mm-40 -58.01 -132.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.447 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.0 99.36 10.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.3 m -51.97 154.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 109.259 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.91 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -80.12 177.79 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.31 109.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.549 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -122.84 45.15 2.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.09 148.85 24.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -169.84 123.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER 179.71 65.22 0.13 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.66 92.48 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.929 2.419 . . . . 0.0 112.401 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER 62.8 142.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.613 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.572 ' O ' ' O ' ' A' ' 15' ' ' ARG . 7.6 t30 51.22 166.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 17' ' ' VAL . 10.0 p -142.02 -3.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.373 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.89 -86.88 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -66.95 176.88 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -1.124 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.4 mt -137.0 -68.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 109.515 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 23' ' ' LYS . 21.1 m-20 -123.92 20.26 9.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.506 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.4 tttt 56.31 -0.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.645 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.7 tttm -167.06 51.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 26' ' ' ASN . 37.3 t0 -95.1 27.3 3.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.412 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.3 OUTLIER 48.08 9.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.237 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 24' ' ' ASP . 61.3 m-20 -117.62 0.7 12.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.39 114.41 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.375 -0.828 . . . . 0.0 109.47 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.83 127.58 11.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.0 m -108.0 140.21 41.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -1.132 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.9 129.57 4.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 ttm -126.53 100.71 6.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -1.12 . . . . 0.0 109.35 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.1 m -117.11 170.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.12 167.42 39.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -136.97 139.33 28.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 38' ' ' GLY . 48.5 Cg_endo -72.93 -59.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.596 2.198 . . . . 0.0 112.259 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.07 -42.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 1.2 m -98.18 -4.49 35.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 41.84 45.76 4.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.671 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 54.3 t0 -120.07 131.17 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -1.092 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 40' ' ' VAL . 8.5 p -104.05 118.42 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.226 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.4 ttt -115.26 153.59 30.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -133.74 121.13 21.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -108.54 112.32 24.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.889 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -114.94 121.69 43.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.33 137.59 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -99.39 123.94 44.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.1 t -118.93 135.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 6.2 t70 -62.82 -59.99 4.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 167.08 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 0.0 109.125 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.72 -22.36 29.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.254 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.57 7.73 5.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.75 132.72 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -1.118 . . . . 0.0 109.434 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 54' ' ' GLU . 16.4 mt -84.28 84.57 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.708 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.9 OUTLIER -43.61 -53.14 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 108.863 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -143.53 -177.22 5.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.1 132.55 4.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -108.69 156.75 19.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.842 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.728 ' CD1' HG21 ' A' ' 74' ' ' THR . 12.5 p90 -139.52 170.6 15.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.958 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -167.72 98.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.38 116.88 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -149.17 96.79 2.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.84 -12.09 0.08 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.671 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.8 m -96.78 168.54 10.44 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.247 -1.149 . . . . 0.0 109.358 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.38 44.14 1.43 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.49 -3.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 109.552 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -97.23 -22.86 16.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.077 ' H ' HD12 ' A' ' 67' ' ' ILE . 3.5 mp -36.8 -36.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -83.17 -57.62 3.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -42.33 -50.59 5.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -36.07 -56.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' OG ' ' A' ' 70' ' ' SER . 7.0 m -64.12 -36.58 84.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 75' ' ' GLU . 8.6 tp -65.46 -79.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 77' ' ' VAL . 7.8 tt -34.93 -41.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 109.74 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.728 HG21 ' CD1' ' A' ' 58' ' ' PHE . 6.6 p -68.25 -35.97 78.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.726 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 72' ' ' LEU . 3.3 mt-10 -85.57 -1.98 57.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -100.99 -23.69 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 73' ' ' ILE . 33.8 m -115.39 50.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.88 . . . . 0.0 109.228 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -120.15 100.46 7.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.699 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.39 77.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -169.97 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -1.17 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.8 173.08 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mt -65.35 -28.03 69.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.57 -19.6 64.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.96 -31.18 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.36 40.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.625 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.69 54.66 0.84 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.9 pt -39.17 -26.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.9 ttmm 49.49 179.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' GLN . 31.5 p-10 -96.27 -55.61 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.1 m -38.27 -24.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.751 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 90' ' ' ASN . 27.5 tt0 -79.29 -52.94 7.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 5.4 tt -59.48 -40.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.273 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -63.52 -46.37 86.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.269 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -37.65 79.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.065 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.88 -37.7 84.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.237 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.28 -20.36 59.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.268 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 67.67 10.26 7.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.1 152.67 92.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.476 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.0 165.74 25.26 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.861 2.374 . . . . 0.0 112.271 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.01 -41.58 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.88 2.387 . . . . 0.0 112.275 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.7 p -45.18 102.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 102' ' ' VAL . 11.0 ttmt 84.53 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 107' ' ' SER . 13.9 p -83.8 -2.73 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.693 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -38.45 -59.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.456 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.693 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 96.5 m -33.26 -48.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.518 ' HB2' HG22 ' A' ' 104' ' ' VAL . 71.0 m -65.14 -60.62 2.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 97.3 mt -42.8 -40.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 109.071 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.535 HD22 ' HE1' ' A' ' 105' ' ' HIS . 0.9 OUTLIER -57.06 -63.56 1.17 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -36.24 -45.42 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.548 ' OE2' ' O ' ' A' ' 111' ' ' GLU . 4.5 tp10 -64.76 -55.78 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.682 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.32 -19.62 23.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 43' ' ' LEU . . . -72.99 -50.27 24.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -31.42 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.165 -0.959 . . . . 0.0 109.362 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -55.5 8.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.7 -52.37 11.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.724 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -59.37 -65.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 117' ' ' ALA . 6.2 mt -36.76 -33.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.086 -1.009 . . . . 0.0 109.65 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 121' ' ' TYR . . . -76.39 -64.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -0.983 . . . . 0.0 109.739 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.531 ' O ' ' OD1' ' A' ' 120' ' ' ASP . 9.4 t0 -52.5 -2.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.562 ' H ' ' C ' ' A' ' 119' ' ' ALA . 69.4 t80 -98.19 -56.96 2.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.52 -26.97 65.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.61 71.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.522 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.4 -40.16 74.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.44 28.99 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . -108.74 -102.85 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.527 ' H ' HD12 ' A' ' 127' ' ' LEU . 3.0 mp -69.33 40.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 109.648 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 126' ' ' GLY . 32.4 mt-10 -147.41 74.07 1.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 30.9 m170 -86.59 14.88 6.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.651 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 129' ' ' HIS . 12.0 m-70 -165.29 -94.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.489 ' CG ' ' H ' ' A' ' 132' ' ' HIS . 23.3 t-80 -162.18 -119.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.489 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 5.1 t60 -66.2 89.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.239 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -127.11 128.19 45.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.433 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -113.08 74.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.526 ' C ' ' O ' ' A' ' 2' ' ' ALA . 71.2 m-85 36.83 -120.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.508 ' C ' ' OE1' ' A' ' 5' ' ' GLU . 48.1 t -110.63 -92.97 0.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -109.83 146.83 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -174.51 73.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 0.0 109.408 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 7' ' ' VAL . 1.5 m -84.84 111.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.76 140.46 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.08 113.81 25.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.36 127.55 36.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.3 -92.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.657 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.56 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.084 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.23 163.51 24.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.767 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.35 108.77 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.894 2.396 . . . . 0.0 112.622 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.717 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -136.16 19.53 3.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.045 179.395 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -109.03 6.11 24.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.193 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 18' ' ' GLY . 3.7 t -71.29 -36.47 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -50.39 -95.22 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -71.11 171.29 11.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -1.203 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mp -103.0 -86.7 0.43 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 23' ' ' LYS . 10.6 t0 -149.54 163.85 36.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 0.0 109.667 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -76.47 -17.13 59.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.224 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 3.0 mmmp? -105.21 27.57 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.852 . . . . 0.0 109.246 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.82 165.19 14.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.0 109.534 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -96.41 9.67 40.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.16 0.58 7.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.88 103.08 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.712 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.56 155.92 34.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 44' ' ' GLN . 67.7 m -136.76 126.92 26.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.247 . . . . 0.0 109.958 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 117' ' ' ALA . . . -109.59 123.25 6.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.7 ttt -130.56 126.58 37.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.14 -1.212 . . . . 0.0 109.851 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.33 -174.34 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 109.026 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.21 144.55 8.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -111.21 132.58 21.67 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.358 -1.083 . . . . 0.0 109.225 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.0 Cg_endo -75.38 -53.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.547 2.165 . . . . 0.0 112.342 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.72 -47.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.7 p -114.48 11.3 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.59 62.28 0.97 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -116.26 117.4 29.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.6 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 40' ' ' VAL . 14.1 p -87.46 119.33 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.555 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.3 ttt -111.4 122.41 47.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 109.659 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -119.44 99.04 6.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 74' ' ' THR . 7.5 tp -101.34 127.98 47.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.583 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -115.72 125.44 52.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -114.75 118.75 34.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.09 142.23 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.559 ' OD2' ' O ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -89.02 -96.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.714 ' OD1' ' ND2' ' A' ' 50' ' ' ASN . 3.7 p30 -153.52 19.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.714 ' ND2' ' OD1' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -145.67 43.86 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.63 31.94 30.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.0 mm -122.11 131.22 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.73 109.8 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.162 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -70.71 -23.57 62.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.851 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -169.91 157.73 6.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.035 . . . . 0.0 109.885 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.74 137.67 43.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.222 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 19.3 mttp -101.45 137.49 39.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.735 ' HB3' HG21 ' A' ' 74' ' ' THR . 23.8 p90 -116.7 137.17 52.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.09 85.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' CD1' ' A' ' 61' ' ' TYR . 1.4 t -143.04 138.54 30.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.434 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -160.79 125.83 3.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.364 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.13 -64.71 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.46 142.55 27.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' A' ' 66' ' ' ALA . . . -76.5 168.35 54.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.26 -32.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -1.108 . . . . 0.0 109.528 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . -67.0 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.31 -72.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 109.425 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.3 -48.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.35 -33.72 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.377 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 67' ' ' ILE . 40.3 t -67.21 -64.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 70' ' ' SER . 7.7 p -43.41 -27.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.083 -1.011 . . . . 0.0 109.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.534 ' O ' ' C ' ' A' ' 73' ' ' ILE . 7.4 tp -78.12 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.863 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.534 ' C ' ' O ' ' A' ' 72' ' ' LEU . 8.4 tt -34.89 -41.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.667 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.735 HG21 ' HB3' ' A' ' 58' ' ' PHE . 74.7 p -61.61 -51.14 69.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 72' ' ' LEU . 14.3 tt0 -70.29 -5.34 27.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -88.94 -30.79 18.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.57 6.09 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -74.21 112.51 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.704 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.63 -9.13 77.2 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.18 -170.97 3.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 109.587 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.34 164.41 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.422 HD22 HG12 ' A' ' 118' ' ' ILE . 27.9 mt -59.51 -24.55 63.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -59.76 -48.05 83.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.93 -36.71 75.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.519 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.55 -26.01 66.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.53 44.62 1.44 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.29 -33.85 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -35.84 -47.76 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 65.17 142.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -66.12 -34.69 78.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.3 p -49.32 -41.28 38.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -58.57 -49.27 78.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.09 -35.36 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.01 -18.77 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.75 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.47 -34.76 17.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.858 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.33 -25.45 25.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.957 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -105.61 -8.8 17.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.66 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' LEU . 23.8 mp0 44.79 15.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.482 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.1 pp -41.61 148.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.539 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.7 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.816 2.344 . . . . 0.0 112.305 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 103' ' ' LYS . 60.9 Cg_endo -82.72 9.62 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.73 2.287 . . . . 0.0 112.228 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.9 m -46.4 -8.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.933 . . . . 0.0 109.338 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.654 ' N ' ' O ' ' A' ' 101' ' ' PRO . 2.7 tttm -172.55 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.863 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.5 63.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.457 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.681 ' CD2' ' H ' ' A' ' 106' ' ' CYS . 26.7 p-80 -96.86 -57.12 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.681 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -57.59 -40.59 79.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -63.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -47.4 -31.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -62.87 -50.68 69.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.021 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.37 -43.61 61.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.9 . . . . 0.0 108.929 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.9 -58.41 7.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.204 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.548 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 24.8 t0 -50.17 -28.91 8.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.645 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -68.67 -69.99 0.29 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.9 tp -38.37 -40.94 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.487 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.6 mmtm -72.64 -29.12 63.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.29 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.645 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.0 -48.23 71.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' HB2' ' N ' ' A' ' 30' ' ' GLY . . . -64.16 -46.73 82.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.205 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.422 HG12 HD22 ' A' ' 82' ' ' LEU . 67.5 mt -54.62 -44.5 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.37 85.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -57.73 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -45.86 -41.58 11.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' O ' ' C ' ' A' ' 123' ' ' ALA . 4.4 tttm -66.95 -45.55 77.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -36.98 -39.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.328 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -42.3 14.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.379 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -100.77 37.06 1.79 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -145.54 -66.05 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.519 ' O ' ' C ' ' A' ' 128' ' ' GLU . 2.9 mm? -59.57 -37.59 78.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 127' ' ' LEU . 55.6 mt-10 37.7 -129.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.426 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -118.2 109.25 16.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -169.86 142.76 2.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.431 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -138.03 -59.52 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.53 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -154.04 157.58 39.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.53 ' C ' ' O ' ' A' ' 132' ' ' HIS . 22.9 m80 -35.34 128.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 109.67 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.477 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.453 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.57 -24.1 11.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.38 -2.38 6.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -65.32 -18.53 65.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.312 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.22 -34.91 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -83.1 -67.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -62.16 135.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.908 . . . . 0.0 109.517 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -55.95 130.75 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.438 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -82.29 21.23 0.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.902 . . . . 0.0 109.634 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.669 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -54.06 174.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 9' ' ' ASP . 65.3 m-85 -150.5 -175.27 5.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 0.0 109.61 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.646 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 50.4 mp0 -98.88 -2.1 38.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -169.66 63.79 0.49 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.15 128.89 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.01 2.473 . . . . 0.0 112.409 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -114.84 -28.48 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -84.18 -145.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 t 59.83 -102.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.36 83.53 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -157.88 166.28 33.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -1.165 . . . . 0.0 109.488 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -105.28 -74.17 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.568 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -90.98 -16.77 27.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.38 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.0 tttm 71.21 -22.73 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -0.865 . . . . 0.0 109.451 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 21' ' ' ASP . 14.2 tttt -66.5 -14.81 62.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.7 t70 69.58 -147.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 77.7 -8.42 1.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -176.83 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.4 t -124.75 99.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.11 139.76 15.4 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -138.95 122.57 17.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.4 148.37 16.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 tpt -145.48 126.67 14.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 109.6 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 m -145.8 155.93 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.337 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.0 159.16 24.54 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -132.35 142.4 44.81 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.294 -1.121 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.522 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.3 Cg_endo -75.31 -51.45 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.673 2.249 . . . . 0.0 112.065 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.35 -49.75 1.0 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 109.217 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.445 ' HB3' ' SG ' ' A' ' 63' ' ' CYS . 50.6 m -102.8 -8.93 20.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.36 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.77 45.68 55.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -120.31 152.31 37.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -1.133 . . . . 0.0 109.591 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.7 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.386 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 ttt -91.47 143.39 26.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -132.57 126.0 31.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.223 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.41 130.76 56.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.769 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -125.8 112.82 16.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.066 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.525 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -107.02 141.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.646 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 1.7 mptt -113.03 137.63 51.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.34 145.04 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 10.4 p-10 -82.75 -96.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.578 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -155.81 16.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.32 4.84 2.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.77 20.31 31.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.7 mm -106.88 146.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -1.14 . . . . 0.0 109.353 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' O ' HG22 ' A' ' 53' ' ' ILE . 23.2 mm -85.87 84.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.688 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -44.87 -54.91 5.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.116 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 161.61 41.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.104 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.37 115.7 12.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 109.887 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -96.43 141.23 29.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 108.93 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CD1' HG21 ' A' ' 74' ' ' THR . 28.1 p90 -137.57 176.3 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.998 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 124.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -160.53 133.57 6.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 15.4 p90 -150.83 125.67 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.45 -42.64 1.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 1.1 m -79.88 142.61 35.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.552 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.81 -5.01 57.73 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.47 -2.81 13.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -91.78 -41.05 10.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.576 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' ALA . 65.6 mt -41.91 -44.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.99 -48.52 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.5 m -67.63 -66.04 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.542 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 69' ' ' SER . 17.9 m -35.7 -41.34 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 20.4 t -68.22 -41.38 81.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -64.64 -65.28 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.573 ' O ' HG22 ' A' ' 77' ' ' VAL . 13.0 tt -41.08 -46.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.938 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.677 HG21 ' CD1' ' A' ' 58' ' ' PHE . 17.2 p -55.58 -44.87 77.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.972 . . . . 0.0 109.699 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.73 -34.8 64.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.065 -1.022 . . . . 0.0 109.677 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.02 -13.56 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 73' ' ' ILE . 6.0 m -121.94 22.38 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -98.85 117.58 33.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.67 5.61 69.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -84.71 -163.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.7 m -116.2 155.91 27.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 109.568 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 82' ' ' LEU . 46.7 mt -59.55 -17.52 33.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.524 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.93 -50.44 14.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.469 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.665 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -66.21 -39.36 89.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -37.1 67.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.37 41.63 3.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -156.32 -37.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -1.154 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 84' ' ' GLU . 5.3 pt -42.06 163.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.385 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -126.88 -173.07 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -100.95 -13.85 18.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -21.81 61.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.277 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.22 -58.97 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.346 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.7 -38.74 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.52 65.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -86.13 -21.36 27.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.75 -48.11 10.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 98' ' ' GLU . 5.4 mt -90.16 -11.23 41.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.877 . . . . 0.0 109.505 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 mt-10 41.67 68.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.662 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.73 150.29 43.76 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.176 -0.953 . . . . 0.0 109.311 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -44.1 147.35 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.567 2.178 . . . . 0.0 112.032 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -69.71 -44.57 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.684 2.256 . . . . 0.0 112.157 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 102' ' ' VAL . 1.7 p -60.0 -2.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -143.04 36.33 1.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 105' ' ' HIS . 5.2 p -84.49 -15.54 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.292 -0.88 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.633 ' C ' ' ND1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -42.43 -44.68 4.11 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 0.0 109.097 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.553 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 57.3 m -40.15 -54.58 2.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 109.836 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 108' ' ' ILE . 96.0 p -64.95 -56.02 15.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.2 mt -43.53 -40.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.125 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.514 HD13 ' HD1' ' A' ' 105' ' ' HIS . 1.2 mp -64.75 -47.84 76.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.101 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -42.18 -48.98 4.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.141 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.13 -35.03 79.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.62 -33.42 74.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.947 . . . . 0.0 109.859 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.32 -47.24 74.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.5 tp -58.98 -39.16 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.183 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.2 ttmt -70.34 -50.87 34.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.52 -32.17 66.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.0 109.384 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -64.93 -58.11 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.216 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -55.55 -48.2 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.95 -36.02 59.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD1' ' NZ ' ' A' ' 124' ' ' LYS . 5.3 t0 -72.59 -55.21 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.466 ' C ' ' O ' ' A' ' 120' ' ' ASP . 22.2 t80 -39.59 -56.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.62 -28.56 67.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -61.0 -46.05 92.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 120' ' ' ASP . 33.6 mmtm -67.26 -20.71 65.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.49 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.52 61.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.82 1.16 2.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.27 35.57 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -1.14 . . . . 0.0 109.279 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -56.42 20.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.573 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -150.01 83.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -75.53 127.26 32.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.68 99.03 8.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.515 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.458 ' ND1' ' HB2' ' A' ' 133' ' ' HIS . 7.3 p80 -72.83 -169.14 0.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.487 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.458 ' HB2' ' ND1' ' A' ' 132' ' ' HIS . 1.2 t-80 64.44 -136.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.485 179.954 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.309 0.576 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.55 95.07 2.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.25 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.3 p -111.52 168.99 9.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -150.62 164.73 35.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -115.45 144.12 44.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.907 HG12 ' H ' ' A' ' 8' ' ' ILE . 3.3 t 60.59 -149.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.907 ' H ' HG12 ' A' ' 7' ' ' VAL . 24.3 mm 57.09 68.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.552 ' O ' ' O ' ' A' ' 10' ' ' HIS . 1.3 m-20 41.68 -158.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.517 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.554 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.7 OUTLIER 52.4 109.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.381 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -81.27 97.11 7.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 46.34 -148.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.494 ' OD1' ' NH1' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -143.33 78.65 14.68 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.866 . . . . 0.0 109.408 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.71 48.38 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.763 2.309 . . . . 0.0 112.359 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.744 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -55.94 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.359 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -125.46 -103.83 0.35 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.0 p -176.76 95.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.943 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 59.03 153.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER 54.2 160.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp 66.91 6.14 4.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 21' ' ' ASP . 38.8 p30 -131.27 167.72 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.33 11.31 3.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -85.67 -14.56 45.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.51 148.52 33.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.534 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 0.3 OUTLIER -72.31 -16.3 61.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.491 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.822 ' ND2' HG23 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -65.11 1.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.822 HG23 ' ND2' ' A' ' 26' ' ' ASN . 79.1 t -135.71 95.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.15 27.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.6 m -105.11 109.89 22.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -1.044 . . . . 0.0 109.328 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.61 91.13 0.76 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -93.92 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -1.22 . . . . 0.0 109.498 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -158.46 173.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' CA ' HD21 ' A' ' 109' ' ' LEU . . . 176.7 159.78 22.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.82 43.72 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.0 Cg_endo -74.82 -56.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.646 2.231 . . . . 0.0 112.381 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -42.52 -36.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -102.4 2.59 36.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.68 52.02 1.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' CB ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -131.11 143.56 50.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.134 . . . . 0.0 109.578 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.73 114.59 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.064 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.1 ttt -108.81 139.02 44.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.895 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -122.66 125.02 44.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.062 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tt -121.04 138.67 54.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.806 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.13 136.95 42.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.61 132.17 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HG3' HD22 ' A' ' 26' ' ' ASN . 16.6 tttp -106.68 135.18 48.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.436 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -114.98 151.33 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.893 . . . . 0.0 109.527 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.46 -106.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -142.1 15.58 2.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.38 -4.24 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.545 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.74 4.73 51.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 mm -94.68 136.47 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.2 115.52 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.72 -39.87 12.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -139.91 -179.25 5.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.952 . . . . 0.0 109.576 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.98 140.88 3.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.81 144.62 44.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.806 ' CG ' HG21 ' A' ' 74' ' ' THR . 0.4 OUTLIER -142.39 150.33 40.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 109.603 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' CG ' ' C ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -154.67 95.89 1.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 148.89 47.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -160.96 154.39 21.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.286 -0.884 . . . . 0.0 109.366 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.4 -53.31 0.7 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CB ' ' A' ' 39' ' ' ASP . 9.0 m -76.11 109.46 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.54 43.83 0.35 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' CYS . 0.3 OUTLIER -163.72 -6.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.456 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' H ' ' H ' ' A' ' 65' ' ' SER . . . -84.57 -38.79 19.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 67' ' ' ILE . 7.2 mm -47.67 -49.36 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.21 -68.34 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.317 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.82 -34.33 2.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.455 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.1 t -64.75 -74.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.963 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 70' ' ' SER . 66.5 m -36.27 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.553 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' SER . 22.2 tp -76.03 -85.37 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 77' ' ' VAL . 1.1 tt -36.99 -33.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.806 HG21 ' CG ' ' A' ' 58' ' ' PHE . 9.7 p -66.99 -46.65 73.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 71' ' ' SER . 2.2 mt-10 -78.23 -7.84 57.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.31 -30.02 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 73' ' ' ILE . 4.8 m -91.67 11.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -87.08 89.83 8.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.38 -14.64 15.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.54 -168.26 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -1.13 . . . . 0.0 109.565 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -119.99 -179.2 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.37 -34.07 65.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -68.89 -11.01 60.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.607 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.85 -49.58 4.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.569 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.8 -26.17 62.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.537 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.3 46.37 1.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -164.05 -38.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -1.127 . . . . 0.0 109.169 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' ALA . 5.2 pt -44.9 166.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 109.466 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -132.7 -179.12 5.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.75 -19.34 24.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.365 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -62.73 -42.13 99.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.06 -60.6 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.176 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.5 mt -51.53 -42.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.895 . . . . 0.0 109.186 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -59.55 -35.14 73.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.195 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.61 -38.71 73.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.88 . . . . 0.0 109.104 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.3 -47.74 80.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.363 -0.835 . . . . 0.0 109.369 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.79 -16.63 21.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.619 ' N ' ' O ' ' A' ' 94' ' ' ALA . 25.8 tt0 45.03 72.93 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.39 150.26 36.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -39.09 141.36 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.961 2.44 . . . . 0.0 112.31 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 103' ' ' LYS . 66.5 Cg_endo -76.89 -15.02 16.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.759 2.306 . . . . 0.0 112.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.73 25.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HZ3' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -170.69 34.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.438 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 105' ' ' HIS . 38.6 t -57.46 -27.48 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.676 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -34.86 -62.14 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.308 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.676 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 38.6 m -37.61 -51.46 1.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.604 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -55.28 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mt -46.65 -40.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.863 . . . . 0.0 109.35 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 ' ND1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -62.72 -37.83 88.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.279 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.31 -58.53 8.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.506 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 112' ' ' ASP . 3.9 tm-20 -58.76 -43.43 90.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.596 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.503 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -60.93 -29.79 69.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.88 -57.22 7.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -51.24 -35.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.506 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -74.28 -48.06 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -55.8 -50.71 69.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.5 -53.73 50.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -58.34 -20.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -77.48 -47.37 19.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.193 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.99 -10.52 59.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.549 ' CE1' ' NZ ' ' A' ' 124' ' ' LYS . 1.9 t80 -91.31 -49.8 6.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.303 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -66.61 -23.62 66.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 0.0 109.203 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 125' ' ' GLN . . . -68.72 -1.75 7.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.549 ' NZ ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -35.75 -30.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 123' ' ' ALA . 20.2 tt0 -97.92 -53.37 3.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.05 34.51 0.47 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.46 -9.23 57.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 109.399 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 54.42 -169.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -159.17 140.8 13.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.504 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 7.8 t-80 -132.24 -127.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 109.371 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.504 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 33.4 t-80 -123.48 -49.32 1.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 109.409 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -106.36 74.33 1.02 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.08 43.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.449 -179.851 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.758 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 79.78 170.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.355 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.4 t80 54.88 85.48 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.413 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -168.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.529 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -96.78 -69.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -89.66 -179.41 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 8' ' ' ILE . 35.2 t -95.66 160.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.832 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -148.02 83.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.655 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.41 127.47 32.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.856 . . . . 0.0 109.765 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -116.84 162.6 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.297 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -113.5 142.11 46.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.156 -0.965 . . . . 0.0 109.732 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -175.63 139.42 0.42 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.224 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.59 160.5 0.1 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.314 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.96 -171.73 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.338 . . . . 0.0 112.283 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.456 ' C ' HD21 ' A' ' 16' ' ' ASN . 44.6 ttm180 -148.23 121.89 9.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.331 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.554 ' OD1' ' NZ ' ' A' ' 46' ' ' LYS . 2.6 m120 -106.99 163.29 13.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 109.602 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' SER . 16.9 t -105.62 114.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 17' ' ' VAL . . . 45.52 -95.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.03 -179.68 7.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.512 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.521 ' N ' ' OG ' ' A' ' 19' ' ' SER . 4.4 mm? -93.2 -165.58 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.92 122.93 11.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.5 -39.05 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.724 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -86.03 51.83 2.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 143.53 32.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.337 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -81.11 -3.4 51.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.39 7.2 26.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.618 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.35 114.74 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.8 138.87 14.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -125.25 114.38 18.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.561 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.12 16.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.83 124.8 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.16 -1.2 . . . . 0.0 109.665 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.56 151.08 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.148 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.05 10.28 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' N ' ' A' ' 39' ' ' ASP . . . -146.56 92.65 5.08 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.29 70.87 7.32 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.755 2.303 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.53 -38.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.365 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . 6.6 t -165.48 -38.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.772 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -62.53 -49.23 75.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.5 t70 84.81 -174.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.65 99.17 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.855 . . . . 0.0 109.25 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.8 ttp -95.73 139.82 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -119.65 107.34 13.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.116 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.13 127.49 52.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.837 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -130.34 120.55 24.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 108.974 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.78 152.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.827 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.554 ' NZ ' ' OD1' ' A' ' 16' ' ' ASN . 24.1 tttt -114.84 154.75 28.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 109.284 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 64.5 t -133.25 121.71 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD1' ' OE1' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -47.63 -53.67 14.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 162.01 -23.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.859 . . . . 0.0 109.252 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -0.74 57.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.44 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.85 8.67 41.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.31 138.63 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.161 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.8 mt -96.83 124.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.301 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.551 ' OE1' ' OD1' ' A' ' 48' ' ' ASP . 19.1 pt-20 -107.65 -30.08 8.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.56 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -124.87 150.36 46.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.08 155.16 42.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 109.588 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 58' ' ' PHE . 1.2 tttm -150.49 143.31 24.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.691 ' CD1' HG21 ' A' ' 74' ' ' THR . 4.5 p90 -138.86 -179.38 5.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -171.32 104.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 t -136.85 144.63 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.589 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.535 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 53.3 t80 -155.0 98.57 2.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 0.7 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -100.71 123.93 45.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 0.0 109.337 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -91.94 123.03 7.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER 72.61 -8.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.18 . . . . 0.0 109.536 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HB3' ' SG ' ' A' ' 63' ' ' CYS . . . -96.44 7.69 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mt -72.99 -38.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -41.95 75.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p -56.8 -38.82 73.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 58' ' ' PHE . 17.5 t -53.47 -46.06 69.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -35.11 79.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.32 -56.27 22.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.949 ' O ' HG22 ' A' ' 77' ' ' VAL . 3.8 tt -58.52 -48.58 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.76 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.691 HG21 ' CD1' ' A' ' 58' ' ' PHE . 23.3 p -60.72 -17.89 51.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 0.0 109.482 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.06 -41.75 10.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -74.22 -7.7 53.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.428 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 73' ' ' ILE . 35.0 m -115.29 36.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.343 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -133.95 78.18 1.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -0.908 . . . . 0.0 109.634 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 0.4 9.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -97.01 -165.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.09 164.65 15.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 82' ' ' LEU . 34.3 mt -58.83 -24.8 62.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -74.67 -26.29 59.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.646 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.76 -50.21 8.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.67 63.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.269 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.02 45.61 3.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -152.45 -38.29 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -1.112 . . . . 0.0 108.688 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 87' ' ' ALA . 4.0 pt -39.35 123.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.534 -0.729 . . . . 0.0 109.119 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -99.17 162.6 12.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.612 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -57.76 -20.1 32.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 1.4 p -77.57 -33.57 53.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.78 -43.68 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 mm -81.61 -33.33 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.912 . . . . 0.0 109.177 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -66.21 -12.5 56.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 -37.44 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.405 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -53.22 43.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.13 -23.98 19.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 51.29 68.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -96.84 146.45 31.33 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.149 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.59 147.24 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.721 2.281 . . . . 0.0 112.247 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 9.55 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.748 2.299 . . . . 0.0 112.168 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 t -92.09 -33.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -105.93 30.02 6.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 103' ' ' LYS . 20.3 t -42.55 -25.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.772 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 4.4 p-80 -52.0 -39.6 59.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 33.9 m -47.93 -60.39 2.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.308 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 109' ' ' LEU . 57.9 m -59.31 -58.81 7.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' CB ' ' A' ' 112' ' ' ASP . 63.7 mt -46.26 -22.1 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 107' ' ' SER . 0.8 OUTLIER -74.43 -57.53 3.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.5 59.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 109.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' A' ' 112' ' ' ASP . 3.3 tm-20 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 10.0 t0 -43.13 -43.33 4.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.52 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.29 -54.48 39.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -47.27 -42.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' CD ' ' OE2' ' A' ' 111' ' ' GLU . 5.6 mttp -68.36 -34.85 76.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.21 -58.55 6.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.496 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.68 -42.36 45.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 122' ' ' LYS . 65.0 mt -63.76 -48.35 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.92 -37.75 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.363 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.6 -38.41 67.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.78 -32.61 74.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 118' ' ' ILE . 7.1 mtpt -78.14 -39.77 40.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -52.63 -54.94 26.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 109.533 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.22 0.07 2.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.271 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 123' ' ' ALA . 2.0 tt0 -151.78 63.33 0.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.632 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -173.93 -44.61 0.05 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 126' ' ' GLY . 6.3 tp -41.71 -47.83 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.683 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 129' ' ' HIS . 1.4 tt0 -69.69 166.14 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.46 ' N ' ' ND1' ' A' ' 129' ' ' HIS . 1.7 m80 -92.32 -146.75 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.407 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -101.84 -166.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -135.28 115.73 13.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.532 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 133' ' ' HIS . 43.4 m-70 -132.29 85.16 2.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 132' ' ' HIS . 14.0 p80 -45.86 126.22 6.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.5 m80 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.446 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.78 129.5 34.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.656 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.4 93.05 4.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.82 120.34 40.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.558 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.81 117.3 1.8 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.363 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -79.95 90.89 5.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.658 ' O ' HG22 ' A' ' 7' ' ' VAL . 12.3 p -142.87 39.42 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.863 . . . . 0.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.41 -104.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.549 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 19.3 t0 65.13 -153.96 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 9' ' ' ASP . 4.6 m-70 -142.16 -16.89 0.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 10' ' ' HIS . 0.2 OUTLIER 56.89 113.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 109.429 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -90.59 120.95 32.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.485 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 9.2 p30 -176.31 52.96 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.393 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 34.4 Cg_endo -67.75 16.62 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.764 2.31 . . . . 0.0 112.091 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.732 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -54.51 129.83 37.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.518 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.596 ' C ' ' H ' ' A' ' 18' ' ' GLY . 6.7 p-10 -146.8 -6.27 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 18' ' ' GLY . 2.6 m -51.58 -3.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 16' ' ' ASN . . . -57.35 -128.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -161.9 -66.28 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -1.113 . . . . 0.0 109.452 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 19' ' ' SER . 13.5 tp 50.98 108.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.567 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 23' ' ' LYS . 34.9 t70 -163.79 -3.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 64.66 -8.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -102.2 19.72 18.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.16 160.63 19.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -3.38 56.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -105.51 -5.89 19.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.33 116.27 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.441 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.05 144.27 17.24 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.2 m -126.7 121.93 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.06 123.77 5.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.477 ' C ' ' SD ' ' A' ' 31' ' ' MET . 2.4 ppp? -131.89 153.11 50.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.677 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -145.26 169.06 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.251 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.1 147.84 18.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -145.73 73.13 13.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -1.123 . . . . 0.0 109.34 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -58.5 71.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.85 2.366 . . . . 0.0 112.097 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -177.95 -89.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.836 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 1.5 t -118.48 -7.98 10.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.665 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -98.71 -23.87 11.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 58.45 -163.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.715 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.0 p -87.24 110.35 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 108.842 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.401 ' CE ' HD13 ' A' ' 43' ' ' LEU . 8.1 ttt -100.55 129.81 46.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.163 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -120.88 108.08 13.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.401 HD13 ' CE ' ' A' ' 41' ' ' MET . 4.5 tp -108.19 115.06 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.722 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.487 HE21 ' HB3' ' A' ' 44' ' ' GLN . 2.2 mt-30 -110.38 118.88 37.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.2 pt -106.25 146.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -115.18 136.58 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.66 145.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.114 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -78.75 -104.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.502 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.5 t70 -141.8 9.15 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.32 12.52 2.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.301 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.04 14.61 57.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -99.87 114.35 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -1.153 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.5 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -50.29 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 49.8 t0 -127.19 170.14 12.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -162.95 115.81 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -98.92 131.69 44.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CD2' ' OG ' ' A' ' 70' ' ' SER . 8.4 p90 -109.72 172.05 7.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.647 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -171.81 112.2 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -156.01 146.99 22.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 4.3 t80 -156.9 106.88 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.36 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.23 -25.73 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 64.4 m -83.64 131.67 34.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -1.068 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.82 9.49 60.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -152.77 -13.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 63' ' ' CYS . . . -93.14 -12.69 29.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' ALA . 20.1 mt -42.15 -45.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.15 89.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -46.41 -53.41 11.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.436 ' OG ' ' CD2' ' A' ' 58' ' ' PHE . 6.9 t -45.17 -48.45 12.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 m -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -64.67 -76.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.832 ' O ' HG22 ' A' ' 77' ' ' VAL . 5.8 tt -35.51 -52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.728 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.605 ' H ' HG23 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -49.54 -52.54 29.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -2.11 30.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 109.891 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -105.11 -4.5 21.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.466 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.832 HG22 ' O ' ' A' ' 73' ' ' ILE . 11.7 m -124.29 5.59 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.504 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -92.76 98.38 11.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.75 11.23 23.37 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -110.74 174.29 5.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -96.71 157.46 15.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.487 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.34 -20.72 63.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -34.89 74.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.57 -32.55 36.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.513 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -73.96 -21.51 59.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.636 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.17 30.08 10.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -147.23 -37.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.151 -1.205 . . . . 0.0 109.507 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.545 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -34.66 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.527 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER 70.39 167.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.369 -0.832 . . . . 0.0 109.516 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 91' ' ' SER . 8.6 p30 -89.74 -54.83 3.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.615 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -37.84 -33.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.482 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -60.28 -53.08 61.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.56 -35.81 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.51 -39.98 81.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.84 -34.12 62.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -54.2 -45.92 72.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.336 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.19 -6.52 19.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 94' ' ' ALA . 16.8 mt-10 53.93 88.5 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -108.03 165.75 12.17 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.53 142.37 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.601 2.201 . . . . 0.0 112.053 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.92 5.75 4.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.705 2.27 . . . . 0.0 112.209 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.15 -25.7 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.643 ' O ' ' N ' ' A' ' 105' ' ' HIS . 4.2 mtpt -118.22 28.15 8.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 103' ' ' LYS . 21.3 t -38.16 -22.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.665 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 3.2 p-80 -44.47 -31.39 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.8 m -60.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 10.2 p -47.15 -56.87 5.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.181 -0.949 . . . . 0.0 109.095 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 6.0 mt -45.67 -36.62 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.91 -49.13 78.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.244 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -61.96 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 109.588 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 112' ' ' ASP . 30.2 tt0 -54.99 -73.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 111' ' ' GLU . 23.0 t0 -34.1 -55.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.656 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 112' ' ' ASP . . . -40.96 -70.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.418 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.513 HG12 ' HB1' ' A' ' 85' ' ' ALA . 1.1 tp -43.49 -31.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.083 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 112' ' ' ASP . 4.1 tptt -64.42 -60.17 3.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.9 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.411 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -67.05 -45.97 75.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 109.409 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.18 -45.36 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.264 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.92 64.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 109.108 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.15 -26.19 37.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 109.271 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 15.8 t80 -76.41 -54.49 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -71.42 0.41 8.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.01 -31.1 22.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -96.62 35.75 1.47 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.459 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -121.94 -31.46 3.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -47.65 -84.93 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 127' ' ' LEU . 25.0 mt -135.8 14.26 3.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -1.196 . . . . 0.0 109.462 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 53.53 11.85 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' N ' ' C ' ' A' ' 127' ' ' LEU . 69.3 m-70 -148.05 158.72 44.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.87 -23.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.095 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.617 ' C ' ' H ' ' A' ' 133' ' ' HIS . 56.0 m80 -65.88 95.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.23 8.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.617 ' H ' ' C ' ' A' ' 131' ' ' HIS . 25.7 t-80 -114.15 -8.76 12.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.495 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.0 t0 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.479 ' C ' ' CG ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER 71.48 -7.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.479 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 178.29 30.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.656 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.12 94.93 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.648 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.12 126.15 7.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.01 127.13 2.27 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 ttt -133.62 98.39 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.283 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -107.49 170.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.41 160.14 26.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . . . -128.91 92.98 38.3 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.152 -1.205 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.85 -16.06 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.679 2.253 . . . . 0.0 112.052 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 -57.16 4.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.9 p -100.91 19.53 17.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.439 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.27 58.32 1.06 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 42.9 t0 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -98.29 122.43 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -108.46 115.66 30.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -110.99 113.64 26.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 9.9 tp -103.64 153.64 20.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.06 111.42 5.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -101.26 146.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -131.15 122.94 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.47 141.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.621 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.687 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -172.47 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 4.3 m-20 -62.73 45.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.4 m-20 78.5 51.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.6 -5.75 72.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.77 156.53 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -1.161 . . . . 0.0 109.385 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.43 94.57 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.73 -25.14 64.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.423 -0.798 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.19 168.47 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.89 131.15 11.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -110.87 163.13 14.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.737 ' CD1' HG21 ' A' ' 74' ' ' THR . 16.2 p90 -142.1 166.6 24.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 109.379 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 101.4 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.391 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -154.1 143.39 21.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 1.2 p90 -161.82 134.7 6.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.04 -52.95 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 168.26 20.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.184 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 38.81 2.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 t -166.29 -47.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -1.161 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.479 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . . . -48.38 -37.56 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -47.52 -19.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.613 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' ALA . . . -95.93 -40.26 9.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.403 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.783 ' O ' HG22 ' A' ' 73' ' ' ILE . 4.7 p -50.92 -38.68 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.321 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.707 ' O ' HG23 ' A' ' 74' ' ' THR . 87.9 p -58.94 -38.89 80.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -63.64 -41.85 98.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 73' ' ' ILE . 1.7 tp -66.65 -73.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.813 ' O ' HG22 ' A' ' 77' ' ' VAL . 6.2 tt -43.26 -28.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.737 HG21 ' CD1' ' A' ' 58' ' ' PHE . 19.2 p -77.5 -41.46 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.59 2.14 38.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -110.6 -30.31 7.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.758 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 73' ' ' ILE . 4.4 m -109.25 50.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -123.82 104.63 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.39 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 6.1 63.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.0 mmtt -98.67 175.22 6.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -1.12 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 t -88.16 154.52 20.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 118' ' ' ILE . 66.4 mt -61.76 -20.16 63.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -64.12 -29.95 71.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -91.56 -35.51 14.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.78 -37.86 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.36 57.57 2.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -163.27 -34.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -1.124 . . . . 0.0 109.004 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 0.8 OUTLIER -45.15 -14.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 87' ' ' ALA . 19.5 mttm 46.68 -173.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.28 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 91' ' ' SER . 24.5 p-10 -97.9 -24.14 15.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.696 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.6 -25.47 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.98 -65.36 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 109.661 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 9.5 tt -49.81 -38.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -59.75 -46.33 89.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.379 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -65.02 -28.48 69.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tm-20 -71.46 -28.99 64.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.426 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 25.8 mt -93.67 -36.96 12.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.339 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 5.7 tt0 69.72 62.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -120.1 149.3 48.87 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.942 . . . . 0.0 109.451 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.96 158.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 103' ' ' LYS . 41.4 Cg_endo -72.05 -51.11 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.766 2.311 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 102' ' ' VAL . 41.4 t -58.04 -2.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 101' ' ' PRO . 13.7 mttp -115.6 12.18 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.24 -1.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.6 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.3 OUTLIER -57.58 -41.62 81.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.981 . . . . 0.0 109.256 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 19.3 m -63.8 -46.82 83.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.841 . . . . 0.0 109.337 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -56.42 -46.45 80.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.343 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 105' ' ' HIS . 19.6 mt -52.89 -45.32 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.305 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 6.0 mp -58.5 -46.58 86.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -52.67 -53.39 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.93 -56.38 19.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.57 -17.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -79.77 -53.42 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.464 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.5 tp -57.25 -30.11 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -43.7 38.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.7 92.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.673 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.4 73.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.556 HG12 HD22 ' A' ' 82' ' ' LEU . 63.7 mt -63.7 -44.88 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.2 -39.77 87.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.14 -31.87 68.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.27 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -39.24 74.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.339 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -77.58 -18.49 56.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.612 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.43 70.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 tptm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.518 -179.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' ND2' ' A' ' 26' ' ' ASN . 1.2 m-20 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.301 0.572 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -74.37 13.09 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.321 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -116.26 22.12 13.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.602 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.53 103.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.92 15.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -127.39 152.06 48.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -1.174 . . . . 0.0 109.693 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 125.5 1.56 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.7 ttp -123.79 140.44 52.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.733 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -141.37 165.1 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.43 160.69 29.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -134.84 145.44 54.69 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.303 -1.116 . . . . 0.0 109.411 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.55 -50.25 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.595 2.197 . . . . 0.0 112.05 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.84 63.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.4 m -93.73 -2.62 53.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.61 42.42 0.67 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 16.9 t0 -118.51 154.46 32.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -1.088 . . . . 0.0 109.821 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.4 t -113.48 99.63 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.767 ' CE ' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -82.02 102.97 11.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -91.91 138.8 31.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.767 HD13 ' CE ' ' A' ' 41' ' ' MET . 7.3 tp -134.66 126.16 28.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -128.21 133.65 48.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -121.7 140.89 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -118.44 140.79 49.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 73.0 t -117.17 143.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER 178.19 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.545 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-20 -62.45 45.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.663 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.1 m-20 81.09 45.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.99 -3.27 86.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 79' ' ' GLY . 40.5 mm -96.49 146.86 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -1.103 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.2 mt -56.48 94.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -0.934 . . . . 0.0 109.445 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -46.47 35.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.25 169.75 22.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.36 121.6 16.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' CD ' ' N ' ' A' ' 57' ' ' LYS . 2.9 mmtm -95.84 154.79 17.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD1' HG21 ' A' ' 74' ' ' THR . 27.4 p90 -141.1 158.32 44.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -160.94 116.64 2.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.21 131.64 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.463 ' C ' ' OD2' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -148.12 103.76 3.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.578 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.581 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . 125.94 22.73 1.72 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -114.25 83.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.157 . . . . 0.0 109.661 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . 33.45 -101.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 67' ' ' ILE . 96.1 p -136.99 19.19 3.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -1.145 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.51 4.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.8 mm -58.2 -61.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 67' ' ' ILE . . . -46.57 -40.13 12.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 73' ' ' ILE . 10.5 m -61.54 -32.51 72.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -61.18 -26.31 67.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.428 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -83.21 -44.58 14.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.96 -45.42 94.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.723 HG23 ' N ' ' A' ' 74' ' ' THR . 17.4 tt -67.34 -55.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.723 ' N ' HG23 ' A' ' 73' ' ' ILE . 10.5 p -53.6 -23.41 10.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.192 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.8 -21.71 21.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -92.68 -9.1 42.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.536 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 73' ' ' ILE . 32.7 m -121.19 12.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.203 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -94.19 123.16 37.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.352 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 71.2 8.9 66.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -97.86 169.21 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -1.122 . . . . 0.0 109.554 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -83.05 162.19 21.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.57 -24.04 61.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -67.07 -31.4 71.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.77 -33.85 21.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -65.25 -36.78 85.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.15 36.15 3.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -147.27 -34.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -1.068 . . . . 0.0 109.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.543 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -33.42 -28.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 87' ' ' ALA . 4.4 ttmt 63.11 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.48 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 92' ' ' GLN . 7.6 p-10 -82.69 -47.74 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.601 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -43.15 -24.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.632 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.8 tp60 -70.55 -53.9 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.657 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.23 -22.12 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 109.621 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.24 -34.07 59.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 9.0 tp10 -85.37 -16.47 39.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.06 -47.4 14.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.462 HD22 ' OG ' ' A' ' 69' ' ' SER . 7.6 mp -87.15 -35.68 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 8.6 tt0 70.21 73.04 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 0.0 109.785 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -106.64 143.72 27.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.875 . . . . 0.0 109.208 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.6 148.0 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.753 2.302 . . . . 0.0 112.45 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.2 Cg_endo -72.79 -13.64 26.83 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.799 2.333 . . . . 0.0 112.196 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.79 -0.1 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 109.54 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 101' ' ' PRO . 21.2 mttp -150.63 55.02 0.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 104' ' ' VAL . 37.0 t -70.1 -2.79 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' CB ' ' A' ' 34' ' ' ALA . 7.5 p-80 -84.03 -26.6 28.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.312 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.69 -60.79 2.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.2 p -54.07 -54.65 36.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.26 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' C ' ' A' ' 109' ' ' LEU . 43.6 mt -44.73 -66.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 108' ' ' ILE . 4.9 mp -35.21 -50.6 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.669 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HA ' ' SD ' ' A' ' 41' ' ' MET . . . -49.9 -56.8 9.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.0 tt0 -68.56 -67.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.2 OUTLIER -34.67 -27.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -78.31 -59.11 2.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.987 . . . . 0.0 109.828 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.562 HG12 ' HB1' ' A' ' 85' ' ' ALA . 3.3 tp -48.09 -37.11 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.2 ttmt -67.76 -47.73 68.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.286 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.4 64.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.1 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.85 -55.74 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.098 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 117' ' ' ALA . 29.8 mt -42.14 -40.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.08 -54.41 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.07 -26.19 25.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -76.73 -57.57 3.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.312 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -69.79 2.93 2.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.8 -49.37 5.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.863 . . . . 0.0 109.647 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 12.3 t0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.26 0.553 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 66.34 -4.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 24' ' ' ASP . 57.8 m-20 -107.71 -0.71 21.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.45 96.25 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.576 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.12 139.11 37.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.433 HG23 HE21 ' A' ' 44' ' ' GLN . 6.6 m -120.61 105.97 11.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -1.12 . . . . 0.0 109.49 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.79 130.04 10.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.6 ttt -132.65 117.01 17.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -1.144 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.9 159.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.98 156.05 16.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . . . -117.83 83.04 17.62 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.335 -1.097 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.54 -16.82 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.913 2.408 . . . . 0.0 112.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.01 -33.64 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.3 p -124.06 23.19 8.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.74 69.17 0.2 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 8.6 t0 -139.67 116.95 11.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.55 110.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 5.7 ttt -97.6 137.02 37.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -128.91 112.8 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.47 139.25 50.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.433 HE21 HG23 ' A' ' 29' ' ' THR . 2.6 mt-30 -134.96 134.75 40.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.82 135.05 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -106.81 133.58 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -107.98 139.68 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 6.4 t0 -82.76 -88.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.3 m-20 -154.76 17.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.0 11.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.01 78.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -83.39 135.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.581 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.34 104.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.114 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.19 -24.04 37.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 109.837 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 45.6 t0 -148.21 150.62 34.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.685 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -142.04 116.61 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.343 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -97.31 152.12 19.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CG ' HG21 ' A' ' 74' ' ' THR . 15.3 p90 -147.59 166.42 27.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -170.79 117.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.407 HG21 ' HB3' ' A' ' 70' ' ' SER . 0.8 OUTLIER -157.23 143.71 18.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.706 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 20.1 p90 -161.92 95.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.34 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.06 -62.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -81.89 146.27 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.417 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.7 10.38 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 7.4 t -136.22 -7.24 2.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -1.134 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.19 -68.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.616 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.83 -34.22 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 65' ' ' SER . . . -58.27 -57.53 12.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -68.2 -41.25 81.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.473 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -61.53 -28.23 69.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 77.4 p -75.0 -49.96 18.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.72 -57.99 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 74' ' ' THR . 18.2 tt -49.15 -45.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 109.512 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 70' ' ' SER . 19.0 p -60.05 -36.25 76.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -77.98 -10.37 59.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 -30.85 12.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.596 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 77' ' ' VAL . 15.3 m -96.81 38.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.671 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.06 102.85 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.16 52.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -104.77 169.39 8.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -1.111 . . . . 0.0 109.429 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -93.54 150.22 20.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.52 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 82' ' ' LEU . 27.9 mt -49.44 -26.51 3.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.63 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -69.04 -32.98 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.93 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -83.46 -34.24 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.55 54.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.27 52.05 3.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -162.43 -39.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -1.186 . . . . 0.0 109.243 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -42.76 -30.28 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.364 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 59.91 175.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -88.52 -44.33 10.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ASN . 43.4 t -38.61 -39.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 95' ' ' GLU . 16.4 tp60 -62.33 -66.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.378 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.4 mt -45.37 -31.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.229 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.36 -19.96 48.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.248 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 92' ' ' GLN . 6.2 tt0 -83.85 -20.03 33.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -97.92 -53.89 3.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -72.91 -5.56 39.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.369 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.507 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 43.26 31.95 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.619 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.95 150.79 36.95 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.334 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.18 157.95 42.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.8 2.333 . . . . 0.0 112.234 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.649 ' O ' HG23 ' A' ' 104' ' ' VAL . 60.9 Cg_endo -76.4 -7.14 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.893 2.395 . . . . 0.0 112.567 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.83 -14.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 105' ' ' HIS . 25.6 mttm -114.42 29.69 7.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 101' ' ' PRO . 21.8 t -66.76 -9.94 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.646 ' O ' HD13 ' A' ' 109' ' ' LEU . 2.2 p-80 -77.35 -25.28 50.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -75.7 -41.81 52.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.138 -0.976 . . . . 0.0 109.121 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -52.97 59.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 7.1 tt -53.9 -38.73 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 108.89 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.646 HD13 ' O ' ' A' ' 105' ' ' HIS . 1.6 mp -53.8 -50.04 67.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -56.82 -54.24 48.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 114' ' ' ILE . 16.2 tt0 -48.93 -63.46 1.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.206 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.42 -27.56 10.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -68.0 -49.04 63.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 111' ' ' GLU . 2.4 tp -56.22 -36.31 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.985 . . . . 0.0 109.26 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -70.87 -57.04 5.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.84 7.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.37 -59.67 3.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.9 mt -46.44 -44.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.424 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . -62.35 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' C ' ' OD1' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -47.89 -17.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.2 t80 -92.59 -29.28 16.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -92.1 3.37 55.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.355 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.44 -52.18 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 109.578 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.2 tttm . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 -179.93 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 37.8 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.343 0.592 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.12 10.42 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.539 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -134.39 21.14 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.39 127.79 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.0 121.67 7.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -102.78 120.65 40.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.538 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.41 100.68 0.89 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ttt -96.68 133.13 41.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -1.095 . . . . 0.0 109.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.41 154.62 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.862 . . . . 0.0 109.222 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.64 143.72 17.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.14 107.18 13.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.34 -1.094 . . . . 0.0 109.083 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -76.52 15.59 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.293 1.996 . . . . 0.0 112.447 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.658 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -112.47 -102.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.832 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -121.04 6.59 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.689 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -91.7 -16.46 51.93 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 29.7 t0 50.86 -151.35 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -1.051 . . . . 0.0 109.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 6.4 t -87.35 136.62 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.7 ttt -127.34 137.41 52.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 109.589 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -124.43 123.37 40.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -119.93 126.51 51.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.958 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.56 143.64 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.515 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.5 pp -132.88 134.16 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -102.97 136.8 42.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.9 136.05 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 38.1 t0 -59.78 -49.44 77.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.31 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.678 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.7 OUTLIER 162.83 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -34.43 9.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.11 -9.73 0.98 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -74.43 134.26 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -1.225 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.04 89.49 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.44 -54.78 39.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.578 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -144.49 152.85 41.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.898 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.594 ' H ' ' HZ3' ' A' ' 78' ' ' LYS . . . -133.58 142.44 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.741 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -114.02 143.28 45.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.053 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.524 ' HB3' HG21 ' A' ' 74' ' ' THR . 4.4 p90 -119.69 165.2 14.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.86 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -171.54 81.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -123.45 152.9 41.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -155.44 95.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . -179.21 -50.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 18.5 m -74.23 125.15 27.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.511 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -43.33 -21.72 0.17 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -120.25 7.9 10.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -1.105 . . . . 0.0 109.274 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 63' ' ' CYS . . . -42.22 -43.18 3.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.518 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.518 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.2 mt -60.72 -29.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -80.58 -71.92 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.733 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.3 p -38.84 -33.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.944 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 74' ' ' THR . 12.4 p -69.19 -63.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 0.8 OUTLIER -48.67 -25.76 1.95 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 109.5 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' C ' ' A' ' 73' ' ' ILE . 39.4 tp -79.15 -81.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 69' ' ' SER . 14.5 tt -41.11 -35.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.614 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 70' ' ' SER . 82.6 p -69.53 -39.48 77.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' LEU . 16.4 tt0 -74.51 -8.33 55.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.327 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.98 -31.88 14.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 114' ' ' ILE . 4.9 m -96.42 13.14 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HZ3' ' H ' ' A' ' 56' ' ' ALA . 4.2 mttm -89.28 93.11 9.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.54 -18.52 24.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -66.52 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.41 167.81 13.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.646 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.38 -30.19 69.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.85 . . . . 0.0 109.56 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.76 -35.05 79.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.1 -45.2 18.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.007 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.16 35.61 2.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -147.4 -38.99 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 109.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.509 HD11 HG12 ' A' ' 114' ' ' ILE . 1.4 pt -41.45 163.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -0.872 . . . . 0.0 109.35 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -136.72 -174.1 3.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -101.55 -5.59 24.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.221 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -64.31 -53.06 54.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 0.0 109.343 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.6 mt-30 -60.76 -62.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 93' ' ' ILE . 37.3 mt -47.21 -25.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.45 -27.27 46.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 92' ' ' GLN . 10.2 mt-10 -87.96 -16.28 34.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.355 -0.841 . . . . 0.0 109.338 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -88.55 -43.41 11.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.67 -14.05 49.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 48.29 74.52 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.371 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -110.77 150.73 42.21 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 109.415 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.02 160.09 48.91 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.748 2.299 . . . . 0.0 112.193 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.0 Cg_endo -66.7 -65.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.904 2.402 . . . . 0.0 112.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.517 HG23 ' C ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER 41.48 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 109.03 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' PRO . 20.1 mttp -138.43 10.96 2.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.683 ' O ' HD12 ' A' ' 108' ' ' ILE . 3.7 t 34.79 53.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.832 ' CE1' ' H ' ' A' ' 37' ' ' CYS . 6.4 p-80 -98.38 -25.54 14.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.84 -70.22 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -51.32 -57.84 7.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 104' ' ' VAL . 37.1 mt -43.07 -34.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.07 81.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.71 68.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' ' 112' ' ' ASP . 56.8 tt0 -66.56 -67.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 111' ' ' GLU . 47.8 t0 -40.56 -29.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -67.1 -59.54 3.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.509 HG12 HD11 ' A' ' 88' ' ' ILE . 1.9 tp -46.21 -33.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.75 61.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.81 64.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.97 -56.8 17.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.5 -44.38 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.626 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.95 -57.54 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 2.4 m-20 -53.89 -53.6 50.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.516 ' O ' ' C ' ' A' ' 122' ' ' LYS . 13.0 t80 -47.37 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 121' ' ' TYR . 11.2 mmtt -36.22 -44.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 120' ' ' ASP . . . -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.569 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' TYR . 3.6 mtpt . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.913 . . . . 0.0 109.424 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 26' ' ' ASN . 26.3 t0 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.509 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.5 OUTLIER 54.64 0.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.075 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -167.82 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.12 113.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.782 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.76 125.32 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -116.13 145.31 43.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.36 134.57 5.4 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.5 mtt -123.47 148.88 45.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.122 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.18 174.01 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.145 -0.972 . . . . 0.0 109.334 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.24 150.27 8.04 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.03 144.42 47.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.504 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 Cg_endo -71.97 -67.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.563 2.176 . . . . 0.0 111.938 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.41 -35.9 0.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.241 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' O ' ' C ' ' A' ' 38' ' ' GLY . 49.9 t -99.13 -4.97 31.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.345 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 36.68 34.66 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 37' ' ' CYS . 13.7 t0 -105.02 114.16 28.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.333 -1.098 . . . . 0.0 109.604 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 40' ' ' VAL . 14.5 p -89.05 109.29 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ttt -99.2 152.32 20.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -147.9 126.93 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.89 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.62 128.42 37.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.034 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -118.52 136.05 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.028 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.4 pp -119.51 144.86 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -111.79 141.98 44.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.81 113.65 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 17.3 t0 -47.45 -67.16 0.3 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.644 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.9 p-10 170.41 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.097 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.39 10.83 23.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.32 15.26 54.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.1 mm -102.52 148.81 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 109.592 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.478 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.3 mm -83.34 84.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.435 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' ' OD1' ' A' ' 55' ' ' ASP . 5.6 tt0 -40.89 -55.76 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' OD1' ' OE2' ' A' ' 54' ' ' GLU . 7.4 p-10 -152.34 170.99 18.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.25 126.52 18.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.474 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -99.28 135.01 41.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 2.6 p90 -109.83 162.46 14.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -171.78 102.24 0.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -164.82 139.74 5.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.651 ' CE2' HD11 ' A' ' 67' ' ' ILE . 3.3 t80 -156.02 95.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.31 -19.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.678 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -141.06 107.27 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -1.045 . . . . 0.0 109.181 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -41.08 -15.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 63' ' ' CYS . 1.8 m -82.49 -22.24 35.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -83.31 -58.7 2.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.651 HD11 ' CE2' ' A' ' 61' ' ' TYR . 42.5 mt -35.68 -59.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.9 m -49.84 -50.56 45.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.479 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 74' ' ' THR . 1.3 t -43.95 -47.57 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.587 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.569 ' O ' ' OG1' ' A' ' 74' ' ' THR . 17.3 p -70.59 -31.41 68.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -68.33 -61.82 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 77' ' ' VAL . 6.1 tt -48.78 -41.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 70' ' ' SER . 23.5 p -55.84 -46.25 78.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.018 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.99 -20.23 64.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 108.916 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.21 -27.68 53.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 73' ' ' ILE . 7.0 m -111.8 -111.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.499 -0.75 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' H ' HG23 ' A' ' 77' ' ' VAL . 8.3 tttm 35.32 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.53 13.85 10.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.56 -166.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -1.113 . . . . 0.0 109.366 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 83' ' ' GLU . 15.5 m -108.34 135.82 49.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.959 . . . . 0.0 109.639 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' SER . 11.4 mt -45.32 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 81' ' ' SER . 5.7 tp10 -77.92 -53.12 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.173 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -32.0 69.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.07 31.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.24 47.2 3.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.61 -33.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.189 . . . . 0.0 109.425 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.5 pt -44.16 175.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -143.19 158.11 43.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -73.99 -38.25 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -52.19 -37.69 55.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.161 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 94' ' ' ALA . 3.5 mm100 -66.18 -68.33 0.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -45.67 -23.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 91' ' ' SER . . . -71.85 -63.45 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.825 . . . . 0.0 109.166 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -49.31 -17.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 108.941 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -80.68 -61.21 2.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 60.2 tp -76.7 -33.45 58.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER 70.0 68.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.035 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.2 pt? -103.72 146.93 33.43 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -40.24 102.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.758 2.305 . . . . 0.0 112.16 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 103' ' ' LYS . 58.8 Cg_endo -78.77 10.15 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.543 2.162 . . . . 0.0 112.41 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -11.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.238 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 101' ' ' PRO . 53.0 tttm -157.14 -34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.381 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t 60.9 60.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.286 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.624 ' O ' HD13 ' A' ' 109' ' ' LEU . 13.3 p-80 -99.27 -47.66 5.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 0.0 109.527 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.403 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.6 m -61.11 -49.38 77.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.509 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.547 ' OG ' HD11 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -50.66 -67.8 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' SER . 3.4 mt -44.87 -38.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.6 mp -60.24 -39.37 86.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -61.67 -52.02 66.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.132 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 112' ' ' ASP . 68.2 tt0 -60.16 -60.31 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -42.76 -33.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -64.28 -60.45 3.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -46.99 -38.4 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' HA ' HD12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -70.35 -57.77 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.99 -39.58 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.01 97.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 109.66 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 115' ' ' LYS . 44.2 mt -64.37 -39.3 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.97 72.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 -42.73 95.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -70.02 -48.66 57.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 123' ' ' ALA . 20.2 tttt -56.96 -30.15 63.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -38.93 -36.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.4 tptt . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.677 ' OD1' ' N ' ' A' ' 25' ' ' SER . 57.6 t0 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.677 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 51.0 m -89.65 5.86 43.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -114.31 -2.71 13.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.19 117.56 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.843 . . . . 0.0 109.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 126.94 9.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 44' ' ' GLN . 3.0 m -112.07 151.2 29.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -1.135 . . . . 0.0 109.299 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.92 153.88 25.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.8 ttm -142.37 141.19 32.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.86 165.96 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.923 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.11 148.53 17.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -141.88 79.16 16.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.333 -1.098 . . . . 0.0 109.619 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.31 12.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.88 2.387 . . . . 0.0 112.269 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.635 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -110.54 -79.16 0.58 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.271 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 1.4 p -134.9 -36.22 0.84 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.188 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.688 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -55.02 -18.86 12.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.535 ' N ' ' HB3' ' A' ' 34' ' ' ALA . 14.7 t0 51.69 -147.69 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 0.0 109.731 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.424 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.98 115.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.88 . . . . 0.0 109.434 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.452 ' CG ' ' N ' ' A' ' 42' ' ' GLN . 9.5 ttt -106.82 157.42 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CG ' ' A' ' 41' ' ' MET . 15.6 tt0 -143.86 130.38 20.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.686 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 1.6 tp -125.45 150.91 46.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.553 ' NE2' ' OG1' ' A' ' 29' ' ' THR . 22.1 mt-30 -142.23 144.33 33.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.539 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.17 155.95 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -130.76 122.79 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.247 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.629 HG11 HD11 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -115.37 140.01 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.786 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' A' ' 50' ' ' ASN . 35.0 m-20 -170.88 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.47 48.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.374 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 78.4 50.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.91 86.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.83 149.49 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -1.103 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mt -82.7 91.44 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -72.83 -38.56 67.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.333 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 47.8 t0 -124.85 158.03 34.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.828 . . . . 0.0 109.236 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -158.67 120.23 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.76 157.33 19.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -140.69 -174.03 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.751 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -169.69 81.61 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.219 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.34 122.34 30.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 105.68 3.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 145.25 -44.57 0.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.466 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 15.9 m -75.0 167.36 22.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.446 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.37 -38.48 0.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -21.01 17.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -1.085 . . . . 0.0 109.498 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -88.6 0.63 56.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 66' ' ' ALA . 8.3 tp -44.36 -31.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -66.46 -47.78 72.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.599 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -43.37 -32.5 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.333 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.7 OUTLIER -58.53 -53.73 55.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 m -65.75 -32.72 74.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 75' ' ' GLU . 1.7 tp -65.1 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.856 . . . . 0.0 109.682 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.733 ' O ' HG22 ' A' ' 77' ' ' VAL . 16.4 tt -37.11 -41.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.963 . . . . 0.0 109.577 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 73' ' ' ILE . 2.4 p -64.77 -32.38 74.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.526 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 72' ' ' LEU . 8.8 mt-10 -86.56 -7.72 58.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -109.04 -5.71 15.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 109.546 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 73' ' ' ILE . 24.9 m -117.52 0.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -95.38 114.83 26.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 109.385 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.82 -8.36 73.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.25 168.69 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.42 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.0 m -88.79 167.59 13.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 HG11 ' A' ' 47' ' ' VAL . 31.7 mt -68.04 -26.61 65.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.565 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -66.52 -20.27 65.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.317 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -97.22 -58.02 2.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.171 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.68 62.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.246 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 118' ' ' ILE . . . -101.44 49.23 1.06 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -168.93 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -1.128 . . . . 0.0 109.094 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 87' ' ' ALA . 5.1 pt -41.38 156.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.5 168.8 9.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.135 -0.978 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.59 -18.47 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 t -66.65 -27.61 67.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.19 -57.87 5.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.533 HG21 ' OG ' ' A' ' 69' ' ' SER . 5.1 mt -62.37 -38.45 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -54.79 -53.51 54.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.348 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -37.02 85.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -52.25 -41.13 62.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 tp -105.8 -29.14 10.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 94' ' ' ALA . 8.9 tm-20 64.58 58.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.347 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.068 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.2 pt? -86.46 143.43 36.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.376 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.61 142.45 1.96 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.574 2.183 . . . . 0.0 112.151 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -76.24 -3.16 13.48 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.719 2.279 . . . . 0.0 111.942 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 102' ' ' VAL . 3.0 t -59.9 -12.21 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HD2' ' SG ' ' A' ' 106' ' ' CYS . 18.0 pttp -156.79 56.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 104' ' ' VAL . 86.0 t -57.3 -11.27 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.284 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.688 ' CE1' ' H ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -54.64 -22.32 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.42 ' SG ' ' HD2' ' A' ' 103' ' ' LYS . 59.5 m -65.03 -61.1 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.0 p -55.15 -51.67 65.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.442 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.9 mt -55.28 -26.52 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.102 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 109' ' ' LEU . 1.9 tp -68.06 -42.11 80.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 109.004 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -58.37 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.82 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 112' ' ' ASP . 7.3 tm-20 -62.33 -64.57 0.89 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.565 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 111' ' ' GLU . 62.2 t0 -39.22 -31.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.711 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -69.01 -56.73 6.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.711 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.8 tp -52.14 -37.05 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 3.1 tttp -67.98 -50.46 55.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.85 73.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.714 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -65.62 -69.7 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.698 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.471 HD13 ' HA3' ' A' ' 86' ' ' GLY . 23.6 mt -42.7 -37.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.685 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.32 85.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 61.0 t0 -61.17 -25.19 66.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.898 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.4 t80 -78.62 -40.77 33.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -84.84 -1.78 56.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.12 24.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.275 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 27' ' ' VAL . 2.8 p30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.296 0.57 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -98.42 9.85 42.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m-80 -118.77 18.27 13.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.558 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 t -126.48 122.34 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.52 123.46 7.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 m -109.21 152.78 24.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -1.186 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.52 110.7 0.45 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 ttt -114.45 103.52 11.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.457 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.0 m -117.2 157.29 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.14 163.23 28.67 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.87 138.03 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.294 -1.121 . . . . 0.0 109.371 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.1 Cg_endo -75.57 -36.24 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -43.01 -53.31 4.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.537 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.4 2.38 20.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.65 58.3 7.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 62.3 t0 -127.75 145.39 50.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.55 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 2.6 m -115.26 114.69 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 ttt -98.93 125.3 44.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.859 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.29 119.15 38.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.023 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.1 110.92 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -118.82 108.96 15.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.042 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 pt -107.87 143.45 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.892 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.667 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 8.0 tttp -109.31 144.27 37.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.013 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.506 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 3.3 t -134.99 149.33 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.737 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.694 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 174.28 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 2.9 m-20 -62.21 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.421 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-20 79.19 48.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.85 . . . . 0.0 109.412 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.37 78.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 53' ' ' ILE . 5.4 mm -89.24 158.85 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.392 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 52' ' ' ILE . 46.8 mt -93.09 90.73 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.59 -38.56 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.708 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 2.3 p30 -147.62 162.08 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.42 119.6 10.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.712 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' HG21 ' A' ' 74' ' ' THR . 6.1 p90 -137.9 163.93 30.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.734 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -158.95 111.1 2.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.207 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -156.81 132.6 9.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.133 -0.979 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.433 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 46.0 t80 -161.65 154.77 20.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 61' ' ' TYR . . . 125.08 -43.24 1.4 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 t -88.95 166.38 13.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.086 -1.243 . . . . 0.0 109.651 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.86 43.4 1.67 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -158.9 -66.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.314 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -36.27 -35.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.315 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 65' ' ' SER . 49.0 mt -54.88 -13.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.258 -0.901 . . . . 0.0 109.314 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -103.22 -53.25 2.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 109.154 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -55.56 -37.87 68.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.0 109.232 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 74' ' ' THR . 59.0 p -59.86 -39.92 86.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.214 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.573 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -62.37 -51.16 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 73' ' ' ILE . 10.7 tp -55.74 -69.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.371 -0.831 . . . . 0.0 109.508 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 74' ' ' THR . 14.5 tt -47.53 -50.37 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.674 ' N ' HG23 ' A' ' 73' ' ' ILE . 6.0 p -47.35 -38.08 12.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.53 -8.58 54.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 108.914 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.7 t90 -92.12 -11.75 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 108.977 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.04 4.22 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -79.33 104.59 10.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.92 35.38 79.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.72 -174.68 2.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 t -106.16 148.71 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.762 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.4 HD22 HG12 ' A' ' 118' ' ' ILE . 27.3 mt -68.77 -20.65 64.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.961 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.93 -9.04 58.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.374 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -102.17 -43.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.18 -12.73 56.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.527 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.04 49.8 3.6 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -178.63 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -1.12 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -32.16 -31.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 109.757 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 87' ' ' ALA . 16.6 mtmt 62.42 128.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.336 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.64 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 2.5 p-10 -54.37 -46.93 73.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 90' ' ' ASN . 15.7 m -35.45 -34.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.386 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 90' ' ' ASN . 42.1 tp60 -73.44 -49.85 24.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.4 mt -50.61 -38.1 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.238 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.88 -61.32 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.64 -10.21 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.722 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -79.58 -67.73 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.1 mt -85.04 -2.21 57.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' LEU . 14.2 mt-10 44.24 75.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.73 143.05 26.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -42.27 157.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.634 2.222 . . . . 0.0 112.306 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 61.2 Cg_endo -77.29 1.38 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.167 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.85 -0.5 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.669 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -134.63 35.42 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -84.12 -40.58 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.554 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 104' ' ' VAL . 16.0 p-80 -40.98 -33.6 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.007 . . . . 0.0 109.342 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.414 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 1.2 m -72.52 -45.93 57.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.258 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.4 t -55.87 -49.97 71.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.047 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.482 ' O ' ' C ' ' A' ' 109' ' ' LEU . 71.5 mt -50.97 -59.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.0 109.174 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.514 ' O ' ' C ' ' A' ' 110' ' ' ALA . 5.1 mp -40.54 -62.09 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.21 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -37.55 -65.68 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.842 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.459 ' C ' ' CD ' ' A' ' 111' ' ' GLU . 4.4 tp10 -42.32 -45.51 4.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -15.18 63.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.177 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -80.22 -45.16 18.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 109.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -63.7 -40.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.213 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.501 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 20.2 mttt -70.94 -34.63 71.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.32 -53.12 61.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.848 . . . . 0.0 109.519 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.34 84.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 115' ' ' LYS . 89.0 mt -59.47 -28.75 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.988 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.52 -46.93 12.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.74 -8.88 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.1 t80 -96.54 -43.62 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.3 tttt -88.38 -5.56 58.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.567 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.42 -21.09 23.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.623 -179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.645 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 1.9 p -75.67 -7.64 54.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.645 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -95.99 8.7 42.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 46' ' ' LYS . 61.2 t -140.87 110.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.706 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.01 152.33 18.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.759 HG23 ' NE2' ' A' ' 44' ' ' GLN . 27.3 m -122.7 154.5 38.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.728 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.95 130.01 3.46 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 9.0 ttt -127.08 135.49 50.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -1.219 . . . . 0.0 109.947 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 31' ' ' MET . 10.9 m -154.76 146.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.0 109.208 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.9 172.26 22.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -141.79 138.77 17.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.302 -1.116 . . . . 0.0 109.198 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.62 -51.57 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.473 2.115 . . . . 0.0 112.172 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.56 -40.99 13.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 34.1 m -100.61 -0.15 38.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 39.25 47.99 2.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -130.14 148.28 51.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -1.119 . . . . 0.0 109.708 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.79 110.54 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.189 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 109' ' ' LEU . 9.4 ttt -104.07 141.5 36.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.709 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -123.08 129.68 51.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 109.156 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.42 125.38 42.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.667 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.759 ' NE2' HG23 ' A' ' 29' ' ' THR . 2.2 mt-30 -121.01 161.29 21.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.0 109.117 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.31 145.42 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HG3' HG22 ' A' ' 27' ' ' VAL . 13.2 tttt -119.64 123.77 44.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 109.093 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.74 134.99 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.2 m-20 -170.67 -31.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -62.94 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.398 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-20 78.88 41.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.12 74.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 53' ' ' ILE . 20.3 mm -100.61 165.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.603 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.567 ' N ' HG22 ' A' ' 52' ' ' ILE . 68.6 mt -79.02 88.47 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -54.19 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.66 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.1 t70 -146.61 163.78 34.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.11 144.94 31.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 169.46 9.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.755 ' CG ' HG21 ' A' ' 74' ' ' THR . 2.6 p90 -168.28 162.93 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.6 119.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.41 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 60' ' ' THR . 5.5 t -161.01 124.86 3.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -148.4 97.61 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.27 -2.44 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.31 -177.54 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.647 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.39 -14.26 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -137.26 -3.25 1.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -1.166 . . . . 0.0 109.655 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -85.74 -44.35 12.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.2 tp -34.36 -29.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.815 . . . . 0.0 109.828 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -91.35 -41.52 10.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 109.962 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.646 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -69.17 -31.31 69.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.992 . . . . 0.0 109.746 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' HG21 ' A' ' 60' ' ' THR . 9.4 m -57.92 -40.53 80.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.0 109.534 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 p -74.3 -41.54 61.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.9 tp -56.07 -59.06 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.908 HG23 ' H ' ' A' ' 74' ' ' THR . 8.7 tt -55.18 -63.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.908 ' H ' HG23 ' A' ' 73' ' ' ILE . 6.0 p -43.26 -25.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' ILE . 24.2 mt-10 -91.9 -12.93 32.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.613 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.619 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.4 m0 -101.14 -13.19 18.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.711 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.521 ' O ' HG21 ' A' ' 53' ' ' ILE . 35.3 m -111.47 34.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 109.694 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.66 ' NZ ' ' OD2' ' A' ' 55' ' ' ASP . 14.4 ttmm -120.25 89.65 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.02 -7.43 23.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -91.73 -174.67 3.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.09 154.14 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.39 -17.25 62.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.53 -40.9 76.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 109.67 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.24 -39.74 53.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.83 82.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.97 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.03 54.82 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.3 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -1.107 . . . . 0.0 109.115 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 87' ' ' ALA . 6.4 pt -42.32 -28.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.2 tttt 65.46 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -71.61 -6.7 42.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.605 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 p -73.61 -30.36 62.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.5 -39.05 91.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.19 -33.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.35 72.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.67 -46.17 14.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -49.77 -36.96 27.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.43 -27.86 12.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.461 ' C ' HD23 ' A' ' 99' ' ' LEU . 8.9 tt0 63.57 74.51 0.42 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.24 159.96 30.06 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.99 160.21 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.876 2.384 . . . . 0.0 112.262 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.12 -14.33 18.82 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.818 2.346 . . . . 0.0 112.279 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.06 -1.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.612 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -146.99 36.68 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.524 ' O ' ' C ' ' A' ' 105' ' ' HIS . 41.3 t -52.45 -33.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.729 ' ND1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -36.07 -58.34 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.659 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 56.8 m -32.63 -62.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.72 -44.04 81.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 109' ' ' LEU . 72.3 mt -58.57 -63.56 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.726 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.729 HD13 ' ND1' ' A' ' 105' ' ' HIS . 1.1 mp -39.09 -41.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.88 -56.95 15.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.617 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 112' ' ' ASP . 3.5 tm-20 -66.39 -68.85 0.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 111' ' ' GLU . 2.4 t0 -37.52 -33.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.494 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 109' ' ' LEU . . . -65.29 -52.61 53.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 111' ' ' GLU . 4.4 tp -51.99 -35.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 32.4 tttt -74.44 -48.24 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.77 -54.53 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.41 -61.11 2.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.331 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . 64.2 mt -39.17 -46.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.261 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.81 65.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -57.04 -18.45 14.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.363 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.495 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 20.6 t80 -77.33 -49.76 14.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.386 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 124' ' ' LYS . 1.3 mptm? -71.88 -47.95 49.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.372 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.06 -14.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.351 0.596 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.28 3.07 5.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.658 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.19 14.95 18.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.86 108.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.632 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.49 148.28 17.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.7 m -139.16 145.96 40.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.563 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 120.19 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.9 mtp -118.49 137.75 52.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -1.183 . . . . 0.0 109.586 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.65 163.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.88 143.8 12.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -127.39 131.79 24.01 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -73.56 -57.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.537 2.158 . . . . 0.0 112.477 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.49 -31.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 109.673 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 35' ' ' PRO . 38.1 m -118.39 1.41 11.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 39.25 55.56 2.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -136.39 163.29 30.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.251 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 79.4 t -127.22 129.05 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.714 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.9 ttt -112.41 119.93 39.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -109.43 119.92 40.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.09 130.4 54.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 148.04 48.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.489 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.0 pt -122.5 146.53 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -110.4 101.77 10.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -0.828 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG21 ' CD2' ' A' ' 121' ' ' TYR . 21.7 t -80.48 129.71 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.641 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 6.5 t0 -64.73 -60.1 3.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' ASP . 6.0 m-20 166.44 -25.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -12.86 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.815 . . . . 0.0 109.328 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.84 20.0 5.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mm -109.88 132.63 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -1.133 . . . . 0.0 109.437 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.76 87.7 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -53.29 -42.64 66.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.89 -178.74 7.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.34 113.29 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.576 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -94.02 126.15 39.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.095 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.681 ' CD1' HG21 ' A' ' 74' ' ' THR . 37.3 p90 -114.72 170.04 8.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.849 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -170.35 97.62 0.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 109.141 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -137.38 133.9 35.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -151.24 144.55 24.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.05 -39.25 2.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -85.67 91.96 8.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 109.278 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.92 52.03 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -151.12 -22.35 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 109.316 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -97.24 -11.28 24.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ALA . 3.1 mm -40.47 -27.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -97.42 -32.36 11.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.308 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.8 t -66.5 -54.05 28.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 74' ' ' THR . 0.7 OUTLIER -37.31 -51.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.517 ' O ' ' OG1' ' A' ' 74' ' ' THR . 9.2 t -62.06 -52.72 62.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 73' ' ' ILE . 43.6 tp -46.66 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.922 HG23 ' H ' ' A' ' 74' ' ' THR . 10.7 tt -43.69 -64.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.819 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.922 ' H ' HG23 ' A' ' 73' ' ' ILE . 16.6 p -35.18 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -83.93 -32.61 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.647 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.8 m95 -82.27 -2.64 53.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.598 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 77' ' ' VAL . 11.7 m -130.16 53.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.742 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -139.19 85.4 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.539 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.1 8.05 45.47 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -90.67 -171.36 3.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -1.149 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 154.76 18.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.94 -24.99 66.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.41 -28.44 66.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 -53.65 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.97 -25.84 22.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.128 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.73 40.87 2.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -151.01 -37.93 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -1.113 . . . . 0.0 108.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.6 pt -41.09 159.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.519 -0.738 . . . . 0.0 109.296 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.06 162.26 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.526 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.22 -25.2 64.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -66.21 -67.57 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.591 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 91' ' ' SER . 13.2 mm-40 -39.3 -60.63 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.8 mt -56.14 -28.68 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 91' ' ' SER . . . -77.42 -15.22 59.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 109.185 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.71 -18.51 21.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.66 -38.31 14.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -80.87 -0.8 40.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.553 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.527 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.3 tt0 37.12 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 109.37 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.7 HD23 ' N ' ' A' ' 99' ' ' LEU . 1.3 pt? -63.0 149.35 90.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.405 ' HG2' HG12 ' A' ' 102' ' ' VAL . 30.5 Cg_endo -67.17 152.82 79.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.685 2.257 . . . . 0.0 111.939 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.1 13.89 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.3 p -79.02 96.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 105' ' ' HIS . 7.0 mttm 67.31 58.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.212 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.3 0.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -0.818 . . . . 0.0 109.262 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.93 -53.95 45.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.637 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 87.6 m -30.96 -58.79 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.031 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -58.84 -56.22 25.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 107' ' ' SER . 44.9 mt -45.29 -51.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -49.63 -43.17 46.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.483 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.04 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -52.78 -40.0 62.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -25.45 68.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -72.11 -62.89 1.27 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -45.31 -36.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.157 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.3 tttt -73.31 -35.8 66.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 109.512 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.88 79.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.489 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -64.54 -38.07 89.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.9 mt -61.2 -38.01 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.66 81.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.716 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.2 -54.71 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.669 ' CD2' HG21 ' A' ' 47' ' ' VAL . 4.0 t80 -53.75 -32.08 50.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.762 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -81.04 -30.71 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.695 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.19 63.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.705 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.395 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.294 0.569 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 63.67 20.42 12.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.278 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.32 38.01 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.03 133.28 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.39 113.14 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -101.71 157.46 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.526 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.31 132.86 3.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.3 ttp -141.56 123.15 15.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -1.171 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.8 149.1 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 39' ' ' ASP . . . -133.06 170.17 22.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -125.61 146.47 54.91 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.354 -1.086 . . . . 0.0 109.278 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 37' ' ' CYS . 37.1 Cg_endo -69.36 -71.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.668 2.245 . . . . 0.0 112.056 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.59 -14.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.176 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 35' ' ' PRO . 1.8 t -117.11 -12.17 10.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.396 -0.815 . . . . 0.0 109.324 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 38.3 33.33 0.17 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' CYS . 39.0 t70 -101.63 148.36 25.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 109.595 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -121.29 97.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.7 ttt -86.98 119.62 27.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -109.14 101.43 10.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.422 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.74 148.48 28.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.67 132.0 25.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.253 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.738 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.5 pt -111.22 141.98 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -114.25 148.44 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.264 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.65 130.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 t0 -70.77 -54.56 11.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.268 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 160.82 -22.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.357 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -94.43 11.05 32.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.8 30.36 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 mm -125.07 138.23 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.96 103.09 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.161 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -75.43 -42.5 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.806 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 86.3 m-20 -143.29 157.93 44.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.763 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.98 137.23 25.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -105.53 141.56 36.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -124.62 163.21 22.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -171.85 109.01 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -161.05 119.63 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -149.56 103.58 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.91 -20.01 0.03 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.4 t -126.74 116.45 20.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -57.17 172.71 2.39 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER 64.63 -69.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -1.173 . . . . 0.0 109.538 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -38.37 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' SER . 1.6 mt -58.65 2.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -106.67 -32.31 8.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 73' ' ' ILE . 17.9 p -58.79 -45.62 89.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.458 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' SER . 35.0 p -53.73 -64.39 0.84 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' SER . 31.9 m -42.32 -45.64 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.914 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 75' ' ' GLU . 56.5 tp -65.41 -84.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.704 HG23 ' N ' ' A' ' 74' ' ' THR . 9.0 tt -33.68 -52.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.704 ' N ' HG23 ' A' ' 73' ' ' ILE . 29.8 p -53.17 -44.21 67.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 72' ' ' LEU . 11.0 tm-20 -78.93 2.18 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.238 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.7 -17.97 14.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.87 . . . . 0.0 109.636 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 114' ' ' ILE . 14.3 m -98.0 -28.17 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.37 128.3 35.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -20.58 28.63 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -91.51 164.53 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.287 -1.125 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -175.4 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.827 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.02 -27.24 60.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.35 -20.59 64.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.004 . . . . 0.0 109.159 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.75 -41.67 8.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.887 . . . . 0.0 109.314 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.61 8.92 15.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.62 -57.69 0.65 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.41 -4.38 29.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -1.146 . . . . 0.0 108.816 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.95 168.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.499 -0.751 . . . . 0.0 109.65 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.423 ' O ' HD12 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -153.67 -175.15 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -94.98 -6.55 42.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.16 56.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -66.61 -59.88 3.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.857 . . . . 0.0 109.327 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 89' ' ' LYS . 3.8 mt -47.24 -41.28 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -68.04 -46.69 70.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -54.21 -25.77 24.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.49 -52.23 7.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.875 . . . . 0.0 109.566 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.8 mt -81.88 -15.87 52.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.5 mm-40 43.36 14.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 99' ' ' LEU . 1.6 pt? -39.96 150.0 0.27 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -41.52 162.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.811 2.341 . . . . 0.0 112.097 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.0 Cg_endo -76.42 -49.56 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.865 2.376 . . . . 0.0 112.469 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.84 27.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' ND1' ' A' ' 105' ' ' HIS . 37.3 mttt -143.45 6.99 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.542 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 105' ' ' HIS . 10.2 p -68.92 -11.44 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.614 ' ND1' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -44.02 -57.38 3.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 105' ' ' HIS . 55.1 m -56.13 -35.1 66.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -51.25 70.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.231 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.549 HG22 ' OD2' ' A' ' 112' ' ' ASP . 61.0 mt -59.16 -36.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.629 ' CD1' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -59.85 -37.72 80.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.229 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -63.83 -51.21 65.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.326 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.24 -53.64 49.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' HG22 ' A' ' 108' ' ' ILE . 2.6 m-20 -48.84 -40.99 31.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.414 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.37 13.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.31 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 77' ' ' VAL . 1.4 tp -46.86 -33.68 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.266 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' C ' ' A' ' 116' ' ' ALA . 10.6 ttmm -67.38 -71.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -38.43 -44.96 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.738 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -53.31 -54.41 36.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.8 mt -54.54 -34.68 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.544 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.98 -56.92 8.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.48 -25.18 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -80.43 -69.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.45 -24.17 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.16 16.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.292 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.28 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.596 ' OD2' ' N ' ' A' ' 26' ' ' ASN . 1.1 t70 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.389 0.614 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 24' ' ' ASP . 92.6 p -75.83 -11.29 59.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.596 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 32.9 m120 -116.44 25.09 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -147.37 107.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.384 -0.822 . . . . 0.0 109.222 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.25 143.83 17.59 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -120.27 132.58 55.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -1.083 . . . . 0.0 109.186 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.08 123.03 4.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttt -125.15 115.91 21.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -1.085 . . . . 0.0 109.117 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.4 166.28 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.77 165.31 31.53 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.591 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -141.1 152.74 65.71 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.237 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.4 Cg_endo -77.09 -64.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.17 -45.76 2.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -94.65 -4.82 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 109.232 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.0 41.37 0.45 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' CYS . 10.0 t70 -115.47 155.63 27.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -1.122 . . . . 0.0 109.761 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.61 105.68 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.18 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.471 ' HG3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -89.53 143.95 26.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.833 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 41' ' ' MET . 5.4 tt0 -129.23 110.04 11.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.125 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 44' ' ' GLN . 5.8 tt -121.97 132.34 54.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.492 ' N ' HD23 ' A' ' 43' ' ' LEU . 8.3 mp0 -124.04 177.96 5.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 44' ' ' GLN . 6.6 pt -154.86 151.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.617 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -114.64 163.6 15.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.348 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 4.9 t -132.5 107.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.545 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.71 -65.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 169.91 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.667 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -92.56 16.4 12.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.37 22.42 60.57 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.52 147.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.503 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.3 mt -82.35 112.99 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.9 -36.42 18.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.759 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.96 165.44 24.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.7 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.08 120.28 4.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -108.02 159.1 16.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD2' HG21 ' A' ' 74' ' ' THR . 2.8 p90 -163.34 162.16 24.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -171.44 119.47 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.342 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 41' ' ' MET . 17.0 p -116.66 102.39 9.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 0.0 109.531 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -109.54 113.49 26.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.37 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.79 -39.5 1.96 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.2 m -79.05 152.14 31.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -1.161 . . . . 0.0 109.574 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.47 38.6 2.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -167.66 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -1.137 . . . . 0.0 109.429 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.541 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -86.44 -36.71 18.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.541 ' C ' ' O ' ' A' ' 66' ' ' ALA . 4.9 mt -36.03 -48.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.74 -54.69 30.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 73' ' ' ILE . 97.1 p -62.0 -49.04 77.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.362 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -47.38 -46.59 26.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -61.59 -35.77 78.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 109.229 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.514 ' CD1' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -69.26 -68.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 69' ' ' SER . 5.9 tt -48.46 -47.57 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 70' ' ' SER . 23.1 p -49.24 -45.43 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.15 0.41 53.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.792 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -17.51 17.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.66 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 114' ' ' ILE . 17.8 m -111.75 10.76 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -85.56 103.48 14.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.99 40.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -97.34 -171.09 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.468 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -112.74 139.72 48.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.0 mt -53.09 -28.72 26.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.259 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.02 -30.09 68.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.02 -57.66 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.272 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.35 -17.6 3.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.198 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.45 49.5 0.86 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -172.69 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -1.096 . . . . 0.0 109.324 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -50.6 178.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -137.1 -168.28 2.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.332 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.429 ' ND2' ' C ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -103.5 -30.78 10.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -51.82 -33.69 36.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' ILE . 2.0 mt-30 -69.48 -66.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 1.8 mt -44.5 -40.8 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.64 -49.63 61.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.934 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.93 -24.41 23.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.532 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 72' ' ' LEU . 3.5 tt0 -82.11 -33.19 29.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.94 -15.07 35.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 48.62 73.41 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.236 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.027 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -129.2 139.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -42.5 146.88 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.55 -20.97 22.88 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.667 2.245 . . . . 0.0 112.126 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.88 -4.68 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.444 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -135.93 16.4 3.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.568 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.525 ' O ' ' C ' ' A' ' 105' ' ' HIS . 8.4 p -60.68 -14.96 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.755 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER -33.95 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.707 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.755 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 77.0 m -31.26 -58.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.539 -0.726 . . . . 0.0 110.121 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -50.39 -64.27 0.86 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 109.62 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 5.6 mt -42.27 -42.61 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.588 HD22 ' HE1' ' A' ' 105' ' ' HIS . 0.6 OUTLIER -64.82 -32.98 74.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -59.71 -48.29 82.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.203 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.529 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 6.3 tp10 -68.91 -51.91 34.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.371 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -53.85 -28.78 38.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.12 -60.73 2.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.455 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -48.26 -33.85 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -76.41 -28.58 56.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -56.8 8.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -52.79 63.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.368 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -48.77 -38.84 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.92 66.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -77.2 -7.76 56.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.52 -38.58 6.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -71.88 -35.62 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.55 -22.26 62.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tptt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.389 179.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -72.7 10.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.778 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -111.2 20.56 17.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 27' ' ' VAL . 45.1 t -137.7 90.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.639 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.43 145.95 48.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 m -135.27 108.86 7.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -1.124 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 117' ' ' ALA . . . -105.82 150.29 16.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 ttm -144.45 127.18 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.357 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.28 161.38 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.48 164.86 18.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB2' HD22 ' A' ' 109' ' ' LEU . . . -136.89 85.69 22.82 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.149 -1.206 . . . . 0.0 109.854 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.08 -20.3 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.712 2.275 . . . . 0.0 111.94 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.42 -53.51 23.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.174 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -103.84 17.84 23.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.198 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.86 55.08 1.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 61' ' ' TYR . 40.6 t0 -126.65 146.37 50.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -1.163 . . . . 0.0 109.713 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.36 113.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 ttt -99.86 134.3 42.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.37 128.97 46.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -129.58 142.85 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.22 150.33 47.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.145 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.05 148.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.943 . . . . 0.0 109.705 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -114.74 120.93 41.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -103.96 127.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.609 ' CG ' ' N ' ' A' ' 49' ' ' ASP . 2.9 t0 -62.89 -94.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.609 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 4.8 t70 -154.22 24.43 0.48 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 14.71 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 25.24 57.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mm -108.69 130.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.582 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -88.45 102.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.195 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.38 -46.64 14.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.58 141.97 51.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.22 129.15 42.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -101.22 164.01 12.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD1' HG21 ' A' ' 74' ' ' THR . 30.2 p90 -156.8 162.73 39.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.574 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.22 98.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.75 138.44 32.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -157.04 123.84 5.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.319 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.05 -61.71 0.36 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 t -84.21 134.39 34.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.712 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.39 20.0 6.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -27.75 6.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.129 . . . . 0.0 109.361 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.27 7.85 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mm -77.9 -40.34 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.835 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.88 -45.25 17.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 109.656 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' ILE . 75.2 m -53.15 -49.34 66.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.562 ' OG ' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -34.35 -66.83 0.15 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.841 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.562 ' N ' ' OG ' ' A' ' 70' ' ' SER . 66.1 m -55.44 -40.44 71.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 73' ' ' ILE . 4.4 tp -60.2 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.933 . . . . 0.0 109.843 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.836 HG23 ' H ' ' A' ' 74' ' ' THR . 5.6 tt -36.44 -62.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.958 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.836 ' H ' HG23 ' A' ' 73' ' ' ILE . 56.8 p -40.34 -39.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mm-40 -86.07 -15.39 41.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.552 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.57 -5.43 55.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 109.688 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.32 20.75 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 109.607 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -96.53 87.97 4.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.66 -3.82 7.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -89.16 167.71 12.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -1.127 . . . . 0.0 109.392 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.55 176.05 5.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.86 -21.34 66.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.575 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -70.55 -40.93 73.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -79.63 -51.01 9.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.706 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.51 63.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 109.408 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.95 26.0 25.21 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.8 18.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 109.202 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.467 HD11 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -79.95 171.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.414 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -136.19 140.57 43.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 108' ' ' ILE . 11.4 p30 -68.36 -23.1 64.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -56.24 -36.35 68.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -59.01 2.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mt -46.77 -40.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -73.73 -42.6 60.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 109.836 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.567 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 2.6 tm-20 -57.6 -30.35 65.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.03 -39.44 29.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.003 . . . . 0.0 109.716 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -95.35 -5.04 44.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.698 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 94' ' ' ALA . 17.6 tp10 41.17 44.68 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 151.26 87.89 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.641 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.03 109.41 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.954 2.436 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 103' ' ' LYS . 65.3 Cg_endo -79.79 -79.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.699 2.266 . . . . 0.0 112.129 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.518 HG23 ' C ' ' A' ' 101' ' ' PRO . 0.4 OUTLIER 53.65 -76.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 101' ' ' PRO . 9.3 mtpp -118.3 -6.21 10.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 108' ' ' ILE . 17.3 t 47.38 60.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.358 -0.839 . . . . 0.0 109.56 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -91.31 -38.75 12.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 1.9 m -71.41 -67.68 0.5 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -37.43 -65.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.307 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.591 ' N ' ' OG ' ' A' ' 107' ' ' SER . 3.3 mt -44.71 -43.08 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.82 HD22 ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -59.95 -37.99 81.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -57.79 -55.67 31.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 114' ' ' ILE . 2.8 tm-20 -57.1 -60.82 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.65 -31.43 2.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 109.031 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -61.2 -53.24 59.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 108.98 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp -49.74 -39.93 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 108.785 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.492 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -73.01 -22.11 60.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.47 -0.769 . . . . 0.0 109.308 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -71.01 -60.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.408 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . -58.62 -34.65 71.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.344 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.23 -43.76 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.0 91.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.89 -26.02 65.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -66.37 -65.06 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -25.37 60.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.38 -47.96 80.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.339 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 mptt . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.847 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t70 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.09 -4.52 29.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.702 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -124.08 20.85 9.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.11 92.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.91 22.43 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -135.12 148.56 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.244 . . . . 0.0 109.862 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.48 140.43 10.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttm -133.86 113.16 11.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.49 149.69 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.93 -178.56 15.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.711 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -148.07 135.52 10.64 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.347 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.31 -38.2 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.458 2.106 . . . . 0.0 112.269 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -60.77 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLY . 20.7 m -87.88 2.44 51.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.16 46.1 3.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.665 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -116.11 148.29 40.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -1.127 . . . . 0.0 109.782 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -110.09 116.46 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.444 ' CE ' HD13 ' A' ' 43' ' ' LEU . 12.9 ttt -105.91 123.27 47.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -112.2 98.41 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.444 HD13 ' CE ' ' A' ' 41' ' ' MET . 8.7 tp -93.7 137.07 33.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.729 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -131.57 123.56 28.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.366 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.467 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.9 pt -105.97 156.26 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.512 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' A' ' 54' ' ' GLU . 7.3 tttm -128.36 149.63 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.38 149.37 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.513 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.5 -96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.82 17.5 0.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -130.83 -25.76 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.673 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.32 9.93 3.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -100.1 133.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 0.0 109.436 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.2 mt -76.26 110.6 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.211 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -87.32 -39.0 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.576 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.37 170.3 16.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.81 120.97 2.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -96.02 161.22 14.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.322 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 58' ' ' PHE . 4.6 p90 -150.32 170.49 18.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 4.8 tttt -172.06 97.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.735 HG21 ' OG ' ' A' ' 70' ' ' SER . 70.6 p -110.23 104.45 13.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.425 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 100.43 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.578 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' CA ' ' OD2' ' A' ' 39' ' ' ASP . . . 148.73 -43.96 0.77 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.665 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.6 m -88.77 105.53 17.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.94 63.14 4.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.47 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.144 -1.209 . . . . 0.0 109.371 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . . . -98.03 -15.96 19.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 68' ' ' ALA . 4.2 mt -42.15 -80.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -34.38 -56.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.674 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -45.35 -58.11 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.735 ' OG ' HG21 ' A' ' 60' ' ' THR . 46.1 m -48.2 -37.96 17.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.882 . . . . 0.0 109.438 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.8 t -70.04 -33.53 72.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 109.411 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 75' ' ' GLU . 30.0 tp -67.31 -68.78 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -41.51 -45.73 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.226 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' SER . 22.6 p -58.72 -33.59 70.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.284 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.4 tt0 -83.19 -5.1 59.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.434 ' HE1' HD11 ' A' ' 72' ' ' LEU . 17.7 m0 -98.72 -26.59 14.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG11 HD11 ' A' ' 114' ' ' ILE . 8.2 m -94.73 -3.13 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.978 . . . . 0.0 109.796 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -81.88 107.72 14.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.46 -21.66 30.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -84.48 178.78 7.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.122 -1.222 . . . . 0.0 109.571 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.96 172.19 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.32 -28.37 62.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 -24.24 66.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 109.21 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.8 -52.66 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.03 -36.77 68.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.349 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.35 48.41 4.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.51 -37.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.162 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -37.74 161.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -130.4 170.94 13.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.529 ' OD1' HD13 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -85.27 -15.17 44.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -59.11 -39.59 82.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -71.46 -52.89 15.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.6 mt -54.72 -41.38 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.83 -29.53 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.76 -42.06 61.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.44 -24.28 60.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.806 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.13 -36.46 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.024 -1.047 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 94' ' ' ALA . 3.5 mt-10 62.32 18.27 10.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.249 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 99' ' ' LEU . 1.9 pt? -48.46 149.72 2.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.0 154.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.266 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 104' ' ' VAL . 45.9 Cg_endo -72.48 -74.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.824 2.349 . . . . 0.0 112.091 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER 43.01 46.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.2 OUTLIER 76.36 10.39 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER 35.92 27.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.711 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.29 -36.22 83.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.366 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 68.9 m -55.5 -65.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.572 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.8 t -53.84 -57.11 12.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.529 HD13 ' OD1' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -47.02 -32.32 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.577 HD13 ' HD1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -70.01 -37.51 75.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.3 88.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.033 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.25 -53.88 21.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 109.273 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -54.13 -23.78 15.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.379 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.06 -50.74 21.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 109.222 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.702 HD11 HG11 ' A' ' 77' ' ' VAL . 1.2 tp -51.6 -39.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 108.963 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 8.4 mttm -74.03 -49.7 23.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.389 -0.819 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -44.98 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -69.53 -59.77 2.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 108.99 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.5 mt -41.06 -38.6 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.021 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.81 -57.84 10.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.052 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -50.71 -32.67 20.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.18 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.87 -60.19 4.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.489 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.55 -44.0 97.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.45 -53.87 32.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.369 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t0 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -71.36 -1.7 13.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.49 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.416 ' C ' HG23 ' A' ' 27' ' ' VAL . 49.2 m-20 -105.19 18.02 23.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.354 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 26' ' ' ASN . 73.6 t -152.94 97.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.515 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.93 150.96 28.34 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -127.57 150.45 49.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.42 126.49 3.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -129.4 123.49 31.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.56 165.86 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.77 165.93 27.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -137.39 132.61 17.85 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.195 -1.18 . . . . 0.0 109.527 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.33 -38.07 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.51 2.14 . . . . 0.0 111.948 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -56.87 11.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.245 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.72 -4.57 54.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.69 47.68 30.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 1.2 t0 -122.19 139.23 54.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -1.106 . . . . 0.0 109.581 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 20.5 m -92.95 123.13 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.858 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 42' ' ' GLN . 2.8 ttt -113.92 144.59 42.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' N ' ' HG3' ' A' ' 41' ' ' MET . 30.9 tt0 -149.29 120.04 7.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.22 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.39 130.85 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -123.73 155.14 38.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -0.909 . . . . 0.0 109.111 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.38 137.9 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -102.48 147.21 27.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.418 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.62 126.52 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.6 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' OD1' ' C ' ' A' ' 48' ' ' ASP . 30.2 t0 -63.29 -96.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 109.416 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -160.0 23.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.92 19.9 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 7.28 88.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.7 mm -99.84 155.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 109.447 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mt -99.08 109.83 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.05 -41.29 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.674 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.53 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 11.2 p-10 -157.62 167.59 29.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.66 129.89 41.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.342 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -95.2 125.63 39.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.696 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -114.58 157.67 22.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -166.13 99.24 0.63 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 60' ' ' THR . 12.5 t -164.41 113.35 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.517 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 60' ' ' THR . 21.6 m-85 -137.53 102.97 4.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.97 -7.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 66' ' ' ALA . 1.1 m -90.75 178.78 5.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.329 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.41 -11.8 14.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -141.43 -16.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.155 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . . . -79.99 -9.64 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 68' ' ' ALA . 1.7 tt -67.69 -40.85 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.652 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.512 ' N ' HG23 ' A' ' 67' ' ' ILE . . . -76.55 -28.76 56.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.657 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.7 p -60.14 -58.63 7.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' THR . 0.9 OUTLIER -34.8 -48.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.74 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -65.15 -46.85 79.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -63.53 -73.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.755 HG23 ' N ' ' A' ' 74' ' ' THR . 14.7 tt -39.22 -56.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.755 ' N ' HG23 ' A' ' 73' ' ' ILE . 22.1 p -46.87 -46.1 20.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.78 -13.9 62.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.633 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.41 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 m0 -89.64 -31.38 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.01 32.15 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.689 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.94 102.14 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.59 8.67 57.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -92.28 -175.81 4.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.64 149.09 24.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.494 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.18 -19.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.144 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -51.81 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ALA . 3.7 mt-10 -68.05 -55.94 10.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.96 -44.26 9.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.96 52.8 4.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -167.2 -46.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -1.15 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -36.1 158.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.429 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -121.84 168.36 11.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 2.1 p-10 -82.83 -20.21 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.5 p -52.26 -40.76 62.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' ILE . 1.7 mm-40 -67.13 -70.93 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 92' ' ' GLN . 22.0 mt -41.57 -39.7 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.42 -53.05 40.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -47.98 -47.54 32.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -38.54 82.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.7 mt -79.66 -26.55 40.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 98' ' ' GLU . 2.7 tm-20 50.91 66.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.708 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 1.047 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.9 pt? -112.44 145.26 32.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.54 153.18 62.95 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.47 11.19 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.878 2.386 . . . . 0.0 112.259 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.569 HG13 ' HG2' ' A' ' 103' ' ' LYS . 8.0 p -82.78 2.04 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.569 ' HG2' HG13 ' A' ' 102' ' ' VAL . 0.6 OUTLIER 179.9 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 105' ' ' HIS . 6.2 p -72.1 -8.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.695 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -39.45 -55.75 1.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.695 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 62.0 m -31.16 -59.38 0.23 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.44 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 5.9 p -61.87 -55.63 27.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.984 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.44 ' N ' ' OG ' ' A' ' 107' ' ' SER . 1.6 mm -45.88 -53.85 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.51 -41.8 61.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 109.942 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.27 -65.12 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 109.671 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 11.7 tt0 -54.29 -41.85 69.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.5 -28.6 68.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.33 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -48.85 -38.05 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 1.1 mmtt -71.44 -31.46 67.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.304 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.94 67.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.63 87.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.393 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.12 -46.95 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.261 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.31 76.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -34.28 72.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.624 ' CE2' ' O ' ' A' ' 25' ' ' SER . 3.7 t80 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.953 . . . . 0.0 109.652 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -33.24 27.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.743 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 4.86 9.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.504 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 26' ' ' ASN . 37.3 t0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.3 OUTLIER 48.08 9.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.237 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 24' ' ' ASP . 61.3 m-20 -117.62 0.7 12.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.39 114.41 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.375 -0.828 . . . . 0.0 109.47 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.83 127.58 11.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.0 m -108.0 140.21 41.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -1.132 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.9 129.57 4.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 ttm -126.53 100.71 6.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -1.12 . . . . 0.0 109.35 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.1 m -117.11 170.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.12 167.42 39.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -136.97 139.33 28.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 38' ' ' GLY . 48.5 Cg_endo -72.93 -59.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.596 2.198 . . . . 0.0 112.259 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.07 -42.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 1.2 m -98.18 -4.49 35.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 41.84 45.76 4.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.671 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 54.3 t0 -120.07 131.17 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -1.092 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 40' ' ' VAL . 8.5 p -104.05 118.42 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.226 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.4 ttt -115.26 153.59 30.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -133.74 121.13 21.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -108.54 112.32 24.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.889 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -114.94 121.69 43.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.33 137.59 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -99.39 123.94 44.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.1 t -118.93 135.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 6.2 t70 -62.82 -59.99 4.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 167.08 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 0.0 109.125 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.72 -22.36 29.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.254 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.57 7.73 5.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.75 132.72 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -1.118 . . . . 0.0 109.434 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 54' ' ' GLU . 16.4 mt -84.28 84.57 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.708 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.9 OUTLIER -43.61 -53.14 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 108.863 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -143.53 -177.22 5.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.1 132.55 4.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -108.69 156.75 19.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.842 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.728 ' CD1' HG21 ' A' ' 74' ' ' THR . 12.5 p90 -139.52 170.6 15.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.958 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -167.72 98.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.38 116.88 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -149.17 96.79 2.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.84 -12.09 0.08 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.671 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.8 m -96.78 168.54 10.44 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.247 -1.149 . . . . 0.0 109.358 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.38 44.14 1.43 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.49 -3.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 109.552 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -97.23 -22.86 16.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.077 HD12 ' H ' ' A' ' 67' ' ' ILE . 3.5 mp -36.8 -36.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -83.17 -57.62 3.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -42.33 -50.59 5.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -36.07 -56.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' OG ' ' A' ' 70' ' ' SER . 7.0 m -64.12 -36.58 84.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 75' ' ' GLU . 8.6 tp -65.46 -79.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 77' ' ' VAL . 7.8 tt -34.93 -41.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 109.74 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.728 HG21 ' CD1' ' A' ' 58' ' ' PHE . 6.6 p -68.25 -35.97 78.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.726 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 72' ' ' LEU . 3.3 mt-10 -85.57 -1.98 57.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -100.99 -23.69 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 73' ' ' ILE . 33.8 m -115.39 50.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.88 . . . . 0.0 109.228 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -120.15 100.46 7.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.699 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.39 77.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -169.97 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -1.17 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.8 173.08 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mt -65.35 -28.03 69.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.57 -19.6 64.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.96 -31.18 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.36 40.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.625 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.69 54.66 0.84 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.9 pt -39.17 -26.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.9 ttmm 49.49 179.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' GLN . 31.5 p-10 -96.27 -55.61 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.1 m -38.27 -24.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.751 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.8 tt0 -79.29 -52.94 7.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 5.4 tt -59.48 -40.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.273 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -63.52 -46.37 86.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.269 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -37.65 79.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.065 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.88 -37.7 84.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.237 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.28 -20.36 59.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.268 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 67.67 10.26 7.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.951 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.1 152.67 92.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.476 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.0 165.74 25.26 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.861 2.374 . . . . 0.0 112.271 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.01 -41.58 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.88 2.387 . . . . 0.0 112.275 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.7 p -45.18 102.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 102' ' ' VAL . 11.0 ttmt 84.53 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 107' ' ' SER . 13.9 p -83.8 -2.73 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.693 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -38.45 -59.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.456 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.693 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 96.5 m -33.26 -48.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.518 ' HB2' HG22 ' A' ' 104' ' ' VAL . 71.0 m -65.14 -60.62 2.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 97.3 mt -42.8 -40.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 109.071 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.535 HD22 ' HE1' ' A' ' 105' ' ' HIS . 0.9 OUTLIER -57.06 -63.56 1.17 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -36.24 -45.42 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.548 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 4.5 tp10 -64.76 -55.78 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.682 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.32 -19.62 23.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 43' ' ' LEU . . . -72.99 -50.27 24.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -31.42 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.165 -0.959 . . . . 0.0 109.362 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -55.5 8.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.7 -52.37 11.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.724 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -59.37 -65.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 117' ' ' ALA . 6.2 mt -36.76 -33.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.086 -1.009 . . . . 0.0 109.65 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 121' ' ' TYR . . . -76.39 -64.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -0.983 . . . . 0.0 109.739 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.531 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 9.4 t0 -52.5 -2.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.562 ' H ' ' C ' ' A' ' 119' ' ' ALA . 69.4 t80 -98.19 -56.96 2.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.52 -26.97 65.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.61 71.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.522 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.524 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.354 0.597 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -96.41 9.67 40.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.524 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -125.16 0.58 7.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.88 103.08 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.712 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.56 155.92 34.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 44' ' ' GLN . 67.7 m -136.76 126.92 26.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.247 . . . . 0.0 109.958 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 117' ' ' ALA . . . -109.59 123.25 6.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.7 ttt -130.56 126.58 37.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.14 -1.212 . . . . 0.0 109.851 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.33 -174.34 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 109.026 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.21 144.55 8.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -111.21 132.58 21.67 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.358 -1.083 . . . . 0.0 109.225 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.0 Cg_endo -75.38 -53.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.547 2.165 . . . . 0.0 112.342 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.72 -47.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.7 p -114.48 11.3 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.59 62.28 0.97 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -116.26 117.4 29.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.6 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 40' ' ' VAL . 14.1 p -87.46 119.33 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.555 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.3 ttt -111.4 122.41 47.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 109.659 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.442 HE21 ' HB2' ' A' ' 42' ' ' GLN . 1.6 tt0 -119.44 99.04 6.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 74' ' ' THR . 7.5 tp -101.34 127.98 47.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.583 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -115.72 125.44 52.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -114.75 118.75 34.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.09 142.23 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.559 ' OD2' ' O ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -89.02 -96.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' OD1' ' A' ' 50' ' ' ASN . 3.7 p30 -153.52 19.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.564 ' OD1' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -145.67 43.86 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.63 31.94 30.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.0 mm -122.11 131.22 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.73 109.8 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.162 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -70.71 -23.57 62.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.851 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -169.91 157.73 6.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.035 . . . . 0.0 109.885 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.74 137.67 43.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.222 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 19.3 mttp -101.45 137.49 39.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.735 ' HB3' HG21 ' A' ' 74' ' ' THR . 23.8 p90 -116.7 137.17 52.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.09 85.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' CD1' ' A' ' 61' ' ' TYR . 1.4 t -143.04 138.54 30.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.434 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -160.79 125.83 3.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.364 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.13 -64.71 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.46 142.55 27.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' A' ' 66' ' ' ALA . . . -76.5 168.35 54.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.26 -32.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -1.108 . . . . 0.0 109.528 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . -67.0 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.31 -72.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 109.425 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.3 -48.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.35 -33.72 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.377 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 67' ' ' ILE . 40.3 t -67.21 -64.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 70' ' ' SER . 7.7 p -43.41 -27.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.083 -1.011 . . . . 0.0 109.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.534 ' O ' ' C ' ' A' ' 73' ' ' ILE . 7.4 tp -78.12 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.863 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.534 ' C ' ' O ' ' A' ' 72' ' ' LEU . 8.4 tt -34.89 -41.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.667 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.735 HG21 ' HB3' ' A' ' 58' ' ' PHE . 74.7 p -61.61 -51.14 69.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 72' ' ' LEU . 14.3 tt0 -70.29 -5.34 27.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -88.94 -30.79 18.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.57 6.09 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -74.21 112.51 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.704 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.63 -9.13 77.2 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.18 -170.97 3.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 109.587 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.34 164.41 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.422 HD22 HG12 ' A' ' 118' ' ' ILE . 27.9 mt -59.51 -24.55 63.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -59.76 -48.05 83.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.93 -36.71 75.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.519 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.55 -26.01 66.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.53 44.62 1.44 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.29 -33.85 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -35.84 -47.76 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 65.17 142.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.422 HD22 ' H ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -66.12 -34.69 78.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.3 p -49.32 -41.28 38.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -58.57 -49.27 78.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.09 -35.36 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.01 -18.77 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.75 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.47 -34.76 17.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.858 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.33 -25.45 25.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.957 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -105.61 -8.8 17.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.66 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' LEU . 23.8 mp0 44.79 15.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.482 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.1 pp -41.61 148.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.539 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.7 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.816 2.344 . . . . 0.0 112.305 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 103' ' ' LYS . 60.9 Cg_endo -82.72 9.62 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.73 2.287 . . . . 0.0 112.228 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.9 m -46.4 -8.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.933 . . . . 0.0 109.338 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.654 ' N ' ' O ' ' A' ' 101' ' ' PRO . 2.7 tttm -172.55 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.863 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.5 63.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.457 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.681 ' CD2' ' H ' ' A' ' 106' ' ' CYS . 26.7 p-80 -96.86 -57.12 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.681 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -57.59 -40.59 79.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -63.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -47.4 -31.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -62.87 -50.68 69.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.021 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.37 -43.61 61.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.9 . . . . 0.0 108.929 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.9 -58.41 7.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.204 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 24.8 t0 -50.17 -28.91 8.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.645 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -68.67 -69.99 0.29 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.9 tp -38.37 -40.94 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.487 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.6 mmtm -72.64 -29.12 63.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.29 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.645 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.0 -48.23 71.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' HB2' ' N ' ' A' ' 30' ' ' GLY . . . -64.16 -46.73 82.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.205 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.422 HG12 HD22 ' A' ' 82' ' ' LEU . 67.5 mt -54.62 -44.5 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.37 85.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -57.73 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -45.86 -41.58 11.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' O ' ' C ' ' A' ' 123' ' ' ALA . 4.4 tttm -66.95 -45.55 77.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -36.98 -39.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.328 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.379 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.7 t70 . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 77.7 -8.42 1.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.456 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -176.83 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.4 t -124.75 99.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.11 139.76 15.4 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -138.95 122.57 17.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.4 148.37 16.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 tpt -145.48 126.67 14.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 109.6 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 m -145.8 155.93 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.337 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.0 159.16 24.54 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -132.35 142.4 44.81 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.294 -1.121 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.522 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.3 Cg_endo -75.31 -51.45 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.673 2.249 . . . . 0.0 112.065 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.35 -49.75 1.0 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 109.217 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 50.6 m -102.8 -8.93 20.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.36 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.77 45.68 55.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -120.31 152.31 37.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -1.133 . . . . 0.0 109.591 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.7 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.386 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 ttt -91.47 143.39 26.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' NE2' HE21 ' A' ' 44' ' ' GLN . 4.8 tt0 -132.57 126.0 31.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.223 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.41 130.76 56.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.769 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.485 HE21 ' NE2' ' A' ' 42' ' ' GLN . 30.1 mt-30 -125.8 112.82 16.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.525 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -107.02 141.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.646 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 1.7 mptt -113.03 137.63 51.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.34 145.04 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 10.4 p-10 -82.75 -96.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.578 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -155.81 16.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.32 4.84 2.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.77 20.31 31.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.7 mm -106.88 146.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -1.14 . . . . 0.0 109.353 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 53' ' ' ILE . 23.2 mm -85.87 84.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.688 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -44.87 -54.91 5.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.116 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 161.61 41.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.104 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.37 115.7 12.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 109.887 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -96.43 141.23 29.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 108.93 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CD1' HG21 ' A' ' 74' ' ' THR . 28.1 p90 -137.57 176.3 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.998 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 124.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -160.53 133.57 6.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 15.4 p90 -150.83 125.67 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.45 -42.64 1.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 1.1 m -79.88 142.61 35.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.552 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.81 -5.01 57.73 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.47 -2.81 13.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -91.78 -41.05 10.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.576 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' ALA . 65.6 mt -41.91 -44.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.99 -48.52 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.5 m -67.63 -66.04 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.542 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 69' ' ' SER . 17.9 m -35.7 -41.34 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 20.4 t -68.22 -41.38 81.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -64.64 -65.28 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.573 ' O ' HG22 ' A' ' 77' ' ' VAL . 13.0 tt -41.08 -46.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.938 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.677 HG21 ' CD1' ' A' ' 58' ' ' PHE . 17.2 p -55.58 -44.87 77.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.972 . . . . 0.0 109.699 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.73 -34.8 64.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.065 -1.022 . . . . 0.0 109.677 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.02 -13.56 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 73' ' ' ILE . 6.0 m -121.94 22.38 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -98.85 117.58 33.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.67 5.61 69.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -84.71 -163.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.7 m -116.2 155.91 27.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 109.568 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 82' ' ' LEU . 46.7 mt -59.55 -17.52 33.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.524 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.93 -50.44 14.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.469 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.665 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -66.21 -39.36 89.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -37.1 67.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.37 41.63 3.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -156.32 -37.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -1.154 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 84' ' ' GLU . 5.3 pt -42.06 163.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.385 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -126.88 -173.07 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -100.95 -13.85 18.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -21.81 61.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.277 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.22 -58.97 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.346 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.7 -38.74 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.52 65.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -86.13 -21.36 27.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.75 -48.11 10.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 98' ' ' GLU . 5.4 mt -90.16 -11.23 41.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.877 . . . . 0.0 109.505 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 mt-10 41.67 68.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.73 150.29 43.76 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.176 -0.953 . . . . 0.0 109.311 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -44.1 147.35 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.567 2.178 . . . . 0.0 112.032 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -69.71 -44.57 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.684 2.256 . . . . 0.0 112.157 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 102' ' ' VAL . 1.7 p -60.0 -2.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -143.04 36.33 1.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 105' ' ' HIS . 5.2 p -84.49 -15.54 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.292 -0.88 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.633 ' C ' ' ND1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -42.43 -44.68 4.11 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 0.0 109.097 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.553 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 57.3 m -40.15 -54.58 2.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 109.836 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 108' ' ' ILE . 96.0 p -64.95 -56.02 15.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.2 mt -43.53 -40.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.125 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.514 HD13 ' HD1' ' A' ' 105' ' ' HIS . 1.2 mp -64.75 -47.84 76.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.101 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -42.18 -48.98 4.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.141 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.13 -35.03 79.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.62 -33.42 74.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.947 . . . . 0.0 109.859 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.32 -47.24 74.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.5 tp -58.98 -39.16 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.183 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.427 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.2 ttmt -70.34 -50.87 34.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.52 -32.17 66.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.0 109.384 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -64.93 -58.11 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.216 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -55.55 -48.2 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.95 -36.02 59.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD1' ' NZ ' ' A' ' 124' ' ' LYS . 5.3 t0 -72.59 -55.21 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.466 ' C ' ' O ' ' A' ' 120' ' ' ASP . 22.2 t80 -39.59 -56.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.62 -28.56 67.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -61.0 -46.05 92.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 120' ' ' ASP . 33.6 mmtm . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.49 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.534 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 0.3 OUTLIER -72.31 -16.3 61.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.491 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.822 ' ND2' HG23 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -65.11 1.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.822 HG23 ' ND2' ' A' ' 26' ' ' ASN . 79.1 t -135.71 95.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.15 27.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.6 m -105.11 109.89 22.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -1.044 . . . . 0.0 109.328 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.61 91.13 0.76 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -93.92 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -1.22 . . . . 0.0 109.498 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -158.46 173.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' CA ' HD21 ' A' ' 109' ' ' LEU . . . 176.7 159.78 22.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.82 43.72 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.0 Cg_endo -74.82 -56.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.646 2.231 . . . . 0.0 112.381 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -42.52 -36.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -102.4 2.59 36.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.68 52.02 1.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' CB ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -131.11 143.56 50.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.134 . . . . 0.0 109.578 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.73 114.59 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.064 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.1 ttt -108.81 139.02 44.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.895 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -122.66 125.02 44.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.062 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tt -121.04 138.67 54.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.806 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.13 136.95 42.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.61 132.17 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HG3' HD22 ' A' ' 26' ' ' ASN . 16.6 tttp -106.68 135.18 48.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.436 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -114.98 151.33 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.893 . . . . 0.0 109.527 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.46 -106.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -142.1 15.58 2.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.38 -4.24 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.545 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.74 4.73 51.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 mm -94.68 136.47 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.2 115.52 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.72 -39.87 12.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -139.91 -179.25 5.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.952 . . . . 0.0 109.576 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.98 140.88 3.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.81 144.62 44.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.806 ' CG ' HG21 ' A' ' 74' ' ' THR . 0.4 OUTLIER -142.39 150.33 40.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 109.603 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' CG ' ' C ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -154.67 95.89 1.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 148.89 47.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -160.96 154.39 21.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.286 -0.884 . . . . 0.0 109.366 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.4 -53.31 0.7 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CB ' ' A' ' 39' ' ' ASP . 9.0 m -76.11 109.46 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.54 43.83 0.35 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' CYS . 0.3 OUTLIER -163.72 -6.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.456 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.41 ' H ' ' H ' ' A' ' 65' ' ' SER . . . -84.57 -38.79 19.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 67' ' ' ILE . 7.2 mm -47.67 -49.36 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.21 -68.34 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.317 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.82 -34.33 2.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.455 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.1 t -64.75 -74.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.963 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 70' ' ' SER . 66.5 m -36.27 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.553 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' SER . 22.2 tp -76.03 -85.37 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 77' ' ' VAL . 1.1 tt -36.99 -33.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.806 HG21 ' CG ' ' A' ' 58' ' ' PHE . 9.7 p -66.99 -46.65 73.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 71' ' ' SER . 2.2 mt-10 -78.23 -7.84 57.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.31 -30.02 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 73' ' ' ILE . 4.8 m -91.67 11.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -87.08 89.83 8.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.38 -14.64 15.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.54 -168.26 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -1.13 . . . . 0.0 109.565 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -119.99 -179.2 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.37 -34.07 65.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -68.89 -11.01 60.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.607 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.85 -49.58 4.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.569 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.8 -26.17 62.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.537 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.3 46.37 1.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -164.05 -38.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -1.127 . . . . 0.0 109.169 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' ALA . 5.2 pt -44.9 166.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 109.466 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -132.7 -179.12 5.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.75 -19.34 24.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.365 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -62.73 -42.13 99.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.06 -60.6 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.176 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.5 mt -51.53 -42.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.895 . . . . 0.0 109.186 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -59.55 -35.14 73.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.195 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.61 -38.71 73.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.88 . . . . 0.0 109.104 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.3 -47.74 80.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.363 -0.835 . . . . 0.0 109.369 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.79 -16.63 21.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.619 ' N ' ' O ' ' A' ' 94' ' ' ALA . 25.8 tt0 45.03 72.93 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.39 150.26 36.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -39.09 141.36 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.961 2.44 . . . . 0.0 112.31 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 103' ' ' LYS . 66.5 Cg_endo -76.89 -15.02 16.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.759 2.306 . . . . 0.0 112.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.73 25.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HZ3' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -170.69 34.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.438 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 105' ' ' HIS . 38.6 t -57.46 -27.48 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.676 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -34.86 -62.14 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.308 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.676 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 38.6 m -37.61 -51.46 1.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.604 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -55.28 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mt -46.65 -40.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.863 . . . . 0.0 109.35 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 ' ND1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -62.72 -37.83 88.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.279 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.31 -58.53 8.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.506 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 112' ' ' ASP . 3.9 tm-20 -58.76 -43.43 90.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.596 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.503 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -60.93 -29.79 69.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.88 -57.22 7.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -51.24 -35.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.506 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -74.28 -48.06 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -55.8 -50.71 69.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.5 -53.73 50.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -58.34 -20.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -77.48 -47.37 19.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.193 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.99 -10.52 59.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.549 ' CE1' ' NZ ' ' A' ' 124' ' ' LYS . 1.9 t80 -91.31 -49.8 6.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.303 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -66.61 -23.62 66.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 0.0 109.203 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.534 ' O ' ' C ' ' A' ' 124' ' ' LYS . . . -68.72 -1.75 7.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.549 ' NZ ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -81.11 -3.4 51.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.39 7.2 26.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.618 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.35 114.74 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.8 138.87 14.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -125.25 114.38 18.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.561 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.12 16.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.83 124.8 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.16 -1.2 . . . . 0.0 109.665 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.56 151.08 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.148 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.05 10.28 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' N ' ' A' ' 39' ' ' ASP . . . -146.56 92.65 5.08 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.29 70.87 7.32 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.755 2.303 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.53 -38.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.365 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . 6.6 t -165.48 -38.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.772 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -62.53 -49.23 75.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.5 t70 84.81 -174.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.65 99.17 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.855 . . . . 0.0 109.25 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.8 ttp -95.73 139.82 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.65 107.34 13.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.116 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.13 127.49 52.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.837 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -130.34 120.55 24.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 108.974 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.78 152.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.827 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 47' ' ' VAL . 24.1 tttt -114.84 154.75 28.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 109.284 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 64.5 t -133.25 121.71 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD1' ' OE1' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -47.63 -53.67 14.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 162.01 -23.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.859 . . . . 0.0 109.252 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.743 ' H ' ' ND2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.8 -0.74 57.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.44 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.85 8.67 41.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.31 138.63 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.161 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.8 mt -96.83 124.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.301 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.551 ' OE1' ' OD1' ' A' ' 48' ' ' ASP . 19.1 pt-20 -107.65 -30.08 8.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.56 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -124.87 150.36 46.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.08 155.16 42.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 109.588 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 58' ' ' PHE . 1.2 tttm -150.49 143.31 24.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.691 ' CD1' HG21 ' A' ' 74' ' ' THR . 4.5 p90 -138.86 -179.38 5.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -171.32 104.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 t -136.85 144.63 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.589 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.535 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 53.3 t80 -155.0 98.57 2.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 0.7 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -100.71 123.93 45.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 0.0 109.337 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -91.94 123.03 7.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER 72.61 -8.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.18 . . . . 0.0 109.536 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HB3' ' SG ' ' A' ' 63' ' ' CYS . . . -96.44 7.69 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mt -72.99 -38.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -41.95 75.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p -56.8 -38.82 73.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 58' ' ' PHE . 17.5 t -53.47 -46.06 69.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -35.11 79.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.32 -56.27 22.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.949 ' O ' HG22 ' A' ' 77' ' ' VAL . 3.8 tt -58.52 -48.58 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.76 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.691 HG21 ' CD1' ' A' ' 58' ' ' PHE . 23.3 p -60.72 -17.89 51.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 0.0 109.482 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.06 -41.75 10.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -74.22 -7.7 53.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.428 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 73' ' ' ILE . 35.0 m -115.29 36.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.343 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -133.95 78.18 1.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -0.908 . . . . 0.0 109.634 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 0.4 9.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -97.01 -165.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.09 164.65 15.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 82' ' ' LEU . 34.3 mt -58.83 -24.8 62.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -74.67 -26.29 59.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.646 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.76 -50.21 8.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.67 63.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.269 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.02 45.61 3.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -152.45 -38.29 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -1.112 . . . . 0.0 108.688 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 87' ' ' ALA . 4.0 pt -39.35 123.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.534 -0.729 . . . . 0.0 109.119 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -99.17 162.6 12.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.612 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -57.76 -20.1 32.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 1.4 p -77.57 -33.57 53.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.78 -43.68 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 mm -81.61 -33.33 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.912 . . . . 0.0 109.177 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -66.21 -12.5 56.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 -37.44 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.405 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -53.22 43.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.13 -23.98 19.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 51.29 68.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -96.84 146.45 31.33 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.149 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.59 147.24 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.721 2.281 . . . . 0.0 112.247 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 9.55 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.748 2.299 . . . . 0.0 112.168 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 t -92.09 -33.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -105.93 30.02 6.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 103' ' ' LYS . 20.3 t -42.55 -25.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.772 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 4.4 p-80 -52.0 -39.6 59.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.627 ' SG ' ' CE1' ' A' ' 105' ' ' HIS . 33.9 m -47.93 -60.39 2.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.308 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 109' ' ' LEU . 57.9 m -59.31 -58.81 7.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' CB ' ' A' ' 112' ' ' ASP . 63.7 mt -46.26 -22.1 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 107' ' ' SER . 0.8 OUTLIER -74.43 -57.53 3.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.5 59.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 109.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' A' ' 112' ' ' ASP . 3.3 tm-20 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 10.0 t0 -43.13 -43.33 4.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.52 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.29 -54.48 39.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -47.27 -42.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' CD ' ' OE2' ' A' ' 111' ' ' GLU . 5.6 mttp -68.36 -34.85 76.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.21 -58.55 6.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.496 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.68 -42.36 45.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 122' ' ' LYS . 65.0 mt -63.76 -48.35 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.92 -37.75 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.363 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.6 -38.41 67.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.78 -32.61 74.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 118' ' ' ILE . 7.1 mtpt -78.14 -39.77 40.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.63 -54.94 26.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.4 mttm . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.271 179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -3.38 56.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -105.51 -5.89 19.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.33 116.27 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.441 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.05 144.27 17.24 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.2 m -126.7 121.93 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.06 123.77 5.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.477 ' C ' ' SD ' ' A' ' 31' ' ' MET . 2.4 ppp? -131.89 153.11 50.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.677 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -145.26 169.06 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.251 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.1 147.84 18.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -145.73 73.13 13.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -1.123 . . . . 0.0 109.34 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -58.5 71.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.85 2.366 . . . . 0.0 112.097 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -177.95 -89.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.836 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 1.5 t -118.48 -7.98 10.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.665 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -98.71 -23.87 11.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 58.45 -163.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.715 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.0 p -87.24 110.35 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 108.842 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.401 ' CE ' HD13 ' A' ' 43' ' ' LEU . 8.1 ttt -100.55 129.81 46.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.163 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.608 ' NE2' ' NE2' ' A' ' 44' ' ' GLN . 30.5 tt0 -120.88 108.08 13.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.401 HD13 ' CE ' ' A' ' 41' ' ' MET . 4.5 tp -108.19 115.06 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.722 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.608 ' NE2' ' NE2' ' A' ' 42' ' ' GLN . 12.3 mt-30 -110.38 118.88 37.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.2 pt -106.25 146.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -115.18 136.58 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.66 145.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.114 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -78.75 -104.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.502 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.5 t70 -141.8 9.15 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.32 12.52 2.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.301 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.04 14.61 57.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -99.87 114.35 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -1.153 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.5 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -50.29 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 49.8 t0 -127.19 170.14 12.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -162.95 115.81 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -98.92 131.69 44.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CD2' ' OG ' ' A' ' 70' ' ' SER . 8.4 p90 -109.72 172.05 7.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.647 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -171.81 112.2 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -156.01 146.99 22.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 4.3 t80 -156.9 106.88 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.36 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.23 -25.73 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 66' ' ' ALA . 64.4 m -83.64 131.67 34.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -1.068 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.82 9.49 60.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -152.77 -13.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 63' ' ' CYS . . . -93.14 -12.69 29.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' ALA . 20.1 mt -42.15 -45.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.15 89.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -46.41 -53.41 11.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.436 ' OG ' ' CD2' ' A' ' 58' ' ' PHE . 6.9 t -45.17 -48.45 12.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 m -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -64.67 -76.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.832 ' O ' HG22 ' A' ' 77' ' ' VAL . 5.8 tt -35.51 -52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.728 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.605 ' H ' HG23 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -49.54 -52.54 29.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -2.11 30.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 109.891 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -105.11 -4.5 21.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.466 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.832 HG22 ' O ' ' A' ' 73' ' ' ILE . 11.7 m -124.29 5.59 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.504 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -92.76 98.38 11.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.75 11.23 23.37 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -110.74 174.29 5.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -96.71 157.46 15.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.487 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.34 -20.72 63.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -34.89 74.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.57 -32.55 36.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.513 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -73.96 -21.51 59.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.636 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.17 30.08 10.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -147.23 -37.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.151 -1.205 . . . . 0.0 109.507 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.545 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -34.66 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.527 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER 70.39 167.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.369 -0.832 . . . . 0.0 109.516 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.765 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -89.74 -54.83 3.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.765 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -37.84 -33.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.482 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -60.28 -53.08 61.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.56 -35.81 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.51 -39.98 81.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.84 -34.12 62.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -54.2 -45.92 72.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.336 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.19 -6.52 19.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 94' ' ' ALA . 16.8 mt-10 53.93 88.5 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -108.03 165.75 12.17 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.53 142.37 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.601 2.201 . . . . 0.0 112.053 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.92 5.75 4.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.705 2.27 . . . . 0.0 112.209 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.15 -25.7 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.643 ' O ' ' N ' ' A' ' 105' ' ' HIS . 4.2 mtpt -118.22 28.15 8.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 103' ' ' LYS . 21.3 t -38.16 -22.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.665 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 3.2 p-80 -44.47 -31.39 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.657 ' SG ' ' CE1' ' A' ' 105' ' ' HIS . 57.8 m -60.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 10.2 p -47.15 -56.87 5.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.181 -0.949 . . . . 0.0 109.095 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 6.0 mt -45.67 -36.62 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.91 -49.13 78.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.244 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -61.96 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 109.588 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 112' ' ' ASP . 30.2 tt0 -54.99 -73.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 111' ' ' GLU . 23.0 t0 -34.1 -55.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.656 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 112' ' ' ASP . . . -40.96 -70.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.418 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.513 HG12 ' HB1' ' A' ' 85' ' ' ALA . 1.1 tp -43.49 -31.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.083 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 112' ' ' ASP . 4.1 tptt -64.42 -60.17 3.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.9 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.411 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -67.05 -45.97 75.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 109.409 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.18 -45.36 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.264 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.92 64.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 109.108 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.15 -26.19 37.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 109.271 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 15.8 t80 -76.41 -54.49 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -71.42 0.41 8.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.01 -31.1 22.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 mptt . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.459 179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.522 ' O ' ' O ' ' A' ' 2' ' ' ALA . 6.5 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.522 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 56.15 155.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.505 ' O ' ' C ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -46.63 -62.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.364 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.505 ' C ' ' O ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -37.3 120.4 0.77 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.9 48.07 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.65 -4.16 8.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.979 HG12 ' H ' ' A' ' 8' ' ' ILE . 3.6 t -93.3 -152.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.979 ' H ' HG12 ' A' ' 7' ' ' VAL . 7.4 mm 44.5 99.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.458 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.637 ' C ' ' CD2' ' A' ' 10' ' ' HIS . 2.1 m-20 -126.41 44.1 2.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.581 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.637 ' CD2' ' C ' ' A' ' 9' ' ' ASP . 13.7 m-70 -150.4 5.52 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.569 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.497 ' O ' ' O ' ' A' ' 10' ' ' HIS . 0.7 OUTLIER 59.71 129.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -53.17 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' TYR . 6.5 m-20 -109.82 145.94 33.05 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.334 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.67 145.3 46.26 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.66 2.24 . . . . 0.0 112.086 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -132.15 34.18 3.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.275 -0.891 . . . . 0.0 109.527 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -132.78 -173.25 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.288 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.621 HG23 ' H ' ' A' ' 19' ' ' SER . 8.7 m -114.42 -119.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -112.98 4.08 25.66 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.621 ' H ' HG23 ' A' ' 17' ' ' VAL . 1.4 t -119.42 163.8 16.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -1.172 . . . . 0.0 109.626 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.625 HD12 ' NZ ' ' A' ' 46' ' ' LYS . 7.1 mt -82.09 -65.01 1.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 23' ' ' LYS . 4.9 m-20 -141.21 20.67 2.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.278 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.64 10.34 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -0.899 . . . . 0.0 109.227 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -75.43 3.49 9.1 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.0 t0 58.37 -146.61 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.296 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.479 ' C ' ' CG ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER 71.48 -7.79 1.15 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.233 -0.917 . . . . 0.0 109.574 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.479 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 178.29 30.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 109.656 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.0 t -149.12 94.93 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.648 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.12 126.15 7.29 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -1.162 . . . . 0.0 109.57 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.01 127.13 2.27 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 18.2 ttt -133.62 98.39 4.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.283 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -107.49 170.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.681 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -141.41 160.14 26.84 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . . . -128.91 92.98 38.3 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.152 -1.205 . . . . 0.0 109.642 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.85 -16.06 0.72 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.679 2.253 . . . . 0.0 112.052 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 -57.16 4.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.9 p -100.91 19.53 17.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.323 -0.861 . . . . 0.0 109.439 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.27 58.32 1.06 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 42.9 t0 -128.59 129.71 46.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -98.29 122.43 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.0 109.198 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.6 ttt -108.46 115.66 30.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.707 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -110.99 113.64 26.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.395 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 9.9 tp -103.64 153.64 20.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.57 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' N ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -144.06 111.42 5.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.598 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -101.26 146.76 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.893 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' NZ ' HD12 ' A' ' 20' ' ' LEU . 6.8 tttm -131.15 122.94 27.5 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.47 141.15 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.621 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.687 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.1 m-20 -172.47 -37.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 109.47 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 4.3 m-20 -62.73 45.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.687 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.4 m-20 78.5 51.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.6 -5.75 72.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.8 mm -90.77 156.53 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -1.161 . . . . 0.0 109.385 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.43 94.57 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -59.73 -25.14 64.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.423 -0.798 . . . . 0.0 109.507 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.19 168.47 9.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.637 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.89 131.15 11.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.24 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -110.87 163.13 14.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.706 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.737 ' CD1' HG21 ' A' ' 74' ' ' THR . 16.2 p90 -142.1 166.6 24.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.845 . . . . 0.0 109.379 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 101.4 0.18 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.391 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -154.1 143.39 21.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.607 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 1.2 p90 -161.82 134.7 6.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.04 -52.95 0.42 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 168.26 20.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -1.184 . . . . 0.0 109.576 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 38.81 2.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 t -166.29 -47.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -1.161 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.479 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . . . -48.38 -37.56 17.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 mt -47.52 -19.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.613 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.415 ' N ' ' C ' ' A' ' 66' ' ' ALA . . . -95.93 -40.26 9.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.403 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.783 ' O ' HG22 ' A' ' 73' ' ' ILE . 4.7 p -50.92 -38.68 51.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.321 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.707 ' O ' HG23 ' A' ' 74' ' ' THR . 87.9 p -58.94 -38.89 80.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -63.64 -41.85 98.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 73' ' ' ILE . 1.7 tp -66.65 -73.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.84 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.813 ' O ' HG22 ' A' ' 77' ' ' VAL . 6.2 tt -43.26 -28.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.922 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.737 HG21 ' CD1' ' A' ' 58' ' ' PHE . 19.2 p -77.5 -41.46 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.119 -0.988 . . . . 0.0 109.789 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -83.59 2.14 38.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -110.6 -30.31 7.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.142 -0.974 . . . . 0.0 109.758 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 73' ' ' ILE . 4.4 m -109.25 50.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.952 . . . . 0.0 109.91 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -123.82 104.63 9.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.142 -0.974 . . . . 0.0 109.39 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.02 6.1 63.57 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.0 mmtt -98.67 175.22 6.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.297 -1.12 . . . . 0.0 109.54 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.3 t -88.16 154.52 20.38 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.54 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.556 HD22 HG12 ' A' ' 118' ' ' ILE . 66.4 mt -61.76 -20.16 63.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.427 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -64.12 -29.95 71.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.384 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -91.56 -35.51 14.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.78 -37.86 79.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.421 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -93.36 57.57 2.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -163.27 -34.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -1.124 . . . . 0.0 109.004 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 0.8 OUTLIER -45.15 -14.08 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 87' ' ' ALA . 19.5 mttm 46.68 -173.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.28 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.674 ' OD1' ' N ' ' A' ' 91' ' ' SER . 24.5 p-10 -97.9 -24.14 15.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.696 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.674 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.6 -25.47 63.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -72.98 -65.36 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.097 -1.002 . . . . 0.0 109.661 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 9.5 tt -49.81 -38.13 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.199 -0.938 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -59.75 -46.33 89.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.166 -0.959 . . . . 0.0 109.379 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -65.02 -28.48 69.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.491 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 4.2 tm-20 -71.46 -28.99 64.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.935 . . . . 0.0 109.426 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 25.8 mt -93.67 -36.96 12.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.897 . . . . 0.0 109.339 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 5.7 tt0 69.72 62.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.538 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.7 OUTLIER -120.1 149.3 48.87 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.942 . . . . 0.0 109.451 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -39.96 158.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.909 2.406 . . . . 0.0 112.38 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 103' ' ' LYS . 41.4 Cg_endo -72.05 -51.11 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.766 2.311 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 102' ' ' VAL . 41.4 t -58.04 -2.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 101' ' ' PRO . 13.7 mttp -115.6 12.18 16.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.24 -1.64 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.282 -0.886 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.6 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.3 OUTLIER -57.58 -41.62 81.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.981 . . . . 0.0 109.256 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 66' ' ' ALA . 19.3 m -63.8 -46.82 83.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.841 . . . . 0.0 109.337 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -56.42 -46.45 80.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.343 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 105' ' ' HIS . 19.6 mt -52.89 -45.32 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.305 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 6.0 mp -58.5 -46.58 86.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -52.67 -53.39 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -61.93 -56.38 19.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.442 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.57 -17.84 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.612 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -79.77 -53.42 6.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.157 -0.964 . . . . 0.0 109.464 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.5 tp -57.25 -30.11 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -43.7 38.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.163 -0.961 . . . . 0.0 109.614 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.7 92.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.673 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.14 -48.4 73.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.556 HG12 HD22 ' A' ' 82' ' ' LEU . 63.7 mt -63.7 -44.88 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.2 -39.77 87.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.295 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.14 -31.87 68.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.27 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.41 -39.24 74.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.234 -0.916 . . . . 0.0 109.339 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -77.58 -18.49 56.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.612 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.78 -30.43 70.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.155 -0.966 . . . . 0.0 109.481 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -101.39 19.59 17.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.518 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -84.61 -40.49 17.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 116.33 24.12 3.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 mt -91.21 23.92 3.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -1.148 . . . . 0.0 109.528 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.87 144.23 26.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.181 -0.949 . . . . 0.0 109.612 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 130' ' ' HIS . 7.2 m80 -148.5 118.35 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.424 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.548 ' O ' ' O ' ' A' ' 129' ' ' HIS . 34.5 m-70 42.65 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.248 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -50.69 129.79 23.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -50.01 173.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.534 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.699 ' ND1' ' N ' ' A' ' 133' ' ' HIS . 0.8 OUTLIER -163.89 163.46 23.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.674 ' CG ' ' O ' ' A' ' 133' ' ' HIS . 37.0 m80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.84 169.11 8.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.479 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.42 ' O ' ' O ' ' A' ' 4' ' ' SER . 5.4 t80 -170.92 177.07 3.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' TYR . 6.3 t -53.5 -174.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.251 -0.906 . . . . 0.0 109.43 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -47.45 -46.18 26.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -170.07 -89.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.7 t -138.43 -47.84 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.7 pt -115.91 145.11 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.552 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' HIS . 5.5 m-20 -114.07 116.64 29.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' ASP . 7.0 t-80 57.69 111.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.393 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.14 118.51 10.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -60.77 136.83 58.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.173 -0.955 . . . . 0.0 109.253 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.73 60.74 2.56 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.13 -0.981 . . . . 0.0 109.786 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.467 ' O ' ' N ' ' A' ' 16' ' ' ASN . 43.3 Cg_endo -72.46 164.62 35.09 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.755 2.303 . . . . 0.0 112.019 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.563 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.9 ttm180 -70.21 50.37 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.129 -0.982 . . . . 0.0 109.484 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.563 ' O ' ' O ' ' A' ' 15' ' ' ARG . 2.9 t30 53.29 161.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.56 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -102.96 -92.74 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.54 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -142.95 -110.83 0.78 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -59.05 167.1 1.78 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD11 ' CE ' ' A' ' 46' ' ' LYS . 6.6 mt -117.11 -132.06 0.32 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -81.85 9.7 7.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.275 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.3 tttt 62.48 -38.44 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.243 -0.911 . . . . 0.0 109.435 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.643 ' N ' ' O ' ' A' ' 21' ' ' ASP . 80.9 tttt -73.8 45.4 0.19 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.472 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.446 ' HB3' ' ND2' ' A' ' 26' ' ' ASN . 1.2 m-20 -131.02 139.47 49.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.581 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -74.37 13.09 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.158 -0.964 . . . . 0.0 109.321 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -116.26 22.12 13.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.602 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.53 103.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.157 -0.964 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.92 15.32 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -127.39 152.06 48.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -1.174 . . . . 0.0 109.693 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.85 125.5 1.56 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.7 ttp -123.79 140.44 52.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -1.188 . . . . 0.0 109.733 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.1 m -141.37 165.1 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.315 -0.866 . . . . 0.0 109.23 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.43 160.69 29.08 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -134.84 145.44 54.69 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.303 -1.116 . . . . 0.0 109.411 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.55 -50.25 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.595 2.197 . . . . 0.0 112.05 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.77 -48.84 63.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.417 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.4 m -93.73 -2.62 53.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.371 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.61 42.42 0.67 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.581 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 16.9 t0 -118.51 154.46 32.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -1.088 . . . . 0.0 109.821 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.4 t -113.48 99.63 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.406 -0.809 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.767 ' CE ' HD13 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -82.02 102.97 11.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.665 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -91.91 138.8 31.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.767 HD13 ' CE ' ' A' ' 41' ' ' MET . 7.3 tp -134.66 126.16 28.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -128.21 133.65 48.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -121.7 140.89 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.578 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.4 ' CE ' HD11 ' A' ' 20' ' ' LEU . 19.7 tttt -118.44 140.79 49.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.242 -0.911 . . . . 0.0 109.481 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 73.0 t -117.17 143.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.908 . . . . 0.0 109.637 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.663 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.4 OUTLIER 178.19 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.245 -0.909 . . . . 0.0 109.545 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.578 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.2 m-20 -62.45 45.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.37 -0.831 . . . . 0.0 109.371 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.663 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.1 m-20 81.09 45.92 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.373 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.99 -3.27 86.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 79' ' ' GLY . 40.5 mm -96.49 146.86 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -1.103 . . . . 0.0 109.467 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.2 mt -56.48 94.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.205 -0.934 . . . . 0.0 109.445 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -46.47 35.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -154.25 169.75 22.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.36 121.6 16.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' CD ' ' N ' ' A' ' 57' ' ' LYS . 2.9 mmtm -95.84 154.79 17.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.949 . . . . 0.0 109.366 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD1' HG21 ' A' ' 74' ' ' THR . 27.4 p90 -141.1 158.32 44.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -160.94 116.64 2.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.548 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.21 131.64 6.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.411 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.463 ' C ' ' OD2' ' A' ' 39' ' ' ASP . 0.1 OUTLIER -148.12 103.76 3.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 109.578 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.581 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . 125.94 22.73 1.72 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER -114.25 83.81 1.94 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -1.157 . . . . 0.0 109.661 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . 33.45 -101.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 67' ' ' ILE . 96.1 p -136.99 19.19 3.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -1.145 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.51 4.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.221 -0.924 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 65' ' ' SER . 1.8 mm -58.2 -61.09 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.321 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.493 ' N ' HG22 ' A' ' 67' ' ' ILE . . . -46.57 -40.13 12.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.519 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 73' ' ' ILE . 10.5 m -61.54 -32.51 72.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 0.6 OUTLIER -61.18 -26.31 67.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.428 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -83.21 -44.58 14.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.229 -0.919 . . . . 0.0 109.655 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.96 -45.42 94.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.956 . . . . 0.0 109.513 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.723 HG23 ' N ' ' A' ' 74' ' ' THR . 17.4 tt -67.34 -55.33 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.723 ' N ' HG23 ' A' ' 73' ' ' ILE . 10.5 p -53.6 -23.41 10.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.327 -0.858 . . . . 0.0 109.192 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.8 -21.71 21.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.341 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -92.68 -9.1 42.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.536 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 73' ' ' ILE . 32.7 m -121.19 12.94 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.203 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -94.19 123.16 37.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.404 -0.81 . . . . 0.0 109.352 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 52' ' ' ILE . . . 71.2 8.9 66.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -97.86 169.21 9.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -1.122 . . . . 0.0 109.554 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -83.05 162.19 21.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.417 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.57 -24.04 61.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -67.07 -31.4 71.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -85.77 -33.85 21.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -65.25 -36.78 85.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -90.15 36.15 3.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.657 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -147.27 -34.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -1.068 . . . . 0.0 109.393 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.543 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -33.42 -28.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.657 ' N ' ' O ' ' A' ' 87' ' ' ALA . 4.4 ttmt 63.11 153.1 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 109.48 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 92' ' ' GLN . 7.6 p-10 -82.69 -47.74 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.885 . . . . 0.0 109.601 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -43.15 -24.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.917 . . . . 0.0 109.632 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.8 tp60 -70.55 -53.9 14.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.657 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.23 -22.12 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 109.621 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -76.24 -34.07 59.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 9.0 tp10 -85.37 -16.47 39.77 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.06 -47.4 14.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.597 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.462 HD22 ' OG ' ' A' ' 69' ' ' SER . 7.6 mp -87.15 -35.68 18.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 8.6 tt0 70.21 73.04 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 0.0 109.785 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -106.64 143.72 27.6 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.299 -0.875 . . . . 0.0 109.208 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.6 148.0 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.753 2.302 . . . . 0.0 112.45 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 103' ' ' LYS . 51.2 Cg_endo -72.79 -13.64 26.83 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.799 2.333 . . . . 0.0 112.196 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.79 -0.1 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 0.0 109.54 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 101' ' ' PRO . 21.2 mttp -150.63 55.02 0.9 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.534 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 104' ' ' VAL . 37.0 t -70.1 -2.79 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.583 ' CD2' ' CB ' ' A' ' 34' ' ' ALA . 7.5 p-80 -84.03 -26.6 28.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.312 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.69 -60.79 2.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 1.2 p -54.07 -54.65 36.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.26 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.533 ' O ' ' C ' ' A' ' 109' ' ' LEU . 43.6 mt -44.73 -66.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' C ' ' O ' ' A' ' 108' ' ' ILE . 4.9 mp -35.21 -50.6 0.54 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.669 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HA ' ' SD ' ' A' ' 41' ' ' MET . . . -49.9 -56.8 9.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.597 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 113' ' ' ALA . 4.0 tt0 -68.56 -67.4 0.47 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.504 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.2 OUTLIER -34.67 -27.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -78.31 -59.11 2.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.12 -0.987 . . . . 0.0 109.828 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.562 HG12 ' HB1' ' A' ' 85' ' ' ALA . 3.3 tp -48.09 -37.11 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.173 -0.954 . . . . 0.0 109.512 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 6.2 ttmt -67.76 -47.73 68.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.215 -0.928 . . . . 0.0 109.286 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.98 -46.4 64.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.277 -0.889 . . . . 0.0 109.1 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.85 -55.74 27.04 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.098 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 117' ' ' ALA . 29.8 mt -42.14 -40.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.08 -54.41 21.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.308 -0.87 . . . . 0.0 109.17 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.07 -26.19 25.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.246 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -76.73 -57.57 3.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -0.869 . . . . 0.0 109.312 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -69.79 2.93 2.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.308 -0.87 . . . . 0.0 109.307 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.512 ' HB2' ' NE2' ' A' ' 130' ' ' HIS . . . -93.8 -49.37 5.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -70.18 -3.57 17.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.863 . . . . 0.0 109.647 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -51.21 21.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.865 ' C ' HD12 ' A' ' 127' ' ' LEU . . . -155.71 20.18 0.52 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.865 HD12 ' C ' ' A' ' 126' ' ' GLY . 6.6 mp -133.02 2.18 3.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -1.175 . . . . 0.0 109.364 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.521 ' C ' ' O ' ' A' ' 127' ' ' LEU . 2.8 mm-40 36.93 -104.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 109.363 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.639 ' O ' ' ND1' ' A' ' 129' ' ' HIS . 6.6 p80 -85.3 141.75 29.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.137 -0.977 . . . . 0.0 109.354 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.512 ' NE2' ' HB2' ' A' ' 123' ' ' ALA . 16.4 m80 -69.5 178.01 2.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.476 ' C ' ' H ' ' A' ' 133' ' ' HIS . 21.0 m170 -80.99 105.26 12.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.925 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -71.68 13.25 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.476 ' H ' ' C ' ' A' ' 131' ' ' HIS . 14.3 m-70 -48.21 111.38 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 109.426 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.496 ' CD2' ' OXT' ' A' ' 134' ' ' HIS . 23.1 t-160 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.426 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.555 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 68.63 -172.87 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.357 -0.839 . . . . 0.0 109.429 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 62.26 73.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.283 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 m -124.81 81.48 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.59 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.04 151.1 28.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.403 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -140.57 43.49 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.636 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 7' ' ' VAL . 2.7 t -54.54 124.51 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.347 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.54 134.05 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 9' ' ' ASP . 22.0 p-10 -116.89 84.79 2.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.865 . . . . 0.0 109.369 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.4 -33.12 0.24 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -97.26 67.15 2.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.417 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.35 160.96 16.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.526 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -125.17 91.66 48.75 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.582 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -80.73 157.74 21.45 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.744 2.296 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -152.08 64.13 0.84 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.566 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.18 175.78 5.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.2 -0.937 . . . . 0.0 109.525 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -126.43 74.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.419 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -56.48 -167.71 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER 74.52 168.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -1.183 . . . . 0.0 109.624 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.617 ' C ' ' H ' ' A' ' 22' ' ' LYS . 4.7 tp 63.37 -18.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.864 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.624 ' H ' ' C ' ' A' ' 19' ' ' SER . 10.0 m-20 -55.57 1.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.126 -0.984 . . . . 0.0 109.559 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.617 ' H ' ' C ' ' A' ' 20' ' ' LEU . 11.7 ttmt 64.32 1.88 1.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.187 -0.946 . . . . 0.0 109.293 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -158.39 30.8 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.386 -0.821 . . . . 0.0 109.151 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' CG ' ' O ' ' A' ' 24' ' ' ASP . 12.3 t0 -91.66 26.7 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.524 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 66.34 -4.9 0.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.463 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' H ' ' C ' ' A' ' 24' ' ' ASP . 57.8 m-20 -107.71 -0.71 21.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.193 -0.942 . . . . 0.0 109.458 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -129.45 96.25 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.576 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.12 139.11 37.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.433 HG23 HE21 ' A' ' 44' ' ' GLN . 6.6 m -120.61 105.97 11.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -1.12 . . . . 0.0 109.49 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.79 130.04 10.1 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 19.6 ttt -132.65 117.01 17.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -1.144 . . . . 0.0 109.455 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -125.9 159.0 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.98 156.05 16.0 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . . . -117.83 83.04 17.62 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.335 -1.097 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -54.54 -16.82 11.38 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.913 2.408 . . . . 0.0 112.113 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.01 -33.64 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' O ' ' C ' ' A' ' 38' ' ' GLY . 3.3 p -124.06 23.19 8.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.929 . . . . 0.0 109.531 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 34.74 69.17 0.2 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.426 ' CB ' ' SG ' ' A' ' 37' ' ' CYS . 8.6 t0 -139.67 116.95 11.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -1.167 . . . . 0.0 109.503 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.55 110.58 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.474 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 5.7 ttt -97.6 137.02 37.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -128.91 112.8 14.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 tp -115.47 139.25 50.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 0.0 109.529 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.433 HE21 HG23 ' A' ' 29' ' ' THR . 2.6 mt-30 -134.96 134.75 40.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.885 . . . . 0.0 109.387 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.82 135.05 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -106.81 133.58 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.406 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -107.98 139.68 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 49' ' ' ASP . 6.4 t0 -82.76 -88.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 2.3 m-20 -154.76 17.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.0 11.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.44 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.47 1.01 78.7 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -83.39 135.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -1.107 . . . . 0.0 109.581 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.34 104.06 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.278 -0.889 . . . . 0.0 109.114 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.19 -24.04 37.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 0.0 109.837 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 45.6 t0 -148.21 150.62 34.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.147 -0.97 . . . . 0.0 109.685 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -142.04 116.61 9.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.343 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -97.31 152.12 19.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.923 . . . . 0.0 109.501 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CG ' HG21 ' A' ' 74' ' ' THR . 15.3 p90 -147.59 166.42 27.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.633 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -170.79 117.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.407 HG21 ' HB3' ' A' ' 70' ' ' SER . 0.8 OUTLIER -157.23 143.71 18.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.706 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 20.1 p90 -161.92 95.55 0.98 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.34 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -167.06 -62.07 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -81.89 146.27 29.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.417 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.7 10.38 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.543 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 7.4 t -136.22 -7.24 2.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -1.134 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.19 -68.97 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.616 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.83 -34.22 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.337 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 65' ' ' SER . . . -58.27 -57.53 12.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.923 . . . . 0.0 109.459 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -68.2 -41.25 81.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.473 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -61.53 -28.23 69.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.893 . . . . 0.0 109.452 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 68' ' ' ALA . 77.4 p -75.0 -49.96 18.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.581 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.5 tp -63.72 -57.99 8.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.782 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 74' ' ' THR . 18.2 tt -49.15 -45.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.13 -0.981 . . . . 0.0 109.512 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 70' ' ' SER . 19.0 p -60.05 -36.25 76.89 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 109.584 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -77.98 -10.37 59.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.469 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -99.09 -30.85 12.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.87 . . . . 0.0 109.596 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 77' ' ' VAL . 15.3 m -96.81 38.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.671 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.06 102.85 10.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.297 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.75 18.16 52.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -104.77 169.39 8.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.311 -1.111 . . . . 0.0 109.429 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 m -93.54 150.22 20.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.909 . . . . 0.0 109.52 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 82' ' ' LEU . 27.9 mt -49.44 -26.51 3.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.63 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -69.04 -32.98 72.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.146 -0.971 . . . . 0.0 109.93 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -83.46 -34.24 25.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 0.0 109.744 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.55 54.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.27 52.05 3.76 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -162.43 -39.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.185 -1.186 . . . . 0.0 109.243 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.7 pt -42.76 -30.28 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.343 -0.848 . . . . 0.0 109.364 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 59.91 175.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.495 ' O ' ' C ' ' A' ' 91' ' ' SER . 0.3 OUTLIER -88.52 -44.33 10.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.445 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.495 ' C ' ' O ' ' A' ' 90' ' ' ASN . 43.4 t -38.61 -39.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.962 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 95' ' ' GLU . 16.4 tp60 -62.33 -66.41 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 109.378 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.4 mt -45.37 -31.4 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.949 . . . . 0.0 109.229 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.36 -19.96 48.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.248 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 92' ' ' GLN . 6.2 tt0 -83.85 -20.03 33.86 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -97.92 -53.89 3.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.285 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 98' ' ' GLU . 0.7 OUTLIER -72.91 -5.56 39.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.369 179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.507 ' CA ' ' OE1' ' A' ' 98' ' ' GLU . 0.0 OUTLIER 43.26 31.95 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.273 -0.892 . . . . 0.0 109.619 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.95 150.79 36.95 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.334 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.18 157.95 42.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.8 2.333 . . . . 0.0 112.234 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.649 ' O ' HG23 ' A' ' 104' ' ' VAL . 60.9 Cg_endo -76.4 -7.14 17.71 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.893 2.395 . . . . 0.0 112.567 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.6 p -82.83 -14.88 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 105' ' ' HIS . 25.6 mttm -114.42 29.69 7.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 101' ' ' PRO . 21.8 t -66.76 -9.94 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.42 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.646 ' O ' HD13 ' A' ' 109' ' ' LEU . 2.2 p-80 -77.35 -25.28 50.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.427 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -75.7 -41.81 52.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.138 -0.976 . . . . 0.0 109.121 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -52.97 59.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.261 -0.9 . . . . 0.0 109.189 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 109' ' ' LEU . 7.1 tt -53.9 -38.73 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.197 -0.939 . . . . 0.0 108.89 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.646 HD13 ' O ' ' A' ' 105' ' ' HIS . 1.6 mp -53.8 -50.04 67.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -0.945 . . . . 0.0 109.165 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -56.82 -54.24 48.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.0 109.088 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 114' ' ' ILE . 16.2 tt0 -48.93 -63.46 1.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.206 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -51.42 -27.56 10.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 0.0 109.3 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -68.0 -49.04 63.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.612 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 111' ' ' GLU . 2.4 tp -56.22 -36.31 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.985 . . . . 0.0 109.26 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.7 OUTLIER -70.87 -57.04 5.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.1 -53.84 7.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.478 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.37 -59.67 3.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.519 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.9 mt -46.44 -44.69 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.424 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 121' ' ' TYR . . . -62.35 -64.94 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.68 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' C ' ' OD1' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -47.89 -17.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.52 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.2 t80 -92.59 -29.28 16.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -92.1 3.37 55.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.355 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.44 -52.18 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.288 -0.883 . . . . 0.0 109.578 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.2 tttm -76.62 47.76 0.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -122.54 -26.93 4.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.27 -0.894 . . . . 0.0 109.485 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.16 -17.29 1.92 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.0 mt -83.89 37.0 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -95.28 109.56 21.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.272 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.67 ' H ' ' CD2' ' A' ' 129' ' ' HIS . 3.7 p80 -69.24 118.84 12.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.564 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.06 -2.11 13.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 t60 65.0 118.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.328 -0.857 . . . . 0.0 109.404 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 134' ' ' HIS . 0.3 OUTLIER -90.93 -58.01 2.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.537 ' C ' ' CG ' ' A' ' 134' ' ' HIS . 40.5 m80 -51.46 89.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.895 . . . . 0.0 109.458 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.579 ' CD2' ' N ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.419 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 28.6 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 170.54 -62.14 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.467 ' O ' ' C ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -148.4 -73.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -0.888 . . . . 0.0 109.362 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.467 ' C ' ' O ' ' A' ' 3' ' ' TYR . 1.7 m 41.59 83.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -145.1 105.65 4.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.45 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -165.12 -27.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.964 . . . . 0.0 109.691 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 7' ' ' VAL . 12.0 t -54.19 -76.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.086 -1.009 . . . . 0.0 109.469 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mt -51.61 118.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 0.0 109.428 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.87 142.95 3.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.905 . . . . 0.0 109.335 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.473 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 1.2 p-80 -177.65 115.14 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.686 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -138.28 -164.33 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -106.27 142.31 36.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.204 -0.935 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' OD1' ' N ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -141.7 162.56 45.94 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.341 -0.849 . . . . 0.0 109.321 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -67.8 -73.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.714 2.276 . . . . 0.0 112.157 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -52.23 151.11 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.319 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -174.14 58.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -54.96 136.39 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -0.871 . . . . 0.0 109.341 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' C ' ' A' ' 19' ' ' SER . . . 96.8 34.54 5.69 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.532 ' C ' ' O ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -36.95 -93.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -1.198 . . . . 0.0 109.387 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mt 45.48 74.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 4.3 t70 -178.02 153.23 0.79 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.878 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -67.65 -18.16 64.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.5 mmtt -95.91 21.45 8.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.358 -0.839 . . . . 0.0 109.39 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.559 ' OD2' ' N ' ' A' ' 21' ' ' ASP . 37.8 m-20 -99.18 162.98 12.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.481 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.12 10.42 25.99 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.135 -0.978 . . . . 0.0 109.539 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -134.39 21.14 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.4 t -118.39 127.79 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 109.397 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.0 121.67 7.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -102.78 120.65 40.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.538 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -117.41 100.68 0.89 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.4 ttt -96.68 133.13 41.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.338 -1.095 . . . . 0.0 109.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.41 154.62 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.862 . . . . 0.0 109.222 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.64 143.72 17.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.14 107.18 13.63 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.34 -1.094 . . . . 0.0 109.083 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -76.52 15.59 1.02 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.293 1.996 . . . . 0.0 112.447 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.658 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -112.47 -102.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.377 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.832 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -121.04 6.59 10.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.689 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -91.7 -16.46 51.93 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 40' ' ' VAL . 29.7 t0 50.86 -151.35 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -1.051 . . . . 0.0 109.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 6.4 t -87.35 136.62 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.908 . . . . 0.0 109.433 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 6.7 ttt -127.34 137.41 52.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.979 . . . . 0.0 109.589 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -124.43 123.37 40.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -119.93 126.51 51.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.958 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -119.56 143.64 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.515 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.5 pp -132.88 134.16 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -102.97 136.8 42.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 109.538 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.9 136.05 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 49' ' ' ASP . 38.1 t0 -59.78 -49.44 77.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.31 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.678 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.7 OUTLIER 162.83 -20.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.379 -0.826 . . . . 0.0 109.231 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.55 -34.43 9.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.875 . . . . 0.0 109.44 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.11 -9.73 0.98 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -74.43 134.26 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -1.225 . . . . 0.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.04 89.49 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.44 -54.78 39.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.578 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -144.49 152.85 41.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.898 . . . . 0.0 109.477 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.594 ' H ' ' HZ3' ' A' ' 78' ' ' LYS . . . -133.58 142.44 48.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.904 . . . . 0.0 109.741 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -114.02 143.28 45.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.053 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.524 ' HB3' HG21 ' A' ' 74' ' ' THR . 4.4 p90 -119.69 165.2 14.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 109.86 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -171.54 81.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.309 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 t -123.45 152.9 41.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -155.44 95.56 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.444 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.55 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . -179.21 -50.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.668 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 18.5 m -74.23 125.15 27.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.511 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -43.33 -21.72 0.17 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -120.25 7.9 10.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -1.105 . . . . 0.0 109.274 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 63' ' ' CYS . . . -42.22 -43.18 3.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.839 . . . . 0.0 109.518 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.518 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.2 mt -60.72 -29.96 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -80.58 -71.92 0.44 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.733 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.3 p -38.84 -33.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.944 . . . . 0.0 109.399 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 74' ' ' THR . 12.4 p -69.19 -63.66 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.518 ' OG ' ' O ' ' A' ' 67' ' ' ILE . 0.8 OUTLIER -48.67 -25.76 1.95 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.968 . . . . 0.0 109.5 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' C ' ' A' ' 73' ' ' ILE . 39.4 tp -79.15 -81.07 0.11 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.604 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 69' ' ' SER . 14.5 tt -41.11 -35.68 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.614 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 70' ' ' SER . 82.6 p -69.53 -39.48 77.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 72' ' ' LEU . 16.4 tt0 -74.51 -8.33 55.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.327 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.98 -31.88 14.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 114' ' ' ILE . 4.9 m -96.42 13.14 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.4 -0.813 . . . . 0.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HZ3' ' H ' ' A' ' 56' ' ' ALA . 4.2 mttm -89.28 93.11 9.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.539 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 111.54 -18.52 24.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -66.52 -162.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.41 167.81 13.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.177 -0.952 . . . . 0.0 109.646 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.5 mt -60.38 -30.19 69.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.339 -0.85 . . . . 0.0 109.56 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -66.76 -35.05 79.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.674 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -80.1 -45.2 18.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.615 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.007 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.16 35.61 2.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -147.4 -38.99 0.19 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -1.131 . . . . 0.0 109.1 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.509 HD11 HG12 ' A' ' 114' ' ' ILE . 1.4 pt -41.45 163.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.305 -0.872 . . . . 0.0 109.35 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -136.72 -174.1 3.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.529 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -101.55 -5.59 24.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.371 -0.83 . . . . 0.0 109.221 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -64.31 -53.06 54.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 0.0 109.343 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.496 ' O ' ' N ' ' A' ' 95' ' ' GLU . 4.6 mt-30 -60.76 -62.41 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.234 -0.916 . . . . 0.0 109.248 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 93' ' ' ILE . 37.3 mt -47.21 -25.8 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.232 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.45 -27.27 46.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 109.139 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 92' ' ' GLN . 10.2 mt-10 -87.96 -16.28 34.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.355 -0.841 . . . . 0.0 109.338 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -88.55 -43.41 11.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.472 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.67 -14.05 49.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 48.29 74.52 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.371 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -110.77 150.73 42.21 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.154 -0.966 . . . . 0.0 109.415 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.02 160.09 48.91 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.748 2.299 . . . . 0.0 112.193 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.0 Cg_endo -66.7 -65.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.904 2.402 . . . . 0.0 112.537 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.517 HG23 ' C ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER 41.48 -87.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.269 -0.894 . . . . 0.0 109.03 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' PRO . 20.1 mttp -138.43 10.96 2.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.683 ' O ' HD12 ' A' ' 108' ' ' ILE . 3.7 t 34.79 53.08 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 109.579 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.832 ' CE1' ' H ' ' A' ' 37' ' ' CYS . 6.4 p-80 -98.38 -25.54 14.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 109.327 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.4 m -62.84 -70.22 0.22 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.393 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -51.32 -57.84 7.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 104' ' ' VAL . 37.1 mt -43.07 -34.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.442 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.88 -44.07 81.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.71 68.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.448 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' ' 112' ' ' ASP . 56.8 tt0 -66.56 -67.69 0.43 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 111' ' ' GLU . 47.8 t0 -40.56 -29.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -67.1 -59.54 3.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.446 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.509 HG12 HD11 ' A' ' 88' ' ' ILE . 1.9 tp -46.21 -33.78 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.26 -34.75 61.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.78 -46.81 64.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.417 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.97 -56.8 17.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.515 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.5 -44.38 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.901 . . . . 0.0 109.626 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.95 -57.54 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.233 -0.917 . . . . 0.0 109.555 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 2.4 m-20 -53.89 -53.6 50.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.516 ' O ' ' C ' ' A' ' 122' ' ' LYS . 13.0 t80 -47.37 -70.62 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.339 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 121' ' ' TYR . 11.2 mmtt -36.22 -44.81 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.33 -0.856 . . . . 0.0 109.538 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 120' ' ' ASP . . . -60.78 -44.17 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.569 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 121' ' ' TYR . 3.6 mtpt -59.46 -40.33 86.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.913 . . . . 0.0 109.424 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.448 ' CD ' ' O ' ' A' ' 125' ' ' GLN . 23.0 tm0? -131.1 74.52 1.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.54 -92.54 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.914 HD12 ' H ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -140.96 18.46 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -1.1 . . . . 0.0 109.379 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 57.93 -173.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.483 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.632 ' HD1' ' C ' ' A' ' 129' ' ' HIS . 0.0 OUTLIER -62.53 163.62 8.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.628 ' C ' ' ND1' ' A' ' 131' ' ' HIS . 0.4 OUTLIER -129.18 66.66 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.241 -0.912 . . . . 0.0 109.461 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.628 ' ND1' ' C ' ' A' ' 130' ' ' HIS . 3.1 m-70 -135.65 138.01 42.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.629 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.71 135.31 17.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.147 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -88.99 42.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.553 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.447 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.0 -32.68 0.55 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -47.31 37.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.611 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 4' ' ' SER . 0.3 OUTLIER -126.17 112.84 16.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.85 . . . . 0.0 109.6 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -174.14 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 tttp 59.0 89.76 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.141 -0.974 . . . . 0.0 109.53 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 p -104.99 141.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.578 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 pt -145.04 118.73 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 3.8 p-10 -85.35 -92.83 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.638 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.682 ' CE1' ' O ' ' A' ' 11' ' ' TYR . 1.7 t60 -152.94 150.26 29.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' O ' ' CE1' ' A' ' 10' ' ' HIS . 2.8 m-85 -140.83 -151.44 0.36 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -94.2 -160.51 0.78 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.35 153.38 42.77 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.909 . . . . 0.0 109.509 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.63 126.43 21.25 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.977 2.451 . . . . 0.0 112.492 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.27 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.818 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.716 ' OD1' HG23 ' A' ' 17' ' ' VAL . 28.6 t-20 46.0 -118.22 0.76 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG23 ' OD1' ' A' ' 16' ' ' ASN . 60.3 t -117.79 -42.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . -160.77 -117.73 0.46 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 68.0 -167.84 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -1.105 . . . . 0.0 109.502 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.475 HD22 ' HZ2' ' A' ' 46' ' ' LYS . 5.7 tp -135.07 77.61 1.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 23' ' ' LYS . 5.1 t70 61.0 154.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.438 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.45 ' NZ ' ' HB3' ' A' ' 22' ' ' LYS . 9.4 mtpm? -73.73 14.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.277 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 21' ' ' ASP . 38.8 mttp -48.58 -20.47 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 26' ' ' ASN . 26.3 t0 42.26 -149.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.442 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.509 ' C ' ' OD1' ' A' ' 26' ' ' ASN . 0.5 OUTLIER 54.64 0.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.075 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.611 ' H ' ' C ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -167.82 25.28 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.382 -0.824 . . . . 0.0 109.326 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.12 113.67 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.782 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.76 125.32 7.18 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.9 m -116.13 145.31 43.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.0 109.565 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.36 134.57 5.4 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 52.5 mtt -123.47 148.88 45.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.122 . . . . 0.0 109.386 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.18 174.01 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.145 -0.972 . . . . 0.0 109.334 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.24 150.27 8.04 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.03 144.42 47.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.252 -1.146 . . . . 0.0 109.504 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' GLY . 42.0 Cg_endo -71.97 -67.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.563 2.176 . . . . 0.0 111.938 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.41 -35.9 0.75 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.241 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' O ' ' C ' ' A' ' 38' ' ' GLY . 49.9 t -99.13 -4.97 31.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.33 -0.856 . . . . 0.0 109.345 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 36.68 34.66 0.1 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 37' ' ' CYS . 13.7 t0 -105.02 114.16 28.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.333 -1.098 . . . . 0.0 109.604 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.71 ' O ' HG13 ' A' ' 40' ' ' VAL . 14.5 p -89.05 109.29 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.302 -0.874 . . . . 0.0 109.16 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 13.4 ttt -99.2 152.32 20.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.82 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -147.9 126.93 12.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.89 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.62 128.42 37.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.034 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -118.52 136.05 54.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.377 -0.827 . . . . 0.0 109.028 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 45' ' ' ILE . 1.4 pp -119.51 144.86 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.149 -0.97 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' HZ2' HD22 ' A' ' 20' ' ' LEU . 2.4 ttmm -111.79 141.98 44.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.81 113.65 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 17.3 t0 -47.45 -67.16 0.3 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.465 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.644 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 2.9 p-10 170.41 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.097 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.39 10.83 23.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.32 15.26 54.09 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.1 mm -102.52 148.81 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -1.16 . . . . 0.0 109.592 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.478 ' O ' ' C ' ' A' ' 54' ' ' GLU . 3.3 mm -83.34 84.99 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.435 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' OE2' ' OD1' ' A' ' 55' ' ' ASP . 5.6 tt0 -40.89 -55.76 2.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.415 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' OD1' ' OE2' ' A' ' 54' ' ' GLU . 7.4 p-10 -152.34 170.99 18.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.25 126.52 18.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.474 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -99.28 135.01 41.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 2.6 p90 -109.83 162.46 14.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.329 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -171.78 102.24 0.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.615 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -164.82 139.74 5.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.549 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.651 ' CE2' HD11 ' A' ' 67' ' ' ILE . 3.3 t80 -156.02 95.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 109.536 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -162.31 -19.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.678 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -141.06 107.27 5.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.423 -1.045 . . . . 0.0 109.181 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 63' ' ' CYS . . . -41.08 -15.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 63' ' ' CYS . 1.8 m -82.49 -22.24 35.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.549 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -83.31 -58.7 2.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.651 HD11 ' CE2' ' A' ' 61' ' ' TYR . 42.5 mt -35.68 -59.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.06 -64.23 0.9 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.259 -0.901 . . . . 0.0 109.451 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' HG22 ' A' ' 73' ' ' ILE . 1.9 m -49.84 -50.56 45.02 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.323 -0.861 . . . . 0.0 109.479 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 74' ' ' THR . 1.3 t -43.95 -47.57 8.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.587 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.569 ' O ' ' OG1' ' A' ' 74' ' ' THR . 17.3 p -70.59 -31.41 68.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.8 tp -68.33 -61.82 1.67 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 77' ' ' VAL . 6.1 tt -48.78 -41.98 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.619 HG23 ' O ' ' A' ' 70' ' ' SER . 23.5 p -55.84 -46.25 78.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.018 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -68.99 -20.23 64.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 108.916 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.21 -27.68 53.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 109.045 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 73' ' ' ILE . 7.0 m -111.8 -111.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.499 -0.75 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' H ' HG23 ' A' ' 77' ' ' VAL . 8.3 tttm 35.32 77.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.53 13.85 10.16 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.56 -166.14 1.25 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -1.113 . . . . 0.0 109.366 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 83' ' ' GLU . 15.5 m -108.34 135.82 49.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.165 -0.959 . . . . 0.0 109.639 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 81' ' ' SER . 11.4 mt -45.32 -14.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 81' ' ' SER . 5.7 tp10 -77.92 -53.12 7.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 109.173 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -32.0 69.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.912 . . . . 0.0 109.15 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.07 31.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.212 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.24 47.2 3.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.574 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.61 -33.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.189 . . . . 0.0 109.425 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.574 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.5 pt -44.16 175.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -143.19 158.11 43.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -73.99 -38.25 64.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.273 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -52.19 -37.69 55.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.267 -0.896 . . . . 0.0 109.161 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 94' ' ' ALA . 3.5 mm100 -66.18 -68.33 0.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.392 -0.818 . . . . 0.0 109.128 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.7 mt -45.67 -23.65 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.293 -0.88 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 91' ' ' SER . . . -71.85 -63.45 1.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.825 . . . . 0.0 109.166 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -49.31 -17.16 0.23 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 108.941 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.445 ' N ' ' C ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -80.68 -61.21 2.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' O ' ' CB ' ' A' ' 98' ' ' GLU . 60.2 tp -76.7 -33.45 58.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.329 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 97' ' ' LEU . 0.5 OUTLIER 70.0 68.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.518 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.035 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.2 pt? -103.72 146.93 33.43 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -40.24 102.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.758 2.305 . . . . 0.0 112.16 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 103' ' ' LYS . 58.8 Cg_endo -78.77 10.15 2.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.543 2.162 . . . . 0.0 112.41 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.61 -11.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.238 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.605 ' N ' ' O ' ' A' ' 101' ' ' PRO . 53.0 tttm -157.14 -34.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.338 -0.852 . . . . 0.0 109.381 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.6 t 60.9 60.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.159 -0.963 . . . . 0.0 109.286 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.624 ' O ' HD13 ' A' ' 109' ' ' LEU . 13.3 p-80 -99.27 -47.66 5.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.361 -0.837 . . . . 0.0 109.527 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.403 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 6.6 m -61.11 -49.38 77.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.509 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.547 ' OG ' HD11 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -50.66 -67.8 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.4 ' C ' ' O ' ' A' ' 107' ' ' SER . 3.4 mt -44.87 -38.81 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.317 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 105' ' ' HIS . 4.6 mp -60.24 -39.37 86.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.296 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -61.67 -52.02 66.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 109.132 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 112' ' ' ASP . 68.2 tt0 -60.16 -60.31 4.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.119 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -42.76 -33.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -64.28 -60.45 3.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -46.99 -38.4 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.932 . . . . 0.0 109.717 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' HA ' HD12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -70.35 -57.77 4.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -48.99 -39.58 27.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.01 97.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 0.0 109.66 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 115' ' ' LYS . 44.2 mt -64.37 -39.3 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.238 -0.914 . . . . 0.0 109.663 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.97 72.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.677 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.45 -42.73 95.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -70.02 -48.66 57.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 125' ' ' GLN . 20.2 tttt -56.96 -30.15 63.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -38.93 -36.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.272 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -73.85 26.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -0.847 . . . . 0.0 109.461 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' A' ' 122' ' ' LYS . 6.5 mm-40 -138.56 26.66 2.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.264 -0.897 . . . . 0.0 109.57 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 128' ' ' GLU . . . -178.95 -68.68 0.06 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.2 49.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -1.149 . . . . 0.0 109.488 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.645 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -121.26 163.82 17.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' A' ' 131' ' ' HIS . 63.8 t-80 -140.21 -46.39 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.178 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.43 66.96 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.36 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 129' ' ' HIS . 0.7 OUTLIER -155.67 137.63 14.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.919 . . . . 0.0 109.457 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -109.06 -114.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.554 ' ND1' ' N ' ' A' ' 133' ' ' HIS . 1.0 OUTLIER -74.5 -141.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.299 -0.876 . . . . 0.0 109.466 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.921 -1.037 . . . . 0.0 109.52 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.555 ' O ' ' CB ' ' A' ' 3' ' ' TYR . . . -91.71 -125.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' O ' ' A' ' 2' ' ' ALA . 2.0 t80 79.13 131.26 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.452 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.9 t -67.77 19.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 3' ' ' TYR . 2.7 tt0 -59.48 147.04 38.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -168.15 72.61 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -0.884 . . . . 0.0 109.697 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 9' ' ' ASP . 3.1 t -107.27 64.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.237 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.76 44.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.63 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -141.87 -146.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.49 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.67 178.41 4.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.463 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.565 ' O ' ' O ' ' A' ' 12' ' ' GLU . 30.5 m-85 -76.39 -11.66 59.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.352 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.565 ' O ' ' O ' ' A' ' 11' ' ' TYR . 27.3 mt-10 52.59 113.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.513 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 50.75 82.22 0.25 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 179.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.736 2.29 . . . . 0.0 112.068 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 17' ' ' VAL . 22.8 ttt180 -146.99 141.02 25.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.395 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.535 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 39.4 t-20 -62.45 55.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.504 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' A' ' 15' ' ' ARG . 94.0 t -48.36 93.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.264 -0.897 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 169.17 159.28 14.48 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 56.19 122.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.137 -1.213 . . . . 0.0 109.357 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -108.69 -109.07 0.33 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.53 ' O ' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -117.31 118.7 32.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.227 -0.921 . . . . 0.0 109.369 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' C ' ' O ' ' A' ' 21' ' ' ASP . 6.1 mtmt -35.15 -37.14 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.488 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -80.42 43.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.882 . . . . 0.0 109.453 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.677 ' OD1' ' N ' ' A' ' 25' ' ' SER . 57.6 t0 -104.49 147.27 27.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 109.389 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.677 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 51.0 m -89.65 5.86 43.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 0.0 109.546 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -114.31 -2.71 13.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.19 117.56 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.843 . . . . 0.0 109.395 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.41 126.94 9.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.553 ' OG1' ' NE2' ' A' ' 44' ' ' GLN . 3.0 m -112.07 151.2 29.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -1.135 . . . . 0.0 109.299 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.92 153.88 25.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 9.8 ttm -142.37 141.19 32.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -1.094 . . . . 0.0 109.318 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.86 165.96 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.923 . . . . 0.0 109.562 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -122.11 148.53 17.1 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.582 ' C ' ' H ' ' A' ' 36' ' ' ALA . . . -141.88 79.16 16.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.333 -1.098 . . . . 0.0 109.619 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.31 12.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.88 2.387 . . . . 0.0 112.269 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.635 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -110.54 -79.16 0.58 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.271 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' H ' ' CE1' ' A' ' 105' ' ' HIS . 1.4 p -134.9 -36.22 0.84 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.188 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.688 ' H ' ' CE1' ' A' ' 105' ' ' HIS . . . -55.02 -18.86 12.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.535 ' N ' ' HB3' ' A' ' 34' ' ' ALA . 14.7 t0 51.69 -147.69 0.42 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -1.123 . . . . 0.0 109.731 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.424 ' H ' ' CG ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER -86.98 115.41 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.88 . . . . 0.0 109.434 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.452 ' CG ' ' N ' ' A' ' 42' ' ' GLN . 9.5 ttt -106.82 157.42 17.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -0.911 . . . . 0.0 109.364 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' N ' ' CG ' ' A' ' 41' ' ' MET . 15.6 tt0 -143.86 130.38 20.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.686 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.463 ' HG ' ' N ' ' A' ' 44' ' ' GLN . 1.6 tp -125.45 150.91 46.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.553 ' NE2' ' OG1' ' A' ' 29' ' ' THR . 22.1 mt-30 -142.23 144.33 33.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.539 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pp -131.17 155.95 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.589 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -130.76 122.79 27.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.247 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.629 HG11 HD11 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -115.37 140.01 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.786 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.669 ' O ' ' N ' ' A' ' 50' ' ' ASN . 35.0 m-20 -170.88 -35.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -62.47 48.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.344 -0.848 . . . . 0.0 109.374 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.669 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 78.4 50.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.08 8.91 86.99 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.83 149.49 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -1.103 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.8 mt -82.7 91.44 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.633 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -72.83 -38.56 67.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.333 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 47.8 t0 -124.85 158.03 34.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.828 . . . . 0.0 109.236 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -158.67 120.23 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 0.0 109.724 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.76 157.33 19.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -140.69 -174.03 3.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.136 -0.977 . . . . 0.0 109.751 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -169.69 81.61 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.219 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.34 122.34 30.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.683 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 105.68 3.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 145.25 -44.57 0.87 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.466 ' SG ' ' HA2' ' A' ' 38' ' ' GLY . 15.9 m -75.0 167.36 22.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -1.082 . . . . 0.0 109.446 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.37 -38.48 0.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.61 -21.01 17.9 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.356 -1.085 . . . . 0.0 109.498 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -88.6 0.63 56.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.459 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 66' ' ' ALA . 8.3 tp -44.36 -31.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 69' ' ' SER . . . -66.46 -47.78 72.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.599 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -43.37 -32.5 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.333 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.483 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.7 OUTLIER -58.53 -53.73 55.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.7 m -65.75 -32.72 74.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 0.0 109.558 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 75' ' ' GLU . 1.7 tp -65.1 -80.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.331 -0.856 . . . . 0.0 109.682 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.733 ' O ' HG22 ' A' ' 77' ' ' VAL . 16.4 tt -37.11 -41.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -0.963 . . . . 0.0 109.577 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 73' ' ' ILE . 2.4 p -64.77 -32.38 74.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.145 -0.972 . . . . 0.0 109.526 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' N ' ' O ' ' A' ' 72' ' ' LEU . 8.8 mt-10 -86.56 -7.72 58.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.241 -0.912 . . . . 0.0 109.635 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -109.04 -5.71 15.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.126 -0.984 . . . . 0.0 109.546 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 73' ' ' ILE . 24.9 m -117.52 0.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.235 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -95.38 114.83 26.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.433 -0.792 . . . . 0.0 109.385 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.82 -8.36 73.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.25 168.69 12.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -1.156 . . . . 0.0 109.42 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.0 m -88.79 167.59 13.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.629 HD11 HG11 ' A' ' 47' ' ' VAL . 31.7 mt -68.04 -26.61 65.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.565 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.602 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -66.52 -20.27 65.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.204 -0.935 . . . . 0.0 109.317 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -97.22 -58.02 2.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.251 -0.906 . . . . 0.0 109.171 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.11 -23.68 62.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.246 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 118' ' ' ILE . . . -101.44 49.23 1.06 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -168.93 -33.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -1.128 . . . . 0.0 109.094 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.458 ' C ' ' O ' ' A' ' 87' ' ' ALA . 5.1 pt -41.38 156.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.5 168.8 9.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.135 -0.978 . . . . 0.0 109.566 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.637 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -85.59 -18.47 33.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.298 -0.876 . . . . 0.0 109.338 179.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 t -66.65 -27.61 67.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.19 -57.87 5.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.533 HG21 ' OG ' ' A' ' 69' ' ' SER . 5.1 mt -62.37 -38.45 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.477 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -54.79 -53.51 54.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.96 . . . . 0.0 109.348 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -65.73 -37.02 85.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.377 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -52.25 -41.13 62.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 0.0 109.552 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 tp -105.8 -29.14 10.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.546 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.58 ' N ' ' O ' ' A' ' 94' ' ' ALA . 8.9 tm-20 64.58 58.71 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.905 . . . . 0.0 109.347 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.068 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.2 pt? -86.46 143.43 36.32 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.376 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.61 142.45 1.96 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.574 2.183 . . . . 0.0 112.151 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -76.24 -3.16 13.48 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.719 2.279 . . . . 0.0 111.942 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 102' ' ' VAL . 3.0 t -59.9 -12.21 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.305 -0.872 . . . . 0.0 109.687 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' NZ ' ' SG ' ' A' ' 106' ' ' CYS . 18.0 pttp -156.79 56.65 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.761 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 104' ' ' VAL . 86.0 t -57.3 -11.27 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.179 -0.951 . . . . 0.0 109.284 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.688 ' CE1' ' H ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -54.64 -22.32 13.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.511 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.499 ' SG ' ' NZ ' ' A' ' 103' ' ' LYS . 59.5 m -65.03 -61.1 2.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.356 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.0 p -55.15 -51.67 65.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.442 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 15.9 mt -55.28 -26.52 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.327 -0.858 . . . . 0.0 109.102 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 109' ' ' LEU . 1.9 tp -68.06 -42.11 80.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 109.004 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -58.37 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.82 . . . . 0.0 109.606 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 112' ' ' ASP . 7.3 tm-20 -62.33 -64.57 0.89 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.565 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.478 ' C ' ' O ' ' A' ' 111' ' ' GLU . 62.2 t0 -39.22 -31.23 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.711 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 111' ' ' GLU . . . -69.01 -56.73 6.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.711 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.8 tp -52.14 -37.05 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.235 -0.915 . . . . 0.0 109.646 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 3.1 tttp -67.98 -50.46 55.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.712 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.07 -38.85 73.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 109.714 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -65.62 -69.7 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.698 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.471 HD13 ' HA3' ' A' ' 86' ' ' GLY . 23.6 mt -42.7 -37.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.327 -0.858 . . . . 0.0 109.685 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.08 -45.32 85.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.537 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 61.0 t0 -61.17 -25.19 66.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -0.898 . . . . 0.0 109.557 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.4 t80 -78.62 -40.77 33.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -0.923 . . . . 0.0 109.577 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -84.84 -1.78 56.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.649 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.4 -26.12 24.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.275 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -84.97 -25.1 27.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 109.51 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -54.14 -54.39 40.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 156.14 36.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.93 -16.79 29.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -1.165 . . . . 0.0 109.247 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -176.88 175.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.872 . . . . 0.0 109.368 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' A' ' 129' ' ' HIS . 0.1 OUTLIER -104.88 140.77 37.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.367 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.658 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 7.2 t-80 -124.13 -143.54 0.32 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.544 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.658 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 0.5 OUTLIER 53.0 3.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.0 109.537 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.572 ' H ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -109.77 -171.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.185 -0.947 . . . . 0.0 109.36 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.496 ' NE2' ' CE1' ' A' ' 132' ' ' HIS . 0.0 OUTLIER -91.81 -176.32 4.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.72 ' ND1' ' N ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.461 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.763 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 1.3 tmt? . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.763 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . 164.57 66.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.902 . . . . 0.0 109.465 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -47.64 125.54 8.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.63 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -104.55 98.33 8.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -37.34 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.964 . . . . 0.0 109.505 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 4' ' ' SER . 8.0 pttp -166.14 -2.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 7' ' ' VAL . 17.0 m -89.37 55.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.157 -0.964 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.3 mt -46.27 91.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.407 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 10' ' ' HIS . 57.0 t0 -93.74 149.21 21.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.363 -0.836 . . . . 0.0 109.538 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.56 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 7.0 m-70 -35.91 114.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -0.92 . . . . 0.0 109.391 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -132.37 22.14 4.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.704 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.53 ' O ' ' C ' ' A' ' 13' ' ' ASN . 1.1 mp0 -125.87 -38.56 2.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' C ' ' O ' ' A' ' 12' ' ' GLU . 2.5 m-80 36.63 83.06 0.21 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.853 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -49.83 110.36 0.37 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.944 2.429 . . . . 0.0 112.446 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -105.59 -81.87 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.251 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.29 -0.57 15.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -75.75 90.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.531 -0.731 . . . . 0.0 109.487 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.16 -179.62 49.05 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 21' ' ' ASP . 4.4 t -169.23 144.23 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER 64.4 -64.5 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.385 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 19' ' ' SER . 0.4 OUTLIER -41.49 146.34 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.9 ptmt -75.66 20.61 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 21' ' ' ASP . 8.9 tttm -104.74 -20.54 13.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.957 . . . . 0.0 109.551 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 27' ' ' VAL . 2.8 p30 -72.3 168.27 18.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -98.42 9.85 42.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 6.4 m-80 -118.77 18.27 13.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.474 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.558 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 t -126.48 122.34 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.467 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.52 123.46 7.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.8 m -109.21 152.78 24.7 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -1.186 . . . . 0.0 109.491 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.52 110.7 0.45 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.5 ttt -114.45 103.52 11.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.457 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.0 m -117.2 157.29 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.946 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.14 163.23 28.67 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.87 138.03 16.65 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.294 -1.121 . . . . 0.0 109.371 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.1 Cg_endo -75.57 -36.24 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.516 2.144 . . . . 0.0 111.999 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -43.01 -53.31 4.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.432 -0.792 . . . . 0.0 109.537 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.4 2.38 20.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.65 58.3 7.63 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 62.3 t0 -127.75 145.39 50.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.55 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 2.6 m -115.26 114.69 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.345 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 ttt -98.93 125.3 44.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.859 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.29 119.15 38.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.288 -0.883 . . . . 0.0 109.023 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -114.1 110.92 20.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.242 -0.911 . . . . 0.0 109.836 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -118.82 108.96 15.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.042 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 pt -107.87 143.45 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.895 . . . . 0.0 109.892 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.667 ' NZ ' ' OD2' ' A' ' 48' ' ' ASP . 8.0 tttp -109.31 144.27 37.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 109.013 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.506 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 3.3 t -134.99 149.33 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 0.0 109.737 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.694 ' O ' ' N ' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 174.28 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.688 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 2.9 m-20 -62.21 47.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.421 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.694 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.3 m-20 79.19 48.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.85 . . . . 0.0 109.412 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.37 78.22 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.479 HG22 ' N ' ' A' ' 53' ' ' ILE . 5.4 mm -89.24 158.85 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.392 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.479 ' N ' HG22 ' A' ' 52' ' ' ILE . 46.8 mt -93.09 90.73 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.438 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -55.59 -38.56 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.708 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 2.3 p30 -147.62 162.08 39.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.42 119.6 10.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.912 . . . . 0.0 109.712 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -102.18 141.98 34.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD2' HG21 ' A' ' 74' ' ' THR . 6.1 p90 -137.9 163.93 30.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 0.0 109.734 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -158.95 111.1 2.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.491 -0.755 . . . . 0.0 109.207 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.5 t -156.81 132.6 9.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.133 -0.979 . . . . 0.0 109.606 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.433 ' CG ' ' N ' ' A' ' 62' ' ' GLY . 46.0 t80 -161.65 154.77 20.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.433 ' N ' ' CG ' ' A' ' 61' ' ' TYR . . . 125.08 -43.24 1.4 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 t -88.95 166.38 13.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.086 -1.243 . . . . 0.0 109.651 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.86 43.4 1.67 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -158.9 -66.32 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.314 -1.109 . . . . 0.0 109.314 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 65' ' ' SER . . . -36.27 -35.51 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 0.0 109.315 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 65' ' ' SER . 49.0 mt -54.88 -13.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.258 -0.901 . . . . 0.0 109.314 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 65' ' ' SER . . . -103.22 -53.25 2.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.843 . . . . 0.0 109.154 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.7 t -55.56 -37.87 68.58 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.259 -0.901 . . . . 0.0 109.232 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 74' ' ' THR . 59.0 p -59.86 -39.92 86.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.264 -0.898 . . . . 0.0 109.214 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.573 ' O ' ' OG1' ' A' ' 74' ' ' THR . 0.4 OUTLIER -62.37 -51.16 68.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 73' ' ' ILE . 10.7 tp -55.74 -69.72 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.371 -0.831 . . . . 0.0 109.508 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.674 HG23 ' N ' ' A' ' 74' ' ' THR . 14.5 tt -47.53 -50.37 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 109.753 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.674 ' N ' HG23 ' A' ' 73' ' ' ILE . 6.0 p -47.35 -38.08 12.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -88.53 -8.58 54.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 0.0 108.914 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.486 ' N ' ' O ' ' A' ' 73' ' ' ILE . 1.7 t90 -92.12 -11.75 34.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 108.977 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.5 m -117.04 4.22 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -79.33 104.59 10.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 0.0 109.491 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.92 35.38 79.07 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -116.72 -174.68 2.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.8 t -106.16 148.71 27.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.958 . . . . 0.0 109.762 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.4 HD22 HG12 ' A' ' 118' ' ' ILE . 27.3 mt -68.77 -20.65 64.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.163 -0.961 . . . . 0.0 109.244 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.93 -9.04 58.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.374 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -102.17 -43.8 5.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.18 -12.73 56.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.527 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.04 49.8 3.6 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -178.63 -27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -1.12 . . . . 0.0 109.681 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.1 pt -32.16 -31.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.415 -0.803 . . . . 0.0 109.757 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 87' ' ' ALA . 16.6 mtmt 62.42 128.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.336 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.64 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 2.5 p-10 -54.37 -46.93 73.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.925 . . . . 0.0 109.407 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.541 ' C ' ' O ' ' A' ' 90' ' ' ASN . 15.7 m -35.45 -34.61 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.853 . . . . 0.0 109.386 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 90' ' ' ASN . 42.1 tp60 -73.44 -49.85 24.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.4 mt -50.61 -38.1 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.225 -0.922 . . . . 0.0 109.238 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.88 -61.32 2.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -58.64 -10.21 2.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.836 . . . . 0.0 109.722 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -79.58 -67.73 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.16 -0.962 . . . . 0.0 109.495 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.1 mt -85.04 -2.21 57.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 97' ' ' LEU . 14.2 mt-10 44.24 75.06 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.73 143.05 26.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -42.27 157.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.634 2.222 . . . . 0.0 112.306 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' HA ' ' CG2' ' A' ' 104' ' ' VAL . 61.2 Cg_endo -77.29 1.38 8.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.708 2.272 . . . . 0.0 112.167 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.5 t -87.85 -0.5 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.669 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 mtmt -134.63 35.42 3.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 101' ' ' PRO . 2.4 t -84.12 -40.58 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.554 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 104' ' ' VAL . 16.0 p-80 -40.98 -33.6 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.007 . . . . 0.0 109.342 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.414 ' N ' ' CD2' ' A' ' 105' ' ' HIS . 1.2 m -72.52 -45.93 57.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.258 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.4 t -55.87 -49.97 71.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.293 -0.88 . . . . 0.0 109.047 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.482 ' O ' ' C ' ' A' ' 109' ' ' LEU . 71.5 mt -50.97 -59.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.0 109.174 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.514 ' O ' ' C ' ' A' ' 110' ' ' ALA . 5.1 mp -40.54 -62.09 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.929 . . . . 0.0 109.21 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 113' ' ' ALA . . . -37.55 -65.68 0.3 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.354 -0.842 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.459 ' C ' ' CD ' ' A' ' 111' ' ' GLU . 4.4 tp10 -42.32 -45.51 4.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.213 -0.929 . . . . 0.0 109.354 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -15.18 63.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.177 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 110' ' ' ALA . . . -80.22 -45.16 18.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.316 -0.865 . . . . 0.0 109.506 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -63.7 -40.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.213 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.501 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 20.2 mttt -70.94 -34.63 71.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.197 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.32 -53.12 61.39 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.848 . . . . 0.0 109.519 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.34 84.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.251 -0.906 . . . . 0.0 109.629 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 115' ' ' LYS . 89.0 mt -59.47 -28.75 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.12 -0.988 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.52 -46.93 12.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.738 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.74 -8.88 55.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.908 . . . . 0.0 109.715 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 1.1 t80 -96.54 -43.62 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.518 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.53 ' O ' ' OE1' ' A' ' 128' ' ' GLU . 41.3 tttt -88.38 -5.56 58.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.567 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HA ' ' CG ' ' A' ' 128' ' ' GLU . . . -89.42 -21.09 23.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -95.7 46.72 1.1 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 109.623 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.28 -34.68 1.61 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 103.92 -10.65 52.24 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 129' ' ' HIS . 1.1 tp -115.33 46.75 1.41 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -1.212 . . . . 0.0 109.677 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -63.36 80.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.922 . . . . 0.0 109.41 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.455 ' N ' ' O ' ' A' ' 127' ' ' LEU . 1.4 t60 -87.8 64.83 8.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -88.21 -91.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.928 . . . . 0.0 109.601 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -162.44 84.05 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 109.598 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.0 OUTLIER -92.69 168.64 11.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.898 . . . . 0.0 109.42 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 134' ' ' HIS . 3.8 m-70 -44.74 105.06 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.557 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 134' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.471 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.591 ' SD ' ' O ' ' A' ' 1' ' ' MET . 1.2 tmt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -139.17 52.08 1.77 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.194 -0.941 . . . . 0.0 109.599 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER 42.05 36.9 0.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.628 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.17 169.56 21.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 109.793 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 12.2 mp0 -87.28 102.4 14.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.846 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -78.4 154.1 30.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG22 ' N ' ' A' ' 8' ' ' ILE . 7.8 p -156.36 164.9 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.584 ' N ' HG22 ' A' ' 7' ' ' VAL . 13.9 mt -72.98 109.31 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 21.6 p-10 -103.95 84.62 2.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -88.8 122.87 32.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.498 ' O ' ' C ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -82.65 3.41 29.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' TYR . 5.6 mm-40 -38.36 114.49 0.37 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.31 -0.869 . . . . 0.0 109.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.34 71.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.008 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -46.94 157.65 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 123.108 2.538 . . . . 0.0 112.583 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.559 ' O ' HG22 ' A' ' 17' ' ' VAL . 20.2 mtt180 -148.1 -134.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.18 58.74 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 109.013 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER -80.51 90.85 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 19' ' ' SER . . . -64.8 179.11 8.28 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.515 ' O ' ' O ' ' A' ' 18' ' ' GLY . 70.9 m -54.52 -162.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -1.221 . . . . 0.0 109.437 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mt -132.34 -74.55 0.51 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.676 ' O ' ' N ' ' A' ' 23' ' ' LYS . 40.7 m-20 -112.52 24.08 12.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.278 -0.889 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER 43.23 13.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.345 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.676 ' N ' ' O ' ' A' ' 21' ' ' ASP . 6.8 mttt -149.35 17.04 0.93 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.257 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.645 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -79.75 153.87 28.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.495 ' O ' ' CZ ' ' A' ' 121' ' ' TYR . 1.9 p -75.67 -7.64 54.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.487 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.645 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -95.99 8.7 42.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.584 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 46' ' ' LYS . 61.2 t -140.87 110.22 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.706 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.01 152.33 18.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.759 HG23 ' NE2' ' A' ' 44' ' ' GLN . 27.3 m -122.7 154.5 38.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.728 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.95 130.01 3.46 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.443 ' O ' HG13 ' A' ' 32' ' ' VAL . 9.0 ttt -127.08 135.49 50.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -1.219 . . . . 0.0 109.947 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 31' ' ' MET . 10.9 m -154.76 146.59 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.388 -0.82 . . . . 0.0 109.208 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.9 172.26 22.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 105' ' ' HIS . . . -141.79 138.77 17.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.302 -1.116 . . . . 0.0 109.198 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.62 -51.57 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.473 2.115 . . . . 0.0 112.172 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.56 -40.99 13.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.49 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 34.1 m -100.61 -0.15 38.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 39.25 47.99 2.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -130.14 148.28 51.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -1.119 . . . . 0.0 109.708 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -117.79 110.54 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.189 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 109' ' ' LEU . 9.4 ttt -104.07 141.5 36.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 0.0 109.709 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -123.08 129.68 51.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.87 . . . . 0.0 109.156 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 tp -126.42 125.38 42.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.667 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.759 ' NE2' HG23 ' A' ' 29' ' ' THR . 2.2 mt-30 -121.01 161.29 21.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 0.0 109.117 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.31 145.42 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 109.914 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HG3' HG22 ' A' ' 27' ' ' VAL . 13.2 tttt -119.64 123.77 44.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.421 -0.799 . . . . 0.0 109.093 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.74 134.99 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.178 -0.951 . . . . 0.0 109.585 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.681 ' O ' ' N ' ' A' ' 50' ' ' ASN . 1.2 m-20 -170.67 -31.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.898 . . . . 0.0 109.723 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 50' ' ' ASN . 0.8 OUTLIER -62.94 45.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 0.0 109.398 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.681 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 m-20 78.88 41.73 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.24 4.12 74.7 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 53' ' ' ILE . 20.3 mm -100.61 165.36 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -1.167 . . . . 0.0 109.603 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.567 ' N ' HG22 ' A' ' 52' ' ' ILE . 68.6 mt -79.02 88.47 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.919 . . . . 0.0 109.39 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.45 -54.19 49.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.66 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 11.1 t70 -146.61 163.78 34.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.11 144.94 31.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.23 169.46 9.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.194 -0.942 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.755 ' CG ' HG21 ' A' ' 74' ' ' THR . 2.6 p90 -168.28 162.93 12.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.6 119.31 1.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.41 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 60' ' ' THR . 5.5 t -161.01 124.86 3.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 0.0 109.43 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -148.4 97.61 2.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 163.27 -2.44 0.06 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.31 -177.54 5.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -1.182 . . . . 0.0 109.647 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.39 -14.26 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 m -137.26 -3.25 1.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -1.166 . . . . 0.0 109.655 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -85.74 -44.35 12.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.524 ' C ' ' O ' ' A' ' 66' ' ' ALA . 1.2 tp -34.36 -29.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.815 . . . . 0.0 109.828 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -91.35 -41.52 10.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -0.969 . . . . 0.0 109.962 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.646 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -69.17 -31.31 69.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.112 -0.992 . . . . 0.0 109.746 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' HG21 ' A' ' 60' ' ' THR . 9.4 m -57.92 -40.53 80.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.2 -0.937 . . . . 0.0 109.534 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 p -74.3 -41.54 61.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.559 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.9 tp -56.07 -59.06 5.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.232 -0.918 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.908 HG23 ' H ' ' A' ' 74' ' ' THR . 8.7 tt -55.18 -63.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.41 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.908 ' H ' HG23 ' A' ' 73' ' ' ILE . 6.0 p -43.26 -25.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' ILE . 24.2 mt-10 -91.9 -12.93 32.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.613 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.619 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.4 m0 -101.14 -13.19 18.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.711 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.521 ' O ' HG21 ' A' ' 53' ' ' ILE . 35.3 m -111.47 34.8 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.067 -1.021 . . . . 0.0 109.694 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.66 ' NZ ' ' OD2' ' A' ' 55' ' ' ASP . 14.4 ttmm -120.25 89.65 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.386 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.02 -7.43 23.48 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -91.73 -174.67 3.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.269 -1.136 . . . . 0.0 109.452 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.09 154.14 20.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.577 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -63.39 -17.25 62.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.257 -0.902 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.53 -40.9 76.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.904 . . . . 0.0 109.67 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.24 -39.74 53.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.83 82.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.97 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.03 54.82 4.3 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -172.3 -32.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.318 -1.107 . . . . 0.0 109.115 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.445 ' C ' ' O ' ' A' ' 87' ' ' ALA . 6.4 pt -42.32 -28.75 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.518 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 87' ' ' ALA . 3.2 tttt 65.46 145.07 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.626 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -71.61 -6.7 42.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.605 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 p -73.61 -30.36 62.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -65.5 -39.05 91.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.494 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mt -81.19 -33.74 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 109.397 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.35 72.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.932 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.67 -46.17 14.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -49.77 -36.96 27.9 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.514 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.43 -27.86 12.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.461 ' C ' HD23 ' A' ' 99' ' ' LEU . 8.9 tt0 63.57 74.51 0.42 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.154 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.839 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -97.24 159.96 30.06 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -73.99 160.21 43.41 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.876 2.384 . . . . 0.0 112.262 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -76.12 -14.33 18.82 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.818 2.346 . . . . 0.0 112.279 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.06 -1.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -0.89 . . . . 0.0 109.612 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -146.99 36.68 0.94 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.524 ' O ' ' C ' ' A' ' 105' ' ' HIS . 41.3 t -52.45 -33.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.314 -0.866 . . . . 0.0 109.547 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.729 ' ND1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -36.07 -58.34 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.484 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.659 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 56.8 m -32.63 -62.5 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 0.0 110.072 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.72 -44.04 81.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.487 ' O ' ' C ' ' A' ' 109' ' ' LEU . 72.3 mt -58.57 -63.56 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.726 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.729 HD13 ' ND1' ' A' ' 105' ' ' HIS . 1.1 mp -39.09 -41.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.88 -56.95 15.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.617 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 112' ' ' ASP . 3.5 tm-20 -66.39 -68.85 0.34 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.33 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.512 ' C ' ' O ' ' A' ' 111' ' ' GLU . 2.4 t0 -37.52 -33.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.494 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 109' ' ' LEU . . . -65.29 -52.61 53.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.445 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 111' ' ' GLU . 4.4 tp -51.99 -35.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.933 . . . . 0.0 109.176 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 32.4 tttt -74.44 -48.24 28.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.77 -54.53 18.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.279 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.469 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -54.41 -61.11 2.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.331 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ALA . 64.2 mt -39.17 -46.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.261 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.81 65.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -57.04 -18.45 14.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.363 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.495 ' CZ ' ' O ' ' A' ' 25' ' ' SER . 20.6 t80 -77.33 -49.76 14.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.904 . . . . 0.0 109.386 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 124' ' ' LYS . 1.3 mptm? -71.88 -47.95 49.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 0.0 109.372 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.06 -14.23 0.22 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.486 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -100.23 -10.19 21.62 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.483 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -109.67 -17.26 13.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.444 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -108.88 -71.05 0.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.522 ' O ' ' O ' ' A' ' 128' ' ' GLU . 6.4 tp -45.99 -39.6 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -1.125 . . . . 0.0 109.438 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 129' ' ' HIS . 0.5 OUTLIER 58.07 125.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.511 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.586 ' N ' ' OE1' ' A' ' 128' ' ' GLU . 35.7 m-70 -86.79 -151.12 0.16 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 109.524 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.51 ' CG ' ' O ' ' A' ' 130' ' ' HIS . 12.2 t-160 -97.74 67.53 2.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.509 ' ND1' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -97.63 36.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.458 ' O ' ' CG ' ' A' ' 133' ' ' HIS . 18.3 t-80 -85.05 111.27 19.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 132' ' ' HIS . 90.3 m-70 -156.93 -98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.51 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.536 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.0 -33.57 76.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.217 -0.927 . . . . 0.0 109.435 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -80.18 -78.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.307 -0.871 . . . . 0.0 109.439 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 3' ' ' TYR . 6.4 t 36.6 44.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -82.65 -95.37 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -120.89 23.22 10.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.341 -0.85 . . . . 0.0 109.301 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t 47.83 78.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.2 pt -45.6 139.91 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.22 153.04 4.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.662 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -67.19 -99.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.531 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.494 ' H ' ' CG ' ' A' ' 10' ' ' HIS . 0.7 OUTLIER -67.76 -173.01 0.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.72 -3.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.524 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.453 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 10.6 m120 -128.15 55.2 15.73 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.523 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 37.9 Cg_endo -69.95 117.83 5.33 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.818 2.345 . . . . 0.0 112.041 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.679 ' O ' ' N ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -126.58 -42.0 1.83 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.18 -0.95 . . . . 0.0 109.58 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -62.07 57.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.679 ' N ' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -137.03 154.39 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.607 ' O ' ' CB ' ' A' ' 19' ' ' SER . . . 113.67 62.46 0.42 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.607 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 2.8 p 83.17 110.55 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -1.139 . . . . 0.0 109.472 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.408 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -79.5 -65.98 0.93 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 109.472 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 22' ' ' LYS . 8.4 t70 -145.09 174.0 11.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 6.0 mttp -88.84 5.06 45.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.937 . . . . 0.0 109.414 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -117.99 30.55 7.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.734 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.38 132.82 54.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.28 3.07 5.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.658 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.19 14.95 18.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.195 -0.94 . . . . 0.0 109.534 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.86 108.7 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.951 . . . . 0.0 109.632 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -111.49 148.28 17.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.7 m -139.16 145.96 40.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.563 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.39 120.19 1.73 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 13.9 mtp -118.49 137.75 52.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -1.183 . . . . 0.0 109.586 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.65 163.11 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -143.88 143.8 12.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -127.39 131.79 24.01 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -73.56 -57.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.537 2.158 . . . . 0.0 112.477 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.49 -31.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 109.673 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.566 ' N ' ' O ' ' A' ' 35' ' ' PRO . 38.1 m -118.39 1.41 11.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.587 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 39.25 55.56 2.44 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -136.39 163.29 30.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -1.1 . . . . 0.0 109.251 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 79.4 t -127.22 129.05 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.714 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.9 ttt -112.41 119.93 39.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 109.323 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -109.43 119.92 40.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.421 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.09 130.4 54.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -125.2 148.04 48.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.194 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.489 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.0 pt -122.5 146.53 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -110.4 101.77 10.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -0.828 . . . . 0.0 109.267 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG21 ' CD2' ' A' ' 121' ' ' TYR . 21.7 t -80.48 129.71 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.641 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.544 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 6.5 t0 -64.73 -60.1 3.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 109.387 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.544 ' CG ' ' O ' ' A' ' 48' ' ' ASP . 6.0 m-20 166.44 -25.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.796 . . . . 0.0 109.167 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.0 -12.86 27.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.815 . . . . 0.0 109.328 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.84 20.0 5.46 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mm -109.88 132.63 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -1.133 . . . . 0.0 109.437 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.1 mt -71.76 87.7 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.93 . . . . 0.0 109.399 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -53.29 -42.64 66.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.89 -178.74 7.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.113 -0.992 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.34 113.29 3.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.576 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -94.02 126.15 39.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.095 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.681 ' CD1' HG21 ' A' ' 74' ' ' THR . 37.3 p90 -114.72 170.04 8.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.849 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -170.35 97.62 0.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.356 -0.84 . . . . 0.0 109.141 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -137.38 133.9 35.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.83 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -151.24 144.55 24.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.307 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.05 -39.25 2.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -85.67 91.96 8.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -1.138 . . . . 0.0 109.278 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.92 52.03 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -151.12 -22.35 0.21 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -1.15 . . . . 0.0 109.316 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' ALA . . . -97.24 -11.28 24.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ALA . 3.1 mm -40.47 -27.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.435 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -97.42 -32.36 11.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.308 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.8 t -66.5 -54.05 28.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.36 -0.838 . . . . 0.0 109.385 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 74' ' ' THR . 0.7 OUTLIER -37.31 -51.64 1.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.517 ' O ' ' OG1' ' A' ' 74' ' ' THR . 9.2 t -62.06 -52.72 62.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 73' ' ' ILE . 43.6 tp -46.66 -76.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.922 HG23 ' H ' ' A' ' 74' ' ' THR . 10.7 tt -43.69 -64.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.819 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.922 ' H ' HG23 ' A' ' 73' ' ' ILE . 16.6 p -35.18 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 109.604 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 73' ' ' ILE . 3.4 mt-10 -83.93 -32.61 25.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.647 ' N ' ' O ' ' A' ' 73' ' ' ILE . 2.8 m95 -82.27 -2.64 53.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.598 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 77' ' ' VAL . 11.7 m -130.16 53.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.191 -0.943 . . . . 0.0 109.742 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -139.19 85.4 2.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.539 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 102.1 8.05 45.47 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 mmtt -90.67 -171.36 3.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -1.149 . . . . 0.0 109.625 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.09 154.76 18.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.94 -24.99 66.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.41 -28.44 66.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.36 -53.65 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.97 -25.84 22.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 109.128 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.73 40.87 2.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -151.01 -37.93 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -1.113 . . . . 0.0 108.81 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 87' ' ' ALA . 3.6 pt -41.09 159.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.519 -0.738 . . . . 0.0 109.296 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.06 162.26 30.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.526 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -69.22 -25.2 64.19 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.422 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -66.21 -67.57 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -0.847 . . . . 0.0 109.591 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.476 ' C ' ' O ' ' A' ' 91' ' ' SER . 13.2 mm-40 -39.3 -60.63 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.649 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 51.8 mt -56.14 -28.68 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.634 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 91' ' ' SER . . . -77.42 -15.22 59.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 109.185 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -94.71 -18.51 21.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.371 -0.83 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -88.66 -38.31 14.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -80.87 -0.8 40.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.553 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.527 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.3 tt0 37.12 25.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 0.0 109.37 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.7 HD23 ' N ' ' A' ' 99' ' ' LEU . 1.3 pt? -63.0 149.35 90.69 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.405 ' HG2' HG12 ' A' ' 102' ' ' VAL . 30.5 Cg_endo -67.17 152.82 79.11 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.685 2.257 . . . . 0.0 111.939 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.1 13.89 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.795 2.33 . . . . 0.0 112.433 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 102' ' ' VAL . 7.3 p -79.02 96.76 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.948 . . . . 0.0 109.394 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 105' ' ' HIS . 7.0 mttm 67.31 58.49 0.54 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.424 -0.797 . . . . 0.0 109.212 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.3 0.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.39 -0.818 . . . . 0.0 109.262 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -53.93 -53.95 45.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.914 . . . . 0.0 109.412 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.637 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 87.6 m -30.96 -58.79 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 110.031 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -58.84 -56.22 25.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.02 -1.05 . . . . 0.0 109.508 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 107' ' ' SER . 44.9 mt -45.29 -51.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.277 -0.89 . . . . 0.0 109.37 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -49.63 -43.17 46.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.483 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.04 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.312 -0.868 . . . . 0.0 109.553 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -52.78 -40.0 62.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -25.45 68.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 114' ' ' ILE . . . -72.11 -62.89 1.27 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.353 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -45.31 -36.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.157 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 11.3 tttt -73.31 -35.8 66.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.368 -0.832 . . . . 0.0 109.512 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.1 -48.88 79.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.642 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.489 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -64.54 -38.07 89.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.953 . . . . 0.0 109.682 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.9 mt -61.2 -38.01 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.575 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.66 81.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.716 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.2 -54.71 13.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 109.795 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.669 ' CD2' HG21 ' A' ' 47' ' ' VAL . 4.0 t80 -53.75 -32.08 50.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.762 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -81.04 -30.71 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.695 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.28 -25.19 63.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.886 . . . . 0.0 109.705 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -94.14 35.94 1.15 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.156 -0.965 . . . . 0.0 109.395 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.9 44.79 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.228 -0.92 . . . . 0.0 109.479 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . -85.69 -95.85 0.77 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.2 mp -64.21 11.87 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.693 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.566 ' H ' ' C ' ' A' ' 126' ' ' GLY . 1.9 mt-10 56.01 176.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.566 ' ND1' ' C ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -154.58 37.72 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.551 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -139.68 -33.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.619 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 133' ' ' HIS . 1.4 t60 48.8 28.25 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -0.964 . . . . 0.0 109.273 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -45.49 -18.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 131' ' ' HIS . 3.3 m-70 -71.13 -168.87 0.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.469 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.7 mpp? . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.23 140.61 49.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 109.43 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -102.57 -128.91 0.23 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -121.55 -25.29 5.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -51.5 172.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.8 tttm 62.85 158.6 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.86 . . . . 0.0 109.591 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 8' ' ' ILE . 10.9 t -135.74 -122.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.479 ' N ' HG12 ' A' ' 7' ' ' VAL . 17.8 mt -150.28 51.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.511 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.639 ' C ' ' CD2' ' A' ' 10' ' ' HIS . 17.4 t0 -133.61 105.29 6.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.287 -0.883 . . . . 0.0 109.618 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.639 ' CD2' ' C ' ' A' ' 9' ' ' ASP . 14.9 m-70 -154.23 -157.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.378 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -80.44 39.08 0.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.2 -0.937 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 49.0 mt-10 -102.24 -80.9 0.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.319 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 2.7 t30 170.23 86.03 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -46.55 133.83 16.56 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.751 2.301 . . . . 0.0 112.043 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.734 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -139.9 129.18 23.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.504 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.99 123.25 18.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 109.45 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.7 m -123.6 138.38 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.513 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.76 -87.41 1.99 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p 58.35 166.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.155 . . . . 0.0 109.46 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 tp 59.0 36.85 24.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.207 -0.933 . . . . 0.0 109.665 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 52.7 t0 -54.13 -23.03 12.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.0 tttp 78.15 -9.48 1.5 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.601 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -140.08 14.1 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.938 . . . . 0.0 109.647 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.11 -159.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.566 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.558 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 63.67 20.42 12.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.274 -0.892 . . . . 0.0 109.278 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.32 38.01 16.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.393 -0.817 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.03 133.28 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.287 -0.883 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -120.39 113.14 2.34 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 m -101.71 157.46 16.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -1.165 . . . . 0.0 109.526 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.31 132.86 3.06 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 10.3 ttp -141.56 123.15 15.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -1.171 . . . . 0.0 109.714 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.8 149.1 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.26 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 39' ' ' ASP . . . -133.06 170.17 22.28 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.63 ' O ' ' N ' ' A' ' 38' ' ' GLY . . . -125.61 146.47 54.91 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.354 -1.086 . . . . 0.0 109.278 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 37' ' ' CYS . 37.1 Cg_endo -69.36 -71.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.668 2.245 . . . . 0.0 112.056 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.59 -14.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.176 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.548 ' N ' ' O ' ' A' ' 35' ' ' PRO . 1.8 t -117.11 -12.17 10.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.396 -0.815 . . . . 0.0 109.324 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . 38.3 33.33 0.17 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' CYS . 39.0 t70 -101.63 148.36 25.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -1.122 . . . . 0.0 109.595 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -121.29 97.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.7 ttt -86.98 119.62 27.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.486 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -109.14 101.43 10.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.422 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.6 tp -106.74 148.48 28.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.488 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.67 132.0 25.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.253 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.738 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.5 pt -111.22 141.98 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -114.25 148.44 37.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.264 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.65 130.09 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.622 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.8 t0 -70.77 -54.56 11.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.268 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 0.9 OUTLIER 160.82 -22.28 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.399 -0.813 . . . . 0.0 109.357 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -94.43 11.05 32.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.543 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.8 30.36 26.67 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 mm -125.07 138.23 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.96 103.09 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.161 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' OD1' ' A' ' 55' ' ' ASP . 0.9 OUTLIER -75.43 -42.5 53.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.806 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 54' ' ' GLU . 86.3 m-20 -143.29 157.93 44.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.763 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.98 137.23 25.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.401 -0.812 . . . . 0.0 109.328 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -105.53 141.56 36.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.741 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -124.62 163.21 22.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.61 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -171.85 109.01 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 t -161.05 119.63 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.163 -0.961 . . . . 0.0 109.597 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -149.56 103.58 3.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.91 -20.01 0.03 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 36.4 t -126.74 116.45 20.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -1.178 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 66' ' ' ALA . . . -57.17 172.71 2.39 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.649 ' O ' ' N ' ' A' ' 67' ' ' ILE . 0.4 OUTLIER 64.63 -69.79 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.205 -1.173 . . . . 0.0 109.538 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 68' ' ' ALA . . . -38.37 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.581 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.649 ' N ' ' O ' ' A' ' 65' ' ' SER . 1.6 mt -58.65 2.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' H ' ' C ' ' A' ' 66' ' ' ALA . . . -106.67 -32.31 8.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.448 ' O ' HG22 ' A' ' 73' ' ' ILE . 17.9 p -58.79 -45.62 89.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.458 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 71' ' ' SER . 35.0 p -53.73 -64.39 0.84 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 109.675 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 70' ' ' SER . 31.9 m -42.32 -45.64 4.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.914 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 75' ' ' GLU . 56.5 tp -65.41 -84.49 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.199 -0.938 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.704 HG23 ' N ' ' A' ' 74' ' ' THR . 9.0 tt -33.68 -52.62 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.704 ' N ' HG23 ' A' ' 73' ' ' ILE . 29.8 p -53.17 -44.21 67.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 72' ' ' LEU . 11.0 tm-20 -78.93 2.18 21.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.238 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -106.7 -17.97 14.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.87 . . . . 0.0 109.636 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 114' ' ' ILE . 14.3 m -98.0 -28.17 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.509 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.37 128.3 35.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -0.894 . . . . 0.0 109.336 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.11 -20.58 28.63 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -91.51 164.53 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.287 -1.125 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -175.4 3.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.827 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.02 -27.24 60.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -62.35 -20.59 64.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.004 . . . . 0.0 109.159 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.75 -41.67 8.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.28 -0.887 . . . . 0.0 109.314 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.61 8.92 15.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.62 -57.69 0.65 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.41 -4.38 29.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.252 -1.146 . . . . 0.0 108.816 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.95 168.71 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.499 -0.751 . . . . 0.0 109.65 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.423 ' O ' HD12 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -153.67 -175.15 5.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -94.98 -6.55 42.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.197 -0.94 . . . . 0.0 109.281 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.77 -44.16 56.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.307 -0.871 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -66.61 -59.88 3.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.857 . . . . 0.0 109.327 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 89' ' ' LYS . 3.8 mt -47.24 -41.28 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.35 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.612 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -68.04 -46.69 70.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -54.21 -25.77 24.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -81.49 -52.23 7.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.875 . . . . 0.0 109.566 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.635 ' O ' ' N ' ' A' ' 99' ' ' LEU . 12.8 mt -81.88 -15.87 52.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.499 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 94' ' ' ALA . 4.5 mm-40 43.36 14.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.843 HD23 ' N ' ' A' ' 99' ' ' LEU . 1.6 pt? -39.96 150.0 0.27 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -41.52 162.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.811 2.341 . . . . 0.0 112.097 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 103' ' ' LYS . 58.0 Cg_endo -76.42 -49.56 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.865 2.376 . . . . 0.0 112.469 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 17.4 m -72.84 27.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.667 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' ND1' ' A' ' 105' ' ' HIS . 37.3 mttt -143.45 6.99 1.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.902 . . . . 0.0 109.542 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 105' ' ' HIS . 10.2 p -68.92 -11.44 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -0.961 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.614 ' ND1' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -44.02 -57.38 3.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.512 ' H ' ' CG ' ' A' ' 105' ' ' HIS . 55.1 m -56.13 -35.1 66.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.181 -0.949 . . . . 0.0 109.374 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -51.25 70.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.231 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.549 HG22 ' OD2' ' A' ' 112' ' ' ASP . 61.0 mt -59.16 -36.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.297 -0.877 . . . . 0.0 109.195 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.629 ' CD1' ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -59.85 -37.72 80.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.229 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -63.83 -51.21 65.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.326 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -63.24 -53.64 49.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' HG22 ' A' ' 108' ' ' ILE . 2.6 m-20 -48.84 -40.99 31.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.174 -0.954 . . . . 0.0 109.414 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.37 13.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.139 -0.975 . . . . 0.0 109.31 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 77' ' ' VAL . 1.4 tp -46.86 -33.68 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.266 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' C ' ' A' ' 116' ' ' ALA . 10.6 ttmm -67.38 -71.36 0.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.447 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . -38.43 -44.96 0.97 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.738 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -53.31 -54.41 36.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.8 mt -54.54 -34.68 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.544 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.98 -56.92 8.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.48 -25.18 35.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.32 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -80.43 -69.42 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.45 -24.17 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.197 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.92 -11.16 16.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.292 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.23 -24.93 3.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.28 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.633 HE21 HD12 ' A' ' 127' ' ' LEU . 31.1 tt0 -170.21 83.81 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 0.0 109.341 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 127' ' ' LEU . . . -66.4 19.15 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD12 HE21 ' A' ' 125' ' ' GLN . 1.1 mp 68.57 23.79 7.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -1.212 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.592 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 28.3 tp10 -142.25 -107.22 0.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.621 ' O ' ' ND1' ' A' ' 130' ' ' HIS . 1.5 t-160 82.36 87.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.343 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.621 ' ND1' ' O ' ' A' ' 129' ' ' HIS . 1.3 m80 -161.63 10.68 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.129 -0.982 . . . . 0.0 109.797 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 41.6 t60 58.63 35.36 24.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 133' ' ' HIS . 15.0 t-80 -117.27 124.24 48.54 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.671 ' O ' ' CE1' ' A' ' 132' ' ' HIS . 0.7 OUTLIER -78.73 140.51 38.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.507 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.551 ' OXT' ' CG ' ' A' ' 134' ' ' HIS . 86.4 t60 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.531 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' O ' ' C ' ' A' ' 2' ' ' ALA . 42.9 mmm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 1' ' ' MET . . . 44.45 32.17 0.69 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 4' ' ' SER . 66.5 t80 -156.8 143.62 18.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.412 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -56.32 163.99 1.49 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.563 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -127.03 160.55 30.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.252 -0.905 . . . . 0.0 109.271 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -177.09 136.92 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.935 . . . . 0.0 109.706 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.9 p -171.63 -21.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.325 -0.859 . . . . 0.0 109.31 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.2 mt -45.46 131.01 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.841 . . . . 0.0 109.565 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -88.21 98.33 11.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.895 . . . . 0.0 109.188 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.447 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 32.7 t-80 -80.69 -17.59 50.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.18 -0.95 . . . . 0.0 109.565 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -72.17 -131.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.495 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -92.84 143.14 26.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.17 -0.956 . . . . 0.0 109.435 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.555 ' C ' HD22 ' A' ' 13' ' ' ASN . 0.2 OUTLIER -133.68 71.17 75.27 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 15' ' ' ARG . 46.9 Cg_endo -73.09 97.78 0.95 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.843 2.362 . . . . 0.0 112.179 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.541 ' C ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -35.77 144.5 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -133.38 119.61 19.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 16' ' ' ASN . 1.0 OUTLIER -42.36 -62.66 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.596 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.44 4.55 73.49 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.92 135.5 52.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.352 -1.087 . . . . 0.0 109.511 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.6 mt -123.74 -57.24 1.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.123 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 23' ' ' LYS . 18.7 m-20 -128.55 8.42 5.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.373 -0.829 . . . . 0.0 109.142 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 49.4 13.38 0.08 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.329 -0.857 . . . . 0.0 109.323 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 21' ' ' ASP . 11.2 tttm -148.69 13.28 0.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.389 -0.819 . . . . 0.0 109.157 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.596 ' OD2' ' N ' ' A' ' 26' ' ' ASN . 1.1 t70 -61.89 170.55 2.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.696 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.57 ' N ' ' CG ' ' A' ' 24' ' ' ASP . 92.6 p -75.83 -11.29 59.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.596 ' N ' ' OD2' ' A' ' 24' ' ' ASP . 32.9 m120 -116.44 25.09 10.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.89 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.3 t -147.37 107.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.384 -0.822 . . . . 0.0 109.222 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.25 143.83 17.59 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.8 m -120.27 132.58 55.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.358 -1.083 . . . . 0.0 109.186 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.08 123.03 4.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttt -125.15 115.91 21.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.356 -1.085 . . . . 0.0 109.117 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.4 166.28 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.82 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -153.77 165.31 31.53 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.591 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -141.1 152.74 65.71 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.237 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.458 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.4 Cg_endo -77.09 -64.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.709 2.273 . . . . 0.0 112.31 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -41.17 -45.76 2.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -94.65 -4.82 46.94 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 0.0 109.232 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 36.0 41.37 0.45 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' CYS . 10.0 t70 -115.47 155.63 27.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -1.122 . . . . 0.0 109.761 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.61 105.68 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.18 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.471 ' HG3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -89.53 143.95 26.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.833 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 41' ' ' MET . 5.4 tt0 -129.23 110.04 11.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.125 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 44' ' ' GLN . 5.8 tt -121.97 132.34 54.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.671 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.492 ' N ' HD23 ' A' ' 43' ' ' LEU . 8.3 mp0 -124.04 177.96 5.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.327 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 44' ' ' GLN . 6.6 pt -154.86 151.29 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.617 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -114.64 163.6 15.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.348 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 4.9 t -132.5 107.56 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.145 -0.972 . . . . 0.0 109.545 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -52.71 -65.06 0.62 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' C ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 169.91 -24.95 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 0.0 109.199 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.667 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -92.56 16.4 12.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.377 -0.827 . . . . 0.0 109.35 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.37 22.42 60.57 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.2 mm -113.52 147.81 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.503 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.3 mt -82.35 112.99 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -86.9 -36.42 18.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.759 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.96 165.44 24.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.965 . . . . 0.0 109.7 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.08 120.28 4.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.352 -0.842 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -108.02 159.1 16.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.597 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.61 ' CD2' HG21 ' A' ' 74' ' ' THR . 2.8 p90 -163.34 162.16 24.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.876 . . . . 0.0 109.423 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -171.44 119.47 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.342 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 41' ' ' MET . 17.0 p -116.66 102.39 9.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 0.0 109.531 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -109.54 113.49 26.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.356 -0.84 . . . . 0.0 109.37 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.79 -39.5 1.96 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.56 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 1.2 m -79.05 152.14 31.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.227 -1.161 . . . . 0.0 109.574 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.47 38.6 2.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.428 ' H ' ' H ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -167.66 -9.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -1.137 . . . . 0.0 109.429 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -86.44 -36.71 18.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.42 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.541 ' C ' ' O ' ' A' ' 66' ' ' ALA . 4.9 mt -36.03 -48.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.74 -54.69 30.34 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 73' ' ' ILE . 97.1 p -62.0 -49.04 77.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.362 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.771 ' O ' HG23 ' A' ' 74' ' ' THR . 0.2 OUTLIER -47.38 -46.59 26.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 109.372 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.6 m -61.59 -35.77 78.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.365 -0.834 . . . . 0.0 109.229 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' CD1' ' OE1' ' A' ' 96' ' ' GLU . 0.6 OUTLIER -69.26 -68.66 0.39 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 69' ' ' SER . 5.9 tt -48.46 -47.57 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.591 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 70' ' ' SER . 23.1 p -49.24 -45.43 44.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -86.15 0.41 53.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.792 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.84 -17.51 17.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.66 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 114' ' ' ILE . 17.8 m -111.75 10.76 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 109.569 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -85.56 103.48 14.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.1 20.99 40.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -97.34 -171.09 2.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -1.128 . . . . 0.0 109.468 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -112.74 139.72 48.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.391 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.0 mt -53.09 -28.72 26.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.259 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.02 -30.09 68.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -88.02 -57.66 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.272 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.35 -17.6 3.19 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.198 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.45 49.5 0.86 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -172.69 -31.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -1.096 . . . . 0.0 109.324 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -50.6 178.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -137.1 -168.28 2.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.332 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.429 ' ND2' ' C ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -103.5 -30.78 10.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.322 179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.8 m -51.82 -33.69 36.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 93' ' ' ILE . 2.0 mt-30 -69.48 -66.77 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 92' ' ' GLN . 1.8 mt -44.5 -40.8 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.64 -49.63 61.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.205 -0.934 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -54.93 -24.41 23.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.532 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' OE1' ' CD1' ' A' ' 72' ' ' LEU . 3.5 tt0 -82.11 -33.19 29.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.94 -15.07 35.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.234 -0.916 . . . . 0.0 109.522 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 48.62 73.41 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -0.928 . . . . 0.0 109.236 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.027 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -129.2 139.77 36.65 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.059 -1.026 . . . . 0.0 109.495 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -42.5 146.88 0.65 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.49 2.127 . . . . 0.0 112.243 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.55 -20.97 22.88 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.667 2.245 . . . . 0.0 112.126 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.88 -4.68 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.444 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -135.93 16.4 3.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.853 . . . . 0.0 109.568 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.525 ' O ' ' C ' ' A' ' 105' ' ' HIS . 8.4 p -60.68 -14.96 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.755 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.1 OUTLIER -33.95 -77.76 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.357 -0.84 . . . . 0.0 109.707 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.755 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 77.0 m -31.26 -58.88 0.24 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.539 -0.726 . . . . 0.0 110.121 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -50.39 -64.27 0.86 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.135 -0.978 . . . . 0.0 109.62 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 5.6 mt -42.27 -42.61 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.588 HD22 ' HE1' ' A' ' 105' ' ' HIS . 0.6 OUTLIER -64.82 -32.98 74.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.351 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 107' ' ' SER . . . -59.71 -48.29 82.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.203 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.529 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 6.3 tp10 -68.91 -51.91 34.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 0.0 109.371 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -53.85 -28.78 38.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.12 -60.73 2.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.34 -0.85 . . . . 0.0 109.455 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -48.26 -33.85 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -76.41 -28.58 56.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.47 -56.8 8.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.948 . . . . 0.0 109.353 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.35 -52.79 63.91 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.368 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.3 mt -48.77 -38.84 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.199 -0.938 . . . . 0.0 109.398 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.5 -32.92 66.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 0.0 109.366 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -77.2 -7.76 56.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -106.52 -38.58 6.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.228 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -71.88 -35.62 69.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.55 -22.26 62.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 109.532 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -84.08 42.12 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.925 . . . . 0.0 109.389 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -106.52 -54.06 2.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.38 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.49 -96.02 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' HA ' HD12 ' A' ' 127' ' ' LEU . 1.1 mp -114.13 23.77 12.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.317 -1.108 . . . . 0.0 109.35 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 129' ' ' HIS . 22.9 mt-10 56.16 -124.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.486 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 128' ' ' GLU . 0.1 OUTLIER -179.43 149.91 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -0.902 . . . . 0.0 109.518 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -145.78 -75.97 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.325 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -129.77 -162.0 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.379 -0.826 . . . . 0.0 109.246 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -141.52 175.86 9.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.389 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.57 ' ND1' ' N ' ' A' ' 133' ' ' HIS . 1.0 OUTLIER -90.66 -112.31 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.203 -0.936 . . . . 0.0 109.43 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.173 -0.954 . . . . 0.0 109.543 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 mtm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.07 169.96 16.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -111.6 -26.66 8.91 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.07 156.23 16.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.95 -31.0 1.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -46.35 126.25 7.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.878 . . . . 0.0 109.58 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.7 m -69.99 -162.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 mt -111.49 -87.08 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.0 109.625 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' O ' ' O ' ' A' ' 10' ' ' HIS . 19.6 p-10 -112.97 89.22 3.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.595 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.543 ' O ' ' O ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -52.59 -166.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.243 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 11' ' ' TYR . 1.4 p90 -100.57 10.23 41.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.445 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -54.34 -92.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 109.242 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -158.7 68.05 3.41 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -59.24 141.19 97.56 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.926 2.417 . . . . 0.0 112.178 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.733 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -111.6 118.47 35.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -100.23 124.91 46.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.87 163.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.418 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 19' ' ' SER . . . -69.56 -72.37 0.87 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.524 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER 58.45 129.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -1.08 . . . . 0.0 109.618 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 tp 55.69 30.57 15.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 12.3 t70 -102.64 -5.55 23.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.9 tttp 72.03 -5.85 1.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.546 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -118.28 18.16 13.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.928 . . . . 0.0 109.744 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -102.59 138.74 39.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 109.457 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 m -72.7 10.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.778 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -111.2 20.56 17.24 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 27' ' ' VAL . 45.1 t -137.7 90.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.639 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.43 145.95 48.5 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.4 m -135.27 108.86 7.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.289 -1.124 . . . . 0.0 109.551 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 117' ' ' ALA . . . -105.82 150.29 16.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 ttm -144.45 127.18 16.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.357 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.28 161.38 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.48 164.86 18.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.236 -1.545 . . . . 0.0 109.236 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.82 ' HB2' HD22 ' A' ' 109' ' ' LEU . . . -136.89 85.69 22.82 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.149 -1.206 . . . . 0.0 109.854 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.08 -20.3 3.09 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.712 2.275 . . . . 0.0 111.94 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.42 -53.51 23.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.174 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.506 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.5 OUTLIER -103.84 17.84 23.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.198 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.86 55.08 1.85 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 61' ' ' TYR . 40.6 t0 -126.65 146.37 50.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -1.163 . . . . 0.0 109.713 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.36 113.08 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 0.0 109.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.1 ttt -99.86 134.3 42.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.37 128.97 46.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 108.96 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -129.58 142.85 50.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.217 -0.927 . . . . 0.0 109.728 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.22 150.33 47.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.853 . . . . 0.0 109.145 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.05 148.3 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.943 . . . . 0.0 109.705 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -114.74 120.93 41.72 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.333 -0.855 . . . . 0.0 109.339 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 t -103.96 127.04 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.609 ' CG ' ' N ' ' A' ' 49' ' ' ASP . 2.9 t0 -62.89 -94.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.609 ' N ' ' CG ' ' A' ' 48' ' ' ASP . 4.8 t70 -154.22 24.43 0.48 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 14.71 1.72 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.347 -0.846 . . . . 0.0 109.394 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.36 25.24 57.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 mm -108.69 130.56 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.582 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -88.45 102.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.195 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.38 -46.64 14.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.828 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.58 141.97 51.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.715 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -130.22 129.15 42.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.467 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -101.22 164.01 12.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.519 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' CD1' HG21 ' A' ' 74' ' ' THR . 30.2 p90 -156.8 162.73 39.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.574 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.22 98.53 0.83 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.359 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.75 138.44 32.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 0.7 OUTLIER -157.04 123.84 5.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -0.92 . . . . 0.0 109.319 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.05 -61.71 0.36 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 2.6 t -84.21 134.39 34.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -1.144 . . . . 0.0 109.712 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.39 20.0 6.43 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -27.75 6.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -1.129 . . . . 0.0 109.361 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.27 7.85 45.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 mm -77.9 -40.34 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.365 -0.835 . . . . 0.0 109.492 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.88 -45.25 17.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.837 . . . . 0.0 109.656 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.559 ' O ' HG22 ' A' ' 73' ' ' ILE . 75.2 m -53.15 -49.34 66.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.562 ' OG ' ' N ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -34.35 -66.83 0.15 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 109.841 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.562 ' N ' ' OG ' ' A' ' 70' ' ' SER . 66.1 m -55.44 -40.44 71.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.915 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' C ' ' A' ' 73' ' ' ILE . 4.4 tp -60.2 -83.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.933 . . . . 0.0 109.843 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.836 HG23 ' H ' ' A' ' 74' ' ' THR . 5.6 tt -36.44 -62.3 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.958 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.836 ' H ' HG23 ' A' ' 73' ' ' ILE . 56.8 p -40.34 -39.04 0.89 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -0.954 . . . . 0.0 110.067 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.1 mm-40 -86.07 -15.39 41.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.552 ' N ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -90.57 -5.43 55.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 109.688 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.32 20.75 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.104 -0.998 . . . . 0.0 109.607 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -96.53 87.97 4.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.428 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 126.66 -3.82 7.56 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -89.16 167.71 12.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -1.127 . . . . 0.0 109.392 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.55 176.05 5.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.549 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.86 -21.34 66.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.575 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -70.55 -40.93 73.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -79.63 -51.01 9.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.706 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.51 63.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.167 -0.958 . . . . 0.0 109.408 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.95 26.0 25.21 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.8 18.59 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 109.202 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.467 HD11 HG12 ' A' ' 114' ' ' ILE . 0.8 OUTLIER -79.95 171.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.372 -0.83 . . . . 0.0 109.414 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -136.19 140.57 43.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 108' ' ' ILE . 11.4 p30 -68.36 -23.1 64.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.2 m -56.24 -36.35 68.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -59.01 2.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.253 -0.904 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mt -46.77 -40.45 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -73.73 -42.6 60.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 0.0 109.836 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.567 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 2.6 tm-20 -57.6 -30.35 65.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.164 -0.96 . . . . 0.0 109.887 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -80.03 -39.44 29.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.003 . . . . 0.0 109.716 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.468 ' O ' ' C ' ' A' ' 98' ' ' GLU . 1.0 OUTLIER -95.35 -5.04 44.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 0.0 109.698 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 94' ' ' ALA . 17.6 tp10 41.17 44.68 2.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.479 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.23 151.26 87.89 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 109.641 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -41.03 109.41 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.954 2.436 . . . . 0.0 112.462 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' A' ' 103' ' ' LYS . 65.3 Cg_endo -79.79 -79.94 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.699 2.266 . . . . 0.0 112.129 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.518 HG23 ' C ' ' A' ' 101' ' ' PRO . 0.4 OUTLIER 53.65 -76.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.314 -0.866 . . . . 0.0 109.669 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.675 ' N ' ' O ' ' A' ' 101' ' ' PRO . 9.3 mtpp -118.3 -6.21 10.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.171 -0.956 . . . . 0.0 109.294 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 108' ' ' ILE . 17.3 t 47.38 60.2 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.358 -0.839 . . . . 0.0 109.56 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 -91.31 -38.75 12.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.918 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' SER . 1.9 m -71.41 -67.68 0.5 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -37.43 -65.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.307 -179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.591 ' N ' ' OG ' ' A' ' 107' ' ' SER . 3.3 mt -44.71 -43.08 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.248 -0.907 . . . . 0.0 108.93 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.82 HD22 ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -59.95 -37.99 81.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.392 -0.818 . . . . 0.0 109.174 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 113' ' ' ALA . . . -57.79 -55.67 31.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.35 -0.844 . . . . 0.0 109.402 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 114' ' ' ILE . 2.8 tm-20 -57.1 -60.82 3.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.293 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -46.65 -31.43 2.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.121 -0.987 . . . . 0.0 109.031 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 110' ' ' ALA . . . -61.2 -53.24 59.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.364 -0.835 . . . . 0.0 108.98 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 3.4 tp -49.74 -39.93 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 0.0 108.785 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.492 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.6 OUTLIER -73.01 -22.11 60.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.47 -0.769 . . . . 0.0 109.308 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -71.01 -60.93 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.408 ' N ' ' HA3' ' A' ' 30' ' ' GLY . . . -58.62 -34.65 71.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.344 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.23 -43.76 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.899 . . . . 0.0 109.409 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.0 91.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.157 -0.964 . . . . 0.0 109.276 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -67.89 -26.02 65.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -66.37 -65.06 0.73 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -25.37 60.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -57.38 -47.96 80.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.339 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -75.11 15.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.295 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 123' ' ' ALA . 13.8 tt0 -117.2 2.84 12.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.36 -1.13 63.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 56.37 38.63 29.9 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -1.123 . . . . 0.0 109.345 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -116.17 119.13 34.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.633 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -123.47 152.59 41.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.359 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.715 ' HD1' ' C ' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -144.77 -42.45 0.24 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.696 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 130' ' ' HIS . 0.7 OUTLIER -43.32 113.0 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.156 -0.965 . . . . 0.0 109.466 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.561 ' O ' ' ND1' ' A' ' 132' ' ' HIS . 56.2 t-80 -100.94 -0.12 37.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.53 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.412 ' ND1' ' O ' ' A' ' 134' ' ' HIS . 16.7 t-80 -90.21 -47.73 7.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.412 ' O ' ' ND1' ' A' ' 133' ' ' HIS . 3.2 t-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.392 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.3 0.571 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.06 -150.13 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.45 148.07 29.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.314 -0.866 . . . . 0.0 109.305 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -99.27 162.47 13.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.206 -0.934 . . . . 0.0 109.33 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.91 3.45 12.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -122.48 -172.11 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.536 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.535 ' O ' ' C ' ' A' ' 8' ' ' ILE . 1.3 m -124.39 -165.28 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.278 -0.889 . . . . 0.0 109.299 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.535 ' C ' ' O ' ' A' ' 7' ' ' VAL . 12.7 tt -37.62 157.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.177 -0.952 . . . . 0.0 109.234 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' OD1' ' N ' ' A' ' 10' ' ' HIS . 11.8 p30 -133.17 -138.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.608 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 0.3 OUTLIER -98.85 172.28 7.53 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.549 -179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -77.83 12.68 1.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 56.65 -171.7 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.49 65.68 72.4 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 109.422 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -45.96 -61.19 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.916 2.411 . . . . 0.0 112.287 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' ASN . 1.1 tpm_? -84.78 110.93 19.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.454 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 15' ' ' ARG . 1.2 m-20 -43.37 142.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -56.94 157.43 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.637 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.35 -74.98 0.56 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.55 138.69 45.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.651 HD12 ' N ' ' A' ' 20' ' ' LEU . 5.2 mp -92.86 -109.17 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.924 . . . . 0.0 109.713 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -81.28 4.66 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 109.784 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 2.3 tttp 74.61 -13.62 0.79 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 109.416 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.26 39.54 3.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.291 -0.88 . . . . 0.0 109.627 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -83.71 163.98 19.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.09 -4.52 29.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.702 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -124.08 20.85 9.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.0 109.514 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.3 t -131.11 92.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.91 22.43 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -135.12 148.56 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.244 . . . . 0.0 109.862 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.48 140.43 10.24 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.9 ttm -133.86 113.16 11.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.139 -1.212 . . . . 0.0 109.725 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -126.49 149.69 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.859 . . . . 0.0 109.186 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -128.93 -178.56 15.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.711 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -148.07 135.52 10.64 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.198 -1.178 . . . . 0.0 109.347 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.31 -38.2 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.458 2.106 . . . . 0.0 112.269 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.6 -60.77 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.888 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' O ' ' C ' ' A' ' 38' ' ' GLY . 20.7 m -87.88 2.44 51.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.289 -0.882 . . . . 0.0 109.067 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 40.16 46.1 3.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.665 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 0.9 OUTLIER -116.11 148.29 40.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -1.127 . . . . 0.0 109.782 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -110.09 116.46 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.444 ' CE ' HD13 ' A' ' 43' ' ' LEU . 12.9 ttt -105.91 123.27 47.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -112.2 98.41 7.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.308 -0.87 . . . . 0.0 108.989 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.444 HD13 ' CE ' ' A' ' 41' ' ' MET . 8.7 tp -93.7 137.07 33.33 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.729 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -131.57 123.56 28.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.366 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.467 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.9 pt -105.97 156.26 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.512 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' NZ ' ' HB3' ' A' ' 54' ' ' GLU . 7.3 tttm -128.36 149.63 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.341 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 t -134.38 149.37 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.253 -0.904 . . . . 0.0 109.513 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.5 -96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.82 17.5 0.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.631 ' OD1' ' N ' ' A' ' 50' ' ' ASN . 0.2 OUTLIER -130.83 -25.76 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.673 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.32 9.93 3.17 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -100.1 133.47 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 0.0 109.436 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.2 mt -76.26 110.6 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.211 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -87.32 -39.0 15.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.576 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.37 170.3 16.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.81 120.97 2.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -96.02 161.22 14.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -0.93 . . . . 0.0 109.322 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.488 ' CD1' ' C ' ' A' ' 58' ' ' PHE . 4.6 p90 -150.32 170.49 18.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' N ' ' CD1' ' A' ' 58' ' ' PHE . 4.8 tttt -172.06 97.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.428 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.735 HG21 ' OG ' ' A' ' 70' ' ' SER . 70.6 p -110.23 104.45 13.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.0 109.425 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 100.43 7.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.578 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' CA ' ' OD2' ' A' ' 39' ' ' ASP . . . 148.73 -43.96 0.77 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.665 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.6 m -88.77 105.53 17.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -83.94 63.14 4.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 177.47 -18.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.144 -1.209 . . . . 0.0 109.371 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . . . -98.03 -15.96 19.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.304 -0.873 . . . . 0.0 109.451 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.546 ' O ' ' C ' ' A' ' 68' ' ' ALA . 4.2 mt -42.15 -80.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.492 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -34.38 -56.92 0.51 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.674 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -45.35 -58.11 3.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.735 ' OG ' HG21 ' A' ' 60' ' ' THR . 46.1 m -48.2 -37.96 17.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.882 . . . . 0.0 109.438 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 74' ' ' THR . 5.8 t -70.04 -33.53 72.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.239 -0.913 . . . . 0.0 109.411 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 75' ' ' GLU . 30.0 tp -67.31 -68.78 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.277 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 69' ' ' SER . 1.0 OUTLIER -41.51 -45.73 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.226 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' SER . 22.6 p -58.72 -33.59 70.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.284 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 72' ' ' LEU . 2.4 tt0 -83.19 -5.1 59.0 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.237 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.434 ' HE1' HD11 ' A' ' 72' ' ' LEU . 17.7 m0 -98.72 -26.59 14.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG11 HD11 ' A' ' 114' ' ' ILE . 8.2 m -94.73 -3.13 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.136 -0.978 . . . . 0.0 109.796 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -81.88 107.72 14.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.63 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.46 -21.66 30.22 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -84.48 178.78 7.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.122 -1.222 . . . . 0.0 109.571 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.96 172.19 8.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.1 mt -73.32 -28.37 62.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -61.39 -24.24 66.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 109.21 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.8 -52.66 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.86 . . . . 0.0 109.336 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.03 -36.77 68.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.349 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -83.35 48.41 4.03 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -166.51 -37.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.162 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' ' O ' ' A' ' 87' ' ' ALA . 1.3 pt -37.74 161.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.641 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -130.4 170.94 13.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.499 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.529 ' OD1' HD13 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -85.27 -15.17 44.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.215 -0.928 . . . . 0.0 109.363 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -59.11 -39.59 82.77 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -71.46 -52.89 15.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.6 mt -54.72 -41.38 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -67.83 -29.53 68.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.76 -42.06 61.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.2 -0.937 . . . . 0.0 109.537 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -73.44 -24.28 60.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.326 -0.859 . . . . 0.0 109.806 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.13 -36.46 6.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.024 -1.047 . . . . 0.0 109.59 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 94' ' ' ALA . 3.5 mt-10 62.32 18.27 10.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.186 -0.946 . . . . 0.0 109.249 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 99' ' ' LEU . 1.9 pt? -48.46 149.72 2.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.331 -0.856 . . . . 0.0 109.639 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -41.0 154.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.803 2.335 . . . . 0.0 112.266 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' N ' ' A' ' 104' ' ' VAL . 45.9 Cg_endo -72.48 -74.85 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.824 2.349 . . . . 0.0 112.091 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 0.2 OUTLIER 43.01 46.6 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.278 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.634 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.2 OUTLIER 76.36 10.39 2.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER 35.92 27.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.447 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.711 ' CE1' ' CB ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.29 -36.22 83.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.915 . . . . 0.0 109.366 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 68.9 m -55.5 -65.66 0.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.572 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.8 t -53.84 -57.11 12.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.529 HD13 ' OD1' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -47.02 -32.32 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.577 HD13 ' HD1' ' A' ' 105' ' ' HIS . 0.8 OUTLIER -70.01 -37.51 75.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.3 88.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 0.0 109.033 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.25 -53.88 21.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.339 -0.85 . . . . 0.0 109.273 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -54.13 -23.78 15.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.379 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.06 -50.74 21.22 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.176 -0.953 . . . . 0.0 109.222 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.702 HD11 HG11 ' A' ' 77' ' ' VAL . 1.2 tp -51.6 -39.66 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.939 . . . . 0.0 108.963 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.457 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 8.4 mttm -74.03 -49.7 23.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.389 -0.819 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.58 -44.98 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.468 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -69.53 -59.77 2.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 108.99 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.468 ' C ' ' O ' ' A' ' 117' ' ' ALA . 3.5 mt -41.06 -38.6 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.021 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.81 -57.84 10.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 109.052 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -50.71 -32.67 20.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.18 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.87 -60.19 4.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.391 -0.818 . . . . 0.0 109.489 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -61.55 -44.0 97.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -0.878 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.45 -53.87 32.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -0.925 . . . . 0.0 109.436 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -29.98 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.176 -0.952 . . . . 0.0 109.369 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.421 ' CG ' ' N ' ' A' ' 126' ' ' GLY . 6.6 tt0 -91.97 -102.71 0.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . 78.4 -25.3 2.39 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 127' ' ' LEU . 4.5 mm? -66.43 20.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.548 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.607 ' H ' ' C ' ' A' ' 126' ' ' GLY . 5.2 mt-10 -74.86 -78.39 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.412 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -111.44 145.62 38.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.444 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -177.64 4.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.707 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 66.64 36.67 4.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.629 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -85.31 -4.99 59.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.239 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -51.12 152.36 2.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 109.434 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' A' ' 133' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.482 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.238 0.542 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' C ' ' CG ' ' A' ' 3' ' ' TYR . . . -81.85 158.14 24.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.435 ' CG ' ' C ' ' A' ' 2' ' ' ALA . 4.0 m-85 68.76 -176.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.506 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.625 ' O ' ' N ' ' A' ' 6' ' ' LYS . 0.5 OUTLIER -133.95 166.04 23.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.284 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 64.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.6 ttmm -93.19 60.63 3.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.347 -0.846 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' C ' ' O ' ' A' ' 6' ' ' LYS . 51.7 t -39.76 137.26 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.885 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.8 mp -87.97 -116.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.648 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.697 ' N ' HG22 ' A' ' 8' ' ' ILE . 49.7 t0 -148.28 -88.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -108.91 -40.52 5.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.162 -0.961 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 174.89 -65.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 179.9 0.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.497 HD22 ' N ' ' A' ' 13' ' ' ASN . 1.3 m-80 58.12 83.56 0.22 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.297 -0.877 . . . . 0.0 109.723 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.28 -134.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.821 2.347 . . . . 0.0 112.038 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -95.86 137.04 35.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.468 ' O ' ' O ' ' A' ' 15' ' ' ARG . 1.4 m120 -59.86 -146.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.407 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.55 146.27 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.109 -0.995 . . . . 0.0 109.476 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -148.92 -61.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.5 m -86.55 164.57 16.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -1.177 . . . . 0.0 109.587 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.39 -88.62 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' O ' ' C ' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -138.64 129.94 27.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 21' ' ' ASP . 9.6 mttt -40.53 -38.78 0.91 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.938 . . . . 0.0 109.433 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.48 48.05 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -125.63 135.3 52.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' ' CE2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -71.36 -1.7 13.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.49 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.416 ' C ' HG23 ' A' ' 27' ' ' VAL . 49.2 m-20 -105.19 18.02 23.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.169 -0.957 . . . . 0.0 109.354 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 26' ' ' ASN . 73.6 t -152.94 97.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.515 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.93 150.96 28.34 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.7 m -127.57 150.45 49.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.42 126.49 3.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -129.4 123.49 31.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.164 -1.198 . . . . 0.0 109.645 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.56 165.86 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -145.77 165.93 27.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.571 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -137.39 132.61 17.85 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.195 -1.18 . . . . 0.0 109.527 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.33 -38.07 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.51 2.14 . . . . 0.0 111.948 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.74 -56.87 11.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.245 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -91.72 -4.57 54.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.69 47.68 30.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 1.2 t0 -122.19 139.23 54.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -1.106 . . . . 0.0 109.581 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.591 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 20.5 m -92.95 123.13 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.326 -0.858 . . . . 0.0 109.25 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.468 ' HG3' ' N ' ' A' ' 42' ' ' GLN . 2.8 ttt -113.92 144.59 42.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.684 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.468 ' N ' ' HG3' ' A' ' 41' ' ' MET . 30.9 tt0 -149.29 120.04 7.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 109.22 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.39 130.85 48.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.731 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -123.73 155.14 38.42 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.245 -0.909 . . . . 0.0 109.111 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.38 137.9 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -102.48 147.21 27.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.228 -0.92 . . . . 0.0 109.418 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.62 126.52 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 109.6 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' OD1' ' C ' ' A' ' 48' ' ' ASP . 30.2 t0 -63.29 -96.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 109.416 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 0.7 OUTLIER -160.0 23.25 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.92 19.9 2.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.51 7.28 88.71 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.7 mm -99.84 155.9 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -1.157 . . . . 0.0 109.447 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.4 mt -99.08 109.83 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.05 -41.29 95.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 109.674 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.53 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 11.2 p-10 -157.62 167.59 29.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 109.6 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.66 129.89 41.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.342 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -95.2 125.63 39.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.696 ' CD1' ' N ' ' A' ' 58' ' ' PHE . 0.1 OUTLIER -114.58 157.67 22.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -166.13 99.24 0.63 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 60' ' ' THR . 12.5 t -164.41 113.35 1.15 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.517 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.497 ' CD1' ' O ' ' A' ' 60' ' ' THR . 21.6 m-85 -137.53 102.97 4.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -0.92 . . . . 0.0 109.528 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 168.97 -7.21 0.05 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 66' ' ' ALA . 1.1 m -90.75 178.78 5.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.15 -1.206 . . . . 0.0 109.329 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.41 -11.8 14.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -141.43 -16.35 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -1.155 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 106' ' ' CYS . . . -79.99 -9.64 59.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 68' ' ' ALA . 1.7 tt -67.69 -40.85 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.652 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.512 ' N ' HG23 ' A' ' 67' ' ' ILE . . . -76.55 -28.76 56.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.657 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.537 ' O ' ' C ' ' A' ' 70' ' ' SER . 1.7 p -60.14 -58.63 7.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.935 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.618 ' O ' HG23 ' A' ' 74' ' ' THR . 0.9 OUTLIER -34.8 -48.02 0.37 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.74 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -65.15 -46.85 79.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.188 -0.945 . . . . 0.0 109.689 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -63.53 -73.14 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.932 . . . . 0.0 109.547 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.755 HG23 ' N ' ' A' ' 74' ' ' THR . 14.7 tt -39.22 -56.64 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.755 ' N ' HG23 ' A' ' 73' ' ' ILE . 22.1 p -46.87 -46.1 20.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 109.587 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -69.78 -13.9 62.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.633 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.41 ' N ' ' O ' ' A' ' 73' ' ' ILE . 17.9 m0 -89.64 -31.38 17.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.791 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 m -107.01 32.15 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 109.689 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.94 102.14 11.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.59 8.67 57.15 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mmtt -92.28 -175.81 4.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -1.142 . . . . 0.0 109.536 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.64 149.09 24.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.251 -0.905 . . . . 0.0 109.494 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.18 -19.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.2 -0.937 . . . . 0.0 109.144 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -51.81 61.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 85' ' ' ALA . 3.7 mt-10 -68.05 -55.94 10.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.551 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 84' ' ' GLU . . . -44.96 -44.26 9.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.31 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -84.96 52.8 4.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -167.2 -46.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -1.15 . . . . 0.0 109.493 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.547 ' O ' ' O ' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -36.1 158.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.429 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -121.84 168.36 11.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.215 -0.928 . . . . 0.0 109.4 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 2.1 p-10 -82.83 -20.21 36.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.5 p -52.26 -40.76 62.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 93' ' ' ILE . 1.7 mm-40 -67.13 -70.93 0.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.218 -0.926 . . . . 0.0 109.457 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 92' ' ' GLN . 22.0 mt -41.57 -39.7 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.42 -53.05 40.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -47.98 -47.54 32.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.684 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -38.54 82.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.7 mt -79.66 -26.55 40.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.503 ' O ' ' CD ' ' A' ' 98' ' ' GLU . 2.7 tm-20 50.91 66.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.708 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 1.047 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.9 pt? -112.44 145.26 32.53 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.329 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.54 153.18 62.95 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.699 2.266 . . . . 0.0 112.35 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.47 11.19 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.878 2.386 . . . . 0.0 112.259 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.569 HG13 ' HG2' ' A' ' 103' ' ' LYS . 8.0 p -82.78 2.04 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.569 ' HG2' HG13 ' A' ' 102' ' ' VAL . 0.6 OUTLIER 179.9 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.215 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 105' ' ' HIS . 6.2 p -72.1 -8.72 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.695 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -39.45 -55.75 1.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.114 -0.991 . . . . 0.0 109.494 -179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.695 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 62.0 m -31.16 -59.38 0.23 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.366 -0.834 . . . . 0.0 110.278 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.44 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 5.9 p -61.87 -55.63 27.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.059 -1.025 . . . . 0.0 109.984 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.44 ' N ' ' OG ' ' A' ' 107' ' ' SER . 1.6 mm -45.88 -53.85 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.169 -0.957 . . . . 0.0 109.832 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.51 -41.8 61.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.278 -0.889 . . . . 0.0 109.942 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.27 -65.12 0.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.087 -1.008 . . . . 0.0 109.671 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 90' ' ' ASN . 11.7 tt0 -54.29 -41.85 69.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.5 -28.6 68.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.33 2.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.228 -0.92 . . . . 0.0 109.674 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -48.85 -38.05 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 1.1 mmtt -71.44 -31.46 67.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.304 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.94 67.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.63 87.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.208 -0.933 . . . . 0.0 109.393 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.12 -46.95 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.261 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.44 -49.31 76.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.286 -0.884 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.86 -34.28 72.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.624 ' CE2' ' O ' ' A' ' 25' ' ' SER . 3.7 t80 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.953 . . . . 0.0 109.652 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.85 -33.24 27.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.743 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.95 4.86 9.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.504 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -112.67 10.34 19.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.556 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -82.18 -68.69 0.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.89 . . . . 0.0 109.398 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.404 ' C ' ' N ' ' A' ' 128' ' ' GLU . . . 133.41 18.52 1.02 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.58 -10.15 0.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.006 -1.29 . . . . 0.0 109.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 129' ' ' HIS . 6.1 tt0 -49.09 -52.97 22.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.316 -0.865 . . . . 0.0 109.536 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.524 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 1.3 t-80 77.4 131.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 51.23 58.07 5.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.263 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.811 ' CD2' ' H ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -83.23 133.96 34.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.444 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -109.68 -49.15 3.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.642 ' ND1' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -175.69 113.97 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.395 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.577 ' ND1' ' C ' ' A' ' 133' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.387 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.385 0.612 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 -4.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.132 -0.98 . . . . 0.0 109.498 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.96 -45.77 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.543 ' O ' ' O ' ' A' ' 5' ' ' GLU . 50.4 m -142.15 151.73 42.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.285 -0.885 . . . . 0.0 109.502 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.543 ' O ' ' O ' ' A' ' 4' ' ' SER . 4.4 mm-40 -58.01 -132.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.447 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.421 ' CB ' ' NZ ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -99.0 99.36 10.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.3 m -51.97 154.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.214 -0.929 . . . . 0.0 109.259 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.91 HD13 ' N ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -80.12 177.79 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.31 109.56 0.2 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.549 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -122.84 45.15 2.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.322 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -102.09 148.85 24.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.565 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -169.84 123.87 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 0.4 OUTLIER 179.71 65.22 0.13 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.45 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.66 92.48 0.95 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.929 2.419 . . . . 0.0 112.401 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.572 ' O ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER 62.8 142.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.613 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.572 ' O ' ' O ' ' A' ' 15' ' ' ARG . 0.8 OUTLIER 51.22 166.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 17' ' ' VAL . 10.0 p -142.02 -3.07 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.373 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.89 -86.88 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -66.95 176.88 1.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -1.124 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.4 mt -137.0 -68.4 0.48 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 109.515 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 23' ' ' LYS . 21.1 m-20 -123.92 20.26 9.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.506 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.4 tttt 56.31 -0.25 0.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.645 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' H ' ' C ' ' A' ' 21' ' ' ASP . 11.7 tttm -167.06 51.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.439 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.586 ' O ' ' N ' ' A' ' 26' ' ' ASN . 37.3 t0 -95.1 27.3 3.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.412 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 25' ' ' SER . 0.3 OUTLIER 48.08 9.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.237 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 24' ' ' ASP . 61.3 m-20 -117.62 0.7 12.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.345 -0.847 . . . . 0.0 109.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.1 t -128.39 114.41 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.375 -0.828 . . . . 0.0 109.47 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -72.83 127.58 11.54 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.0 m -108.0 140.21 41.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -1.132 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.9 129.57 4.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.7 ttm -126.53 100.71 6.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.297 -1.12 . . . . 0.0 109.35 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.1 m -117.11 170.95 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.12 167.42 39.8 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 105' ' ' HIS . . . -136.97 139.33 28.36 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.389 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 38' ' ' GLY . 48.5 Cg_endo -72.93 -59.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.596 2.198 . . . . 0.0 112.259 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -40.07 -42.11 1.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' NE2' ' A' ' 105' ' ' HIS . 1.2 m -98.18 -4.49 35.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 35' ' ' PRO . . . 41.84 45.76 4.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.671 ' OD2' ' N ' ' A' ' 63' ' ' CYS . 54.3 t0 -120.07 131.17 55.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -1.092 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 40' ' ' VAL . 8.5 p -104.05 118.42 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.268 -0.895 . . . . 0.0 109.226 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.4 ttt -115.26 153.59 30.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.898 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -133.74 121.13 21.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.385 -0.822 . . . . 0.0 109.016 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.447 ' HB2' ' HB1' ' A' ' 113' ' ' ALA . 0.8 OUTLIER -108.54 112.32 24.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 109.889 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -114.94 121.69 43.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.204 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 pt -113.33 137.59 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.734 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -99.39 123.94 44.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 51.1 t -118.93 135.45 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' CB ' ' A' ' 49' ' ' ASP . 6.2 t70 -62.82 -59.99 4.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 0.5 OUTLIER 167.08 -24.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 0.0 109.125 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -84.72 -22.36 29.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.398 -0.814 . . . . 0.0 109.254 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.57 7.73 5.12 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.8 mm -94.75 132.72 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -1.118 . . . . 0.0 109.434 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 54' ' ' GLU . 16.4 mt -84.28 84.57 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.708 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.9 OUTLIER -43.61 -53.14 5.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 108.863 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -143.53 -177.22 5.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -162.1 132.55 4.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.787 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -108.69 156.75 19.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.842 . . . . 0.0 109.375 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.728 ' CD1' HG21 ' A' ' 74' ' ' THR . 12.5 p90 -139.52 170.6 15.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.958 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -167.72 98.7 0.48 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.9 . . . . 0.0 109.617 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.38 116.88 11.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -149.17 96.79 2.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.387 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.84 -12.09 0.08 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.671 ' N ' ' OD2' ' A' ' 39' ' ' ASP . 1.8 m -96.78 168.54 10.44 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.247 -1.149 . . . . 0.0 109.358 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.38 44.14 1.43 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.49 -3.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -1.16 . . . . 0.0 109.552 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -97.23 -22.86 16.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.077 HD12 ' H ' ' A' ' 67' ' ' ILE . 3.5 mp -36.8 -36.78 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' ALA . . . -83.17 -57.62 3.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.52 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.5 OUTLIER -42.33 -50.59 5.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.52 ' C ' ' O ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -36.07 -56.18 0.74 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.713 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.409 ' N ' ' OG ' ' A' ' 70' ' ' SER . 7.0 m -64.12 -36.58 84.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 75' ' ' GLU . 8.6 tp -65.46 -79.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.674 ' O ' HG22 ' A' ' 77' ' ' VAL . 7.8 tt -34.93 -41.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.851 . . . . 0.0 109.74 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.728 HG21 ' CD1' ' A' ' 58' ' ' PHE . 6.6 p -68.25 -35.97 78.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.922 . . . . 0.0 109.726 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.593 ' N ' ' O ' ' A' ' 72' ' ' LEU . 3.3 mt-10 -85.57 -1.98 57.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.574 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -100.99 -23.69 14.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 73' ' ' ILE . 33.8 m -115.39 50.28 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.88 . . . . 0.0 109.228 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -120.15 100.46 7.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.699 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.51 11.39 77.76 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -169.97 2.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -1.17 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.8 173.08 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.538 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mt -65.35 -28.03 69.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -63.57 -19.6 64.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.96 -31.18 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.89 -25.36 40.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.625 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.69 54.66 0.84 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 89' ' ' LYS . . . -170.04 -34.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -1.155 . . . . 0.0 109.296 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 89' ' ' LYS . 1.9 pt -39.17 -26.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.401 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 87' ' ' ALA . 2.9 ttmm 49.49 179.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.296 -0.877 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' GLN . 31.5 p-10 -96.27 -55.61 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.571 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 1.1 m -38.27 -24.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 109.751 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 90' ' ' ASN . 5.8 tt0 -79.29 -52.94 7.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.608 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 94' ' ' ALA . 5.4 tt -59.48 -40.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 109.273 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' N ' ' CG2' ' A' ' 93' ' ' ILE . . . -63.52 -46.37 86.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.269 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.81 -37.65 79.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.065 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -66.88 -37.7 84.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.302 -0.874 . . . . 0.0 109.237 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.28 -20.36 59.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 109.268 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 67.67 10.26 7.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.526 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.951 ' O ' HD23 ' A' ' 99' ' ' LEU . 0.4 OUTLIER -72.1 152.67 92.67 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.163 -0.961 . . . . 0.0 109.476 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.0 165.74 25.26 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.861 2.374 . . . . 0.0 112.271 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -77.01 -41.58 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.88 2.387 . . . . 0.0 112.275 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.638 ' O ' ' CB ' ' A' ' 103' ' ' LYS . 1.7 p -45.18 102.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.502 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 102' ' ' VAL . 11.0 ttmt 84.53 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.518 HG22 ' HB2' ' A' ' 107' ' ' SER . 13.9 p -83.8 -2.73 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.693 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -38.45 -59.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.456 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.693 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 96.5 m -33.26 -48.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.398 -0.814 . . . . 0.0 109.799 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.518 ' HB2' HG22 ' A' ' 104' ' ' VAL . 71.0 m -65.14 -60.62 2.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.448 ' C ' ' O ' ' A' ' 107' ' ' SER . 97.3 mt -42.8 -40.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.16 -0.963 . . . . 0.0 109.071 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.535 HD22 ' HE1' ' A' ' 105' ' ' HIS . 0.9 OUTLIER -57.06 -63.56 1.17 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -36.24 -45.42 0.46 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.361 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.548 ' O ' ' OE2' ' A' ' 111' ' ' GLU . 4.5 tp10 -64.76 -55.78 17.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.682 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.32 -19.62 23.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -0.97 . . . . 0.0 109.622 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 43' ' ' LEU . . . -72.99 -50.27 24.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.377 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -31.42 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.165 -0.959 . . . . 0.0 109.362 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.43 -55.5 8.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.7 -52.37 11.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.724 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.518 ' O ' ' C ' ' A' ' 118' ' ' ILE . . . -59.37 -65.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 109.738 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' C ' ' O ' ' A' ' 117' ' ' ALA . 6.2 mt -36.76 -33.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.086 -1.009 . . . . 0.0 109.65 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 121' ' ' TYR . . . -76.39 -64.05 1.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.127 -0.983 . . . . 0.0 109.739 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.531 ' OD1' ' O ' ' A' ' 120' ' ' ASP . 9.4 t0 -52.5 -2.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 0.0 109.869 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.562 ' H ' ' C ' ' A' ' 119' ' ' ALA . 69.4 t80 -98.19 -56.96 2.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.662 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -68.52 -26.97 65.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.478 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.61 71.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.522 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -70.4 -40.16 74.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -103.44 28.99 5.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.412 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 128' ' ' GLU . . . -108.74 -102.85 2.8 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.527 HD12 ' H ' ' A' ' 127' ' ' LEU . 3.0 mp -69.33 40.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 109.648 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 126' ' ' GLY . 32.4 mt-10 -147.41 74.07 1.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.472 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 30.9 m170 -86.59 14.88 6.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 109.651 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' A' ' 129' ' ' HIS . 12.0 m-70 -165.29 -94.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.493 ' CD2' ' H ' ' A' ' 132' ' ' HIS . 77.0 t60 -162.18 -119.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.493 ' H ' ' CD2' ' A' ' 131' ' ' HIS . 5.1 t60 -66.2 89.43 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.239 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -127.11 128.19 45.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.433 -179.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.526 ' O ' ' C ' ' A' ' 3' ' ' TYR . . . -113.08 74.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.526 ' C ' ' O ' ' A' ' 2' ' ' ALA . 71.2 m-85 36.83 -120.07 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 109.526 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.508 ' C ' ' OE1' ' A' ' 5' ' ' GLU . 48.1 t -110.63 -92.97 0.44 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.582 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -109.83 146.83 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 109.694 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -174.51 73.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 0.0 109.408 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' H ' ' A' ' 7' ' ' VAL . 1.5 m -84.84 111.28 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -119.76 140.46 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.35 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.08 113.81 25.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.622 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.36 127.55 36.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.292 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -83.3 -92.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.657 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.56 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.084 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.23 163.51 24.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.767 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.35 108.77 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.894 2.396 . . . . 0.0 112.622 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.717 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -136.16 19.53 3.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.247 -0.908 . . . . 0.0 109.045 179.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 16' ' ' ASN . 2.6 t30 -109.03 6.11 24.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.193 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 18' ' ' GLY . 3.7 t -71.29 -36.47 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.465 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' VAL . . . -50.39 -95.22 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -71.11 171.29 11.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -1.203 . . . . 0.0 109.191 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mp -103.0 -86.7 0.43 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 23' ' ' LYS . 10.6 t0 -149.54 163.85 36.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 0.0 109.667 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -76.47 -17.13 59.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.224 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' H ' ' CG ' ' A' ' 21' ' ' ASP . 3.0 mmmp? -105.21 27.57 8.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.336 -0.852 . . . . 0.0 109.246 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.524 ' OD2' ' ND2' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -88.82 165.19 14.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.0 109.534 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -96.41 9.67 40.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.361 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.524 ' ND2' ' OD2' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -125.16 0.58 7.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.88 103.08 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.712 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.56 155.92 34.45 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.435 HG23 ' HG3' ' A' ' 44' ' ' GLN . 67.7 m -136.76 126.92 26.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.081 -1.247 . . . . 0.0 109.958 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' N ' ' HB2' ' A' ' 117' ' ' ALA . . . -109.59 123.25 6.74 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.7 ttt -130.56 126.58 37.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.14 -1.212 . . . . 0.0 109.851 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.33 -174.34 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.385 -0.822 . . . . 0.0 109.026 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.21 144.55 8.93 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 109' ' ' LEU . . . -111.21 132.58 21.67 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.358 -1.083 . . . . 0.0 109.225 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.537 ' O ' ' C ' ' A' ' 36' ' ' ALA . 58.0 Cg_endo -75.38 -53.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.547 2.165 . . . . 0.0 112.342 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -35.72 -47.41 0.49 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.529 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' O ' ' C ' ' A' ' 38' ' ' GLY . 1.7 p -114.48 11.3 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.59 62.28 0.97 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -116.26 117.4 29.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -1.15 . . . . 0.0 109.6 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 40' ' ' VAL . 14.1 p -87.46 119.33 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 0.0 109.555 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.3 ttt -111.4 122.41 47.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 109.659 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.442 HE21 ' HB2' ' A' ' 42' ' ' GLN . 1.6 tt0 -119.44 99.04 6.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 109.388 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 74' ' ' THR . 7.5 tp -101.34 127.98 47.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.583 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 57' ' ' LYS . 0.4 OUTLIER -115.72 125.44 52.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 pt -109.58 142.82 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -114.75 118.75 34.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.09 142.23 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 0.0 109.495 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.559 ' OD2' ' O ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -89.02 -96.73 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.564 ' OD1' ' OD1' ' A' ' 50' ' ' ASN . 3.7 p30 -153.52 19.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.564 ' OD1' ' OD1' ' A' ' 49' ' ' ASP . 0.4 OUTLIER -145.67 43.86 1.27 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.497 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.63 31.94 30.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.559 ' O ' ' OD2' ' A' ' 48' ' ' ASP . 4.0 mm -122.11 131.22 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -1.131 . . . . 0.0 109.503 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 mt -86.73 109.8 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.162 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -70.71 -23.57 62.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.367 -0.833 . . . . 0.0 109.851 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -169.91 157.73 6.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.035 . . . . 0.0 109.885 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.74 137.67 43.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.222 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 44' ' ' GLN . 19.3 mttp -101.45 137.49 39.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.735 ' HB3' HG21 ' A' ' 74' ' ' THR . 23.8 p90 -116.7 137.17 52.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.09 85.26 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.515 ' C ' ' CD1' ' A' ' 61' ' ' TYR . 1.4 t -143.04 138.54 30.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 109.434 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.515 ' CD1' ' C ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -160.79 125.83 3.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.91 . . . . 0.0 109.364 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.13 -64.71 0.28 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.46 142.55 27.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -1.113 . . . . 0.0 109.481 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' A' ' 66' ' ' ALA . . . -76.5 168.35 54.75 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 65.26 -32.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -1.108 . . . . 0.0 109.528 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . -67.0 -46.41 74.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -51.31 -72.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 109.425 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' C ' ' O ' ' A' ' 67' ' ' ILE . . . -35.3 -48.6 0.47 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.35 -33.72 59.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.377 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.655 ' N ' ' O ' ' A' ' 67' ' ' ILE . 40.3 t -67.21 -64.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 70' ' ' SER . 7.7 p -43.41 -27.92 0.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.083 -1.011 . . . . 0.0 109.312 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.534 ' O ' ' C ' ' A' ' 73' ' ' ILE . 7.4 tp -78.12 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.863 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.534 ' C ' ' O ' ' A' ' 72' ' ' LEU . 8.4 tt -34.89 -41.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 0.0 109.667 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.735 HG21 ' HB3' ' A' ' 58' ' ' PHE . 74.7 p -61.61 -51.14 69.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.194 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 72' ' ' LEU . 14.3 tt0 -70.29 -5.34 27.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.912 . . . . 0.0 109.389 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -88.94 -30.79 18.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.261 -0.899 . . . . 0.0 109.445 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.57 6.09 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.895 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -74.21 112.51 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.704 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.63 -9.13 77.2 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -83.18 -170.97 3.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -1.163 . . . . 0.0 109.587 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.34 164.41 12.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.479 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.422 HD22 HG12 ' A' ' 118' ' ' ILE . 27.9 mt -59.51 -24.55 63.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -59.76 -48.05 83.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.329 -0.857 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -69.93 -36.71 75.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.519 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.55 -26.01 66.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.548 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.53 44.62 1.44 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.525 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -160.29 -33.85 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -1.167 . . . . 0.0 109.444 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.525 ' C ' ' O ' ' A' ' 87' ' ' ALA . 1.0 OUTLIER -35.84 -47.76 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 65.17 142.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.323 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.422 HD22 ' H ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -66.12 -34.69 78.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 0.0 109.635 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.3 p -49.32 -41.28 38.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.457 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -58.57 -49.27 78.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.3 mt -65.09 -35.36 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.01 -18.77 64.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.75 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -88.47 -34.76 17.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.858 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.33 -25.45 25.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.145 -0.972 . . . . 0.0 109.957 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -105.61 -8.8 17.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.66 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' LEU . 23.8 mp0 44.79 15.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.885 . . . . 0.0 109.482 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.1 pp -41.61 148.52 0.44 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 109.539 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -41.7 101.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.816 2.344 . . . . 0.0 112.305 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.654 ' O ' ' N ' ' A' ' 103' ' ' LYS . 60.9 Cg_endo -82.72 9.62 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.73 2.287 . . . . 0.0 112.228 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 24.9 m -46.4 -8.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.933 . . . . 0.0 109.338 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.654 ' N ' ' O ' ' A' ' 101' ' ' PRO . 2.7 tttm -172.55 -31.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.318 -0.863 . . . . 0.0 109.53 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.7 t 63.5 63.23 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.88 . . . . 0.0 109.457 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.681 ' CD2' ' H ' ' A' ' 106' ' ' CYS . 26.7 p-80 -96.86 -57.12 2.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.681 ' H ' ' CD2' ' A' ' 105' ' ' HIS . 2.2 m -57.59 -40.59 79.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -63.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.7 mt -47.4 -31.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.265 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 34' ' ' ALA . 0.7 OUTLIER -62.87 -50.68 69.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.021 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -51.37 -43.61 61.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.259 -0.9 . . . . 0.0 108.929 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.9 -58.41 7.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.204 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 24.8 t0 -50.17 -28.91 8.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.645 ' O ' ' N ' ' A' ' 116' ' ' ALA . . . -68.67 -69.99 0.29 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.379 -0.825 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.513 ' C ' ' O ' ' A' ' 113' ' ' ALA . 1.9 tp -38.37 -40.94 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.156 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.487 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.6 mmtm -72.64 -29.12 63.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.29 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.645 ' N ' ' O ' ' A' ' 113' ' ' ALA . . . -66.0 -48.23 71.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.233 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' HB2' ' N ' ' A' ' 30' ' ' GLY . . . -64.16 -46.73 82.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.205 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.422 HG12 HD22 ' A' ' 82' ' ' LEU . 67.5 mt -54.62 -44.5 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.37 85.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.45 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -57.73 4.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.459 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -45.86 -41.58 11.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.436 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' O ' ' C ' ' A' ' 123' ' ' ALA . 4.4 tttm -66.95 -45.55 77.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 122' ' ' LYS . . . -36.98 -39.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -0.828 . . . . 0.0 109.328 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -42.3 14.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.393 -0.817 . . . . 0.0 109.379 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -100.77 37.06 1.79 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.454 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 122' ' ' LYS . . . -145.54 -66.05 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.519 ' O ' ' C ' ' A' ' 128' ' ' GLU . 2.9 mm? -59.57 -37.59 78.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -1.148 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 127' ' ' LEU . 55.6 mt-10 37.7 -129.31 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -0.868 . . . . 0.0 109.426 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -118.2 109.25 16.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.475 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -169.86 142.76 2.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.431 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -138.03 -59.52 0.65 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.297 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.53 ' O ' ' C ' ' A' ' 133' ' ' HIS . 0.1 OUTLIER -154.04 157.58 39.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.53 ' C ' ' O ' ' A' ' 132' ' ' HIS . 22.9 m80 -35.34 128.58 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.935 . . . . 0.0 109.67 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 134' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.453 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.57 -24.1 11.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.38 -2.38 6.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.163 -0.961 . . . . 0.0 109.576 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 t -65.32 -18.53 65.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.312 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.22 -34.91 28.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -83.1 -67.5 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -62.16 135.85 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.908 . . . . 0.0 109.517 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -55.95 130.75 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.22 -0.925 . . . . 0.0 109.438 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.48 ' O ' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -82.29 21.23 0.95 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.902 . . . . 0.0 109.634 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.669 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -54.06 174.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.214 -0.929 . . . . 0.0 109.42 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CE2' ' O ' ' A' ' 9' ' ' ASP . 65.3 m-85 -150.5 -175.27 5.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 0.0 109.61 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.646 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 50.4 mp0 -98.88 -2.1 38.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -169.66 63.79 0.49 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -41.15 128.89 3.08 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 123.01 2.473 . . . . 0.0 112.409 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -114.84 -28.48 7.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.883 HD22 ' H ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -84.18 -145.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.526 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG23 ' ND2' ' A' ' 16' ' ' ASN . 31.1 t 59.83 -102.61 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.247 -0.908 . . . . 0.0 109.331 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.36 83.53 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -157.88 166.28 33.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -1.165 . . . . 0.0 109.488 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -105.28 -74.17 0.66 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.568 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -90.98 -16.77 27.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.38 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 21' ' ' ASP . 10.0 tttm 71.21 -22.73 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -0.865 . . . . 0.0 109.451 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 21' ' ' ASP . 14.2 tttt -66.5 -14.81 62.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.541 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.7 t70 69.58 -147.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 24' ' ' ASP . 0.9 OUTLIER 77.7 -8.42 1.68 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' CG ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -176.83 27.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.376 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.4 t -124.75 99.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.11 139.76 15.4 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -138.95 122.57 17.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -122.4 148.37 16.99 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 tpt -145.48 126.67 14.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -1.16 . . . . 0.0 109.6 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.6 m -145.8 155.93 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.379 -0.825 . . . . 0.0 109.337 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.0 159.16 24.54 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . . . -132.35 142.4 44.81 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.294 -1.121 . . . . 0.0 109.353 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.522 ' O ' ' C ' ' A' ' 36' ' ' ALA . 59.3 Cg_endo -75.31 -51.45 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.673 2.249 . . . . 0.0 112.065 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -37.35 -49.75 1.0 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.187 -0.945 . . . . 0.0 109.217 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.445 ' HB3' ' SG ' ' A' ' 63' ' ' CYS . 50.6 m -102.8 -8.93 20.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.36 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.77 45.68 55.0 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -120.31 152.31 37.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -1.133 . . . . 0.0 109.591 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -116.7 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 0.0 109.386 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 16.6 ttt -91.47 143.39 26.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 0.0 109.608 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' NE2' HE21 ' A' ' 44' ' ' GLN . 4.8 tt0 -132.57 126.0 31.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.223 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.41 130.76 56.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.769 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.485 HE21 ' NE2' ' A' ' 42' ' ' GLN . 30.1 mt-30 -125.8 112.82 16.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 109.066 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.525 HG12 ' HB1' ' A' ' 117' ' ' ALA . 1.0 OUTLIER -107.02 141.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.646 -179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 1.7 mptt -113.03 137.63 51.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.236 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.34 145.04 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 0.0 109.653 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.598 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 10.4 p-10 -82.75 -96.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 0.0 109.47 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.578 ' H ' ' CG ' ' A' ' 48' ' ' ASP . 0.6 OUTLIER -155.81 16.63 0.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -137.32 4.84 2.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.77 20.31 31.78 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.7 mm -106.88 146.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -1.14 . . . . 0.0 109.353 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 53' ' ' ILE . 23.2 mm -85.87 84.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.955 . . . . 0.0 109.688 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -44.87 -54.91 5.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.116 179.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.33 161.61 41.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 109.104 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.37 115.7 12.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 109.887 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -96.43 141.23 29.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 108.93 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CD1' HG21 ' A' ' 74' ' ' THR . 28.1 p90 -137.57 176.3 8.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.998 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -166.3 124.36 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.396 -0.815 . . . . 0.0 109.348 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 t -160.53 133.57 6.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 61' ' ' TYR . 15.4 p90 -150.83 125.67 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.45 -42.64 1.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 1.1 m -79.88 142.61 35.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -1.113 . . . . 0.0 109.552 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.81 -5.01 57.73 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.47 -2.81 13.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -1.094 . . . . 0.0 109.407 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 67' ' ' ILE . . . -91.78 -41.05 10.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.576 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 66' ' ' ALA . 65.6 mt -41.91 -44.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.479 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.99 -48.52 44.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 109.536 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' LEU . 46.5 m -67.63 -66.04 0.61 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.542 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.536 ' C ' ' O ' ' A' ' 69' ' ' SER . 17.9 m -35.7 -41.34 0.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -0.878 . . . . 0.0 109.521 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.564 ' O ' ' OG1' ' A' ' 74' ' ' THR . 20.4 t -68.22 -41.38 81.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -64.64 -65.28 0.7 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.439 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.573 ' O ' HG22 ' A' ' 77' ' ' VAL . 13.0 tt -41.08 -46.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.938 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.677 HG21 ' CD1' ' A' ' 58' ' ' PHE . 17.2 p -55.58 -44.87 77.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.144 -0.972 . . . . 0.0 109.699 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.73 -34.8 64.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.065 -1.022 . . . . 0.0 109.677 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.02 -13.56 62.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 0.0 109.461 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 73' ' ' ILE . 6.0 m -121.94 22.38 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -98.85 117.58 33.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.67 5.61 69.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -84.71 -163.48 0.82 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -1.147 . . . . 0.0 109.302 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.7 m -116.2 155.91 27.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.121 -0.987 . . . . 0.0 109.568 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 82' ' ' LEU . 46.7 mt -59.55 -17.52 33.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.524 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -75.93 -50.44 14.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 109.469 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.665 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -66.21 -39.36 89.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.8 -37.1 67.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -86.37 41.63 3.1 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -156.32 -37.04 0.08 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.238 -1.154 . . . . 0.0 109.098 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 84' ' ' GLU . 5.3 pt -42.06 163.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.385 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -126.88 -173.07 2.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -100.95 -13.85 18.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.87 -21.81 61.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.277 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -72.22 -58.97 2.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 109.346 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.7 -38.74 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.52 65.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -86.13 -21.36 27.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.894 . . . . 0.0 109.623 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -83.75 -48.11 10.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.197 -0.939 . . . . 0.0 109.714 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 98' ' ' GLU . 5.4 mt -90.16 -11.23 41.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.877 . . . . 0.0 109.505 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 97' ' ' LEU . 2.7 mt-10 41.67 68.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.311 -0.868 . . . . 0.0 109.883 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -89.73 150.29 43.76 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.176 -0.953 . . . . 0.0 109.311 179.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -44.1 147.35 1.42 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.567 2.178 . . . . 0.0 112.032 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 103' ' ' LYS . 37.9 Cg_endo -69.71 -44.57 2.03 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.684 2.256 . . . . 0.0 112.157 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 102' ' ' VAL . 1.7 p -60.0 -2.67 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 109.435 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.5 OUTLIER -143.04 36.33 1.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.54 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' C ' ' A' ' 105' ' ' HIS . 5.2 p -84.49 -15.54 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.292 -0.88 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.633 ' C ' ' ND1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -42.43 -44.68 4.11 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 0.0 109.097 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.553 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 57.3 m -40.15 -54.58 2.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.312 -0.868 . . . . 0.0 109.836 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 108' ' ' ILE . 96.0 p -64.95 -56.02 15.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.099 -1.001 . . . . 0.0 109.808 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 107' ' ' SER . 25.2 mt -43.53 -40.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.125 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.514 HD13 ' HD1' ' A' ' 105' ' ' HIS . 1.2 mp -64.75 -47.84 76.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.101 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 109' ' ' LEU . . . -42.18 -48.98 4.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.141 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -66.13 -35.03 79.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 109.525 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -68.62 -33.42 74.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.947 . . . . 0.0 109.859 -179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.32 -47.24 74.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.5 tp -58.98 -39.16 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.214 -0.929 . . . . 0.0 109.183 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 2.2 ttmt -70.34 -50.87 34.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -0.88 . . . . 0.0 109.387 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -57.52 -32.17 66.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.0 109.384 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -64.93 -58.11 7.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.216 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -55.55 -48.2 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.95 -36.02 59.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.477 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.56 ' OD1' ' NZ ' ' A' ' 124' ' ' LYS . 5.3 t0 -72.59 -55.21 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.466 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.466 ' C ' ' O ' ' A' ' 120' ' ' ASP . 22.2 t80 -39.59 -56.03 1.74 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 0.0 109.535 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tttm -68.62 -28.56 67.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 120' ' ' ASP . . . -61.0 -46.05 92.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.33 -0.856 . . . . 0.0 109.565 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.56 ' NZ ' ' OD1' ' A' ' 120' ' ' ASP . 33.6 mmtm -67.26 -20.71 65.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.382 -0.824 . . . . 0.0 109.49 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -128.52 61.12 1.49 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.258 -0.902 . . . . 0.0 109.606 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -137.82 1.16 2.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.0 mt -128.27 35.57 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -1.14 . . . . 0.0 109.279 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.45 -56.42 20.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.573 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -150.01 83.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -75.53 127.26 32.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.68 99.03 8.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 109.515 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.458 ' ND1' ' HB2' ' A' ' 133' ' ' HIS . 7.3 p80 -72.83 -169.14 0.54 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.205 -0.934 . . . . 0.0 109.487 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.458 ' HB2' ' ND1' ' A' ' 132' ' ' HIS . 1.2 t-80 64.44 -136.39 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.929 . . . . 0.0 109.389 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.485 179.954 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.309 0.576 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.55 95.07 2.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.25 172.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.906 . . . . 0.0 109.513 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.3 p -111.52 168.99 9.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -150.62 164.73 35.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.25 -0.906 . . . . 0.0 109.457 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -115.45 144.12 44.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.549 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.907 HG12 ' H ' ' A' ' 8' ' ' ILE . 3.3 t 60.59 -149.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.475 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.907 ' H ' HG12 ' A' ' 7' ' ' VAL . 24.3 mm 57.09 68.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.552 ' O ' ' O ' ' A' ' 10' ' ' HIS . 1.3 m-20 41.68 -158.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.517 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.554 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.7 OUTLIER 52.4 109.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 0.0 109.381 -179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -81.27 97.11 7.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.702 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 46.34 -148.56 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.494 ' OD1' ' NH1' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -143.33 78.65 14.68 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.866 . . . . 0.0 109.408 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.71 48.38 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.763 2.309 . . . . 0.0 112.359 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.744 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -55.94 -176.84 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.196 -0.94 . . . . 0.0 109.359 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -125.46 -103.83 0.35 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.451 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.745 ' O ' HG13 ' A' ' 17' ' ' VAL . 9.0 p -176.76 95.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.943 . . . . 0.0 109.397 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.531 ' O ' ' O ' ' A' ' 19' ' ' SER . . . 59.03 153.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER 54.2 160.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -1.14 . . . . 0.0 109.569 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp 66.91 6.14 4.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 21' ' ' ASP . 38.8 p30 -131.27 167.72 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.33 11.31 3.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -85.67 -14.56 45.12 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.729 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.51 148.52 33.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.534 ' O ' ' CD1' ' A' ' 121' ' ' TYR . 0.3 OUTLIER -72.31 -16.3 61.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.0 109.491 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.822 ' ND2' HG23 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -65.11 1.0 1.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.822 HG23 ' ND2' ' A' ' 26' ' ' ASN . 79.1 t -135.71 95.53 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.52 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.4 138.15 27.22 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.6 m -105.11 109.89 22.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.424 -1.044 . . . . 0.0 109.328 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.61 91.13 0.76 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.478 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -93.92 140.74 29.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -1.22 . . . . 0.0 109.498 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.478 HG13 ' O ' ' A' ' 31' ' ' MET . 0.0 OUTLIER -158.46 173.79 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.328 -0.857 . . . . 0.0 109.383 179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' CA ' HD21 ' A' ' 109' ' ' LEU . . . 176.7 159.78 22.71 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.82 43.72 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.479 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 38' ' ' GLY . 59.0 Cg_endo -74.82 -56.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.646 2.231 . . . . 0.0 112.381 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 35' ' ' PRO . . . -42.52 -36.07 1.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 109.676 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' C ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -102.4 2.59 36.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 37' ' ' CYS . . . 37.68 52.02 1.92 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' CB ' ' SG ' ' A' ' 63' ' ' CYS . 0.4 OUTLIER -131.11 143.56 50.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.134 . . . . 0.0 109.578 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.73 114.59 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.064 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.1 ttt -108.81 139.02 44.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.895 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -122.66 125.02 44.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.062 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tt -121.04 138.67 54.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.146 -0.971 . . . . 0.0 109.806 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -135.13 136.95 42.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.61 132.17 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 0.0 109.884 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' HG3' HD22 ' A' ' 26' ' ' ASN . 16.6 tttp -106.68 135.18 48.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.867 . . . . 0.0 109.436 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 t -114.98 151.33 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.893 . . . . 0.0 109.527 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -85.46 -106.22 0.05 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.636 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -142.1 15.58 2.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.491 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.38 -4.24 3.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 0.0 109.545 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.74 4.73 51.81 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 mm -94.68 136.47 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -1.135 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.2 115.52 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.72 -39.87 12.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -139.91 -179.25 5.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.952 . . . . 0.0 109.576 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.98 140.88 3.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.81 144.62 44.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -0.852 . . . . 0.0 109.355 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.806 ' CG ' HG21 ' A' ' 74' ' ' THR . 0.4 OUTLIER -142.39 150.33 40.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 109.603 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' CG ' ' C ' ' A' ' 58' ' ' PHE . 0.0 OUTLIER -154.67 95.89 1.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.25 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.78 148.89 47.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.536 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -160.96 154.39 21.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.286 -0.884 . . . . 0.0 109.366 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.4 -53.31 0.7 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.51 ' SG ' ' CB ' ' A' ' 39' ' ' ASP . 9.0 m -76.11 109.46 9.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -1.156 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -68.54 43.83 0.35 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' CYS . 0.3 OUTLIER -163.72 -6.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.456 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' H ' ' H ' ' A' ' 65' ' ' SER . . . -84.57 -38.79 19.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 67' ' ' ILE . 7.2 mm -47.67 -49.36 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.21 -68.34 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.0 109.317 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 m -44.82 -34.33 2.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.455 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.1 t -64.75 -74.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.963 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.525 ' C ' ' O ' ' A' ' 70' ' ' SER . 66.5 m -36.27 -28.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.553 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 70' ' ' SER . 22.2 tp -76.03 -85.37 0.05 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.631 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 77' ' ' VAL . 1.1 tt -36.99 -33.02 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.334 -0.854 . . . . 0.0 109.732 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.806 HG21 ' CG ' ' A' ' 58' ' ' PHE . 9.7 p -66.99 -46.65 73.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.278 -0.889 . . . . 0.0 109.684 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' OE2' ' O ' ' A' ' 71' ' ' SER . 2.2 mt-10 -78.23 -7.84 57.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -88.31 -30.02 19.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 73' ' ' ILE . 4.8 m -91.67 11.54 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -87.08 89.83 8.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.587 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.38 -14.64 15.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.54 -168.26 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -1.13 . . . . 0.0 109.565 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -119.99 -179.2 3.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.5 mt -73.37 -34.07 65.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -68.89 -11.01 60.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.607 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -100.85 -49.58 4.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.569 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.8 -26.17 62.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.537 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.3 46.37 1.84 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' ILE . . . -164.05 -38.11 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.283 -1.127 . . . . 0.0 109.169 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 87' ' ' ALA . 5.2 pt -44.9 166.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.408 -0.808 . . . . 0.0 109.466 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -132.7 -179.12 5.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -89.75 -19.34 24.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.365 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -62.73 -42.13 99.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.434 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.06 -60.6 3.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.176 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.5 mt -51.53 -42.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.895 . . . . 0.0 109.186 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -59.55 -35.14 73.64 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.195 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -70.61 -38.71 73.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.88 . . . . 0.0 109.104 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -57.3 -47.74 80.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.363 -0.835 . . . . 0.0 109.369 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.79 -16.63 21.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.294 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.619 ' N ' ' O ' ' A' ' 94' ' ' ALA . 25.8 tt0 45.03 72.93 0.18 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.623 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.39 150.26 36.79 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -39.09 141.36 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.961 2.44 . . . . 0.0 112.31 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 103' ' ' LYS . 66.5 Cg_endo -76.89 -15.02 16.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.759 2.306 . . . . 0.0 112.515 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.5 m -75.73 25.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.459 ' HZ3' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -170.69 34.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.438 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 105' ' ' HIS . 38.6 t -57.46 -27.48 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.333 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.676 ' CG ' ' N ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER -34.86 -62.14 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.308 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.676 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 38.6 m -37.61 -51.46 1.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 109.604 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -55.28 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.472 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.4 mt -46.65 -40.94 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.863 . . . . 0.0 109.35 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.534 HD13 ' ND1' ' A' ' 105' ' ' HIS . 0.5 OUTLIER -62.72 -37.83 88.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.279 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.31 -58.53 8.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.378 -0.826 . . . . 0.0 109.506 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 112' ' ' ASP . 3.9 tm-20 -58.76 -43.43 90.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 109.596 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.503 ' N ' ' OE1' ' A' ' 111' ' ' GLU . 0.8 OUTLIER -60.93 -29.79 69.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.55 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.88 -57.22 7.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.398 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -51.24 -35.05 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.506 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -74.28 -48.06 30.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.601 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 119' ' ' ALA . . . -55.8 -50.71 69.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.512 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.5 -53.73 50.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.2 mt -58.34 -20.88 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 116' ' ' ALA . . . -77.48 -47.37 19.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.193 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.99 -10.52 59.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.353 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.549 ' CE1' ' NZ ' ' A' ' 124' ' ' LYS . 1.9 t80 -91.31 -49.8 6.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.303 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -66.61 -23.62 66.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.15 -0.969 . . . . 0.0 109.203 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 125' ' ' GLN . . . -68.72 -1.75 7.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.549 ' NZ ' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -35.75 -30.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.497 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.589 ' N ' ' O ' ' A' ' 123' ' ' ALA . 20.2 tt0 -97.92 -53.37 3.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 130.05 34.51 0.47 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.9 mt -71.46 -9.23 57.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 109.399 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 54.42 -169.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 0.0 109.563 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -159.17 140.8 13.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.504 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 25.6 t60 -132.24 -127.21 0.18 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -0.881 . . . . 0.0 109.371 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.504 ' H ' ' CG ' ' A' ' 130' ' ' HIS . 33.4 t-80 -123.48 -49.32 1.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 109.409 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.497 ' O ' ' CD2' ' A' ' 132' ' ' HIS . 24.1 p-80 -106.36 74.33 1.02 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.48 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 133' ' ' HIS . 0.7 OUTLIER -111.08 43.29 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.449 -179.851 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.758 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 79.78 170.94 0.16 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.899 . . . . 0.0 109.355 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.4 t80 54.88 85.48 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.9 . . . . 0.0 109.413 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -168.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.529 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -96.78 -69.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -89.66 -179.41 5.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 8' ' ' ILE . 35.2 t -95.66 160.15 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.832 HG23 ' O ' ' A' ' 8' ' ' ILE . 0.9 OUTLIER -148.02 83.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.655 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -71.41 127.47 32.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.856 . . . . 0.0 109.765 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.559 ' H ' ' CD2' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -116.84 162.6 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.297 179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -113.5 142.11 46.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.156 -0.965 . . . . 0.0 109.732 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -175.63 139.42 0.42 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.224 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.59 160.5 0.1 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.314 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.96 -171.73 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.808 2.338 . . . . 0.0 112.283 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -148.23 121.89 9.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.331 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.713 ' ND2' ' NZ ' ' A' ' 46' ' ' LYS . 15.8 m-20 -106.99 163.29 13.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.142 -0.974 . . . . 0.0 109.602 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 19' ' ' SER . 16.9 t -105.62 114.46 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 17' ' ' VAL . . . 45.52 -95.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -150.03 -179.68 7.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -1.161 . . . . 0.0 109.512 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.521 ' N ' ' OG ' ' A' ' 19' ' ' SER . 4.4 mm? -93.2 -165.58 1.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.451 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -53.92 122.93 11.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.5 -39.05 4.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.724 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -86.03 51.83 2.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.148 -0.97 . . . . 0.0 109.632 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.65 143.53 32.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.337 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -81.11 -3.4 51.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.89 . . . . 0.0 109.529 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.39 7.2 26.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.618 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.35 114.74 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.956 . . . . 0.0 109.712 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.8 138.87 14.97 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -125.25 114.38 18.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.561 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.6 146.12 16.03 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.83 124.8 27.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.16 -1.2 . . . . 0.0 109.665 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.56 151.08 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.364 -0.835 . . . . 0.0 109.148 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.05 10.28 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.554 ' HB3' ' N ' ' A' ' 39' ' ' ASP . . . -146.56 92.65 5.08 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.29 70.87 7.32 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.755 2.303 . . . . 0.0 112.171 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -176.53 -38.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.365 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 105' ' ' HIS . 6.6 t -165.48 -38.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.772 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -62.53 -49.23 75.55 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.652 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 1.5 t70 84.81 -174.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.704 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 m -90.65 99.17 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.331 -0.855 . . . . 0.0 109.25 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.8 ttp -95.73 139.82 31.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.762 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.65 107.34 13.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.116 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.13 127.49 52.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.116 -0.99 . . . . 0.0 109.837 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -130.34 120.55 24.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 108.974 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.78 152.21 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.227 -0.921 . . . . 0.0 109.827 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.713 ' NZ ' ' ND2' ' A' ' 16' ' ' ASN . 24.1 tttt -114.84 154.75 28.05 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.337 -0.852 . . . . 0.0 109.284 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.406 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 64.5 t -133.25 121.71 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.987 . . . . 0.0 109.589 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' OD1' ' OE1' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -47.63 -53.67 14.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' A' ' 48' ' ' ASP . 1.0 OUTLIER 162.01 -23.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.325 -0.859 . . . . 0.0 109.252 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.743 ' H ' ' ND2' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -89.8 -0.74 57.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.44 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.85 8.67 41.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -100.31 138.63 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.161 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 53.8 mt -96.83 124.31 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.301 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.551 ' OE1' ' OD1' ' A' ' 48' ' ' ASP . 19.1 pt-20 -107.65 -30.08 8.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.981 . . . . 0.0 109.56 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -124.87 150.36 46.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.099 -1.001 . . . . 0.0 109.515 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.08 155.16 42.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.342 -0.849 . . . . 0.0 109.588 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HG3' ' N ' ' A' ' 58' ' ' PHE . 1.2 tttm -150.49 143.31 24.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.367 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.691 ' CD1' HG21 ' A' ' 74' ' ' THR . 4.5 p90 -138.86 -179.38 5.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -171.32 104.35 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.284 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.9 t -136.85 144.63 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.589 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.535 ' O ' ' OD2' ' A' ' 39' ' ' ASP . 53.3 t80 -155.0 98.57 2.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -0.963 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.06 0.7 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 66' ' ' ALA . 0.1 OUTLIER -100.71 123.93 45.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -1.181 . . . . 0.0 109.337 179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 65' ' ' SER . . . -91.94 123.03 7.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.9 OUTLIER 72.61 -8.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.18 . . . . 0.0 109.536 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HB3' ' SG ' ' A' ' 63' ' ' CYS . . . -96.44 7.69 45.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.0 109.391 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mt -72.99 -38.64 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.679 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.88 -41.95 75.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p -56.8 -38.82 73.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.342 -0.849 . . . . 0.0 109.563 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.48 ' OG ' ' CE2' ' A' ' 58' ' ' PHE . 17.5 t -53.47 -46.06 69.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.149 -0.969 . . . . 0.0 109.552 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -35.11 79.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.432 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.1 tp -61.32 -56.27 22.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.0 109.681 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.949 ' O ' HG22 ' A' ' 77' ' ' VAL . 3.8 tt -58.52 -48.58 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.76 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.691 HG21 ' CD1' ' A' ' 58' ' ' PHE . 23.3 p -60.72 -17.89 51.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 0.0 109.482 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -91.06 -41.75 10.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.4 m0 -74.22 -7.7 53.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.299 -0.876 . . . . 0.0 109.428 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 73' ' ' ILE . 35.0 m -115.29 36.77 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.343 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -133.95 78.18 1.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.247 -0.908 . . . . 0.0 109.634 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.6 0.4 9.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -97.01 -165.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.115 -1.227 . . . . 0.0 109.472 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.09 164.65 15.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 82' ' ' LEU . 34.3 mt -58.83 -24.8 62.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.611 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -74.67 -26.29 59.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.646 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.76 -50.21 8.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -0.951 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.67 63.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.269 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -87.02 45.61 3.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -152.45 -38.29 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.309 -1.112 . . . . 0.0 108.688 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 87' ' ' ALA . 4.0 pt -39.35 123.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.534 -0.729 . . . . 0.0 109.119 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -99.17 162.6 12.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.558 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.612 ' OD1' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -57.76 -20.1 32.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.194 -0.941 . . . . 0.0 108.978 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.455 ' HA ' ' HB3' ' A' ' 94' ' ' ALA . 1.4 p -77.57 -33.57 53.96 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -49.78 -43.68 48.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 mm -81.61 -33.33 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -0.912 . . . . 0.0 109.177 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -66.21 -12.5 56.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 109.501 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 -37.44 7.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.91 . . . . 0.0 109.405 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -53.22 43.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.13 -23.98 19.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 51.29 68.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.728 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.1 OUTLIER -96.84 146.45 31.33 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.149 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -39.59 147.24 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.721 2.281 . . . . 0.0 112.247 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -72.95 9.55 1.33 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.748 2.299 . . . . 0.0 112.168 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.9 t -92.09 -33.08 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -105.93 30.02 6.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.377 -0.827 . . . . 0.0 109.448 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 103' ' ' LYS . 20.3 t -42.55 -25.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.772 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 4.4 p-80 -52.0 -39.6 59.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.54 ' N ' ' CG ' ' A' ' 105' ' ' HIS . 33.9 m -47.93 -60.39 2.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -0.999 . . . . 0.0 109.308 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 109' ' ' LEU . 57.9 m -59.31 -58.81 7.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.689 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.456 ' O ' ' CB ' ' A' ' 112' ' ' ASP . 63.7 mt -46.26 -22.1 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 107' ' ' SER . 0.8 OUTLIER -74.43 -57.53 3.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.5 59.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 109.788 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' A' ' 112' ' ' ASP . 3.3 tm-20 -64.21 -62.24 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.152 -0.968 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.58 ' N ' ' CD ' ' A' ' 111' ' ' GLU . 10.0 t0 -43.13 -43.33 4.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 0.0 109.52 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.29 -54.48 39.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.264 -0.897 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 115' ' ' LYS . 1.4 tp -47.27 -42.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' CD ' ' OE2' ' A' ' 111' ' ' GLU . 5.6 mttp -68.36 -34.85 76.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -0.952 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.21 -58.55 6.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.496 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -49.68 -42.36 45.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.257 -0.902 . . . . 0.0 109.618 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.409 HG22 ' HD3' ' A' ' 122' ' ' LYS . 65.0 mt -63.76 -48.35 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.407 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.92 -37.75 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.882 . . . . 0.0 109.363 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.6 -38.41 67.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.78 -32.61 74.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.38 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.409 ' HD3' HG22 ' A' ' 118' ' ' ILE . 7.1 mtpt -78.14 -39.77 40.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.322 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' A' ' 125' ' ' GLN . . . -52.63 -54.94 26.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.304 -0.873 . . . . 0.0 109.533 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -66.22 0.07 2.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 0.0 109.271 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' H ' ' C ' ' A' ' 123' ' ' ALA . 2.0 tt0 -151.78 63.33 0.86 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.632 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 127' ' ' LEU . . . -173.93 -44.61 0.05 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 126' ' ' GLY . 6.3 tp -41.71 -47.83 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.264 -1.139 . . . . 0.0 109.683 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 129' ' ' HIS . 1.4 tt0 -69.69 166.14 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.46 ' ND1' ' N ' ' A' ' 129' ' ' HIS . 1.7 m80 -92.32 -146.75 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.91 . . . . 0.0 109.407 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -101.84 -166.78 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -135.28 115.73 13.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.532 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 133' ' ' HIS . 43.4 m-70 -132.29 85.16 2.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 132' ' ' HIS . 14.0 p80 -45.86 126.22 6.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.946 . . . . 0.0 109.395 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.5 m80 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.446 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mmm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.78 129.5 34.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.656 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -107.4 93.05 4.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.932 . . . . 0.0 109.362 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.82 120.34 40.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.558 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.81 117.3 1.8 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.363 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -79.95 90.89 5.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.658 ' O ' HG22 ' A' ' 7' ' ' VAL . 12.3 p -142.87 39.42 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.863 . . . . 0.0 109.234 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.41 -104.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.337 -0.852 . . . . 0.0 109.481 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.549 ' O ' ' ND1' ' A' ' 10' ' ' HIS . 19.3 t0 65.13 -153.96 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.549 ' ND1' ' O ' ' A' ' 9' ' ' ASP . 4.6 m-70 -142.16 -16.89 0.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' O ' ' O ' ' A' ' 10' ' ' HIS . 0.2 OUTLIER 56.89 113.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.947 . . . . 0.0 109.429 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -90.59 120.95 32.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.45 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.531 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -176.31 52.96 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.393 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 13' ' ' ASN . 34.4 Cg_endo -67.75 16.62 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.764 2.31 . . . . 0.0 112.091 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.732 HH11 ' CG ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -54.51 129.83 37.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.925 . . . . 0.0 109.518 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.596 ' C ' ' H ' ' A' ' 18' ' ' GLY . 6.7 p-10 -146.8 -6.27 0.52 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.56 ' O ' ' O ' ' A' ' 18' ' ' GLY . 2.6 m -51.58 -3.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.579 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 16' ' ' ASN . . . -57.35 -128.77 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' ' O ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -161.9 -66.28 0.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.308 -1.113 . . . . 0.0 109.452 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.562 ' O ' ' O ' ' A' ' 19' ' ' SER . 13.5 tp 50.98 108.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.343 -0.848 . . . . 0.0 109.567 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 23' ' ' LYS . 34.9 t70 -163.79 -3.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.391 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 64.66 -8.66 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.403 -0.811 . . . . 0.0 109.589 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -102.2 19.72 18.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 0.0 109.582 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -115.16 160.63 19.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -3.38 56.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.673 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -105.51 -5.89 19.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.6 t -117.33 116.27 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.441 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.05 144.27 17.24 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.2 m -126.7 121.93 33.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -125.06 123.77 5.12 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.477 ' C ' ' SD ' ' A' ' 31' ' ' MET . 2.4 ppp? -131.89 153.11 50.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.677 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -145.26 169.06 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.344 -0.847 . . . . 0.0 109.251 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -118.1 147.84 18.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 36' ' ' ALA . . . -145.73 73.13 13.85 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -1.123 . . . . 0.0 109.34 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -58.5 71.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.85 2.366 . . . . 0.0 112.097 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ALA . . . -177.95 -89.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.836 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.572 ' O ' ' SG ' ' A' ' 63' ' ' CYS . 1.5 t -118.48 -7.98 10.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.665 ' N ' ' NE2' ' A' ' 105' ' ' HIS . . . -98.71 -23.87 11.52 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.441 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 58.45 -163.26 0.21 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 109.715 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 40' ' ' VAL . 2.0 p -87.24 110.35 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 108.842 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.401 ' CE ' HD13 ' A' ' 43' ' ' LEU . 8.1 ttt -100.55 129.81 46.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.966 . . . . 0.0 110.163 -179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.608 ' NE2' ' NE2' ' A' ' 44' ' ' GLN . 30.5 tt0 -120.88 108.08 13.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 0.0 108.852 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.401 HD13 ' CE ' ' A' ' 41' ' ' MET . 4.5 tp -108.19 115.06 29.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.722 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.608 ' NE2' ' NE2' ' A' ' 42' ' ' GLN . 12.3 mt-30 -110.38 118.88 37.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB1' ' A' ' 117' ' ' ALA . 2.2 pt -106.25 146.61 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.379 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -115.18 136.58 52.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.214 -0.929 . . . . 0.0 109.676 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.66 145.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.873 . . . . 0.0 109.114 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -78.75 -104.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.536 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.502 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.5 t70 -141.8 9.15 1.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -139.32 12.52 2.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.301 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.04 14.61 57.46 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -99.87 114.35 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -1.153 . . . . 0.0 109.493 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.2 mt -57.5 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 109.415 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.41 -50.29 27.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 49.8 t0 -127.19 170.14 12.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' N ' ' OD1' ' A' ' 55' ' ' ASP . . . -162.95 115.81 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -98.92 131.69 44.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CD2' ' OG ' ' A' ' 70' ' ' SER . 8.4 p90 -109.72 172.05 7.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.914 . . . . 0.0 109.647 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -171.81 112.2 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.183 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 t -156.01 146.99 22.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 0.0 109.878 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' O ' ' CD2' ' A' ' 61' ' ' TYR . 4.3 t80 -156.9 106.88 2.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.339 -0.851 . . . . 0.0 109.36 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 164.23 -25.73 0.19 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.572 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 64.4 m -83.64 131.67 34.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -1.068 . . . . 0.0 109.495 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.82 9.49 60.18 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -152.77 -13.61 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB3' ' CB ' ' A' ' 63' ' ' CYS . . . -93.14 -12.69 29.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.419 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 66' ' ' ALA . 20.1 mt -42.15 -45.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.61 -45.15 89.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.522 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -46.41 -53.41 11.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.436 ' OG ' ' CD2' ' A' ' 58' ' ' PHE . 6.9 t -45.17 -48.45 12.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.514 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 m -61.04 -36.42 79.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' ' C ' ' A' ' 73' ' ' ILE . 2.1 tp -64.67 -76.84 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.832 ' O ' HG22 ' A' ' 77' ' ' VAL . 5.8 tt -35.51 -52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 109.728 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.605 ' H ' HG23 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -49.54 -52.54 29.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.25 -0.906 . . . . 0.0 109.95 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -76.41 -2.11 30.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.956 . . . . 0.0 109.891 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -105.11 -4.5 21.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.103 -0.998 . . . . 0.0 109.466 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.832 HG22 ' O ' ' A' ' 73' ' ' ILE . 11.7 m -124.29 5.59 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.504 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -92.76 98.38 11.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 109.404 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 108.75 11.23 23.37 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -110.74 174.29 5.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.3 m -96.71 157.46 15.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -0.926 . . . . 0.0 109.487 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt -61.34 -20.72 63.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.65 -34.89 74.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.57 -32.55 36.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.598 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.513 ' HB1' HG12 ' A' ' 114' ' ' ILE . . . -73.96 -21.51 59.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.636 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.17 30.08 10.57 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.545 ' O ' ' C ' ' A' ' 88' ' ' ILE . . . -147.23 -37.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.151 -1.205 . . . . 0.0 109.507 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.545 ' C ' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -34.66 -34.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 109.527 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER 70.39 167.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.369 -0.832 . . . . 0.0 109.516 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.765 ' ND2' ' N ' ' A' ' 91' ' ' SER . 0.8 OUTLIER -89.74 -54.83 3.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.765 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -37.84 -33.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.482 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -60.28 -53.08 61.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 109.394 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.56 -35.81 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 98' ' ' GLU . . . -58.51 -39.98 81.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -74.84 -34.12 62.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -54.2 -45.92 72.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 0.0 109.336 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.19 -6.52 19.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.331 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 94' ' ' ALA . 16.8 mt-10 53.93 88.5 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.36 -0.838 . . . . 0.0 109.699 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -108.03 165.75 12.17 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.53 142.37 40.26 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.601 2.201 . . . . 0.0 112.053 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.92 5.75 4.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.705 2.27 . . . . 0.0 112.209 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.15 -25.7 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.664 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.643 ' O ' ' N ' ' A' ' 105' ' ' HIS . 4.2 mtpt -118.22 28.15 8.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.261 -0.9 . . . . 0.0 109.526 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 103' ' ' LYS . 21.3 t -38.16 -22.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.665 ' NE2' ' N ' ' A' ' 38' ' ' GLY . 3.2 p-80 -44.47 -31.39 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.527 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.8 m -60.31 -72.92 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 0.0 109.504 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 108' ' ' ILE . 10.2 p -47.15 -56.87 5.83 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.181 -0.949 . . . . 0.0 109.095 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.454 ' N ' ' OG ' ' A' ' 107' ' ' SER . 6.0 mt -45.67 -36.62 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.151 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.91 -49.13 78.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 109.244 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.14 -61.96 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.371 -0.831 . . . . 0.0 109.588 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' A' ' 112' ' ' ASP . 30.2 tt0 -54.99 -73.12 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.57 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.531 ' C ' ' O ' ' A' ' 111' ' ' GLU . 23.0 t0 -34.1 -55.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.423 -0.798 . . . . 0.0 109.656 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.449 ' C ' ' O ' ' A' ' 112' ' ' ASP . . . -40.96 -70.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 0.0 109.418 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.513 HG12 ' HB1' ' A' ' 85' ' ' ALA . 1.1 tp -43.49 -31.54 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.083 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' N ' ' O ' ' A' ' 112' ' ' ASP . 4.1 tptt -64.42 -60.17 3.47 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.99 -31.9 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.411 ' HB1' HG12 ' A' ' 45' ' ' ILE . . . -67.05 -45.97 75.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.972 . . . . 0.0 109.409 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.18 -45.36 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.264 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.92 64.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 109.108 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.15 -26.19 37.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.384 -0.822 . . . . 0.0 109.271 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 15.8 t80 -76.41 -54.49 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.323 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -71.42 0.41 8.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.419 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -86.01 -31.1 22.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -96.62 35.75 1.47 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 109.459 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -121.94 -31.46 3.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -47.65 -84.93 0.02 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HA ' HD23 ' A' ' 127' ' ' LEU . 25.0 mt -135.8 14.26 3.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -1.196 . . . . 0.0 109.462 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 53.53 11.85 0.32 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.24 -0.912 . . . . 0.0 109.35 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' N ' ' C ' ' A' ' 127' ' ' LEU . 31.5 m80 -148.05 158.72 44.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.87 -23.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 109.095 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.617 ' C ' ' H ' ' A' ' 133' ' ' HIS . 56.0 m80 -65.88 95.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.23 8.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.34 -0.85 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.617 ' H ' ' C ' ' A' ' 131' ' ' HIS . 25.7 t-80 -114.15 -8.76 12.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.7 t60 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.495 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_